Cell type,SNP-eGene,ONTOLOGY,GO ID,Description,pvalue,p.adjust,GeneRatio,BgRatio
CD4T,rs111454690_HLA-DRB5,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,5.66e-18,2.79e-15,11/19,94/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0006613,cotranslational protein targeting to membrane,9.16e-18,2.79e-15,11/19,98/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0045047,protein targeting to ER,2.51e-17,5.10e-15,11/19,107/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,3.45e-17,5.25e-15,11/19,110/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",6.99e-17,8.49e-15,11/19,117/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0006413,translational initiation,1.06e-16,1.08e-14,12/19,179/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0070972,protein localization to endoplasmic reticulum,2.31e-16,2.01e-14,11/19,130/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0006612,protein targeting to membrane,3.90e-15,2.96e-13,11/19,167/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0019083,viral transcription,5.42e-15,3.66e-13,11/19,172/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0019080,viral gene expression,1.46e-14,8.59e-13,11/19,188/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,1.55e-14,8.59e-13,11/19,189/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0090150,establishment of protein localization to membrane,8.04e-13,4.07e-11,11/19,270/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0006402,mRNA catabolic process,5.34e-12,2.50e-10,11/19,321/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0006401,RNA catabolic process,1.41e-11,6.14e-10,11/19,351/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0006605,protein targeting,1.81e-11,7.32e-10,11/19,359/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0034655,nucleobase-containing compound catabolic process,1.84e-10,6.73e-09,11/19,445/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0072657,protein localization to membrane,1.88e-10,6.73e-09,11/19,446/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0046700,heterocycle catabolic process,2.39e-10,8.07e-09,11/19,456/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0044270,cellular nitrogen compound catabolic process,2.56e-10,8.20e-09,11/19,459/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0019439,aromatic compound catabolic process,2.88e-10,8.34e-09,11/19,464/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0072594,establishment of protein localization to organelle,2.88e-10,8.34e-09,11/19,464/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:1901361,organic cyclic compound catabolic process,3.30e-10,9.13e-09,11/19,470/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0002181,cytoplasmic translation,9.95e-07,2.63e-05,5/19,92/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0006417,regulation of translation,3.12e-04,7.90e-03,5/19,302/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0010608,posttranscriptional regulation of gene expression,3.84e-04,9.33e-03,6/19,497/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0031640,killing of cells of other organism,5.54e-04,1.25e-02,2/19,17/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,5.54e-04,1.25e-02,2/19,17/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0034248,regulation of cellular amide metabolic process,5.99e-04,1.30e-02,5/19,348/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0000028,ribosomal small subunit assembly,6.22e-04,1.30e-02,2/19,18/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0071346,cellular response to interferon-gamma,1.70e-03,3.44e-02,3/19,116/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0019730,antimicrobial humoral response,1.86e-03,3.65e-02,2/19,31/9080
CD4T,rs111454690_HLA-DRB5,BP,GO:0034341,response to interferon-gamma,2.30e-03,4.37e-02,3/19,129/9080
CD4T,rs111454690_HLA-DRB5,CC,GO:0022626,cytosolic ribosome,9.05e-18,8.69e-16,11/19,101/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0044391,ribosomal subunit,4.60e-15,2.21e-13,11/19,175/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0005840,ribosome,3.33e-14,1.07e-12,11/19,209/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0022625,cytosolic large ribosomal subunit,6.99e-10,1.68e-08,6/19,54/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0022627,cytosolic small ribosomal subunit,1.99e-08,3.81e-07,5/19,44/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0015934,large ribosomal subunit,4.86e-08,6.47e-07,6/19,108/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0005925,focal adhesion,4.99e-08,6.47e-07,8/19,296/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0030055,cell-substrate junction,5.39e-08,6.47e-07,8/19,299/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0070161,anchoring junction,1.01e-07,1.07e-06,9/19,466/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0015935,small ribosomal subunit,2.14e-07,2.06e-06,5/19,70/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0042788,polysomal ribosome,3.65e-07,3.19e-06,4/19,31/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0005844,polysome,6.22e-06,4.98e-05,4/19,62/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0042613,MHC class II protein complex,2.53e-04,1.87e-03,2/19,12/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0098794,postsynapse,2.72e-04,1.87e-03,5/19,303/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0014069,postsynaptic density,3.88e-04,2.38e-03,4/19,178/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0032279,asymmetric synapse,3.97e-04,2.38e-03,4/19,179/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0098984,neuron to neuron synapse,4.50e-04,2.45e-03,4/19,185/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0099572,postsynaptic specialization,4.59e-04,2.45e-03,4/19,186/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0042611,MHC protein complex,6.51e-04,3.29e-03,2/19,19/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0030666,endocytic vesicle membrane,7.89e-04,3.66e-03,3/19,92/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0030669,clathrin-coated endocytic vesicle membrane,8.76e-04,3.66e-03,2/19,22/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0071556,integral component of lumenal side of endoplasmic reticulum membrane,8.76e-04,3.66e-03,2/19,22/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0098553,lumenal side of endoplasmic reticulum membrane,8.76e-04,3.66e-03,2/19,22/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0098576,lumenal side of membrane,1.32e-03,5.29e-03,2/19,27/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0045334,clathrin-coated endocytic vesicle,1.74e-03,6.70e-03,2/19,31/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0012507,ER to Golgi transport vesicle membrane,4.49e-03,1.66e-02,2/19,50/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0030139,endocytic vesicle,6.33e-03,2.25e-02,3/19,191/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0032588,trans-Golgi network membrane,7.49e-03,2.57e-02,2/19,65/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0030665,clathrin-coated vesicle membrane,8.41e-03,2.78e-02,2/19,69/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0030134,COPII-coated ER to Golgi transport vesicle,9.62e-03,3.08e-02,2/19,74/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0030660,Golgi-associated vesicle membrane,1.23e-02,3.80e-02,2/19,84/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0042587,glycogen granule,1.41e-02,4.10e-02,1/19,7/9383
CD4T,rs111454690_HLA-DRB5,CC,GO:0072357,PTW/PP1 phosphatase complex,1.41e-02,4.10e-02,1/19,7/9383
CD4T,rs111454690_HLA-DRB5,MF,GO:0003735,structural constituent of ribosome,8.66e-16,7.10e-14,11/19,150/9332
CD4T,rs111454690_HLA-DRB5,MF,GO:0005198,structural molecule activity,4.56e-12,1.87e-10,11/19,325/9332
CD4T,rs111454690_HLA-DRB5,MF,GO:0019843,rRNA binding,1.66e-04,3.59e-03,3/19,54/9332
CD4T,rs111454690_HLA-DRB5,MF,GO:0070181,small ribosomal subunit rRNA binding,1.75e-04,3.59e-03,2/19,10/9332
CD4T,rs111454690_HLA-DRB5,MF,GO:0042605,peptide antigen binding,4.63e-04,7.60e-03,2/19,16/9332
CD4T,rs111454690_HLA-DRB5,MF,GO:0048027,mRNA 5'-UTR binding,8.85e-04,1.21e-02,2/19,22/9332
CD4T,rs111454690_HLA-DRB5,MF,GO:0003823,antigen binding,1.76e-03,2.07e-02,2/19,31/9332
CD4T,rs1131017_RPS26,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,1.66e-97,6.93e-94,77/330,94/9080
CD4T,rs1131017_RPS26,BP,GO:0006613,cotranslational protein targeting to membrane,6.98e-97,1.46e-93,78/330,98/9080
CD4T,rs1131017_RPS26,BP,GO:0045047,protein targeting to ER,1.74e-89,2.42e-86,77/330,107/9080
CD4T,rs1131017_RPS26,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,6.33e-88,6.60e-85,77/330,110/9080
CD4T,rs1131017_RPS26,BP,GO:0006413,translational initiation,1.90e-87,1.59e-84,92/330,179/9080
CD4T,rs1131017_RPS26,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",2.06e-86,1.43e-83,78/330,117/9080
CD4T,rs1131017_RPS26,BP,GO:0070972,protein localization to endoplasmic reticulum,5.87e-81,3.50e-78,78/330,130/9080
CD4T,rs1131017_RPS26,BP,GO:0006612,protein targeting to membrane,2.45e-72,1.28e-69,80/330,167/9080
CD4T,rs1131017_RPS26,BP,GO:0019080,viral gene expression,2.05e-71,9.50e-69,83/330,188/9080
CD4T,rs1131017_RPS26,BP,GO:0019083,viral transcription,5.12e-71,2.13e-68,80/330,172/9080
CD4T,rs1131017_RPS26,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,9.61e-70,3.65e-67,82/330,189/9080
CD4T,rs1131017_RPS26,BP,GO:0090150,establishment of protein localization to membrane,9.55e-60,3.32e-57,86/330,270/9080
CD4T,rs1131017_RPS26,BP,GO:0006402,mRNA catabolic process,2.23e-58,7.15e-56,91/330,321/9080
CD4T,rs1131017_RPS26,BP,GO:0006401,RNA catabolic process,7.85e-57,2.34e-54,93/330,351/9080
CD4T,rs1131017_RPS26,BP,GO:0034655,nucleobase-containing compound catabolic process,5.51e-51,1.53e-48,97/330,445/9080
CD4T,rs1131017_RPS26,BP,GO:0046700,heterocycle catabolic process,5.88e-50,1.53e-47,97/330,456/9080
CD4T,rs1131017_RPS26,BP,GO:0072657,protein localization to membrane,6.84e-50,1.68e-47,96/330,446/9080
CD4T,rs1131017_RPS26,BP,GO:0044270,cellular nitrogen compound catabolic process,1.11e-49,2.57e-47,97/330,459/9080
CD4T,rs1131017_RPS26,BP,GO:0006605,protein targeting,1.99e-49,4.37e-47,87/330,359/9080
CD4T,rs1131017_RPS26,BP,GO:0019439,aromatic compound catabolic process,3.14e-49,6.55e-47,97/330,464/9080
CD4T,rs1131017_RPS26,BP,GO:1901361,organic cyclic compound catabolic process,1.08e-48,2.14e-46,97/330,470/9080
CD4T,rs1131017_RPS26,BP,GO:0072594,establishment of protein localization to organelle,1.47e-42,2.80e-40,90/330,464/9080
CD4T,rs1131017_RPS26,BP,GO:0002181,cytoplasmic translation,1.48e-36,2.69e-34,42/330,92/9080
CD4T,rs1131017_RPS26,BP,GO:0022613,ribonucleoprotein complex biogenesis,8.77e-20,1.52e-17,57/330,397/9080
CD4T,rs1131017_RPS26,BP,GO:0042255,ribosome assembly,4.67e-18,7.80e-16,22/330,55/9080
CD4T,rs1131017_RPS26,BP,GO:0042254,ribosome biogenesis,1.41e-15,2.26e-13,42/330,277/9080
CD4T,rs1131017_RPS26,BP,GO:0022618,ribonucleoprotein complex assembly,1.46e-15,2.26e-13,33/330,171/9080
CD4T,rs1131017_RPS26,BP,GO:0071826,ribonucleoprotein complex subunit organization,5.02e-15,7.48e-13,33/330,178/9080
CD4T,rs1131017_RPS26,BP,GO:0042273,ribosomal large subunit biogenesis,1.12e-13,1.61e-11,20/330,67/9080
CD4T,rs1131017_RPS26,BP,GO:0046649,lymphocyte activation,1.14e-10,1.59e-08,48/330,482/9080
CD4T,rs1131017_RPS26,BP,GO:0042110,T cell activation,1.34e-10,1.80e-08,39/330,341/9080
CD4T,rs1131017_RPS26,BP,GO:0098609,cell-cell adhesion,3.43e-10,4.47e-08,43/330,415/9080
CD4T,rs1131017_RPS26,BP,GO:0007159,leukocyte cell-cell adhesion,1.01e-09,1.28e-07,31/330,245/9080
CD4T,rs1131017_RPS26,BP,GO:0006364,rRNA processing,1.06e-09,1.30e-07,28/330,204/9080
CD4T,rs1131017_RPS26,BP,GO:0042274,ribosomal small subunit biogenesis,2.14e-09,2.56e-07,16/330,69/9080
CD4T,rs1131017_RPS26,BP,GO:0016072,rRNA metabolic process,2.57e-09,2.98e-07,28/330,212/9080
CD4T,rs1131017_RPS26,BP,GO:0000028,ribosomal small subunit assembly,3.62e-09,4.06e-07,9/330,18/9080
CD4T,rs1131017_RPS26,BP,GO:0051249,regulation of lymphocyte activation,3.69e-09,4.06e-07,34/330,303/9080
CD4T,rs1131017_RPS26,BP,GO:0050863,regulation of T cell activation,4.34e-09,4.65e-07,29/330,231/9080
CD4T,rs1131017_RPS26,BP,GO:0000027,ribosomal large subunit assembly,7.06e-09,7.37e-07,10/330,25/9080
CD4T,rs1131017_RPS26,BP,GO:1903037,regulation of leukocyte cell-cell adhesion,7.33e-09,7.46e-07,28/330,222/9080
CD4T,rs1131017_RPS26,BP,GO:0002694,regulation of leukocyte activation,8.87e-09,8.81e-07,36/330,345/9080
CD4T,rs1131017_RPS26,BP,GO:0042098,T cell proliferation,9.83e-09,9.54e-07,21/330,132/9080
CD4T,rs1131017_RPS26,BP,GO:0050865,regulation of cell activation,1.10e-08,1.05e-06,37/330,364/9080
CD4T,rs1131017_RPS26,BP,GO:0002507,tolerance induction,1.17e-08,1.09e-06,9/330,20/9080
CD4T,rs1131017_RPS26,BP,GO:0030155,regulation of cell adhesion,2.25e-08,2.03e-06,40/330,424/9080
CD4T,rs1131017_RPS26,BP,GO:0070661,leukocyte proliferation,2.28e-08,2.03e-06,25/330,191/9080
CD4T,rs1131017_RPS26,BP,GO:0046651,lymphocyte proliferation,2.75e-08,2.39e-06,24/330,179/9080
CD4T,rs1131017_RPS26,BP,GO:0071346,cellular response to interferon-gamma,3.11e-08,2.64e-06,19/330,116/9080
CD4T,rs1131017_RPS26,BP,GO:0032943,mononuclear cell proliferation,3.42e-08,2.80e-06,24/330,181/9080
CD4T,rs1131017_RPS26,BP,GO:0045785,positive regulation of cell adhesion,3.42e-08,2.80e-06,30/330,268/9080
CD4T,rs1131017_RPS26,BP,GO:0042129,regulation of T cell proliferation,4.05e-08,3.20e-06,18/330,106/9080
CD4T,rs1131017_RPS26,BP,GO:0002250,adaptive immune response,4.06e-08,3.20e-06,30/330,270/9080
CD4T,rs1131017_RPS26,BP,GO:0022407,regulation of cell-cell adhesion,6.68e-08,5.08e-06,30/330,276/9080
CD4T,rs1131017_RPS26,BP,GO:0050870,positive regulation of T cell activation,6.70e-08,5.08e-06,22/330,160/9080
CD4T,rs1131017_RPS26,BP,GO:1903039,positive regulation of leukocyte cell-cell adhesion,7.06e-08,5.26e-06,23/330,174/9080
CD4T,rs1131017_RPS26,BP,GO:0070663,regulation of leukocyte proliferation,7.73e-08,5.66e-06,21/330,148/9080
CD4T,rs1131017_RPS26,BP,GO:0022409,positive regulation of cell-cell adhesion,9.73e-08,7.00e-06,24/330,191/9080
CD4T,rs1131017_RPS26,BP,GO:0050900,leukocyte migration,1.08e-07,7.64e-06,28/330,251/9080
CD4T,rs1131017_RPS26,BP,GO:0002183,cytoplasmic translational initiation,1.54e-07,1.07e-05,10/330,33/9080
CD4T,rs1131017_RPS26,BP,GO:0050670,regulation of lymphocyte proliferation,1.60e-07,1.09e-05,20/330,141/9080
CD4T,rs1131017_RPS26,BP,GO:0034341,response to interferon-gamma,1.79e-07,1.19e-05,19/330,129/9080
CD4T,rs1131017_RPS26,BP,GO:0032944,regulation of mononuclear cell proliferation,1.80e-07,1.19e-05,20/330,142/9080
CD4T,rs1131017_RPS26,BP,GO:0042102,positive regulation of T cell proliferation,2.36e-07,1.54e-05,14/330,72/9080
CD4T,rs1131017_RPS26,BP,GO:0050671,positive regulation of lymphocyte proliferation,3.04e-07,1.95e-05,16/330,96/9080
CD4T,rs1131017_RPS26,BP,GO:0032946,positive regulation of mononuclear cell proliferation,3.52e-07,2.23e-05,16/330,97/9080
CD4T,rs1131017_RPS26,BP,GO:0001732,formation of cytoplasmic translation initiation complex,3.94e-07,2.41e-05,7/330,15/9080
CD4T,rs1131017_RPS26,BP,GO:1901798,positive regulation of signal transduction by p53 class mediator,3.94e-07,2.41e-05,7/330,15/9080
CD4T,rs1131017_RPS26,BP,GO:0006417,regulation of translation,4.86e-07,2.94e-05,30/330,302/9080
CD4T,rs1131017_RPS26,BP,GO:0051251,positive regulation of lymphocyte activation,5.32e-07,3.17e-05,24/330,209/9080
CD4T,rs1131017_RPS26,BP,GO:0010608,posttranscriptional regulation of gene expression,5.98e-07,3.51e-05,41/330,497/9080
CD4T,rs1131017_RPS26,BP,GO:0070665,positive regulation of leukocyte proliferation,7.14e-07,4.14e-05,16/330,102/9080
CD4T,rs1131017_RPS26,BP,GO:0050777,negative regulation of immune response,9.59e-07,5.48e-05,15/330,92/9080
CD4T,rs1131017_RPS26,BP,GO:0002480,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent",1.22e-06,6.86e-05,5/330,7/9080
CD4T,rs1131017_RPS26,BP,GO:0002643,regulation of tolerance induction,1.69e-06,9.41e-05,6/330,12/9080
CD4T,rs1131017_RPS26,BP,GO:0036336,dendritic cell migration,2.72e-06,1.49e-04,7/330,19/9080
CD4T,rs1131017_RPS26,BP,GO:0001817,regulation of cytokine production,3.02e-06,1.64e-04,36/330,436/9080
CD4T,rs1131017_RPS26,BP,GO:0002696,positive regulation of leukocyte activation,3.24e-06,1.73e-04,24/330,231/9080
CD4T,rs1131017_RPS26,BP,GO:0050867,positive regulation of cell activation,4.72e-06,2.49e-04,24/330,236/9080
CD4T,rs1131017_RPS26,BP,GO:0060333,interferon-gamma-mediated signaling pathway,5.07e-06,2.64e-04,12/330,68/9080
CD4T,rs1131017_RPS26,BP,GO:0019883,antigen processing and presentation of endogenous antigen,5.17e-06,2.66e-04,6/330,14/9080
CD4T,rs1131017_RPS26,BP,GO:0001816,cytokine production,5.51e-06,2.81e-04,38/330,485/9080
CD4T,rs1131017_RPS26,BP,GO:0040017,positive regulation of locomotion,5.99e-06,3.01e-04,27/330,289/9080
CD4T,rs1131017_RPS26,BP,GO:0051272,positive regulation of cellular component movement,6.81e-06,3.38e-04,27/330,291/9080
CD4T,rs1131017_RPS26,BP,GO:0002484,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,8.32e-06,4.00e-04,4/330,5/9080
CD4T,rs1131017_RPS26,BP,GO:0002486,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",8.32e-06,4.00e-04,4/330,5/9080
CD4T,rs1131017_RPS26,BP,GO:0002407,dendritic cell chemotaxis,8.35e-06,4.00e-04,6/330,15/9080
CD4T,rs1131017_RPS26,BP,GO:0034248,regulation of cellular amide metabolic process,9.12e-06,4.32e-04,30/330,348/9080
CD4T,rs1131017_RPS26,BP,GO:0060326,cell chemotaxis,1.03e-05,4.83e-04,18/330,153/9080
CD4T,rs1131017_RPS26,BP,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1.04e-05,4.83e-04,19/330,168/9080
CD4T,rs1131017_RPS26,BP,GO:0006959,humoral immune response,1.06e-05,4.86e-04,13/330,85/9080
CD4T,rs1131017_RPS26,BP,GO:0050921,positive regulation of chemotaxis,1.09e-05,4.93e-04,12/330,73/9080
CD4T,rs1131017_RPS26,BP,GO:0046641,positive regulation of alpha-beta T cell proliferation,1.30e-05,5.81e-04,6/330,16/9080
CD4T,rs1131017_RPS26,BP,GO:2000147,positive regulation of cell motility,1.37e-05,6.08e-04,26/330,285/9080
CD4T,rs1131017_RPS26,BP,GO:0032649,regulation of interferon-gamma production,1.91e-05,8.33e-04,11/330,65/9080
CD4T,rs1131017_RPS26,BP,GO:0001818,negative regulation of cytokine production,1.92e-05,8.33e-04,18/330,160/9080
CD4T,rs1131017_RPS26,BP,GO:0032673,regulation of interleukin-4 production,2.15e-05,9.23e-04,7/330,25/9080
CD4T,rs1131017_RPS26,BP,GO:0002698,negative regulation of immune effector process,2.18e-05,9.29e-04,12/330,78/9080
CD4T,rs1131017_RPS26,BP,GO:0030335,positive regulation of cell migration,3.08e-05,1.30e-03,25/330,281/9080
CD4T,rs1131017_RPS26,BP,GO:0032633,interleukin-4 production,3.72e-05,1.54e-03,7/330,27/9080
CD4T,rs1131017_RPS26,BP,GO:0002683,negative regulation of immune system process,3.77e-05,1.54e-03,24/330,267/9080
CD4T,rs1131017_RPS26,BP,GO:0006875,cellular metal ion homeostasis,3.77e-05,1.54e-03,24/330,267/9080
CD4T,rs1131017_RPS26,BP,GO:0002483,antigen processing and presentation of endogenous peptide antigen,3.95e-05,1.58e-03,5/330,12/9080
CD4T,rs1131017_RPS26,BP,GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,3.95e-05,1.58e-03,5/330,12/9080
CD4T,rs1131017_RPS26,BP,GO:0045727,positive regulation of translation,4.16e-05,1.65e-03,14/330,110/9080
CD4T,rs1131017_RPS26,BP,GO:0097190,apoptotic signaling pathway,4.55e-05,1.79e-03,33/330,435/9080
CD4T,rs1131017_RPS26,BP,GO:0002819,regulation of adaptive immune response,4.60e-05,1.80e-03,14/330,111/9080
CD4T,rs1131017_RPS26,BP,GO:0046631,alpha-beta T cell activation,5.09e-05,1.97e-03,14/330,112/9080
CD4T,rs1131017_RPS26,BP,GO:0034470,ncRNA processing,5.18e-05,1.98e-03,28/330,344/9080
CD4T,rs1131017_RPS26,BP,GO:0002664,regulation of T cell tolerance induction,5.50e-05,2.09e-03,4/330,7/9080
CD4T,rs1131017_RPS26,BP,GO:0006874,cellular calcium ion homeostasis,5.91e-05,2.22e-03,19/330,190/9080
CD4T,rs1131017_RPS26,BP,GO:0001916,positive regulation of T cell mediated cytotoxicity,6.22e-05,2.32e-03,5/330,13/9080
CD4T,rs1131017_RPS26,BP,GO:0032609,interferon-gamma production,6.65e-05,2.46e-03,11/330,74/9080
CD4T,rs1131017_RPS26,BP,GO:0055065,metal ion homeostasis,6.89e-05,2.50e-03,25/330,295/9080
CD4T,rs1131017_RPS26,BP,GO:0009611,response to wounding,6.89e-05,2.50e-03,26/330,313/9080
CD4T,rs1131017_RPS26,BP,GO:0055074,calcium ion homeostasis,7.32e-05,2.63e-03,19/330,193/9080
CD4T,rs1131017_RPS26,BP,GO:0046635,positive regulation of alpha-beta T cell activation,7.83e-05,2.79e-03,9/330,51/9080
CD4T,rs1131017_RPS26,BP,GO:0050778,positive regulation of immune response,7.88e-05,2.79e-03,32/330,428/9080
CD4T,rs1131017_RPS26,BP,GO:0072503,cellular divalent inorganic cation homeostasis,8.64e-05,3.03e-03,20/330,212/9080
CD4T,rs1131017_RPS26,BP,GO:0002521,leukocyte differentiation,9.00e-05,3.13e-03,28/330,355/9080
CD4T,rs1131017_RPS26,BP,GO:0046640,regulation of alpha-beta T cell proliferation,1.00e-04,3.46e-03,6/330,22/9080
CD4T,rs1131017_RPS26,BP,GO:0002274,myeloid leukocyte activation,1.09e-04,3.74e-03,33/330,455/9080
CD4T,rs1131017_RPS26,BP,GO:0002695,negative regulation of leukocyte activation,1.15e-04,3.90e-03,13/330,106/9080
CD4T,rs1131017_RPS26,BP,GO:0030098,lymphocyte differentiation,1.22e-04,4.12e-03,22/330,252/9080
CD4T,rs1131017_RPS26,BP,GO:0001819,positive regulation of cytokine production,1.25e-04,4.14e-03,24/330,288/9080
CD4T,rs1131017_RPS26,BP,GO:2001233,regulation of apoptotic signaling pathway,1.25e-04,4.14e-03,24/330,288/9080
CD4T,rs1131017_RPS26,BP,GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,1.32e-04,4.32e-03,6/330,23/9080
CD4T,rs1131017_RPS26,BP,GO:0072507,divalent inorganic cation homeostasis,1.35e-04,4.41e-03,20/330,219/9080
CD4T,rs1131017_RPS26,BP,GO:0051480,regulation of cytosolic calcium ion concentration,1.40e-04,4.54e-03,15/330,138/9080
CD4T,rs1131017_RPS26,BP,GO:2001242,regulation of intrinsic apoptotic signaling pathway,1.43e-04,4.58e-03,14/330,123/9080
CD4T,rs1131017_RPS26,BP,GO:0002709,regulation of T cell mediated immunity,1.58e-04,5.00e-03,8/330,44/9080
CD4T,rs1131017_RPS26,BP,GO:0030334,regulation of cell migration,1.58e-04,5.00e-03,33/330,464/9080
CD4T,rs1131017_RPS26,BP,GO:0016064,immunoglobulin mediated immune response,1.77e-04,5.52e-03,10/330,69/9080
CD4T,rs1131017_RPS26,BP,GO:0030003,cellular cation homeostasis,1.77e-04,5.52e-03,25/330,313/9080
CD4T,rs1131017_RPS26,BP,GO:0002517,T cell tolerance induction,1.87e-04,5.69e-03,4/330,9/9080
CD4T,rs1131017_RPS26,BP,GO:0045060,negative thymic T cell selection,1.87e-04,5.69e-03,4/330,9/9080
CD4T,rs1131017_RPS26,BP,GO:1904667,negative regulation of ubiquitin protein ligase activity,1.87e-04,5.69e-03,4/330,9/9080
CD4T,rs1131017_RPS26,BP,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1.93e-04,5.79e-03,12/330,97/9080
CD4T,rs1131017_RPS26,BP,GO:0032703,negative regulation of interleukin-2 production,1.93e-04,5.79e-03,5/330,16/9080
CD4T,rs1131017_RPS26,BP,GO:0006446,regulation of translational initiation,2.00e-04,5.96e-03,10/330,70/9080
CD4T,rs1131017_RPS26,BP,GO:0008284,positive regulation of cell population proliferation,2.01e-04,5.96e-03,33/330,470/9080
CD4T,rs1131017_RPS26,BP,GO:0006873,cellular ion homeostasis,2.05e-04,6.04e-03,25/330,316/9080
CD4T,rs1131017_RPS26,BP,GO:2000145,regulation of cell motility,2.09e-04,6.08e-03,34/330,491/9080
CD4T,rs1131017_RPS26,BP,GO:0002449,lymphocyte mediated immunity,2.10e-04,6.08e-03,16/330,159/9080
CD4T,rs1131017_RPS26,BP,GO:0046633,alpha-beta T cell proliferation,2.17e-04,6.25e-03,6/330,25/9080
CD4T,rs1131017_RPS26,BP,GO:0019724,B cell mediated immunity,2.25e-04,6.43e-03,10/330,71/9080
CD4T,rs1131017_RPS26,BP,GO:0042060,wound healing,2.27e-04,6.43e-03,22/330,263/9080
CD4T,rs1131017_RPS26,BP,GO:0046634,regulation of alpha-beta T cell activation,2.53e-04,7.14e-03,10/330,72/9080
CD4T,rs1131017_RPS26,BP,GO:0007204,positive regulation of cytosolic calcium ion concentration,2.57e-04,7.19e-03,14/330,130/9080
CD4T,rs1131017_RPS26,BP,GO:0006935,chemotaxis,2.63e-04,7.32e-03,23/330,284/9080
CD4T,rs1131017_RPS26,BP,GO:0000470,maturation of LSU-rRNA,2.74e-04,7.48e-03,6/330,26/9080
CD4T,rs1131017_RPS26,BP,GO:0002707,negative regulation of lymphocyte mediated immunity,2.74e-04,7.48e-03,6/330,26/9080
CD4T,rs1131017_RPS26,BP,GO:0043065,positive regulation of apoptotic process,2.74e-04,7.48e-03,31/330,438/9080
CD4T,rs1131017_RPS26,BP,GO:0001525,angiogenesis,2.77e-04,7.50e-03,20/330,231/9080
CD4T,rs1131017_RPS26,BP,GO:0034660,ncRNA metabolic process,2.78e-04,7.50e-03,29/330,399/9080
CD4T,rs1131017_RPS26,BP,GO:0050866,negative regulation of cell activation,2.86e-04,7.66e-03,13/330,116/9080
CD4T,rs1131017_RPS26,BP,GO:0055080,cation homeostasis,2.89e-04,7.68e-03,26/330,342/9080
CD4T,rs1131017_RPS26,BP,GO:0042330,taxis,2.91e-04,7.69e-03,23/330,286/9080
CD4T,rs1131017_RPS26,BP,GO:0043383,negative T cell selection,3.02e-04,7.94e-03,4/330,10/9080
CD4T,rs1131017_RPS26,BP,GO:0048514,blood vessel morphogenesis,3.11e-04,8.12e-03,22/330,269/9080
CD4T,rs1131017_RPS26,BP,GO:0042119,neutrophil activation,3.14e-04,8.13e-03,27/330,363/9080
CD4T,rs1131017_RPS26,BP,GO:0070098,chemokine-mediated signaling pathway,3.16e-04,8.13e-03,7/330,37/9080
CD4T,rs1131017_RPS26,BP,GO:0043068,positive regulation of programmed cell death,3.21e-04,8.23e-03,31/330,442/9080
CD4T,rs1131017_RPS26,BP,GO:0098771,inorganic ion homeostasis,3.31e-04,8.42e-03,26/330,345/9080
CD4T,rs1131017_RPS26,BP,GO:0034250,positive regulation of cellular amide metabolic process,3.52e-04,8.91e-03,14/330,134/9080
CD4T,rs1131017_RPS26,BP,GO:0001914,regulation of T cell mediated cytotoxicity,3.56e-04,8.96e-03,5/330,18/9080
CD4T,rs1131017_RPS26,BP,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,3.67e-04,9.18e-03,9/330,62/9080
CD4T,rs1131017_RPS26,BP,GO:0036230,granulocyte activation,3.90e-04,9.69e-03,27/330,368/9080
CD4T,rs1131017_RPS26,BP,GO:0002700,regulation of production of molecular mediator of immune response,3.95e-04,9.70e-03,11/330,90/9080
CD4T,rs1131017_RPS26,BP,GO:0030048,actin filament-based movement,3.95e-04,9.70e-03,8/330,50/9080
CD4T,rs1131017_RPS26,BP,GO:0009617,response to bacterium,4.12e-04,1.00e-02,23/330,293/9080
CD4T,rs1131017_RPS26,BP,GO:0002685,regulation of leukocyte migration,4.34e-04,1.04e-02,13/330,121/9080
CD4T,rs1131017_RPS26,BP,GO:0002687,positive regulation of leukocyte migration,4.41e-04,1.04e-02,10/330,77/9080
CD4T,rs1131017_RPS26,BP,GO:1903038,negative regulation of leukocyte cell-cell adhesion,4.41e-04,1.04e-02,10/330,77/9080
CD4T,rs1131017_RPS26,BP,GO:0030217,T cell differentiation,4.50e-04,1.04e-02,17/330,187/9080
CD4T,rs1131017_RPS26,BP,GO:0021932,hindbrain radial glia guided cell migration,4.51e-04,1.04e-02,3/330,5/9080
CD4T,rs1131017_RPS26,BP,GO:2000508,regulation of dendritic cell chemotaxis,4.51e-04,1.04e-02,3/330,5/9080
CD4T,rs1131017_RPS26,BP,GO:2000510,positive regulation of dendritic cell chemotaxis,4.51e-04,1.04e-02,3/330,5/9080
CD4T,rs1131017_RPS26,BP,GO:0097193,intrinsic apoptotic signaling pathway,4.54e-04,1.04e-02,19/330,222/9080
CD4T,rs1131017_RPS26,BP,GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,4.54e-04,1.04e-02,8/330,51/9080
CD4T,rs1131017_RPS26,BP,GO:0016444,somatic cell DNA recombination,4.54e-04,1.04e-02,8/330,51/9080
CD4T,rs1131017_RPS26,BP,GO:0034109,homotypic cell-cell adhesion,4.54e-04,1.04e-02,8/330,51/9080
CD4T,rs1131017_RPS26,BP,GO:0010942,positive regulation of cell death,4.68e-04,1.07e-02,32/330,472/9080
CD4T,rs1131017_RPS26,BP,GO:0030595,leukocyte chemotaxis,4.70e-04,1.07e-02,13/330,122/9080
CD4T,rs1131017_RPS26,BP,GO:0051250,negative regulation of lymphocyte activation,4.78e-04,1.08e-02,11/330,92/9080
CD4T,rs1131017_RPS26,BP,GO:0002548,monocyte chemotaxis,5.15e-04,1.16e-02,6/330,29/9080
CD4T,rs1131017_RPS26,BP,GO:0048872,homeostasis of number of cells,5.41e-04,1.21e-02,17/330,190/9080
CD4T,rs1131017_RPS26,BP,GO:0002440,production of molecular mediator of immune response,5.52e-04,1.22e-02,14/330,140/9080
CD4T,rs1131017_RPS26,BP,GO:0014070,response to organic cyclic compound,5.52e-04,1.22e-02,33/330,497/9080
CD4T,rs1131017_RPS26,BP,GO:0031348,negative regulation of defense response,5.95e-04,1.31e-02,13/330,125/9080
CD4T,rs1131017_RPS26,BP,GO:0032663,regulation of interleukin-2 production,6.08e-04,1.33e-02,7/330,41/9080
CD4T,rs1131017_RPS26,BP,GO:0050920,regulation of chemotaxis,6.24e-04,1.36e-02,12/330,110/9080
CD4T,rs1131017_RPS26,BP,GO:0032102,negative regulation of response to external stimulus,6.48e-04,1.40e-02,17/330,193/9080
CD4T,rs1131017_RPS26,BP,GO:0007162,negative regulation of cell adhesion,6.56e-04,1.41e-02,15/330,159/9080
CD4T,rs1131017_RPS26,BP,GO:0002367,cytokine production involved in immune response,6.60e-04,1.41e-02,9/330,67/9080
CD4T,rs1131017_RPS26,BP,GO:0043534,blood vessel endothelial cell migration,6.60e-04,1.41e-02,9/330,67/9080
CD4T,rs1131017_RPS26,BP,GO:0002718,regulation of cytokine production involved in immune response,6.75e-04,1.43e-02,8/330,54/9080
CD4T,rs1131017_RPS26,BP,GO:0002285,lymphocyte activation involved in immune response,7.46e-04,1.56e-02,13/330,128/9080
CD4T,rs1131017_RPS26,BP,GO:0002711,positive regulation of T cell mediated immunity,7.51e-04,1.56e-02,6/330,31/9080
CD4T,rs1131017_RPS26,BP,GO:0019730,antimicrobial humoral response,7.51e-04,1.56e-02,6/330,31/9080
CD4T,rs1131017_RPS26,BP,GO:0051606,detection of stimulus,7.53e-04,1.56e-02,11/330,97/9080
CD4T,rs1131017_RPS26,BP,GO:0002446,neutrophil mediated immunity,7.78e-04,1.61e-02,26/330,365/9080
CD4T,rs1131017_RPS26,BP,GO:0001906,cell killing,8.08e-04,1.65e-02,10/330,83/9080
CD4T,rs1131017_RPS26,BP,GO:0006954,inflammatory response,8.16e-04,1.65e-02,27/330,386/9080
CD4T,rs1131017_RPS26,BP,GO:1990868,response to chemokine,8.19e-04,1.65e-02,7/330,43/9080
CD4T,rs1131017_RPS26,BP,GO:1990869,cellular response to chemokine,8.19e-04,1.65e-02,7/330,43/9080
CD4T,rs1131017_RPS26,BP,GO:0002456,T cell mediated immunity,8.21e-04,1.65e-02,9/330,69/9080
CD4T,rs1131017_RPS26,BP,GO:0050868,negative regulation of T cell activation,8.21e-04,1.65e-02,9/330,69/9080
CD4T,rs1131017_RPS26,BP,GO:0002645,positive regulation of tolerance induction,8.77e-04,1.73e-02,3/330,6/9080
CD4T,rs1131017_RPS26,BP,GO:0002676,regulation of chronic inflammatory response,8.77e-04,1.73e-02,3/330,6/9080
CD4T,rs1131017_RPS26,BP,GO:0019731,antibacterial humoral response,8.77e-04,1.73e-02,3/330,6/9080
CD4T,rs1131017_RPS26,BP,GO:0032713,negative regulation of interleukin-4 production,8.77e-04,1.73e-02,3/330,6/9080
CD4T,rs1131017_RPS26,BP,GO:1900024,regulation of substrate adhesion-dependent cell spreading,8.96e-04,1.76e-02,6/330,32/9080
CD4T,rs1131017_RPS26,BP,GO:0030029,actin filament-based process,9.14e-04,1.78e-02,28/330,409/9080
CD4T,rs1131017_RPS26,BP,GO:0002253,activation of immune response,9.41e-04,1.82e-02,23/330,311/9080
CD4T,rs1131017_RPS26,BP,GO:0071677,positive regulation of mononuclear cell migration,9.44e-04,1.82e-02,4/330,13/9080
CD4T,rs1131017_RPS26,BP,GO:0071385,cellular response to glucocorticoid stimulus,1.06e-03,2.04e-02,6/330,33/9080
CD4T,rs1131017_RPS26,BP,GO:0002200,somatic diversification of immune receptors,1.10e-03,2.09e-02,8/330,58/9080
CD4T,rs1131017_RPS26,BP,GO:0033077,T cell differentiation in thymus,1.10e-03,2.09e-02,8/330,58/9080
CD4T,rs1131017_RPS26,BP,GO:0050801,ion homeostasis,1.11e-03,2.11e-02,26/330,374/9080
CD4T,rs1131017_RPS26,BP,GO:0043312,neutrophil degranulation,1.20e-03,2.26e-02,25/330,356/9080
CD4T,rs1131017_RPS26,BP,GO:0043516,"regulation of DNA damage response, signal transduction by p53 class mediator",1.21e-03,2.27e-02,5/330,23/9080
CD4T,rs1131017_RPS26,BP,GO:0002792,negative regulation of peptide secretion,1.24e-03,2.31e-02,7/330,46/9080
CD4T,rs1131017_RPS26,BP,GO:0032623,interleukin-2 production,1.24e-03,2.31e-02,7/330,46/9080
CD4T,rs1131017_RPS26,BP,GO:0002283,neutrophil activation involved in immune response,1.25e-03,2.31e-02,25/330,357/9080
CD4T,rs1131017_RPS26,BP,GO:0002704,negative regulation of leukocyte mediated immunity,1.25e-03,2.31e-02,6/330,34/9080
CD4T,rs1131017_RPS26,BP,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,1.28e-03,2.36e-02,4/330,14/9080
CD4T,rs1131017_RPS26,BP,GO:0001944,vasculature development,1.34e-03,2.46e-02,24/330,339/9080
CD4T,rs1131017_RPS26,BP,GO:0035710,"CD4-positive, alpha-beta T cell activation",1.37e-03,2.49e-02,9/330,74/9080
CD4T,rs1131017_RPS26,BP,GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,1.41e-03,2.56e-02,7/330,47/9080
CD4T,rs1131017_RPS26,BP,GO:0002697,regulation of immune effector process,1.42e-03,2.57e-02,19/330,244/9080
CD4T,rs1131017_RPS26,BP,GO:0055082,cellular chemical homeostasis,1.44e-03,2.59e-02,27/330,401/9080
CD4T,rs1131017_RPS26,BP,GO:0071384,cellular response to corticosteroid stimulus,1.46e-03,2.62e-02,6/330,35/9080
CD4T,rs1131017_RPS26,BP,GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,1.48e-03,2.62e-02,5/330,24/9080
CD4T,rs1131017_RPS26,BP,GO:0002444,myeloid leukocyte mediated immunity,1.49e-03,2.62e-02,27/330,402/9080
CD4T,rs1131017_RPS26,BP,GO:0021535,cell migration in hindbrain,1.49e-03,2.62e-02,3/330,7/9080
CD4T,rs1131017_RPS26,BP,GO:0045586,regulation of gamma-delta T cell differentiation,1.49e-03,2.62e-02,3/330,7/9080
CD4T,rs1131017_RPS26,BP,GO:1903054,negative regulation of extracellular matrix organization,1.49e-03,2.62e-02,3/330,7/9080
CD4T,rs1131017_RPS26,BP,GO:0050728,negative regulation of inflammatory response,1.50e-03,2.63e-02,9/330,75/9080
CD4T,rs1131017_RPS26,BP,GO:0042113,B cell activation,1.65e-03,2.87e-02,15/330,174/9080
CD4T,rs1131017_RPS26,BP,GO:0031342,negative regulation of cell killing,1.70e-03,2.95e-02,4/330,15/9080
CD4T,rs1131017_RPS26,BP,GO:0001913,T cell mediated cytotoxicity,1.79e-03,3.09e-02,5/330,25/9080
CD4T,rs1131017_RPS26,BP,GO:0043487,regulation of RNA stability,1.80e-03,3.10e-02,14/330,158/9080
CD4T,rs1131017_RPS26,BP,GO:0007249,I-kappaB kinase/NF-kappaB signaling,1.83e-03,3.12e-02,17/330,212/9080
CD4T,rs1131017_RPS26,BP,GO:0022408,negative regulation of cell-cell adhesion,1.83e-03,3.12e-02,11/330,108/9080
CD4T,rs1131017_RPS26,BP,GO:0031960,response to corticosteroid,1.99e-03,3.37e-02,9/330,78/9080
CD4T,rs1131017_RPS26,BP,GO:0045619,regulation of lymphocyte differentiation,2.06e-03,3.48e-02,12/330,126/9080
CD4T,rs1131017_RPS26,BP,GO:0035239,tube morphogenesis,2.09e-03,3.52e-02,26/330,391/9080
CD4T,rs1131017_RPS26,BP,GO:0002455,humoral immune response mediated by circulating immunoglobulin,2.20e-03,3.66e-02,4/330,16/9080
CD4T,rs1131017_RPS26,BP,GO:0051444,negative regulation of ubiquitin-protein transferase activity,2.20e-03,3.66e-02,4/330,16/9080
CD4T,rs1131017_RPS26,BP,GO:1900120,regulation of receptor binding,2.20e-03,3.66e-02,4/330,16/9080
CD4T,rs1131017_RPS26,BP,GO:0031343,positive regulation of cell killing,2.27e-03,3.73e-02,6/330,38/9080
CD4T,rs1131017_RPS26,BP,GO:0010959,regulation of metal ion transport,2.28e-03,3.73e-02,14/330,162/9080
CD4T,rs1131017_RPS26,BP,GO:0002706,regulation of lymphocyte mediated immunity,2.29e-03,3.73e-02,10/330,95/9080
CD4T,rs1131017_RPS26,BP,GO:0006812,cation transport,2.30e-03,3.73e-02,29/330,456/9080
CD4T,rs1131017_RPS26,BP,GO:0002702,positive regulation of production of molecular mediator of immune response,2.32e-03,3.73e-02,8/330,65/9080
CD4T,rs1131017_RPS26,BP,GO:0010811,positive regulation of cell-substrate adhesion,2.32e-03,3.73e-02,8/330,65/9080
CD4T,rs1131017_RPS26,BP,GO:0032071,regulation of endodeoxyribonuclease activity,2.32e-03,3.73e-02,3/330,8/9080
CD4T,rs1131017_RPS26,BP,GO:0046643,regulation of gamma-delta T cell activation,2.32e-03,3.73e-02,3/330,8/9080
CD4T,rs1131017_RPS26,BP,GO:2001187,"positive regulation of CD8-positive, alpha-beta T cell activation",2.32e-03,3.73e-02,3/330,8/9080
CD4T,rs1131017_RPS26,BP,GO:0002429,immune response-activating cell surface receptor signaling pathway,2.43e-03,3.88e-02,20/330,275/9080
CD4T,rs1131017_RPS26,BP,GO:0002757,immune response-activating signal transduction,2.43e-03,3.88e-02,20/330,275/9080
CD4T,rs1131017_RPS26,BP,GO:0070848,response to growth factor,2.48e-03,3.94e-02,24/330,355/9080
CD4T,rs1131017_RPS26,BP,GO:0045581,negative regulation of T cell differentiation,2.57e-03,4.06e-02,5/330,27/9080
CD4T,rs1131017_RPS26,BP,GO:0003012,muscle system process,2.71e-03,4.26e-02,15/330,183/9080
CD4T,rs1131017_RPS26,BP,GO:0031579,membrane raft organization,2.80e-03,4.35e-02,4/330,17/9080
CD4T,rs1131017_RPS26,BP,GO:0043371,"negative regulation of CD4-positive, alpha-beta T cell differentiation",2.80e-03,4.35e-02,4/330,17/9080
CD4T,rs1131017_RPS26,BP,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,2.80e-03,4.35e-02,4/330,17/9080
CD4T,rs1131017_RPS26,BP,GO:0001568,blood vessel development,2.81e-03,4.35e-02,22/330,318/9080
CD4T,rs1131017_RPS26,BP,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,2.81e-03,4.35e-02,8/330,67/9080
CD4T,rs1131017_RPS26,BP,GO:0002690,positive regulation of leukocyte chemotaxis,2.87e-03,4.43e-02,7/330,53/9080
CD4T,rs1131017_RPS26,BP,GO:0071407,cellular response to organic cyclic compound,2.92e-03,4.48e-02,22/330,319/9080
CD4T,rs1131017_RPS26,BP,GO:1903311,regulation of mRNA metabolic process,3.00e-03,4.57e-02,20/330,280/9080
CD4T,rs1131017_RPS26,BP,GO:0001503,ossification,3.00e-03,4.57e-02,15/330,185/9080
CD4T,rs1131017_RPS26,BP,GO:0030036,actin cytoskeleton organization,3.03e-03,4.59e-02,25/330,381/9080
CD4T,rs1131017_RPS26,BP,GO:0007566,embryo implantation,3.03e-03,4.59e-02,5/330,28/9080
CD4T,rs1131017_RPS26,BP,GO:0051224,negative regulation of protein transport,3.06e-03,4.60e-02,9/330,83/9080
CD4T,rs1131017_RPS26,BP,GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,3.09e-03,4.62e-02,8/330,68/9080
CD4T,rs1131017_RPS26,BP,GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,3.09e-03,4.62e-02,8/330,68/9080
CD4T,rs1131017_RPS26,BP,GO:0071363,cellular response to growth factor stimulus,3.12e-03,4.66e-02,23/330,341/9080
CD4T,rs1131017_RPS26,BP,GO:0090087,regulation of peptide transport,3.16e-03,4.70e-02,26/330,403/9080
CD4T,rs1131017_RPS26,BP,GO:0043488,regulation of mRNA stability,3.34e-03,4.78e-02,13/330,151/9080
CD4T,rs1131017_RPS26,BP,GO:0050852,T cell receptor signaling pathway,3.37e-03,4.78e-02,14/330,169/9080
CD4T,rs1131017_RPS26,BP,GO:2000059,negative regulation of ubiquitin-dependent protein catabolic process,3.38e-03,4.78e-02,6/330,41/9080
CD4T,rs1131017_RPS26,BP,GO:0038094,Fc-gamma receptor signaling pathway,3.39e-03,4.78e-02,8/330,69/9080
CD4T,rs1131017_RPS26,BP,GO:0090288,negative regulation of cellular response to growth factor stimulus,3.39e-03,4.78e-02,8/330,69/9080
CD4T,rs1131017_RPS26,BP,GO:0016045,detection of bacterium,3.39e-03,4.78e-02,3/330,9/9080
CD4T,rs1131017_RPS26,BP,GO:0030049,muscle filament sliding,3.39e-03,4.78e-02,3/330,9/9080
CD4T,rs1131017_RPS26,BP,GO:0033275,actin-myosin filament sliding,3.39e-03,4.78e-02,3/330,9/9080
CD4T,rs1131017_RPS26,BP,GO:0042492,gamma-delta T cell differentiation,3.39e-03,4.78e-02,3/330,9/9080
CD4T,rs1131017_RPS26,BP,GO:0043517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",3.39e-03,4.78e-02,3/330,9/9080
CD4T,rs1131017_RPS26,BP,GO:0046598,positive regulation of viral entry into host cell,3.39e-03,4.78e-02,3/330,9/9080
CD4T,rs1131017_RPS26,BP,GO:0050710,negative regulation of cytokine secretion,3.39e-03,4.78e-02,3/330,9/9080
CD4T,rs1131017_RPS26,BP,GO:0075294,positive regulation by symbiont of entry into host,3.39e-03,4.78e-02,3/330,9/9080
CD4T,rs1131017_RPS26,BP,GO:0150079,negative regulation of neuroinflammatory response,3.39e-03,4.78e-02,3/330,9/9080
CD4T,rs1131017_RPS26,BP,GO:1900121,negative regulation of receptor binding,3.39e-03,4.78e-02,3/330,9/9080
CD4T,rs1131017_RPS26,BP,GO:0032689,negative regulation of interferon-gamma production,3.50e-03,4.88e-02,4/330,18/9080
CD4T,rs1131017_RPS26,BP,GO:0045061,thymic T cell selection,3.50e-03,4.88e-02,4/330,18/9080
CD4T,rs1131017_RPS26,BP,GO:0046639,negative regulation of alpha-beta T cell differentiation,3.50e-03,4.88e-02,4/330,18/9080
CD4T,rs1131017_RPS26,BP,GO:0031341,regulation of cell killing,3.56e-03,4.93e-02,7/330,55/9080
CD4T,rs1131017_RPS26,BP,GO:0002369,T cell cytokine production,3.56e-03,4.93e-02,5/330,29/9080
CD4T,rs1131017_RPS26,BP,GO:0046632,alpha-beta T cell differentiation,3.59e-03,4.97e-02,9/330,85/9080
CD4T,rs1131017_RPS26,CC,GO:0022626,cytosolic ribosome,2.30e-95,1.08e-92,78/336,101/9383
CD4T,rs1131017_RPS26,CC,GO:0044391,ribosomal subunit,1.14e-70,2.66e-68,80/336,175/9383
CD4T,rs1131017_RPS26,CC,GO:0005840,ribosome,3.63e-67,5.67e-65,83/336,209/9383
CD4T,rs1131017_RPS26,CC,GO:0022625,cytosolic large ribosomal subunit,5.97e-62,7.00e-60,47/336,54/9383
CD4T,rs1131017_RPS26,CC,GO:0015934,large ribosomal subunit,6.42e-40,6.02e-38,47/336,108/9383
CD4T,rs1131017_RPS26,CC,GO:0022627,cytosolic small ribosomal subunit,1.76e-37,1.38e-35,32/336,44/9383
CD4T,rs1131017_RPS26,CC,GO:0005925,focal adhesion,5.70e-37,3.82e-35,68/336,296/9383
CD4T,rs1131017_RPS26,CC,GO:0030055,cell-substrate junction,1.13e-36,6.65e-35,68/336,299/9383
CD4T,rs1131017_RPS26,CC,GO:0015935,small ribosomal subunit,4.47e-31,2.33e-29,34/336,70/9383
CD4T,rs1131017_RPS26,CC,GO:0042788,polysomal ribosome,1.60e-27,7.48e-26,23/336,31/9383
CD4T,rs1131017_RPS26,CC,GO:0070161,anchoring junction,1.22e-26,5.20e-25,71/336,466/9383
CD4T,rs1131017_RPS26,CC,GO:0005844,polysome,2.90e-23,1.13e-21,27/336,62/9383
CD4T,rs1131017_RPS26,CC,GO:0009986,cell surface,1.48e-13,5.35e-12,43/336,334/9383
CD4T,rs1131017_RPS26,CC,GO:0098552,side of membrane,2.52e-12,8.44e-11,38/336,290/9383
CD4T,rs1131017_RPS26,CC,GO:0042611,MHC protein complex,2.11e-10,6.58e-09,10/336,19/9383
CD4T,rs1131017_RPS26,CC,GO:0009897,external side of plasma membrane,7.52e-09,2.20e-07,23/336,157/9383
CD4T,rs1131017_RPS26,CC,GO:0016282,eukaryotic 43S preinitiation complex,2.49e-08,6.88e-07,8/336,16/9383
CD4T,rs1131017_RPS26,CC,GO:0071556,integral component of lumenal side of endoplasmic reticulum membrane,2.87e-08,7.08e-07,9/336,22/9383
CD4T,rs1131017_RPS26,CC,GO:0098553,lumenal side of endoplasmic reticulum membrane,2.87e-08,7.08e-07,9/336,22/9383
CD4T,rs1131017_RPS26,CC,GO:0070993,translation preinitiation complex,4.56e-08,1.07e-06,8/336,17/9383
CD4T,rs1131017_RPS26,CC,GO:0030666,endocytic vesicle membrane,1.36e-07,3.03e-06,16/336,92/9383
CD4T,rs1131017_RPS26,CC,GO:0033290,eukaryotic 48S preinitiation complex,1.96e-07,4.18e-06,7/336,14/9383
CD4T,rs1131017_RPS26,CC,GO:0098576,lumenal side of membrane,2.31e-07,4.70e-06,9/336,27/9383
CD4T,rs1131017_RPS26,CC,GO:0005852,eukaryotic translation initiation factor 3 complex,6.14e-07,1.20e-05,7/336,16/9383
CD4T,rs1131017_RPS26,CC,GO:0042612,MHC class I protein complex,1.13e-06,2.12e-05,5/336,7/9383
CD4T,rs1131017_RPS26,CC,GO:0098984,neuron to neuron synapse,2.68e-06,4.83e-05,21/336,185/9383
CD4T,rs1131017_RPS26,CC,GO:0012507,ER to Golgi transport vesicle membrane,8.69e-06,1.51e-04,10/336,50/9383
CD4T,rs1131017_RPS26,CC,GO:0099572,postsynaptic specialization,1.06e-05,1.77e-04,20/336,186/9383
CD4T,rs1131017_RPS26,CC,GO:0098794,postsynapse,1.11e-05,1.79e-04,27/336,303/9383
CD4T,rs1131017_RPS26,CC,GO:0030139,endocytic vesicle,1.57e-05,2.46e-04,20/336,191/9383
CD4T,rs1131017_RPS26,CC,GO:0030863,cortical cytoskeleton,1.78e-05,2.70e-04,10/336,54/9383
CD4T,rs1131017_RPS26,CC,GO:0014069,postsynaptic density,1.96e-05,2.87e-04,19/336,178/9383
CD4T,rs1131017_RPS26,CC,GO:0032279,asymmetric synapse,2.12e-05,3.01e-04,19/336,179/9383
CD4T,rs1131017_RPS26,CC,GO:0045121,membrane raft,2.48e-05,3.32e-04,19/336,181/9383
CD4T,rs1131017_RPS26,CC,GO:0098857,membrane microdomain,2.48e-05,3.32e-04,19/336,181/9383
CD4T,rs1131017_RPS26,CC,GO:0042613,MHC class II protein complex,3.68e-05,4.79e-04,5/336,12/9383
CD4T,rs1131017_RPS26,CC,GO:0005884,actin filament,3.94e-05,4.99e-04,11/336,71/9383
CD4T,rs1131017_RPS26,CC,GO:0098589,membrane region,4.53e-05,5.60e-04,19/336,189/9383
CD4T,rs1131017_RPS26,CC,GO:0071541,"eukaryotic translation initiation factor 3 complex, eIF3m",5.19e-05,6.24e-04,4/336,7/9383
CD4T,rs1131017_RPS26,CC,GO:0030134,COPII-coated ER to Golgi transport vesicle,5.84e-05,6.85e-04,11/336,74/9383
CD4T,rs1131017_RPS26,CC,GO:0031252,cell leading edge,6.35e-05,7.27e-04,23/336,262/9383
CD4T,rs1131017_RPS26,CC,GO:0031256,leading edge membrane,1.01e-04,1.12e-03,12/336,92/9383
CD4T,rs1131017_RPS26,CC,GO:0072562,blood microparticle,2.41e-04,2.63e-03,7/336,36/9383
CD4T,rs1131017_RPS26,CC,GO:0015629,actin cytoskeleton,3.84e-04,4.10e-03,22/336,277/9383
CD4T,rs1131017_RPS26,CC,GO:0001726,ruffle,6.52e-04,6.79e-03,13/336,128/9383
CD4T,rs1131017_RPS26,CC,GO:0005791,rough endoplasmic reticulum,7.87e-04,7.92e-03,8/336,56/9383
CD4T,rs1131017_RPS26,CC,GO:0030660,Golgi-associated vesicle membrane,7.94e-04,7.92e-03,10/336,84/9383
CD4T,rs1131017_RPS26,CC,GO:0034715,pICln-Sm protein complex,8.40e-04,8.21e-03,3/336,6/9383
CD4T,rs1131017_RPS26,CC,GO:0030669,clathrin-coated endocytic vesicle membrane,9.10e-04,8.71e-03,5/336,22/9383
CD4T,rs1131017_RPS26,CC,GO:0001725,stress fiber,1.36e-03,1.25e-02,6/336,35/9383
CD4T,rs1131017_RPS26,CC,GO:0097517,contractile actin filament bundle,1.36e-03,1.25e-02,6/336,35/9383
CD4T,rs1131017_RPS26,CC,GO:0032432,actin filament bundle,1.83e-03,1.65e-02,6/336,37/9383
CD4T,rs1131017_RPS26,CC,GO:0001772,immunological synapse,2.11e-03,1.87e-02,6/336,38/9383
CD4T,rs1131017_RPS26,CC,GO:0005751,mitochondrial respiratory chain complex IV,2.23e-03,1.91e-02,3/336,8/9383
CD4T,rs1131017_RPS26,CC,GO:0005938,cell cortex,2.24e-03,1.91e-02,14/336,164/9383
CD4T,rs1131017_RPS26,CC,GO:0032587,ruffle membrane,2.57e-03,2.15e-02,8/336,67/9383
CD4T,rs1131017_RPS26,CC,GO:0030176,integral component of endoplasmic reticulum membrane,2.89e-03,2.38e-02,11/336,116/9383
CD4T,rs1131017_RPS26,CC,GO:0031968,organelle outer membrane,2.95e-03,2.39e-02,13/336,151/9383
CD4T,rs1131017_RPS26,CC,GO:0062023,collagen-containing extracellular matrix,3.24e-03,2.57e-02,10/336,101/9383
CD4T,rs1131017_RPS26,CC,GO:0019867,outer membrane,3.31e-03,2.59e-02,13/336,153/9383
CD4T,rs1131017_RPS26,CC,GO:0098797,plasma membrane protein complex,3.38e-03,2.60e-02,17/336,228/9383
CD4T,rs1131017_RPS26,CC,GO:0042641,actomyosin,3.56e-03,2.69e-02,6/336,42/9383
CD4T,rs1131017_RPS26,CC,GO:0030670,phagocytic vesicle membrane,3.64e-03,2.71e-02,7/336,56/9383
CD4T,rs1131017_RPS26,CC,GO:0030141,secretory granule,3.73e-03,2.71e-02,30/336,500/9383
CD4T,rs1131017_RPS26,CC,GO:0031227,intrinsic component of endoplasmic reticulum membrane,3.76e-03,2.71e-02,11/336,120/9383
CD4T,rs1131017_RPS26,CC,GO:0034774,secretory granule lumen,4.10e-03,2.91e-02,16/336,213/9383
CD4T,rs1131017_RPS26,CC,GO:0031253,cell projection membrane,4.36e-03,3.02e-02,13/336,158/9383
CD4T,rs1131017_RPS26,CC,GO:0031983,vesicle lumen,4.49e-03,3.02e-02,16/336,215/9383
CD4T,rs1131017_RPS26,CC,GO:0060205,cytoplasmic vesicle lumen,4.49e-03,3.02e-02,16/336,215/9383
CD4T,rs1131017_RPS26,CC,GO:0045334,clathrin-coated endocytic vesicle,4.51e-03,3.02e-02,5/336,31/9383
CD4T,rs1131017_RPS26,CC,GO:0045335,phagocytic vesicle,4.59e-03,3.03e-02,10/336,106/9383
CD4T,rs1131017_RPS26,CC,GO:0070069,cytochrome complex,4.97e-03,3.23e-02,4/336,20/9383
CD4T,rs1131017_RPS26,CC,GO:0031012,extracellular matrix,5.13e-03,3.29e-02,11/336,125/9383
CD4T,rs1131017_RPS26,CC,GO:0005885,Arp2/3 protein complex,6.06e-03,3.79e-02,3/336,11/9383
CD4T,rs1131017_RPS26,CC,GO:0045277,respiratory chain complex IV,6.06e-03,3.79e-02,3/336,11/9383
CD4T,rs1131017_RPS26,CC,GO:0005798,Golgi-associated vesicle,6.87e-03,4.24e-02,11/336,130/9383
CD4T,rs1131017_RPS26,CC,GO:0031258,lamellipodium membrane,7.87e-03,4.66e-02,3/336,12/9383
CD4T,rs1131017_RPS26,CC,GO:0034709,methylosome,7.87e-03,4.66e-02,3/336,12/9383
CD4T,rs1131017_RPS26,CC,GO:0098554,cytoplasmic side of endoplasmic reticulum membrane,7.87e-03,4.66e-02,3/336,12/9383
CD4T,rs1131017_RPS26,CC,GO:0005887,integral component of plasma membrane,7.94e-03,4.66e-02,28/336,483/9383
CD4T,rs1131017_RPS26,CC,GO:0044853,plasma membrane raft,8.49e-03,4.92e-02,6/336,50/9383
CD4T,rs1131017_RPS26,MF,GO:0003735,structural constituent of ribosome,1.61e-76,9.91e-74,79/331,150/9332
CD4T,rs1131017_RPS26,MF,GO:0005198,structural molecule activity,1.92e-56,5.89e-54,89/331,325/9332
CD4T,rs1131017_RPS26,MF,GO:0019843,rRNA binding,3.38e-17,6.91e-15,21/331,54/9332
CD4T,rs1131017_RPS26,MF,GO:0050839,cell adhesion molecule binding,4.61e-11,5.83e-09,37/331,307/9332
CD4T,rs1131017_RPS26,MF,GO:0045296,cadherin binding,4.74e-11,5.83e-09,32/331,236/9332
CD4T,rs1131017_RPS26,MF,GO:0042605,peptide antigen binding,7.33e-10,7.50e-08,9/331,16/9332
CD4T,rs1131017_RPS26,MF,GO:0045182,translation regulator activity,2.21e-09,1.94e-07,20/331,113/9332
CD4T,rs1131017_RPS26,MF,GO:0003823,antigen binding,4.25e-09,3.10e-07,11/331,31/9332
CD4T,rs1131017_RPS26,MF,GO:0008135,"translation factor activity, RNA binding",4.54e-09,3.10e-07,16/331,74/9332
CD4T,rs1131017_RPS26,MF,GO:0019956,chemokine binding,5.39e-09,3.31e-07,9/331,19/9332
CD4T,rs1131017_RPS26,MF,GO:0090079,"translation regulator activity, nucleic acid binding",1.31e-08,7.32e-07,17/331,90/9332
CD4T,rs1131017_RPS26,MF,GO:0019957,C-C chemokine binding,1.84e-07,9.40e-06,7/331,14/9332
CD4T,rs1131017_RPS26,MF,GO:0051015,actin filament binding,2.48e-07,1.17e-05,17/331,109/9332
CD4T,rs1131017_RPS26,MF,GO:0048027,mRNA 5'-UTR binding,4.77e-07,2.09e-05,8/331,22/9332
CD4T,rs1131017_RPS26,MF,GO:0003743,translation initiation factor activity,6.60e-07,2.70e-05,11/331,48/9332
CD4T,rs1131017_RPS26,MF,GO:0019955,cytokine binding,8.50e-07,3.26e-05,13/331,70/9332
CD4T,rs1131017_RPS26,MF,GO:0016493,C-C chemokine receptor activity,2.65e-06,9.55e-05,6/331,13/9332
CD4T,rs1131017_RPS26,MF,GO:0001637,G protein-coupled chemoattractant receptor activity,4.49e-06,1.42e-04,6/331,14/9332
CD4T,rs1131017_RPS26,MF,GO:0004950,chemokine receptor activity,4.49e-06,1.42e-04,6/331,14/9332
CD4T,rs1131017_RPS26,MF,GO:0003729,mRNA binding,4.62e-06,1.42e-04,23/331,225/9332
CD4T,rs1131017_RPS26,MF,GO:1990948,ubiquitin ligase inhibitor activity,7.56e-06,2.21e-04,4/331,5/9332
CD4T,rs1131017_RPS26,MF,GO:0003779,actin binding,8.30e-06,2.32e-04,23/331,233/9332
CD4T,rs1131017_RPS26,MF,GO:0044548,S100 protein binding,2.11e-05,5.63e-04,5/331,11/9332
CD4T,rs1131017_RPS26,MF,GO:0055105,ubiquitin-protein transferase inhibitor activity,2.20e-05,5.64e-04,4/331,6/9332
CD4T,rs1131017_RPS26,MF,GO:0140375,immune receptor activity,2.37e-05,5.83e-04,11/331,68/9332
CD4T,rs1131017_RPS26,MF,GO:0050840,extracellular matrix binding,4.84e-05,1.14e-03,6/331,20/9332
CD4T,rs1131017_RPS26,MF,GO:0048306,calcium-dependent protein binding,5.41e-05,1.23e-03,8/331,39/9332
CD4T,rs1131017_RPS26,MF,GO:0038023,signaling receptor activity,9.13e-05,1.92e-03,26/331,326/9332
CD4T,rs1131017_RPS26,MF,GO:0060089,molecular transducer activity,9.13e-05,1.92e-03,26/331,326/9332
CD4T,rs1131017_RPS26,MF,GO:0005031,tumor necrosis factor-activated receptor activity,9.72e-05,1.92e-03,4/331,8/9332
CD4T,rs1131017_RPS26,MF,GO:0042608,T cell receptor binding,9.72e-05,1.92e-03,4/331,8/9332
CD4T,rs1131017_RPS26,MF,GO:0005035,death receptor activity,1.70e-04,3.11e-03,4/331,9/9332
CD4T,rs1131017_RPS26,MF,GO:0008097,5S rRNA binding,1.70e-04,3.11e-03,4/331,9/9332
CD4T,rs1131017_RPS26,MF,GO:0003746,translation elongation factor activity,1.72e-04,3.11e-03,5/331,16/9332
CD4T,rs1131017_RPS26,MF,GO:0005539,glycosaminoglycan binding,2.09e-04,3.67e-03,9/331,59/9332
CD4T,rs1131017_RPS26,MF,GO:0043021,ribonucleoprotein complex binding,2.69e-04,4.59e-03,13/331,118/9332
CD4T,rs1131017_RPS26,MF,GO:0004896,cytokine receptor activity,3.36e-04,5.58e-03,8/331,50/9332
CD4T,rs1131017_RPS26,MF,GO:0016494,C-X-C chemokine receptor activity,4.19e-04,6.47e-03,3/331,5/9332
CD4T,rs1131017_RPS26,MF,GO:0055102,lipase inhibitor activity,4.19e-04,6.47e-03,3/331,5/9332
CD4T,rs1131017_RPS26,MF,GO:0005509,calcium ion binding,4.22e-04,6.47e-03,19/331,226/9332
CD4T,rs1131017_RPS26,MF,GO:0004888,transmembrane signaling receptor activity,5.24e-04,7.84e-03,19/331,230/9332
CD4T,rs1131017_RPS26,MF,GO:0001653,peptide receptor activity,5.49e-04,7.84e-03,6/331,30/9332
CD4T,rs1131017_RPS26,MF,GO:0008528,G protein-coupled peptide receptor activity,5.49e-04,7.84e-03,6/331,30/9332
CD4T,rs1131017_RPS26,MF,GO:0031386,protein tag,6.14e-04,8.56e-03,4/331,12/9332
CD4T,rs1131017_RPS26,MF,GO:0004857,enzyme inhibitor activity,6.50e-04,8.87e-03,16/331,180/9332
CD4T,rs1131017_RPS26,MF,GO:0050998,nitric-oxide synthase binding,8.17e-04,1.09e-02,3/331,6/9332
CD4T,rs1131017_RPS26,MF,GO:0023026,MHC class II protein complex binding,1.17e-03,1.50e-02,4/331,14/9332
CD4T,rs1131017_RPS26,MF,GO:0043236,laminin binding,1.17e-03,1.50e-02,4/331,14/9332
CD4T,rs1131017_RPS26,MF,GO:0097718,disordered domain specific binding,1.33e-03,1.59e-02,5/331,24/9332
CD4T,rs1131017_RPS26,MF,GO:0098631,cell adhesion mediator activity,1.33e-03,1.59e-02,5/331,24/9332
CD4T,rs1131017_RPS26,MF,GO:0032395,MHC class II receptor activity,1.39e-03,1.59e-02,3/331,7/9332
CD4T,rs1131017_RPS26,MF,GO:0042609,CD4 receptor binding,1.39e-03,1.59e-02,3/331,7/9332
CD4T,rs1131017_RPS26,MF,GO:0046977,TAP binding,1.39e-03,1.59e-02,3/331,7/9332
CD4T,rs1131017_RPS26,MF,GO:0043022,ribosome binding,1.39e-03,1.59e-02,7/331,48/9332
CD4T,rs1131017_RPS26,MF,GO:0055106,ubiquitin-protein transferase regulator activity,2.02e-03,2.25e-02,4/331,16/9332
CD4T,rs1131017_RPS26,MF,GO:0004129,cytochrome-c oxidase activity,2.56e-03,2.71e-02,4/331,17/9332
CD4T,rs1131017_RPS26,MF,GO:0015002,heme-copper terminal oxidase activity,2.56e-03,2.71e-02,4/331,17/9332
CD4T,rs1131017_RPS26,MF,GO:0016676,"oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor",2.56e-03,2.71e-02,4/331,17/9332
CD4T,rs1131017_RPS26,MF,GO:0008296,3'-5'-exodeoxyribonuclease activity,3.17e-03,3.28e-02,3/331,9/9332
CD4T,rs1131017_RPS26,MF,GO:0016675,"oxidoreductase activity, acting on a heme group of donors",3.21e-03,3.28e-02,4/331,18/9332
CD4T,rs1131017_RPS26,MF,GO:0042277,peptide binding,3.60e-03,3.63e-02,12/331,138/9332
CD4T,rs1131017_RPS26,MF,GO:0019901,protein kinase binding,3.83e-03,3.80e-02,28/331,462/9332
CD4T,rs1131017_RPS26,MF,GO:0030898,actin-dependent ATPase activity,4.41e-03,4.16e-02,3/331,10/9332
CD4T,rs1131017_RPS26,MF,GO:0042056,chemoattractant activity,4.41e-03,4.16e-02,3/331,10/9332
CD4T,rs1131017_RPS26,MF,GO:0070181,small ribosomal subunit rRNA binding,4.41e-03,4.16e-02,3/331,10/9332
CD4T,rs1131017_RPS26,MF,GO:0023023,MHC protein complex binding,4.80e-03,4.46e-02,4/331,20/9332
CD4T,rs2741159_KRT1,BP,GO:0042113,B cell activation,8.59e-06,7.82e-03,4/8,174/9080
CD4T,rs2741159_KRT1,BP,GO:0046649,lymphocyte activation,2.02e-05,9.21e-03,5/8,482/9080
CD4T,rs2741159_KRT1,BP,GO:0050864,regulation of B cell activation,4.60e-05,1.39e-02,3/8,87/9080
CD4T,rs2741159_KRT1,BP,GO:0051249,regulation of lymphocyte activation,7.65e-05,1.41e-02,4/8,303/9080
CD4T,rs2741159_KRT1,BP,GO:0045596,negative regulation of cell differentiation,1.02e-04,1.41e-02,4/8,326/9080
CD4T,rs2741159_KRT1,BP,GO:0051896,regulation of protein kinase B signaling,1.11e-04,1.41e-02,3/8,117/9080
CD4T,rs2741159_KRT1,BP,GO:0002694,regulation of leukocyte activation,1.27e-04,1.41e-02,4/8,345/9080
CD4T,rs2741159_KRT1,BP,GO:0010712,regulation of collagen metabolic process,1.28e-04,1.41e-02,2/8,20/9080
CD4T,rs2741159_KRT1,BP,GO:0043491,protein kinase B signaling,1.49e-04,1.41e-02,3/8,129/9080
CD4T,rs2741159_KRT1,BP,GO:0050865,regulation of cell activation,1.56e-04,1.41e-02,4/8,364/9080
CD4T,rs2741159_KRT1,BP,GO:0045599,negative regulation of fat cell differentiation,1.70e-04,1.41e-02,2/8,23/9080
CD4T,rs2741159_KRT1,BP,GO:0051093,negative regulation of developmental process,3.68e-04,2.72e-02,4/8,454/9080
CD4T,rs2741159_KRT1,BP,GO:0002088,lens development in camera-type eye,3.98e-04,2.72e-02,2/8,35/9080
CD4T,rs2741159_KRT1,BP,GO:0071356,cellular response to tumor necrosis factor,4.19e-04,2.72e-02,3/8,183/9080
CD4T,rs2741159_KRT1,BP,GO:0034612,response to tumor necrosis factor,5.43e-04,3.11e-02,3/8,200/9080
CD4T,rs2741159_KRT1,BP,GO:0032963,collagen metabolic process,5.48e-04,3.11e-02,2/8,41/9080
CD4T,rs2741159_KRT1,MF,GO:0001618,virus receptor activity,3.71e-04,9.84e-03,2/7,40/9332
CD4T,rs2741159_KRT1,MF,GO:0140272,exogenous protein binding,3.71e-04,9.84e-03,2/7,40/9332
CD4T,rs4147638_SMDT1,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,6.60e-33,1.64e-30,17/19,94/9080
CD4T,rs4147638_SMDT1,BP,GO:0006613,cotranslational protein targeting to membrane,1.43e-32,1.78e-30,17/19,98/9080
CD4T,rs4147638_SMDT1,BP,GO:0045047,protein targeting to ER,7.25e-32,6.00e-30,17/19,107/9080
CD4T,rs4147638_SMDT1,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,1.21e-31,7.48e-30,17/19,110/9080
CD4T,rs4147638_SMDT1,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",3.73e-31,1.85e-29,17/19,117/9080
CD4T,rs4147638_SMDT1,BP,GO:0070972,protein localization to endoplasmic reticulum,2.53e-30,1.05e-28,17/19,130/9080
CD4T,rs4147638_SMDT1,BP,GO:0006612,protein targeting to membrane,2.28e-28,8.09e-27,17/19,167/9080
CD4T,rs4147638_SMDT1,BP,GO:0019083,viral transcription,3.86e-28,1.20e-26,17/19,172/9080
CD4T,rs4147638_SMDT1,BP,GO:0006413,translational initiation,7.86e-28,2.16e-26,17/19,179/9080
CD4T,rs4147638_SMDT1,BP,GO:0019080,viral gene expression,1.88e-27,4.65e-26,17/19,188/9080
CD4T,rs4147638_SMDT1,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,2.06e-27,4.65e-26,17/19,189/9080
CD4T,rs4147638_SMDT1,BP,GO:0090150,establishment of protein localization to membrane,1.09e-24,2.26e-23,17/19,270/9080
CD4T,rs4147638_SMDT1,BP,GO:0006402,mRNA catabolic process,2.23e-23,4.25e-22,17/19,321/9080
CD4T,rs4147638_SMDT1,BP,GO:0072657,protein localization to membrane,3.61e-23,6.40e-22,18/19,446/9080
CD4T,rs4147638_SMDT1,BP,GO:0006401,RNA catabolic process,1.05e-22,1.73e-21,17/19,351/9080
CD4T,rs4147638_SMDT1,BP,GO:0006605,protein targeting,1.55e-22,2.40e-21,17/19,359/9080
CD4T,rs4147638_SMDT1,BP,GO:0034655,nucleobase-containing compound catabolic process,6.31e-21,9.21e-20,17/19,445/9080
CD4T,rs4147638_SMDT1,BP,GO:0046700,heterocycle catabolic process,9.61e-21,1.32e-19,17/19,456/9080
CD4T,rs4147638_SMDT1,BP,GO:0044270,cellular nitrogen compound catabolic process,1.08e-20,1.40e-19,17/19,459/9080
CD4T,rs4147638_SMDT1,BP,GO:0019439,aromatic compound catabolic process,1.30e-20,1.53e-19,17/19,464/9080
CD4T,rs4147638_SMDT1,BP,GO:0072594,establishment of protein localization to organelle,1.30e-20,1.53e-19,17/19,464/9080
CD4T,rs4147638_SMDT1,BP,GO:1901361,organic cyclic compound catabolic process,1.62e-20,1.82e-19,17/19,470/9080
CD4T,rs4147638_SMDT1,BP,GO:0042273,ribosomal large subunit biogenesis,3.23e-09,3.49e-08,6/19,67/9080
CD4T,rs4147638_SMDT1,BP,GO:0022613,ribonucleoprotein complex biogenesis,3.34e-08,3.45e-07,9/19,397/9080
CD4T,rs4147638_SMDT1,BP,GO:0042254,ribosome biogenesis,3.83e-08,3.80e-07,8/19,277/9080
CD4T,rs4147638_SMDT1,BP,GO:0042255,ribosome assembly,7.38e-08,7.04e-07,5/19,55/9080
CD4T,rs4147638_SMDT1,BP,GO:0022618,ribonucleoprotein complex assembly,9.05e-07,8.31e-06,6/19,171/9080
CD4T,rs4147638_SMDT1,BP,GO:0002181,cytoplasmic translation,9.95e-07,8.81e-06,5/19,92/9080
CD4T,rs4147638_SMDT1,BP,GO:0071826,ribonucleoprotein complex subunit organization,1.15e-06,9.79e-06,6/19,178/9080
CD4T,rs4147638_SMDT1,BP,GO:0006364,rRNA processing,2.54e-06,2.10e-05,6/19,204/9080
CD4T,rs4147638_SMDT1,BP,GO:0016072,rRNA metabolic process,3.18e-06,2.54e-05,6/19,212/9080
CD4T,rs4147638_SMDT1,BP,GO:0000027,ribosomal large subunit assembly,1.74e-05,1.35e-04,3/19,25/9080
CD4T,rs4147638_SMDT1,BP,GO:0034470,ncRNA processing,5.05e-05,3.80e-04,6/19,344/9080
CD4T,rs4147638_SMDT1,BP,GO:0034660,ncRNA metabolic process,1.15e-04,8.42e-04,6/19,399/9080
CD4T,rs4147638_SMDT1,BP,GO:0000028,ribosomal small subunit assembly,6.22e-04,4.41e-03,2/19,18/9080
CD4T,rs4147638_SMDT1,CC,GO:0022626,cytosolic ribosome,1.43e-32,7.45e-31,17/19,101/9383
CD4T,rs4147638_SMDT1,CC,GO:0044391,ribosomal subunit,3.01e-28,7.83e-27,17/19,175/9383
CD4T,rs4147638_SMDT1,CC,GO:0005840,ribosome,6.99e-27,1.21e-25,17/19,209/9383
CD4T,rs4147638_SMDT1,CC,GO:0022625,cytosolic large ribosomal subunit,3.04e-16,3.95e-15,9/19,54/9383
CD4T,rs4147638_SMDT1,CC,GO:0022627,cytosolic small ribosomal subunit,8.68e-15,9.03e-14,8/19,44/9383
CD4T,rs4147638_SMDT1,CC,GO:0015934,large ribosomal subunit,2.12e-13,1.84e-12,9/19,108/9383
CD4T,rs4147638_SMDT1,CC,GO:0015935,small ribosomal subunit,4.50e-13,3.34e-12,8/19,70/9383
CD4T,rs4147638_SMDT1,CC,GO:0005925,focal adhesion,6.03e-11,3.85e-10,10/19,296/9383
CD4T,rs4147638_SMDT1,CC,GO:0030055,cell-substrate junction,6.67e-11,3.85e-10,10/19,299/9383
CD4T,rs4147638_SMDT1,CC,GO:0070161,anchoring junction,5.12e-09,2.66e-08,10/19,466/9383
CD4T,rs4147638_SMDT1,CC,GO:0014069,postsynaptic density,9.47e-07,4.24e-06,6/19,178/9383
CD4T,rs4147638_SMDT1,CC,GO:0032279,asymmetric synapse,9.79e-07,4.24e-06,6/19,179/9383
CD4T,rs4147638_SMDT1,CC,GO:0098984,neuron to neuron synapse,1.19e-06,4.27e-06,6/19,185/9383
CD4T,rs4147638_SMDT1,CC,GO:0099572,postsynaptic specialization,1.23e-06,4.27e-06,6/19,186/9383
CD4T,rs4147638_SMDT1,CC,GO:0098794,postsynapse,1.23e-06,4.27e-06,7/19,303/9383
CD4T,rs4147638_SMDT1,CC,GO:0005844,polysome,6.22e-06,2.02e-05,4/19,62/9383
CD4T,rs4147638_SMDT1,CC,GO:0042788,polysomal ribosome,3.05e-05,9.34e-05,3/19,31/9383
CD4T,rs4147638_SMDT1,CC,GO:0044305,calyx of Held,1.61e-02,4.65e-02,1/19,8/9383
CD4T,rs4147638_SMDT1,MF,GO:0003735,structural constituent of ribosome,2.10e-29,7.35e-28,17/19,150/9332
CD4T,rs4147638_SMDT1,MF,GO:0005198,structural molecule activity,6.58e-26,1.15e-24,18/19,325/9332
CD4T,rs4147638_SMDT1,MF,GO:0019843,rRNA binding,5.87e-08,6.85e-07,5/19,54/9332
CD4T,rs4147638_SMDT1,MF,GO:0008097,5S rRNA binding,1.40e-04,1.23e-03,2/19,9/9332
CD4T,rs4147638_SMDT1,MF,GO:0048027,mRNA 5'-UTR binding,8.85e-04,5.59e-03,2/19,22/9332
CD4T,rs4147638_SMDT1,MF,GO:0003729,mRNA binding,9.59e-04,5.59e-03,4/19,225/9332
CD4T,rs4147638_SMDT1,MF,GO:1990948,ubiquitin ligase inhibitor activity,1.01e-02,4.26e-02,1/19,5/9332
CD4T,rs4147638_SMDT1,MF,GO:0050998,nitric-oxide synthase binding,1.22e-02,4.26e-02,1/19,6/9332
CD4T,rs4147638_SMDT1,MF,GO:0055105,ubiquitin-protein transferase inhibitor activity,1.22e-02,4.26e-02,1/19,6/9332
CD4T,rs4147638_SMDT1,MF,GO:0099186,structural constituent of postsynapse,1.22e-02,4.26e-02,1/19,6/9332
CD4T,rs4147638_SMDT1,MF,GO:0098918,structural constituent of synapse,1.42e-02,4.51e-02,1/19,7/9332
CD4T,rs7605824_SH3YL1,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,4.36e-32,9.91e-30,17/20,94/9080
CD4T,rs7605824_SH3YL1,BP,GO:0006613,cotranslational protein targeting to membrane,9.46e-32,1.07e-29,17/20,98/9080
CD4T,rs7605824_SH3YL1,BP,GO:0045047,protein targeting to ER,4.79e-31,3.63e-29,17/20,107/9080
CD4T,rs7605824_SH3YL1,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,7.96e-31,4.52e-29,17/20,110/9080
CD4T,rs7605824_SH3YL1,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",2.46e-30,1.12e-28,17/20,117/9080
CD4T,rs7605824_SH3YL1,BP,GO:0006413,translational initiation,1.56e-29,5.42e-28,18/20,179/9080
CD4T,rs7605824_SH3YL1,BP,GO:0070972,protein localization to endoplasmic reticulum,1.67e-29,5.42e-28,17/20,130/9080
CD4T,rs7605824_SH3YL1,BP,GO:0006612,protein targeting to membrane,1.50e-27,4.25e-26,17/20,167/9080
CD4T,rs7605824_SH3YL1,BP,GO:0019083,viral transcription,2.53e-27,6.39e-26,17/20,172/9080
CD4T,rs7605824_SH3YL1,BP,GO:0019080,viral gene expression,1.23e-26,2.79e-25,17/20,188/9080
CD4T,rs7605824_SH3YL1,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,1.35e-26,2.79e-25,17/20,189/9080
CD4T,rs7605824_SH3YL1,BP,GO:0006402,mRNA catabolic process,8.29e-25,1.57e-23,18/20,321/9080
CD4T,rs7605824_SH3YL1,BP,GO:0006401,RNA catabolic process,4.29e-24,7.50e-23,18/20,351/9080
CD4T,rs7605824_SH3YL1,BP,GO:0090150,establishment of protein localization to membrane,7.10e-24,1.15e-22,17/20,270/9080
CD4T,rs7605824_SH3YL1,BP,GO:0034655,nucleobase-containing compound catabolic process,3.31e-22,5.01e-21,18/20,445/9080
CD4T,rs7605824_SH3YL1,BP,GO:0046700,heterocycle catabolic process,5.17e-22,7.34e-21,18/20,456/9080
CD4T,rs7605824_SH3YL1,BP,GO:0044270,cellular nitrogen compound catabolic process,5.83e-22,7.78e-21,18/20,459/9080
CD4T,rs7605824_SH3YL1,BP,GO:0019439,aromatic compound catabolic process,7.10e-22,8.96e-21,18/20,464/9080
CD4T,rs7605824_SH3YL1,BP,GO:1901361,organic cyclic compound catabolic process,8.98e-22,1.07e-20,18/20,470/9080
CD4T,rs7605824_SH3YL1,BP,GO:0006605,protein targeting,9.96e-22,1.13e-20,17/20,359/9080
CD4T,rs7605824_SH3YL1,BP,GO:0072657,protein localization to membrane,4.18e-20,4.52e-19,17/20,446/9080
CD4T,rs7605824_SH3YL1,BP,GO:0072594,establishment of protein localization to organelle,8.24e-20,8.50e-19,17/20,464/9080
CD4T,rs7605824_SH3YL1,BP,GO:0042255,ribosome assembly,1.36e-09,1.34e-08,6/20,55/9080
CD4T,rs7605824_SH3YL1,BP,GO:0042254,ribosome biogenesis,6.22e-08,5.88e-07,8/20,277/9080
CD4T,rs7605824_SH3YL1,BP,GO:0000027,ribosomal large subunit assembly,2.10e-07,1.91e-06,4/20,25/9080
CD4T,rs7605824_SH3YL1,BP,GO:0042273,ribosomal large subunit biogenesis,2.68e-07,2.34e-06,5/20,67/9080
CD4T,rs7605824_SH3YL1,BP,GO:0022613,ribonucleoprotein complex biogenesis,9.87e-07,8.30e-06,8/20,397/9080
CD4T,rs7605824_SH3YL1,BP,GO:0002181,cytoplasmic translation,1.32e-06,1.07e-05,5/20,92/9080
CD4T,rs7605824_SH3YL1,BP,GO:0042274,ribosomal small subunit biogenesis,1.35e-05,1.06e-04,4/20,69/9080
CD4T,rs7605824_SH3YL1,BP,GO:0022618,ribonucleoprotein complex assembly,2.75e-05,2.08e-04,5/20,171/9080
CD4T,rs7605824_SH3YL1,BP,GO:0071826,ribonucleoprotein complex subunit organization,3.34e-05,2.45e-04,5/20,178/9080
CD4T,rs7605824_SH3YL1,BP,GO:0006364,rRNA processing,9.04e-04,6.41e-03,4/20,204/9080
CD4T,rs7605824_SH3YL1,BP,GO:0016072,rRNA metabolic process,1.04e-03,7.18e-03,4/20,212/9080
CD4T,rs7605824_SH3YL1,BP,GO:0034470,ncRNA processing,6.06e-03,4.05e-02,4/20,344/9080
CD4T,rs7605824_SH3YL1,CC,GO:0022626,cytosolic ribosome,9.47e-32,3.22e-30,17/20,101/9383
CD4T,rs7605824_SH3YL1,CC,GO:0044391,ribosomal subunit,1.97e-27,3.36e-26,17/20,175/9383
CD4T,rs7605824_SH3YL1,CC,GO:0005840,ribosome,4.57e-26,5.18e-25,17/20,209/9383
CD4T,rs7605824_SH3YL1,CC,GO:0022625,cytosolic large ribosomal subunit,1.25e-20,1.06e-19,11/20,54/9383
CD4T,rs7605824_SH3YL1,CC,GO:0015934,large ribosomal subunit,4.30e-17,2.93e-16,11/20,108/9383
CD4T,rs7605824_SH3YL1,CC,GO:0005925,focal adhesion,1.17e-10,6.29e-10,10/20,296/9383
CD4T,rs7605824_SH3YL1,CC,GO:0030055,cell-substrate junction,1.30e-10,6.29e-10,10/20,299/9383
CD4T,rs7605824_SH3YL1,CC,GO:0022627,cytosolic small ribosomal subunit,2.75e-10,1.17e-09,6/20,44/9383
CD4T,rs7605824_SH3YL1,CC,GO:0042788,polysomal ribosome,4.20e-09,1.59e-08,5/20,31/9383
CD4T,rs7605824_SH3YL1,CC,GO:0015935,small ribosomal subunit,4.95e-09,1.68e-08,6/20,70/9383
CD4T,rs7605824_SH3YL1,CC,GO:0070161,anchoring junction,9.79e-09,3.03e-08,10/20,466/9383
CD4T,rs7605824_SH3YL1,CC,GO:0005844,polysome,1.54e-07,4.35e-07,5/20,62/9383
CD4T,rs7605824_SH3YL1,CC,GO:0014069,postsynaptic density,4.78e-04,1.19e-03,4/20,178/9383
CD4T,rs7605824_SH3YL1,CC,GO:0032279,asymmetric synapse,4.89e-04,1.19e-03,4/20,179/9383
CD4T,rs7605824_SH3YL1,CC,GO:0098984,neuron to neuron synapse,5.53e-04,1.20e-03,4/20,185/9383
CD4T,rs7605824_SH3YL1,CC,GO:0099572,postsynaptic specialization,5.65e-04,1.20e-03,4/20,186/9383
CD4T,rs7605824_SH3YL1,CC,GO:0098794,postsynapse,3.43e-03,6.86e-03,4/20,303/9383
CD4T,rs7605824_SH3YL1,CC,GO:0031616,spindle pole centrosome,1.90e-02,3.59e-02,1/20,9/9383
CD4T,rs7605824_SH3YL1,MF,GO:0003735,structural constituent of ribosome,1.38e-28,5.94e-27,17/20,150/9332
CD4T,rs7605824_SH3YL1,MF,GO:0005198,structural molecule activity,1.12e-22,2.41e-21,17/20,325/9332
CD4T,rs7605824_SH3YL1,MF,GO:0019843,rRNA binding,4.53e-06,6.49e-05,4/20,54/9332
CD4T,rs7605824_SH3YL1,MF,GO:0008097,5S rRNA binding,1.56e-04,1.67e-03,2/20,9/9332
CD4T,rs7605824_SH3YL1,MF,GO:0048027,mRNA 5'-UTR binding,9.82e-04,8.45e-03,2/20,22/9332
CD4T,rs7632486_CMTM8,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,1.70e-09,5.37e-07,6/13,94/9080
CD4T,rs7632486_CMTM8,BP,GO:0006613,cotranslational protein targeting to membrane,2.19e-09,5.37e-07,6/13,98/9080
CD4T,rs7632486_CMTM8,BP,GO:0045047,protein targeting to ER,3.73e-09,5.42e-07,6/13,107/9080
CD4T,rs7632486_CMTM8,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,4.41e-09,5.42e-07,6/13,110/9080
CD4T,rs7632486_CMTM8,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",6.42e-09,6.30e-07,6/13,117/9080
CD4T,rs7632486_CMTM8,BP,GO:0070972,protein localization to endoplasmic reticulum,1.21e-08,9.92e-07,6/13,130/9080
CD4T,rs7632486_CMTM8,BP,GO:0006612,protein targeting to membrane,5.46e-08,3.83e-06,6/13,167/9080
CD4T,rs7632486_CMTM8,BP,GO:0019083,viral transcription,6.51e-08,4.00e-06,6/13,172/9080
CD4T,rs7632486_CMTM8,BP,GO:0006413,translational initiation,8.26e-08,4.51e-06,6/13,179/9080
CD4T,rs7632486_CMTM8,BP,GO:0019080,viral gene expression,1.11e-07,5.10e-06,6/13,188/9080
CD4T,rs7632486_CMTM8,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,1.14e-07,5.10e-06,6/13,189/9080
CD4T,rs7632486_CMTM8,BP,GO:0090150,establishment of protein localization to membrane,9.42e-07,3.85e-05,6/13,270/9080
CD4T,rs7632486_CMTM8,BP,GO:0072594,establishment of protein localization to organelle,1.14e-06,4.31e-05,7/13,464/9080
CD4T,rs7632486_CMTM8,BP,GO:0006402,mRNA catabolic process,2.59e-06,9.09e-05,6/13,321/9080
CD4T,rs7632486_CMTM8,BP,GO:0006401,RNA catabolic process,4.36e-06,1.43e-04,6/13,351/9080
CD4T,rs7632486_CMTM8,BP,GO:0006605,protein targeting,4.97e-06,1.52e-04,6/13,359/9080
CD4T,rs7632486_CMTM8,BP,GO:0034655,nucleobase-containing compound catabolic process,1.71e-05,4.73e-04,6/13,445/9080
CD4T,rs7632486_CMTM8,BP,GO:0072657,protein localization to membrane,1.74e-05,4.73e-04,6/13,446/9080
CD4T,rs7632486_CMTM8,BP,GO:0031343,positive regulation of cell killing,1.88e-05,4.78e-04,3/13,38/9080
CD4T,rs7632486_CMTM8,BP,GO:0046700,heterocycle catabolic process,1.97e-05,4.78e-04,6/13,456/9080
CD4T,rs7632486_CMTM8,BP,GO:0044270,cellular nitrogen compound catabolic process,2.05e-05,4.78e-04,6/13,459/9080
CD4T,rs7632486_CMTM8,BP,GO:0019439,aromatic compound catabolic process,2.18e-05,4.86e-04,6/13,464/9080
CD4T,rs7632486_CMTM8,BP,GO:1901361,organic cyclic compound catabolic process,2.34e-05,5.00e-04,6/13,470/9080
CD4T,rs7632486_CMTM8,BP,GO:0002480,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent",3.96e-05,8.10e-04,2/13,7/9080
CD4T,rs7632486_CMTM8,BP,GO:0031341,regulation of cell killing,5.76e-05,1.13e-03,3/13,55/9080
CD4T,rs7632486_CMTM8,BP,GO:0002483,antigen processing and presentation of endogenous peptide antigen,1.24e-04,2.17e-03,2/13,12/9080
CD4T,rs7632486_CMTM8,BP,GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,1.24e-04,2.17e-03,2/13,12/9080
CD4T,rs7632486_CMTM8,BP,GO:0090343,positive regulation of cell aging,1.24e-04,2.17e-03,2/13,12/9080
CD4T,rs7632486_CMTM8,BP,GO:0001916,positive regulation of T cell mediated cytotoxicity,1.46e-04,2.48e-03,2/13,13/9080
CD4T,rs7632486_CMTM8,BP,GO:0019883,antigen processing and presentation of endogenous antigen,1.71e-04,2.79e-03,2/13,14/9080
CD4T,rs7632486_CMTM8,BP,GO:0001906,cell killing,1.97e-04,3.12e-03,3/13,83/9080
CD4T,rs7632486_CMTM8,BP,GO:0001914,regulation of T cell mediated cytotoxicity,2.86e-04,4.39e-03,2/13,18/9080
CD4T,rs7632486_CMTM8,BP,GO:0071346,cellular response to interferon-gamma,5.29e-04,7.87e-03,3/13,116/9080
CD4T,rs7632486_CMTM8,BP,GO:0001913,T cell mediated cytotoxicity,5.57e-04,8.05e-03,2/13,25/9080
CD4T,rs7632486_CMTM8,BP,GO:0034341,response to interferon-gamma,7.22e-04,1.01e-02,3/13,129/9080
CD4T,rs7632486_CMTM8,BP,GO:0002711,positive regulation of T cell mediated immunity,8.60e-04,1.17e-02,2/13,31/9080
CD4T,rs7632486_CMTM8,BP,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,9.16e-04,1.22e-02,2/13,32/9080
CD4T,rs7632486_CMTM8,BP,GO:0090342,regulation of cell aging,1.29e-03,1.67e-02,2/13,38/9080
CD4T,rs7632486_CMTM8,BP,GO:0002709,regulation of T cell mediated immunity,1.73e-03,2.18e-02,2/13,44/9080
CD4T,rs7632486_CMTM8,BP,GO:0001910,regulation of leukocyte mediated cytotoxicity,1.81e-03,2.22e-02,2/13,45/9080
CD4T,rs7632486_CMTM8,BP,GO:0002479,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",3.63e-03,4.35e-02,2/13,64/9080
CD4T,rs7632486_CMTM8,BP,GO:0001909,leukocyte mediated cytotoxicity,3.74e-03,4.37e-02,2/13,65/9080
CD4T,rs7632486_CMTM8,BP,GO:0002708,positive regulation of lymphocyte mediated immunity,3.85e-03,4.39e-02,2/13,66/9080
CD4T,rs7632486_CMTM8,BP,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,3.97e-03,4.39e-02,2/13,67/9080
CD4T,rs7632486_CMTM8,BP,GO:0060333,interferon-gamma-mediated signaling pathway,4.09e-03,4.39e-02,2/13,68/9080
CD4T,rs7632486_CMTM8,BP,GO:0002456,T cell mediated immunity,4.21e-03,4.39e-02,2/13,69/9080
CD4T,rs7632486_CMTM8,BP,GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,4.21e-03,4.39e-02,2/13,69/9080
CD4T,rs7632486_CMTM8,BP,GO:0002821,positive regulation of adaptive immune response,4.57e-03,4.68e-02,2/13,72/9080
CD4T,rs7632486_CMTM8,CC,GO:0022626,cytosolic ribosome,2.16e-09,1.95e-07,6/13,101/9383
CD4T,rs7632486_CMTM8,CC,GO:0044391,ribosomal subunit,5.95e-08,2.68e-06,6/13,175/9383
CD4T,rs7632486_CMTM8,CC,GO:0005840,ribosome,1.71e-07,5.14e-06,6/13,209/9383
CD4T,rs7632486_CMTM8,CC,GO:0022627,cytosolic small ribosomal subunit,2.92e-07,6.56e-06,4/13,44/9383
CD4T,rs7632486_CMTM8,CC,GO:0015935,small ribosomal subunit,1.93e-06,3.48e-05,4/13,70/9383
CD4T,rs7632486_CMTM8,CC,GO:0042612,MHC class I protein complex,3.71e-05,5.56e-04,2/13,7/9383
CD4T,rs7632486_CMTM8,CC,GO:0042611,MHC protein complex,2.99e-04,3.84e-03,2/13,19/9383
CD4T,rs7632486_CMTM8,CC,GO:0012507,ER to Golgi transport vesicle membrane,2.09e-03,2.32e-02,2/13,50/9383
CD4T,rs7632486_CMTM8,CC,GO:0022625,cytosolic large ribosomal subunit,2.43e-03,2.32e-02,2/13,54/9383
CD4T,rs7632486_CMTM8,CC,GO:0030670,phagocytic vesicle membrane,2.62e-03,2.32e-02,2/13,56/9383
CD4T,rs7632486_CMTM8,CC,GO:0070161,anchoring junction,3.00e-03,2.32e-02,4/13,466/9383
CD4T,rs7632486_CMTM8,CC,GO:0055038,recycling endosome membrane,3.10e-03,2.32e-02,2/13,61/9383
CD4T,rs7632486_CMTM8,CC,GO:0030134,COPII-coated ER to Golgi transport vesicle,4.52e-03,3.13e-02,2/13,74/9383
CD4T,rs7632486_CMTM8,CC,GO:0030660,Golgi-associated vesicle membrane,5.79e-03,3.61e-02,2/13,84/9383
CD4T,rs7632486_CMTM8,CC,GO:0005638,lamin filament,6.91e-03,3.61e-02,1/13,5/9383
CD4T,rs7632486_CMTM8,CC,GO:0030666,endocytic vesicle membrane,6.91e-03,3.61e-02,2/13,92/9383
CD4T,rs7632486_CMTM8,CC,GO:0005925,focal adhesion,7.03e-03,3.61e-02,3/13,296/9383
CD4T,rs7632486_CMTM8,CC,GO:0030055,cell-substrate junction,7.23e-03,3.61e-02,3/13,299/9383
CD4T,rs7632486_CMTM8,CC,GO:0031901,early endosome membrane,7.81e-03,3.70e-02,2/13,98/9383
CD4T,rs7632486_CMTM8,CC,GO:0045335,phagocytic vesicle,9.09e-03,3.95e-02,2/13,106/9383
CD4T,rs7632486_CMTM8,CC,GO:0015934,large ribosomal subunit,9.43e-03,3.95e-02,2/13,108/9383
CD4T,rs7632486_CMTM8,CC,GO:0042824,MHC class I peptide loading complex,9.66e-03,3.95e-02,1/13,7/9383
CD4T,rs7632486_CMTM8,CC,GO:0030176,integral component of endoplasmic reticulum membrane,1.08e-02,3.97e-02,2/13,116/9383
CD4T,rs7632486_CMTM8,CC,GO:0030658,transport vesicle membrane,1.15e-02,3.97e-02,2/13,120/9383
CD4T,rs7632486_CMTM8,CC,GO:0031227,intrinsic component of endoplasmic reticulum membrane,1.15e-02,3.97e-02,2/13,120/9383
CD4T,rs7632486_CMTM8,CC,GO:0055037,recycling endosome,1.17e-02,3.97e-02,2/13,121/9383
CD4T,rs7632486_CMTM8,CC,GO:0030662,coated vesicle membrane,1.19e-02,3.97e-02,2/13,122/9383
CD4T,rs7632486_CMTM8,CC,GO:0005798,Golgi-associated vesicle,1.34e-02,4.32e-02,2/13,130/9383
CD4T,rs7632486_CMTM8,CC,GO:0005652,nuclear lamina,1.51e-02,4.70e-02,1/13,11/9383
CD4T,rs7632486_CMTM8,MF,GO:0003735,structural constituent of ribosome,2.44e-08,1.07e-06,6/13,150/9332
CD4T,rs7632486_CMTM8,MF,GO:0005198,structural molecule activity,2.38e-06,5.23e-05,6/13,325/9332
CD4T,rs7632486_CMTM8,MF,GO:0048027,mRNA 5'-UTR binding,4.07e-04,5.97e-03,2/13,22/9332
CD4T,rs7632486_CMTM8,MF,GO:0048306,calcium-dependent protein binding,1.29e-03,1.42e-02,2/13,39/9332
CD4T,rs9022_CLN8,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,1.04e-03,4.67e-02,2/5,94/9080
CD4T,rs9022_CLN8,BP,GO:0006613,cotranslational protein targeting to membrane,1.13e-03,4.67e-02,2/5,98/9080
CD4T,rs9022_CLN8,BP,GO:0072594,establishment of protein localization to organelle,1.23e-03,4.67e-02,3/5,464/9080
CD4T,rs9022_CLN8,BP,GO:0045047,protein targeting to ER,1.34e-03,4.67e-02,2/5,107/9080
CD4T,rs9022_CLN8,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,1.42e-03,4.67e-02,2/5,110/9080
CD4T,rs9022_CLN8,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",1.61e-03,4.67e-02,2/5,117/9080
CD4T,rs9022_CLN8,BP,GO:0070972,protein localization to endoplasmic reticulum,1.98e-03,4.67e-02,2/5,130/9080
CD4T,rs9022_CLN8,BP,GO:0010616,negative regulation of cardiac muscle adaptation,2.75e-03,4.67e-02,1/5,5/9080
CD4T,rs9022_CLN8,BP,GO:0055015,ventricular cardiac muscle cell development,2.75e-03,4.67e-02,1/5,5/9080
CD4T,rs9022_CLN8,BP,GO:1903026,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,2.75e-03,4.67e-02,1/5,5/9080
CD4T,rs9022_CLN8,BP,GO:1903243,negative regulation of cardiac muscle hypertrophy in response to stress,2.75e-03,4.67e-02,1/5,5/9080
CD4T,rs9022_CLN8,BP,GO:0006612,protein targeting to membrane,3.24e-03,4.67e-02,2/5,167/9080
CD4T,rs9022_CLN8,BP,GO:0010612,regulation of cardiac muscle adaptation,3.30e-03,4.67e-02,1/5,6/9080
CD4T,rs9022_CLN8,BP,GO:0030952,establishment or maintenance of cytoskeleton polarity,3.30e-03,4.67e-02,1/5,6/9080
CD4T,rs9022_CLN8,BP,GO:0042989,sequestering of actin monomers,3.30e-03,4.67e-02,1/5,6/9080
CD4T,rs9022_CLN8,BP,GO:1903242,regulation of cardiac muscle hypertrophy in response to stress,3.30e-03,4.67e-02,1/5,6/9080
CD4T,rs9022_CLN8,BP,GO:0019083,viral transcription,3.44e-03,4.67e-02,2/5,172/9080
CD4T,rs9022_CLN8,BP,GO:0006413,translational initiation,3.72e-03,4.67e-02,2/5,179/9080
CD4T,rs9022_CLN8,BP,GO:0051351,positive regulation of ligase activity,3.85e-03,4.67e-02,1/5,7/9080
CD4T,rs9022_CLN8,BP,GO:0051574,positive regulation of histone H3-K9 methylation,3.85e-03,4.67e-02,1/5,7/9080
CD4T,rs9022_CLN8,BP,GO:0019080,viral gene expression,4.09e-03,4.67e-02,2/5,188/9080
CD4T,rs9022_CLN8,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,4.14e-03,4.67e-02,2/5,189/9080
CD4T,rs9022_CLN8,BP,GO:0007253,cytoplasmic sequestering of NF-kappaB,4.40e-03,4.67e-02,1/5,8/9080
CD4T,rs9022_CLN8,BP,GO:0014745,negative regulation of muscle adaptation,4.40e-03,4.67e-02,1/5,8/9080
CD4T,rs9022_CLN8,BP,GO:0051340,regulation of ligase activity,4.40e-03,4.67e-02,1/5,8/9080
CD4T,rs9022_CLN8,BP,GO:0055012,ventricular cardiac muscle cell differentiation,4.40e-03,4.67e-02,1/5,8/9080
CD4T,rs9022_CLN8,BP,GO:2001028,positive regulation of endothelial cell chemotaxis,4.40e-03,4.67e-02,1/5,8/9080
CD4T,rs9022_CLN8,BP,GO:2001171,positive regulation of ATP biosynthetic process,4.40e-03,4.67e-02,1/5,8/9080
CD4T,rs9022_CLN8,BP,GO:0030810,positive regulation of nucleotide biosynthetic process,4.95e-03,4.74e-02,1/5,9/9080
CD4T,rs9022_CLN8,BP,GO:1900112,regulation of histone H3-K9 trimethylation,4.95e-03,4.74e-02,1/5,9/9080
CD4T,rs9022_CLN8,BP,GO:1900373,positive regulation of purine nucleotide biosynthetic process,4.95e-03,4.74e-02,1/5,9/9080
CD4T,rs9022_CLN8,BP,GO:0007084,mitotic nuclear envelope reassembly,5.50e-03,4.80e-02,1/5,10/9080
CD4T,rs9022_CLN8,BP,GO:1903025,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,5.50e-03,4.80e-02,1/5,10/9080
CD4T,rs9022_CLN8,BP,GO:2001026,regulation of endothelial cell chemotaxis,5.50e-03,4.80e-02,1/5,10/9080
CD4T,rs9022_CLN8,BP,GO:0003299,muscle hypertrophy in response to stress,6.59e-03,4.82e-02,1/5,12/9080
CD4T,rs9022_CLN8,BP,GO:0014887,cardiac muscle adaptation,6.59e-03,4.82e-02,1/5,12/9080
CD4T,rs9022_CLN8,BP,GO:0014898,cardiac muscle hypertrophy in response to stress,6.59e-03,4.82e-02,1/5,12/9080
CD4T,rs9022_CLN8,BP,GO:0090343,positive regulation of cell aging,6.59e-03,4.82e-02,1/5,12/9080
CD4T,rs9022_CLN8,BP,GO:2000678,negative regulation of transcription regulatory region DNA binding,6.59e-03,4.82e-02,1/5,12/9080
CD4T,rs9022_CLN8,BP,GO:2001169,regulation of ATP biosynthetic process,6.59e-03,4.82e-02,1/5,12/9080
CD4T,rs9022_CLN8,BP,GO:0010463,mesenchymal cell proliferation,7.14e-03,4.82e-02,1/5,13/9080
CD4T,rs9022_CLN8,BP,GO:0010464,regulation of mesenchymal cell proliferation,7.14e-03,4.82e-02,1/5,13/9080
CD4T,rs9022_CLN8,BP,GO:0032717,negative regulation of interleukin-8 production,7.14e-03,4.82e-02,1/5,13/9080
CD4T,rs9022_CLN8,BP,GO:0036124,histone H3-K9 trimethylation,7.14e-03,4.82e-02,1/5,13/9080
CD4T,rs9022_CLN8,BP,GO:0035767,endothelial cell chemotaxis,7.69e-03,4.83e-02,1/5,14/9080
CD4T,rs9022_CLN8,BP,GO:0042994,cytoplasmic sequestering of transcription factor,7.69e-03,4.83e-02,1/5,14/9080
CD4T,rs9022_CLN8,BP,GO:0010155,regulation of proton transport,8.23e-03,4.83e-02,1/5,15/9080
CD4T,rs9022_CLN8,BP,GO:0090201,negative regulation of release of cytochrome c from mitochondria,8.23e-03,4.83e-02,1/5,15/9080
CD4T,rs9022_CLN8,BP,GO:1901223,negative regulation of NIK/NF-kappaB signaling,8.23e-03,4.83e-02,1/5,15/9080
CD4T,rs9022_CLN8,BP,GO:0010639,negative regulation of organelle organization,8.24e-03,4.83e-02,2/5,269/9080
CD4T,rs9022_CLN8,BP,GO:0090150,establishment of protein localization to membrane,8.30e-03,4.83e-02,2/5,270/9080
CD4T,rs9022_CLN8,CC,GO:0022626,cytosolic ribosome,1.12e-03,3.33e-02,2/5,101/9383
CD4T,rs9022_CLN8,CC,GO:0005638,lamin filament,2.66e-03,3.33e-02,1/5,5/9383
CD4T,rs9022_CLN8,CC,GO:0044391,ribosomal subunit,3.33e-03,3.33e-02,2/5,175/9383
CD4T,rs9022_CLN8,CC,GO:0005840,ribosome,4.72e-03,3.51e-02,2/5,209/9383
CD4T,rs9022_CLN8,CC,GO:0005652,nuclear lamina,5.85e-03,3.51e-02,1/5,11/9383
CD4T,rs9022_CLN8,MF,GO:0003735,structural constituent of ribosome,2.49e-03,1.76e-02,2/5,150/9332
CD4T,rs9022_CLN8,MF,GO:0050786,RAGE receptor binding,5.35e-03,1.76e-02,1/5,10/9332
CD4T,rs9022_CLN8,MF,GO:0003779,actin binding,5.91e-03,1.76e-02,2/5,233/9332
CD4T,rs9022_CLN8,MF,GO:0003785,actin monomer binding,8.01e-03,1.76e-02,1/5,15/9332
CD4T,rs9022_CLN8,MF,GO:0005198,structural molecule activity,1.13e-02,1.76e-02,2/5,325/9332
CD4T,rs9022_CLN8,MF,GO:0048027,mRNA 5'-UTR binding,1.17e-02,1.76e-02,1/5,22/9332
CD4T,rs9022_CLN8,MF,GO:0048306,calcium-dependent protein binding,2.07e-02,2.66e-02,1/5,39/9332
CD4T,rs9271520_HLA-DQA2,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,1.08e-10,3.38e-08,7/16,94/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0006613,cotranslational protein targeting to membrane,1.45e-10,3.38e-08,7/16,98/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0045047,protein targeting to ER,2.71e-10,3.85e-08,7/16,107/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,3.30e-10,3.85e-08,7/16,110/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",5.12e-10,4.77e-08,7/16,117/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0070972,protein localization to endoplasmic reticulum,1.08e-09,8.37e-08,7/16,130/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0006612,protein targeting to membrane,6.25e-09,4.16e-07,7/16,167/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0019083,viral transcription,7.68e-09,4.47e-07,7/16,172/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0006413,translational initiation,1.01e-08,5.25e-07,7/16,179/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0019080,viral gene expression,1.43e-08,6.27e-07,7/16,188/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,1.48e-08,6.27e-07,7/16,189/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0090150,establishment of protein localization to membrane,1.73e-07,6.72e-06,7/16,270/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0072657,protein localization to membrane,2.89e-07,1.04e-05,8/16,446/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0006402,mRNA catabolic process,5.62e-07,1.87e-05,7/16,321/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0006401,RNA catabolic process,1.03e-06,3.20e-05,7/16,351/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0006605,protein targeting,1.20e-06,3.49e-05,7/16,359/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0034655,nucleobase-containing compound catabolic process,5.04e-06,1.38e-04,7/16,445/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0046700,heterocycle catabolic process,5.93e-06,1.48e-04,7/16,456/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0044270,cellular nitrogen compound catabolic process,6.19e-06,1.48e-04,7/16,459/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0019439,aromatic compound catabolic process,6.65e-06,1.48e-04,7/16,464/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0072594,establishment of protein localization to organelle,6.65e-06,1.48e-04,7/16,464/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:1901361,organic cyclic compound catabolic process,7.24e-06,1.53e-04,7/16,470/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0042255,ribosome assembly,1.11e-04,2.26e-03,3/16,55/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0000028,ribosomal small subunit assembly,4.38e-04,8.51e-03,2/16,18/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0071346,cellular response to interferon-gamma,1.01e-03,1.88e-02,3/16,116/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0042254,ribosome biogenesis,1.15e-03,2.07e-02,4/16,277/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0034341,response to interferon-gamma,1.37e-03,2.37e-02,3/16,129/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0031343,positive regulation of cell killing,1.97e-03,3.28e-02,2/16,38/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0030490,maturation of SSU-rRNA,3.00e-03,4.77e-02,2/16,47/9080
CD4T,rs9271520_HLA-DQA2,BP,GO:0022618,ribonucleoprotein complex assembly,3.07e-03,4.77e-02,3/16,171/9080
CD4T,rs9271520_HLA-DQA2,CC,GO:0022626,cytosolic ribosome,1.43e-10,1.45e-08,7/16,101/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0044391,ribosomal subunit,6.91e-09,3.49e-07,7/16,175/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0005840,ribosome,2.37e-08,7.99e-07,7/16,209/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0022625,cytosolic large ribosomal subunit,1.69e-06,4.28e-05,4/16,54/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0015934,large ribosomal subunit,2.72e-05,5.49e-04,4/16,108/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0022627,cytosolic small ribosomal subunit,5.16e-05,8.69e-04,3/16,44/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0005925,focal adhesion,9.91e-05,1.31e-03,5/16,296/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0030055,cell-substrate junction,1.04e-04,1.31e-03,5/16,299/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0015935,small ribosomal subunit,2.08e-04,2.33e-03,3/16,70/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0042611,MHC protein complex,4.58e-04,4.63e-03,2/16,19/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0062023,collagen-containing extracellular matrix,6.12e-04,5.62e-03,3/16,101/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0070161,anchoring junction,8.18e-04,6.89e-03,5/16,466/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0031012,extracellular matrix,1.14e-03,8.29e-03,3/16,125/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0098552,side of membrane,1.21e-03,8.29e-03,4/16,290/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0042788,polysomal ribosome,1.23e-03,8.29e-03,2/16,31/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0014069,postsynaptic density,3.13e-03,1.79e-02,3/16,178/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0032279,asymmetric synapse,3.18e-03,1.79e-02,3/16,179/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0012507,ER to Golgi transport vesicle membrane,3.18e-03,1.79e-02,2/16,50/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0098984,neuron to neuron synapse,3.49e-03,1.79e-02,3/16,185/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0099572,postsynaptic specialization,3.55e-03,1.79e-02,3/16,186/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0005844,polysome,4.86e-03,2.34e-02,2/16,62/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0030134,COPII-coated ER to Golgi transport vesicle,6.86e-03,3.15e-02,2/16,74/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0030660,Golgi-associated vesicle membrane,8.76e-03,3.85e-02,2/16,84/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0019897,extrinsic component of plasma membrane,9.79e-03,4.12e-02,2/16,89/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0030666,endocytic vesicle membrane,1.04e-02,4.22e-02,2/16,92/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0042612,MHC class I protein complex,1.19e-02,4.44e-02,1/16,7/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0042824,MHC class I peptide loading complex,1.19e-02,4.44e-02,1/16,7/9383
CD4T,rs9271520_HLA-DQA2,CC,GO:0098794,postsynapse,1.37e-02,4.93e-02,3/16,303/9383
CD4T,rs9271520_HLA-DQA2,MF,GO:0003735,structural constituent of ribosome,1.39e-09,6.54e-08,7/15,150/9332
CD4T,rs9271520_HLA-DQA2,MF,GO:0005198,structural molecule activity,2.95e-07,6.93e-06,7/15,325/9332
CD4T,rs9271520_HLA-DQA2,MF,GO:0048306,calcium-dependent protein binding,2.97e-05,4.65e-04,3/15,39/9332
CD4T,rs9271520_HLA-DQA2,MF,GO:0019843,rRNA binding,7.93e-05,9.32e-04,3/15,54/9332
CD4T,rs9271520_HLA-DQA2,MF,GO:0070181,small ribosomal subunit rRNA binding,1.08e-04,1.01e-03,2/15,10/9332
CD4T,rs9271520_HLA-DQA2,MF,GO:0048027,mRNA 5'-UTR binding,5.47e-04,4.28e-03,2/15,22/9332
CD4T,rs9271520_HLA-DQA2,MF,GO:0003729,mRNA binding,5.08e-03,3.02e-02,3/15,225/9332
CD4T,rs9271520_HLA-DQA2,MF,GO:0005509,calcium ion binding,5.14e-03,3.02e-02,3/15,226/9332
CD4T,rs1131017_RPS26_positive,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,4.71e-122,9.24e-119,77/179,94/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0006613,cotranslational protein targeting to membrane,8.40e-122,9.24e-119,78/179,98/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0045047,protein targeting to ER,6.15e-114,4.51e-111,77/179,107/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,2.35e-112,1.29e-109,77/179,110/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0006413,translational initiation,1.15e-111,5.07e-109,89/179,179/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",3.41e-111,1.25e-108,78/179,117/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0070972,protein localization to endoplasmic reticulum,1.55e-103,4.88e-101,77/179,130/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0006612,protein targeting to membrane,1.18e-95,3.24e-93,79/179,167/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0019080,viral gene expression,4.98e-94,1.22e-91,81/179,188/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0019083,viral transcription,1.86e-92,4.09e-90,78/179,172/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,3.64e-90,7.29e-88,79/179,189/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0090150,establishment of protein localization to membrane,4.51e-77,8.28e-75,80/179,270/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0006402,mRNA catabolic process,2.89e-73,4.89e-71,82/179,321/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0006401,RNA catabolic process,9.11e-70,1.43e-67,82/179,351/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0006605,protein targeting,1.77e-67,2.59e-65,81/179,359/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0034655,nucleobase-containing compound catabolic process,4.61e-62,6.34e-60,83/179,445/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0046700,heterocycle catabolic process,3.82e-61,4.95e-59,83/179,456/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0044270,cellular nitrogen compound catabolic process,6.74e-61,8.24e-59,83/179,459/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0019439,aromatic compound catabolic process,1.72e-60,1.99e-58,83/179,464/9080
CD4T,rs1131017_RPS26_positive,BP,GO:1901361,organic cyclic compound catabolic process,5.19e-60,5.71e-58,83/179,470/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0072657,protein localization to membrane,4.21e-58,4.42e-56,80/179,446/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0072594,establishment of protein localization to organelle,1.11e-56,1.11e-54,80/179,464/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0002181,cytoplasmic translation,1.03e-46,9.84e-45,41/179,92/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0022613,ribonucleoprotein complex biogenesis,2.28e-31,2.10e-29,54/179,397/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0042254,ribosome biogenesis,4.70e-25,4.14e-23,41/179,277/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0042255,ribosome assembly,6.11e-24,5.17e-22,22/179,55/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0022618,ribonucleoprotein complex assembly,1.08e-21,8.82e-20,31/179,171/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0071826,ribonucleoprotein complex subunit organization,3.78e-21,2.97e-19,31/179,178/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0042273,ribosomal large subunit biogenesis,6.99e-19,5.31e-17,20/179,67/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0006364,rRNA processing,2.27e-15,1.66e-13,27/179,204/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0016072,rRNA metabolic process,6.02e-15,4.28e-13,27/179,212/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0042274,ribosomal small subunit biogenesis,2.04e-13,1.41e-11,16/179,69/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0000028,ribosomal small subunit assembly,1.54e-11,1.02e-09,9/179,18/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0000027,ribosomal large subunit assembly,1.74e-11,1.13e-09,10/179,25/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0002183,cytoplasmic translational initiation,4.31e-10,2.71e-08,10/179,33/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0034470,ncRNA processing,6.26e-10,3.83e-08,27/179,344/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0034660,ncRNA metabolic process,3.69e-09,2.20e-07,28/179,399/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0001732,formation of cytoplasmic translation initiation complex,5.80e-09,3.36e-07,7/179,15/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0006417,regulation of translation,1.07e-07,6.02e-06,22/179,302/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0034248,regulation of cellular amide metabolic process,1.22e-06,6.74e-05,22/179,348/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0000470,maturation of LSU-rRNA,8.95e-06,4.81e-04,6/179,26/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0045727,positive regulation of translation,1.01e-05,5.28e-04,11/179,110/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0010608,posttranscriptional regulation of gene expression,1.35e-05,6.91e-04,25/179,497/9080
CD4T,rs1131017_RPS26_positive,BP,GO:1904667,negative regulation of ubiquitin protein ligase activity,1.70e-05,8.53e-04,4/179,9/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0034250,positive regulation of cellular amide metabolic process,6.45e-05,3.16e-03,11/179,134/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0006414,translational elongation,1.15e-04,5.49e-03,10/179,119/9080
CD4T,rs1131017_RPS26_positive,BP,GO:2000059,negative regulation of ubiquitin-dependent protein catabolic process,1.37e-04,6.41e-03,6/179,41/9080
CD4T,rs1131017_RPS26_positive,BP,GO:1901798,positive regulation of signal transduction by p53 class mediator,1.68e-04,7.72e-03,4/179,15/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0051444,negative regulation of ubiquitin-protein transferase activity,2.21e-04,9.92e-03,4/179,16/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0030490,maturation of SSU-rRNA,2.96e-04,1.30e-02,6/179,47/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0006446,regulation of translational initiation,4.33e-04,1.87e-02,7/179,70/9080
CD4T,rs1131017_RPS26_positive,BP,GO:1904666,regulation of ubiquitin protein ligase activity,5.53e-04,2.34e-02,4/179,20/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0000462,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",5.66e-04,2.35e-02,5/179,35/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0001731,formation of translation preinitiation complex,8.16e-04,3.33e-02,3/179,10/9080
CD4T,rs1131017_RPS26_positive,BP,GO:1903051,negative regulation of proteolysis involved in cellular protein catabolic process,9.34e-04,3.74e-02,6/179,58/9080
CD4T,rs1131017_RPS26_positive,BP,GO:0071353,cellular response to interleukin-4,1.14e-03,4.48e-02,4/179,24/9080
CD4T,rs1131017_RPS26_positive,CC,GO:0022626,cytosolic ribosome,1.65e-119,4.45e-117,78/185,101/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0044391,ribosomal subunit,4.55e-95,6.14e-93,80/185,175/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0005840,ribosome,1.65e-92,1.48e-90,83/185,209/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0022625,cytosolic large ribosomal subunit,2.13e-75,1.44e-73,47/185,54/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0015934,large ribosomal subunit,5.52e-53,2.98e-51,47/185,108/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0022627,cytosolic small ribosomal subunit,2.89e-46,1.30e-44,32/185,44/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0015935,small ribosomal subunit,2.73e-40,1.05e-38,34/185,70/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0042788,polysomal ribosome,1.03e-33,3.47e-32,23/185,31/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0005844,polysome,8.78e-29,2.63e-27,26/185,62/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0005925,focal adhesion,7.38e-25,1.99e-23,42/185,296/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0030055,cell-substrate junction,1.11e-24,2.73e-23,42/185,299/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0070161,anchoring junction,5.00e-18,1.13e-16,43/185,466/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0033290,eukaryotic 48S preinitiation complex,3.16e-09,6.56e-08,7/185,14/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0005852,eukaryotic translation initiation factor 3 complex,1.02e-08,1.83e-07,7/185,16/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0016282,eukaryotic 43S preinitiation complex,1.02e-08,1.83e-07,7/185,16/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0014069,postsynaptic density,1.17e-08,1.98e-07,18/185,178/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0032279,asymmetric synapse,1.28e-08,2.04e-07,18/185,179/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0070993,translation preinitiation complex,1.70e-08,2.55e-07,7/185,17/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0098984,neuron to neuron synapse,2.16e-08,3.07e-07,18/185,185/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0099572,postsynaptic specialization,2.35e-08,3.17e-07,18/185,186/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0098794,postsynapse,2.04e-06,2.63e-05,20/185,303/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0071541,"eukaryotic translation initiation factor 3 complex, eIF3m",4.89e-06,6.00e-05,4/185,7/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0005791,rough endoplasmic reticulum,1.24e-05,1.46e-04,8/185,56/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0034715,pICln-Sm protein complex,1.44e-04,1.62e-03,3/185,6/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0034709,methylosome,1.46e-03,1.51e-02,3/185,12/9383
CD4T,rs1131017_RPS26_positive,CC,GO:0098554,cytoplasmic side of endoplasmic reticulum membrane,1.46e-03,1.51e-02,3/185,12/9383
CD4T,rs1131017_RPS26_positive,MF,GO:0003735,structural constituent of ribosome,1.31e-100,4.44e-98,79/183,150/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0005198,structural molecule activity,8.40e-70,1.43e-67,80/183,325/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0019843,rRNA binding,1.29e-22,1.46e-20,21/183,54/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0045182,translation regulator activity,4.80e-13,4.08e-11,19/183,113/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0008135,"translation factor activity, RNA binding",9.12e-12,6.20e-10,15/183,74/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0090079,"translation regulator activity, nucleic acid binding",1.50e-11,8.50e-10,16/183,90/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0048027,mRNA 5'-UTR binding,4.75e-09,2.31e-07,8/183,22/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0003743,translation initiation factor activity,2.26e-08,9.59e-07,10/183,48/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0003729,mRNA binding,3.95e-07,1.49e-05,18/183,225/9332
CD4T,rs1131017_RPS26_positive,MF,GO:1990948,ubiquitin ligase inhibitor activity,7.05e-07,2.40e-05,4/183,5/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0055105,ubiquitin-protein transferase inhibitor activity,2.08e-06,6.44e-05,4/183,6/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0045296,cadherin binding,3.60e-06,1.02e-04,17/183,236/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0050839,cell adhesion molecule binding,8.76e-06,2.29e-04,19/183,307/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0003746,translation elongation factor activity,1.01e-05,2.44e-04,5/183,16/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0008097,5S rRNA binding,1.67e-05,3.78e-04,4/183,9/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0043022,ribosome binding,3.71e-05,7.89e-04,7/183,48/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0043021,ribonucleoprotein complex binding,1.03e-04,2.05e-03,10/183,118/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0055106,ubiquitin-protein transferase regulator activity,2.17e-04,4.09e-03,4/183,16/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0070181,small ribosomal subunit rRNA binding,8.04e-04,1.44e-02,3/183,10/9332
CD4T,rs1131017_RPS26_positive,MF,GO:0005539,glycosaminoglycan binding,9.97e-04,1.69e-02,6/183,59/9332
CD4T,rs1131017_RPS26_negative,BP,GO:0098609,cell-cell adhesion,1.60e-13,5.61e-10,32/151,415/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0046649,lymphocyte activation,3.24e-13,5.67e-10,34/151,482/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042110,T cell activation,1.45e-12,1.69e-09,28/151,341/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030155,regulation of cell adhesion,9.49e-12,8.31e-09,30/151,424/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002694,regulation of leukocyte activation,1.19e-11,8.32e-09,27/151,345/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051249,regulation of lymphocyte activation,2.40e-11,1.40e-08,25/151,303/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050865,regulation of cell activation,4.12e-11,2.06e-08,27/151,364/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071346,cellular response to interferon-gamma,6.42e-11,2.81e-08,16/151,116/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0034341,response to interferon-gamma,3.27e-10,1.27e-07,16/151,129/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045785,positive regulation of cell adhesion,4.75e-10,1.62e-07,22/151,268/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002250,adaptive immune response,5.47e-10,1.62e-07,22/151,270/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0007159,leukocyte cell-cell adhesion,5.54e-10,1.62e-07,21/151,245/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050863,regulation of T cell activation,1.24e-09,3.34e-07,20/151,231/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001817,regulation of cytokine production,2.37e-09,5.92e-07,27/151,436/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030029,actin filament-based process,2.82e-09,6.57e-07,26/151,409/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903037,regulation of leukocyte cell-cell adhesion,4.04e-09,8.84e-07,19/151,222/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0022407,regulation of cell-cell adhesion,4.85e-09,9.98e-07,21/151,276/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001816,cytokine production,5.49e-09,1.07e-06,28/151,485/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0040017,positive regulation of locomotion,1.10e-08,2.03e-06,21/151,289/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0060333,interferon-gamma-mediated signaling pathway,1.27e-08,2.22e-06,11/151,68/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0022409,positive regulation of cell-cell adhesion,1.57e-08,2.61e-06,17/151,191/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002507,tolerance induction,1.98e-08,3.07e-06,7/151,20/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070663,regulation of leukocyte proliferation,2.02e-08,3.07e-06,15/151,148/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051050,positive regulation of transport,2.22e-08,3.24e-06,27/151,484/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002480,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent",2.43e-08,3.41e-06,5/151,7/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903039,positive regulation of leukocyte cell-cell adhesion,2.69e-08,3.62e-06,16/151,174/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050900,leukocyte migration,3.04e-08,3.94e-06,19/151,251/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050778,positive regulation of immune response,3.24e-08,4.00e-06,25/151,428/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050777,negative regulation of immune response,3.34e-08,4.00e-06,12/151,92/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042098,T cell proliferation,3.43e-08,4.00e-06,14/151,132/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2000147,positive regulation of cell motility,4.56e-08,5.15e-06,20/151,285/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0019883,antigen processing and presentation of endogenous antigen,5.15e-08,5.64e-06,6/151,14/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050870,positive regulation of T cell activation,5.79e-08,6.14e-06,15/151,160/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051251,positive regulation of lymphocyte activation,5.99e-08,6.17e-06,17/151,209/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051272,positive regulation of cellular component movement,6.45e-08,6.45e-06,20/151,291/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030036,actin cytoskeleton organization,6.76e-08,6.57e-06,23/151,381/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050670,regulation of lymphocyte proliferation,7.96e-08,7.15e-06,14/151,141/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0055065,metal ion homeostasis,8.08e-08,7.15e-06,20/151,295/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002683,negative regulation of immune system process,8.17e-08,7.15e-06,19/151,267/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0006875,cellular metal ion homeostasis,8.17e-08,7.15e-06,19/151,267/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0006954,inflammatory response,8.58e-08,7.25e-06,23/151,386/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032944,regulation of mononuclear cell proliferation,8.70e-08,7.25e-06,14/151,142/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070661,leukocyte proliferation,1.00e-07,8.15e-06,16/151,191/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1.11e-07,8.84e-06,15/151,168/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002695,negative regulation of leukocyte activation,1.66e-07,1.26e-05,12/151,106/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042129,regulation of T cell proliferation,1.66e-07,1.26e-05,12/151,106/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030335,positive regulation of cell migration,1.83e-07,1.36e-05,19/151,281/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0055080,cation homeostasis,2.01e-07,1.47e-05,21/151,342/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030003,cellular cation homeostasis,2.13e-07,1.52e-05,20/151,313/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0098771,inorganic ion homeostasis,2.33e-07,1.63e-05,21/151,345/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0006873,cellular ion homeostasis,2.49e-07,1.69e-05,20/151,316/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0046651,lymphocyte proliferation,2.56e-07,1.69e-05,15/151,179/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002696,positive regulation of leukocyte activation,2.56e-07,1.69e-05,17/151,231/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002819,regulation of adaptive immune response,2.77e-07,1.79e-05,12/151,111/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032943,mononuclear cell proliferation,2.96e-07,1.88e-05,15/151,181/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050867,positive regulation of cell activation,3.48e-07,2.18e-05,17/151,236/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002484,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,3.63e-07,2.19e-05,4/151,5/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002486,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",3.63e-07,2.19e-05,4/151,5/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001818,negative regulation of cytokine production,3.86e-07,2.29e-05,14/151,160/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0072503,cellular divalent inorganic cation homeostasis,4.20e-07,2.45e-05,16/151,212/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051480,regulation of cytosolic calcium ion concentration,4.38e-07,2.50e-05,13/151,138/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050866,negative regulation of cell activation,4.49e-07,2.50e-05,12/151,116/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010959,regulation of metal ion transport,4.50e-07,2.50e-05,14/151,162/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2000145,regulation of cell motility,4.57e-07,2.50e-05,25/151,491/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050671,positive regulation of lymphocyte proliferation,4.90e-07,2.64e-05,11/151,96/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002709,regulation of T cell mediated immunity,5.19e-07,2.75e-05,8/151,44/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,5.44e-07,2.80e-05,11/151,97/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032946,positive regulation of mononuclear cell proliferation,5.44e-07,2.80e-05,11/151,97/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0006874,cellular calcium ion homeostasis,5.55e-07,2.82e-05,15/151,190/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030334,regulation of cell migration,6.03e-07,3.02e-05,24/151,464/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0072507,divalent inorganic cation homeostasis,6.52e-07,3.22e-05,16/151,219/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0055074,calcium ion homeostasis,6.79e-07,3.30e-05,15/151,193/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0055082,cellular chemical homeostasis,7.01e-07,3.36e-05,22/151,401/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002483,antigen processing and presentation of endogenous peptide antigen,8.58e-07,4.01e-05,5/151,12/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,8.58e-07,4.01e-05,5/151,12/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050801,ion homeostasis,8.86e-07,4.08e-05,21/151,374/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070665,positive regulation of leukocyte proliferation,9.08e-07,4.13e-05,11/151,102/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0009611,response to wounding,9.63e-07,4.32e-05,19/151,313/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001525,angiogenesis,1.33e-06,5.89e-05,16/151,231/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001916,positive regulation of T cell mediated cytotoxicity,1.38e-06,6.02e-05,5/151,13/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030048,actin filament-based movement,1.44e-06,6.24e-05,8/151,50/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0007204,positive regulation of cytosolic calcium ion concentration,1.54e-06,6.58e-05,12/151,130/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002521,leukocyte differentiation,1.57e-06,6.61e-05,20/151,355/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002274,myeloid leukocyte activation,1.59e-06,6.61e-05,23/151,455/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0097435,supramolecular fiber organization,2.14e-06,8.72e-05,21/151,395/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0048514,blood vessel morphogenesis,2.17e-06,8.72e-05,17/151,269/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002700,regulation of production of molecular mediator of immune response,2.20e-06,8.72e-05,10/151,90/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002449,lymphocyte mediated immunity,2.22e-06,8.72e-05,13/151,159/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0007162,negative regulation of cell adhesion,2.22e-06,8.72e-05,13/151,159/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002718,regulation of cytokine production involved in immune response,2.65e-06,1.03e-04,8/151,54/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042102,positive regulation of T cell proliferation,2.67e-06,1.03e-04,9/151,72/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051250,negative regulation of lymphocyte activation,2.69e-06,1.03e-04,10/151,92/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0007015,actin filament organization,3.37e-06,1.26e-04,16/151,248/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002440,production of molecular mediator of immune response,3.38e-06,1.26e-04,12/151,140/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043269,regulation of ion transport,4.37e-06,1.61e-04,16/151,253/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032703,negative regulation of interleukin-2 production,4.49e-06,1.64e-04,5/151,16/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001819,positive regulation of cytokine production,5.47e-06,1.97e-04,17/151,288/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002478,antigen processing and presentation of exogenous peptide antigen,5.63e-06,2.00e-04,12/151,147/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0006909,phagocytosis,5.67e-06,2.00e-04,13/151,173/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030001,metal ion transport,5.72e-06,2.00e-04,19/151,353/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0006812,cation transport,5.86e-06,2.03e-04,22/151,456/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0019884,antigen processing and presentation of exogenous antigen,6.94e-06,2.38e-04,12/151,150/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042060,wound healing,7.17e-06,2.44e-04,16/151,263/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042119,neutrophil activation,8.55e-06,2.83e-04,19/151,363/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001914,regulation of T cell mediated cytotoxicity,8.56e-06,2.83e-04,5/151,18/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002285,lymphocyte activation involved in immune response,8.57e-06,2.83e-04,11/151,128/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0097190,apoptotic signaling pathway,9.67e-06,3.16e-04,21/151,435/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002711,positive regulation of T cell mediated immunity,1.00e-05,3.24e-04,6/151,31/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0036230,granulocyte activation,1.04e-05,3.33e-04,19/151,368/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071356,cellular response to tumor necrosis factor,1.05e-05,3.33e-04,13/151,183/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0090087,regulation of peptide transport,1.07e-05,3.38e-04,20/151,403/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002702,positive regulation of production of molecular mediator of immune response,1.10e-05,3.43e-04,8/151,65/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0048002,antigen processing and presentation of peptide antigen,1.11e-05,3.43e-04,12/151,157/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0036336,dendritic cell migration,1.15e-05,3.52e-04,5/151,19/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001944,vasculature development,1.24e-05,3.74e-04,18/151,339/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002697,regulation of immune effector process,1.24e-05,3.74e-04,15/151,244/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002429,immune response-activating cell surface receptor signaling pathway,1.26e-05,3.74e-04,16/151,275/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002757,immune response-activating signal transduction,1.26e-05,3.74e-04,16/151,275/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002367,cytokine production involved in immune response,1.38e-05,4.03e-04,8/151,67/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1.38e-05,4.03e-04,8/151,67/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071385,cellular response to glucocorticoid stimulus,1.46e-05,4.24e-04,6/151,33/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032970,regulation of actin filament-based process,1.50e-05,4.29e-04,14/151,218/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002253,activation of immune response,1.51e-05,4.29e-04,17/151,311/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,1.54e-05,4.32e-04,8/151,68/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,1.54e-05,4.32e-04,8/151,68/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002456,T cell mediated immunity,1.72e-05,4.71e-04,8/151,69/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0038094,Fc-gamma receptor signaling pathway,1.72e-05,4.71e-04,8/151,69/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050868,negative regulation of T cell activation,1.72e-05,4.71e-04,8/151,69/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051093,negative regulation of developmental process,1.85e-05,5.02e-04,21/151,454/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0034109,homotypic cell-cell adhesion,1.92e-05,5.17e-04,7/151,51/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001568,blood vessel development,2.01e-05,5.38e-04,17/151,318/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071384,cellular response to corticosteroid stimulus,2.09e-05,5.54e-04,6/151,35/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0003013,circulatory system process,2.19e-05,5.75e-04,13/151,196/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0014070,response to organic cyclic compound,2.27e-05,5.94e-04,22/151,497/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002699,positive regulation of immune effector process,2.30e-05,5.96e-04,11/151,142/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002821,positive regulation of adaptive immune response,2.36e-05,6.08e-04,8/151,72/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0035239,tube morphogenesis,2.44e-05,6.19e-04,19/151,391/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051223,regulation of protein transport,2.44e-05,6.19e-04,19/151,391/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050921,positive regulation of chemotaxis,2.62e-05,6.59e-04,8/151,73/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002706,regulation of lymphocyte mediated immunity,2.66e-05,6.66e-04,9/151,95/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0034612,response to tumor necrosis factor,2.71e-05,6.72e-04,13/151,200/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0009617,response to bacterium,2.76e-05,6.81e-04,16/151,293/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002431,Fc receptor mediated stimulatory signaling pathway,2.89e-05,7.07e-04,8/151,74/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070098,chemokine-mediated signaling pathway,2.91e-05,7.07e-04,6/151,37/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070371,ERK1 and ERK2 cascade,2.98e-05,7.20e-04,11/151,146/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002768,immune response-regulating cell surface receptor signaling pathway,3.00e-05,7.20e-04,16/151,295/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0008284,positive regulation of cell population proliferation,3.10e-05,7.35e-04,21/151,470/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042113,B cell activation,3.12e-05,7.35e-04,12/151,174/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002764,immune response-regulating signaling pathway,3.13e-05,7.35e-04,16/151,296/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0003015,heart process,3.15e-05,7.35e-04,9/151,97/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002643,regulation of tolerance induction,3.28e-05,7.60e-04,4/151,12/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010942,positive regulation of cell death,3.30e-05,7.61e-04,21/151,472/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002446,neutrophil mediated immunity,3.34e-05,7.64e-04,18/151,365/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031343,positive regulation of cell killing,3.41e-05,7.74e-04,6/151,38/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032956,regulation of actin cytoskeleton organization,3.51e-05,7.93e-04,13/151,205/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002444,myeloid leukocyte mediated immunity,3.58e-05,8.00e-04,19/151,402/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043065,positive regulation of apoptotic process,3.59e-05,8.00e-04,20/151,438/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903038,negative regulation of leukocyte cell-cell adhesion,3.87e-05,8.58e-04,8/151,77/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043068,positive regulation of programmed cell death,4.08e-05,8.99e-04,20/151,442/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031348,negative regulation of defense response,4.15e-05,9.08e-04,10/151,125/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002698,negative regulation of immune effector process,4.26e-05,9.26e-04,8/151,78/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1905475,regulation of protein localization to membrane,4.44e-05,9.61e-04,10/151,126/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0060326,cell chemotaxis,4.60e-05,9.88e-04,11/151,153/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001913,T cell mediated cytotoxicity,4.83e-05,1.03e-03,5/151,25/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070201,regulation of establishment of protein localization,5.00e-05,1.06e-03,19/151,412/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0003012,muscle system process,5.12e-05,1.08e-03,12/151,183/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032663,regulation of interleukin-2 production,5.33e-05,1.12e-03,6/151,41/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043408,regulation of MAPK cascade,5.86e-05,1.22e-03,18/151,381/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002707,negative regulation of lymphocyte mediated immunity,5.91e-05,1.22e-03,5/151,26/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0019882,antigen processing and presentation,6.32e-05,1.30e-03,12/151,187/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,6.46e-05,1.32e-03,4/151,14/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0034762,regulation of transmembrane transport,6.64e-05,1.35e-03,13/151,218/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0098660,inorganic ion transmembrane transport,6.88e-05,1.39e-03,16/151,316/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1990868,response to chemokine,7.03e-05,1.41e-03,6/151,43/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1990869,cellular response to chemokine,7.03e-05,1.41e-03,6/151,43/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045581,negative regulation of T cell differentiation,7.15e-05,1.42e-03,5/151,27/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1905477,positive regulation of protein localization to membrane,7.28e-05,1.43e-03,8/151,84/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0006935,chemotaxis,7.29e-05,1.43e-03,15/151,284/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0048872,homeostasis of number of cells,7.37e-05,1.43e-03,12/151,190/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0022408,negative regulation of cell-cell adhesion,7.38e-05,1.43e-03,9/151,108/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043270,positive regulation of ion transport,7.38e-05,1.43e-03,9/151,108/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030098,lymphocyte differentiation,7.47e-05,1.44e-03,14/151,252/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071407,cellular response to organic cyclic compound,7.69e-05,1.47e-03,16/151,319/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042330,taxis,7.90e-05,1.50e-03,15/151,286/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043312,neutrophil degranulation,8.36e-05,1.58e-03,17/151,356/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070372,regulation of ERK1 and ERK2 cascade,8.51e-05,1.59e-03,10/151,136/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2001233,regulation of apoptotic signaling pathway,8.54e-05,1.59e-03,15/151,288/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001776,leukocyte homeostasis,8.60e-05,1.59e-03,7/151,64/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002283,neutrophil activation involved in immune response,8.65e-05,1.59e-03,17/151,357/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002676,regulation of chronic inflammatory response,8.69e-05,1.59e-03,3/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002407,dendritic cell chemotaxis,8.70e-05,1.59e-03,4/151,15/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031342,negative regulation of cell killing,8.70e-05,1.59e-03,4/151,15/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051222,positive regulation of protein transport,9.17e-05,1.66e-03,13/151,225/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050864,regulation of B cell activation,9.35e-05,1.69e-03,8/151,87/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032649,regulation of interferon-gamma production,9.50e-05,1.71e-03,7/151,65/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1904062,regulation of cation transmembrane transport,9.62e-05,1.72e-03,10/151,138/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0098662,inorganic cation transmembrane transport,9.97e-05,1.77e-03,15/151,292/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032623,interleukin-2 production,1.04e-04,1.83e-03,6/151,46/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002708,positive regulation of lymphocyte mediated immunity,1.05e-04,1.84e-03,7/151,66/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050727,regulation of inflammatory response,1.09e-04,1.92e-03,12/151,198/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0110053,regulation of actin filament organization,1.13e-04,1.98e-03,11/151,169/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043534,blood vessel endothelial cell migration,1.15e-04,2.00e-03,7/151,67/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0035295,tube development,1.18e-04,2.03e-03,20/151,477/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032680,regulation of tumor necrosis factor production,1.27e-04,2.18e-03,7/151,68/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032677,regulation of interleukin-8 production,1.32e-04,2.26e-03,6/151,48/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0016064,immunoglobulin mediated immune response,1.39e-04,2.35e-03,7/151,69/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0006816,calcium ion transport,1.40e-04,2.35e-03,11/151,173/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0034765,regulation of ion transmembrane transport,1.40e-04,2.35e-03,11/151,173/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045620,negative regulation of lymphocyte differentiation,1.43e-04,2.38e-03,5/151,31/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903779,regulation of cardiac conduction,1.43e-04,2.38e-03,5/151,31/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043371,"negative regulation of CD4-positive, alpha-beta T cell differentiation",1.48e-04,2.45e-03,4/151,17/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0098655,cation transmembrane transport,1.51e-04,2.49e-03,16/151,338/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1902532,negative regulation of intracellular signal transduction,1.51e-04,2.49e-03,16/151,338/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032637,interleukin-8 production,1.66e-04,2.66e-03,6/151,50/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,1.67e-04,2.66e-03,5/151,32/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1900024,regulation of substrate adhesion-dependent cell spreading,1.67e-04,2.66e-03,5/151,32/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002286,T cell activation involved in immune response,1.67e-04,2.66e-03,7/151,71/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002576,platelet degranulation,1.67e-04,2.66e-03,7/151,71/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0019724,B cell mediated immunity,1.67e-04,2.66e-03,7/151,71/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,1.67e-04,2.66e-03,7/151,71/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1904951,positive regulation of establishment of protein localization,1.68e-04,2.66e-03,13/151,239/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002685,regulation of leukocyte migration,1.78e-04,2.80e-03,9/151,121/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0046634,regulation of alpha-beta T cell activation,1.82e-04,2.86e-03,7/151,72/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0046635,positive regulation of alpha-beta T cell activation,1.86e-04,2.91e-03,6/151,51/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0046639,negative regulation of alpha-beta T cell differentiation,1.88e-04,2.92e-03,4/151,18/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032640,tumor necrosis factor production,1.99e-04,3.08e-03,7/151,73/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051606,detection of stimulus,2.01e-04,3.10e-03,8/151,97/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032609,interferon-gamma production,2.17e-04,3.33e-03,7/151,74/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002704,negative regulation of leukocyte mediated immunity,2.24e-04,3.43e-03,5/151,34/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051651,maintenance of location in cell,2.27e-04,3.46e-03,9/151,125/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050728,negative regulation of inflammatory response,2.36e-04,3.56e-03,7/151,75/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043299,leukocyte degranulation,2.36e-04,3.56e-03,17/151,388/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2001187,"positive regulation of CD8-positive, alpha-beta T cell activation",2.37e-04,3.56e-03,3/151,8/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0097191,extrinsic apoptotic signaling pathway,2.38e-04,3.56e-03,10/151,154/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0072659,protein localization to plasma membrane,2.40e-04,3.58e-03,11/151,184/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001667,ameboidal-type cell migration,2.48e-04,3.67e-03,12/151,216/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051924,regulation of calcium ion transport,2.48e-04,3.67e-03,8/151,100/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071706,tumor necrosis factor superfamily cytokine production,2.56e-04,3.77e-03,7/151,76/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903827,regulation of cellular protein localization,2.58e-04,3.79e-03,17/151,391/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0008015,blood circulation,2.64e-04,3.85e-03,11/151,186/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002275,myeloid cell activation involved in immune response,2.66e-04,3.87e-03,17/151,392/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030217,T cell differentiation,2.76e-04,3.99e-03,11/151,187/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002687,positive regulation of leukocyte migration,2.78e-04,3.99e-03,7/151,77/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2001234,negative regulation of apoptotic signaling pathway,2.78e-04,3.99e-03,10/151,157/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031341,regulation of cell killing,2.84e-04,4.05e-03,6/151,55/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031960,response to corticosteroid,3.01e-04,4.29e-03,7/151,78/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002791,regulation of peptide secretion,3.03e-04,4.29e-03,11/151,189/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0019058,viral life cycle,3.05e-04,4.31e-03,13/151,254/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0007186,G protein-coupled receptor signaling pathway,3.26e-04,4.58e-03,14/151,290/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051235,maintenance of location,3.32e-04,4.62e-03,11/151,191/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1902903,regulation of supramolecular fiber organization,3.32e-04,4.62e-03,12/151,223/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045596,negative regulation of cell differentiation,3.33e-04,4.62e-03,15/151,326/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0016045,detection of bacterium,3.52e-04,4.76e-03,3/151,9/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030049,muscle filament sliding,3.52e-04,4.76e-03,3/151,9/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0033275,actin-myosin filament sliding,3.52e-04,4.76e-03,3/151,9/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0046598,positive regulation of viral entry into host cell,3.52e-04,4.76e-03,3/151,9/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050710,negative regulation of cytokine secretion,3.52e-04,4.76e-03,3/151,9/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0075294,positive regulation by symbiont of entry into host,3.52e-04,4.76e-03,3/151,9/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0150079,negative regulation of neuroinflammatory response,3.52e-04,4.76e-03,3/151,9/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032102,negative regulation of response to external stimulus,3.63e-04,4.88e-03,11/151,193/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1902105,regulation of leukocyte differentiation,3.79e-04,5.04e-03,11/151,194/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0033077,T cell differentiation in thymus,3.80e-04,5.04e-03,6/151,58/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0034767,positive regulation of ion transmembrane transport,3.80e-04,5.04e-03,6/151,58/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0035637,multicellular organismal signaling,3.80e-04,5.04e-03,6/151,58/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0019722,calcium-mediated signaling,3.94e-04,5.21e-03,8/151,107/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002703,regulation of leukocyte mediated immunity,4.03e-04,5.31e-03,9/151,135/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2001236,regulation of extrinsic apoptotic signaling pathway,4.20e-04,5.51e-03,8/151,108/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002724,regulation of T cell cytokine production,4.26e-04,5.54e-03,4/151,22/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2000515,"negative regulation of CD4-positive, alpha-beta T cell activation",4.26e-04,5.54e-03,4/151,22/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002720,positive regulation of cytokine production involved in immune response,4.34e-04,5.60e-03,5/151,39/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050663,cytokine secretion,4.34e-04,5.60e-03,5/151,39/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032388,positive regulation of intracellular transport,4.35e-04,5.60e-03,10/151,166/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001906,cell killing,4.42e-04,5.64e-03,7/151,83/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002377,immunoglobulin production,4.42e-04,5.64e-03,7/151,83/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903706,regulation of hemopoiesis,4.44e-04,5.66e-03,15/151,335/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0061061,muscle structure development,4.59e-04,5.80e-03,14/151,300/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0022604,regulation of cell morphogenesis,4.59e-04,5.80e-03,13/151,265/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050920,regulation of chemotaxis,4.75e-04,5.99e-03,8/151,110/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0017014,protein nitrosylation,4.97e-04,6.18e-03,3/151,10/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0018119,peptidyl-cysteine S-nitrosylation,4.97e-04,6.18e-03,3/151,10/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0098543,detection of other organism,4.97e-04,6.18e-03,3/151,10/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031532,actin cytoskeleton reorganization,5.00e-04,6.18e-03,6/151,61/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0048013,ephrin receptor signaling pathway,5.00e-04,6.18e-03,6/151,61/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050852,T cell receptor signaling pathway,5.01e-04,6.18e-03,10/151,169/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043516,"regulation of DNA damage response, signal transduction by p53 class mediator",5.09e-04,6.25e-03,4/151,23/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0006959,humoral immune response,5.11e-04,6.25e-03,7/151,85/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0046631,alpha-beta T cell activation,5.36e-04,6.54e-03,8/151,112/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070838,divalent metal ion transport,5.56e-04,6.76e-03,11/151,203/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031347,regulation of defense response,5.91e-04,7.16e-03,17/151,420/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0007596,blood coagulation,6.02e-04,7.22e-03,10/151,173/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050918,positive chemotaxis,6.03e-04,7.22e-03,4/151,24/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,6.03e-04,7.22e-03,4/151,24/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0072511,divalent inorganic cation transport,6.04e-04,7.22e-03,11/151,205/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0035722,interleukin-12-mediated signaling pathway,6.17e-04,7.34e-03,5/151,42/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050817,coagulation,6.30e-04,7.45e-03,10/151,174/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002705,positive regulation of leukocyte mediated immunity,6.30e-04,7.45e-03,7/151,88/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1902107,positive regulation of leukocyte differentiation,6.40e-04,7.54e-03,8/151,115/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002479,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",6.49e-04,7.62e-03,6/151,64/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0034220,ion transmembrane transport,6.53e-04,7.64e-03,18/151,463/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002544,chronic inflammatory response,6.75e-04,7.74e-03,3/151,11/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045953,negative regulation of natural killer cell mediated cytotoxicity,6.75e-04,7.74e-03,3/151,11/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0098581,detection of external biotic stimulus,6.75e-04,7.74e-03,3/151,11/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0099515,actin filament-based transport,6.75e-04,7.74e-03,3/151,11/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0150105,protein localization to cell-cell junction,6.75e-04,7.74e-03,3/151,11/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070374,positive regulation of ERK1 and ERK2 cascade,6.75e-04,7.74e-03,7/151,89/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0033674,positive regulation of kinase activity,6.81e-04,7.79e-03,15/151,349/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071349,cellular response to interleukin-12,6.88e-04,7.85e-03,5/151,43/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903829,positive regulation of cellular protein localization,6.93e-04,7.87e-03,12/151,242/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001909,leukocyte mediated cytotoxicity,7.05e-04,7.95e-03,6/151,65/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903076,regulation of protein localization to plasma membrane,7.05e-04,7.95e-03,6/151,65/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032673,regulation of interleukin-4 production,7.08e-04,7.95e-03,4/151,25/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0046636,negative regulation of alpha-beta T cell activation,7.08e-04,7.95e-03,4/151,25/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0007599,hemostasis,7.20e-04,7.97e-03,10/151,177/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043903,regulation of symbiotic process,7.20e-04,7.97e-03,10/151,177/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,7.22e-04,7.97e-03,7/151,90/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051017,actin filament bundle assembly,7.22e-04,7.97e-03,7/151,90/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0061572,actin filament bundle organization,7.22e-04,7.97e-03,7/151,90/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0061337,cardiac conduction,7.66e-04,8.41e-03,5/151,44/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070671,response to interleukin-12,7.66e-04,8.41e-03,5/151,44/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903311,regulation of mRNA metabolic process,7.71e-04,8.41e-03,13/151,280/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0060047,heart contraction,7.71e-04,8.41e-03,7/151,91/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050708,regulation of protein secretion,7.85e-04,8.54e-03,10/151,179/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0007249,I-kappaB kinase/NF-kappaB signaling,7.99e-04,8.66e-03,11/151,212/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070848,response to growth factor,8.11e-04,8.77e-03,15/151,355/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1990778,protein localization to cell periphery,8.30e-04,8.94e-03,11/151,213/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010035,response to inorganic substance,8.42e-04,9.04e-03,14/151,319/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001910,regulation of leukocyte mediated cytotoxicity,8.51e-04,9.05e-03,5/151,45/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002381,immunoglobulin production involved in immunoglobulin mediated immune response,8.51e-04,9.05e-03,5/151,45/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002637,regulation of immunoglobulin production,8.51e-04,9.05e-03,5/151,45/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002716,negative regulation of natural killer cell mediated immunity,8.88e-04,9.41e-03,3/151,12/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070482,response to oxygen levels,8.90e-04,9.41e-03,12/151,249/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051384,response to glucocorticoid,8.97e-04,9.46e-03,6/151,68/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002792,negative regulation of peptide secretion,9.42e-04,9.85e-03,5/151,46/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0008064,regulation of actin polymerization or depolymerization,9.45e-04,9.85e-03,8/151,122/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030595,leukocyte chemotaxis,9.45e-04,9.85e-03,8/151,122/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030832,regulation of actin filament length,9.45e-04,9.85e-03,8/151,122/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002639,positive regulation of immunoglobulin production,9.58e-04,9.92e-03,4/151,27/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032633,interleukin-4 production,9.58e-04,9.92e-03,4/151,27/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0000904,cell morphogenesis involved in differentiation,9.62e-04,9.94e-03,15/151,361/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,9.69e-04,9.98e-03,6/151,69/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043086,negative regulation of catalytic activity,1.02e-03,1.05e-02,17/151,441/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002790,peptide secretion,1.02e-03,1.05e-02,12/151,253/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071396,cellular response to lipid,1.04e-03,1.06e-02,14/151,326/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,1.05e-03,1.06e-02,6/151,70/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043030,regulation of macrophage activation,1.10e-03,1.12e-02,4/151,28/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030198,extracellular matrix organization,1.11e-03,1.12e-02,8/151,125/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043062,extracellular structure organization,1.11e-03,1.12e-02,8/151,125/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0061041,regulation of wound healing,1.13e-03,1.13e-02,6/151,71/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032386,regulation of intracellular transport,1.13e-03,1.14e-02,12/151,256/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071677,positive regulation of mononuclear cell migration,1.14e-03,1.14e-02,3/151,13/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2001185,"regulation of CD8-positive, alpha-beta T cell activation",1.14e-03,1.14e-02,3/151,13/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010638,positive regulation of organelle organization,1.15e-03,1.15e-02,17/151,446/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0097193,intrinsic apoptotic signaling pathway,1.16e-03,1.15e-02,11/151,222/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045619,regulation of lymphocyte differentiation,1.17e-03,1.15e-02,8/151,126/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0090066,regulation of anatomical structure size,1.17e-03,1.15e-02,12/151,257/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045185,maintenance of protein location,1.21e-03,1.19e-02,6/151,72/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0006936,muscle contraction,1.23e-03,1.20e-02,8/151,127/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070588,calcium ion transmembrane transport,1.23e-03,1.20e-02,8/151,127/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043487,regulation of RNA stability,1.25e-03,1.21e-02,9/151,158/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0072593,reactive oxygen species metabolic process,1.25e-03,1.21e-02,9/151,158/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002260,lymphocyte homeostasis,1.26e-03,1.21e-02,5/151,49/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002369,T cell cytokine production,1.26e-03,1.21e-02,4/151,29/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002548,monocyte chemotaxis,1.26e-03,1.21e-02,4/151,29/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0021762,substantia nigra development,1.26e-03,1.21e-02,4/151,29/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0007417,central nervous system development,1.28e-03,1.23e-02,18/151,491/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043254,regulation of protein-containing complex assembly,1.28e-03,1.23e-02,13/151,296/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1902905,positive regulation of supramolecular fiber organization,1.36e-03,1.29e-02,8/151,129/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043410,positive regulation of MAPK cascade,1.38e-03,1.31e-02,12/151,262/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042692,muscle cell differentiation,1.43e-03,1.36e-02,9/151,161/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051014,actin filament severing,1.43e-03,1.36e-02,3/151,14/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050707,regulation of cytokine secretion,1.44e-03,1.36e-02,4/151,30/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032675,regulation of interleukin-6 production,1.50e-03,1.41e-02,6/151,75/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,1.51e-03,1.41e-02,5/151,51/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0016444,somatic cell DNA recombination,1.51e-03,1.41e-02,5/151,51/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1904064,positive regulation of cation transmembrane transport,1.51e-03,1.41e-02,5/151,51/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0035304,regulation of protein dephosphorylation,1.51e-03,1.41e-02,7/151,102/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050678,regulation of epithelial cell proliferation,1.56e-03,1.45e-02,9/151,163/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071363,cellular response to growth factor stimulus,1.59e-03,1.48e-02,14/151,341/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032653,regulation of interleukin-10 production,1.63e-03,1.50e-02,4/151,31/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0034330,cell junction organization,1.63e-03,1.50e-02,13/151,304/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,1.65e-03,1.52e-02,8/151,133/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0036293,response to decreased oxygen levels,1.66e-03,1.52e-02,11/151,232/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010631,epithelial cell migration,1.69e-03,1.54e-02,9/151,165/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0090132,epithelium migration,1.69e-03,1.54e-02,9/151,165/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1904375,regulation of protein localization to cell periphery,1.72e-03,1.56e-02,6/151,77/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0033157,regulation of intracellular protein transport,1.75e-03,1.59e-02,10/151,199/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0090130,tissue migration,1.77e-03,1.59e-02,9/151,166/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032516,positive regulation of phosphoprotein phosphatase activity,1.77e-03,1.59e-02,3/151,15/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1901798,positive regulation of signal transduction by p53 class mediator,1.77e-03,1.59e-02,3/151,15/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051051,negative regulation of transport,1.78e-03,1.59e-02,11/151,234/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0014896,muscle hypertrophy,1.80e-03,1.61e-02,5/151,53/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050851,antigen receptor-mediated signaling pathway,1.82e-03,1.63e-02,10/151,200/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071887,leukocyte apoptotic process,1.84e-03,1.63e-02,6/151,78/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070252,actin-mediated cell contraction,1.84e-03,1.63e-02,4/151,32/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045580,regulation of T cell differentiation,1.99e-03,1.77e-02,7/151,107/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050792,regulation of viral process,2.00e-03,1.77e-02,9/151,169/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030855,epithelial cell differentiation,2.02e-03,1.78e-02,12/151,274/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0034113,heterotypic cell-cell adhesion,2.07e-03,1.81e-02,4/151,33/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0035307,positive regulation of protein dephosphorylation,2.07e-03,1.81e-02,4/151,33/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0019932,second-messenger-mediated signaling,2.08e-03,1.82e-02,9/151,170/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,2.09e-03,1.82e-02,6/151,80/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045165,cell fate commitment,2.09e-03,1.82e-02,6/151,80/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0022898,regulation of transmembrane transporter activity,2.10e-03,1.82e-02,7/151,108/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0061448,connective tissue development,2.10e-03,1.82e-02,7/151,108/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070227,lymphocyte apoptotic process,2.12e-03,1.83e-02,5/151,55/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0046641,positive regulation of alpha-beta T cell proliferation,2.15e-03,1.85e-02,3/151,16/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2000637,positive regulation of gene silencing by miRNA,2.15e-03,1.85e-02,3/151,16/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0009306,protein secretion,2.17e-03,1.85e-02,11/151,240/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0035592,establishment of protein localization to extracellular region,2.17e-03,1.85e-02,11/151,240/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050878,regulation of body fluid levels,2.17e-03,1.85e-02,11/151,240/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0090316,positive regulation of intracellular protein transport,2.18e-03,1.86e-02,8/151,139/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,2.23e-03,1.89e-02,6/151,81/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0060401,cytosolic calcium ion transport,2.23e-03,1.89e-02,6/151,81/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002312,B cell activation involved in immune response,2.30e-03,1.92e-02,5/151,56/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0007187,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",2.30e-03,1.92e-02,5/151,56/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0033138,positive regulation of peptidyl-serine phosphorylation,2.30e-03,1.92e-02,5/151,56/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042116,macrophage activation,2.30e-03,1.92e-02,5/151,56/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043535,regulation of blood vessel endothelial cell migration,2.30e-03,1.92e-02,5/151,56/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032613,interleukin-10 production,2.31e-03,1.92e-02,4/151,34/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043536,positive regulation of blood vessel endothelial cell migration,2.31e-03,1.92e-02,4/151,34/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0048857,neural nucleus development,2.31e-03,1.92e-02,4/151,34/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071692,protein localization to extracellular region,2.31e-03,1.92e-02,11/151,242/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030833,regulation of actin filament polymerization,2.33e-03,1.93e-02,7/151,110/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071900,regulation of protein serine/threonine kinase activity,2.36e-03,1.94e-02,13/151,317/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,2.37e-03,1.94e-02,6/151,82/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032635,interleukin-6 production,2.37e-03,1.94e-02,6/151,82/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0034764,positive regulation of transmembrane transport,2.37e-03,1.94e-02,6/151,82/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0046718,viral entry into host cell,2.37e-03,1.94e-02,6/151,82/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051048,negative regulation of secretion,2.37e-03,1.94e-02,6/151,82/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045860,positive regulation of protein kinase activity,2.43e-03,1.98e-02,13/151,318/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0060322,head development,2.46e-03,2.00e-02,15/151,397/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0034446,substrate adhesion-dependent cell spreading,2.49e-03,2.01e-02,5/151,57/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0008154,actin polymerization or depolymerization,2.49e-03,2.01e-02,8/151,142/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051495,positive regulation of cytoskeleton organization,2.49e-03,2.01e-02,8/151,142/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002712,regulation of B cell mediated immunity,2.58e-03,2.05e-02,4/151,35/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002889,regulation of immunoglobulin mediated immune response,2.58e-03,2.05e-02,4/151,35/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0150076,neuroinflammatory response,2.58e-03,2.05e-02,4/151,35/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0009595,detection of biotic stimulus,2.58e-03,2.05e-02,3/151,17/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031579,membrane raft organization,2.58e-03,2.05e-02,3/151,17/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0060148,positive regulation of posttranscriptional gene silencing,2.58e-03,2.05e-02,3/151,17/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903708,positive regulation of hemopoiesis,2.60e-03,2.05e-02,8/151,143/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002424,T cell mediated immune response to tumor cell,2.66e-03,2.05e-02,2/151,5/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002475,antigen processing and presentation via MHC class Ib,2.66e-03,2.05e-02,2/151,5/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010616,negative regulation of cardiac muscle adaptation,2.66e-03,2.05e-02,2/151,5/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0021932,hindbrain radial glia guided cell migration,2.66e-03,2.05e-02,2/151,5/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0035740,"CD8-positive, alpha-beta T cell proliferation",2.66e-03,2.05e-02,2/151,5/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0048290,isotype switching to IgA isotypes,2.66e-03,2.05e-02,2/151,5/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0060613,fat pad development,2.66e-03,2.05e-02,2/151,5/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0098703,calcium ion import across plasma membrane,2.66e-03,2.05e-02,2/151,5/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1900122,positive regulation of receptor binding,2.66e-03,2.05e-02,2/151,5/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1902656,calcium ion import into cytosol,2.66e-03,2.05e-02,2/151,5/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903243,negative regulation of cardiac muscle hypertrophy in response to stress,2.66e-03,2.05e-02,2/151,5/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903613,regulation of protein tyrosine phosphatase activity,2.66e-03,2.05e-02,2/151,5/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2000564,"regulation of CD8-positive, alpha-beta T cell proliferation",2.66e-03,2.05e-02,2/151,5/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903034,regulation of response to wounding,2.68e-03,2.05e-02,6/151,84/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002200,somatic diversification of immune receptors,2.68e-03,2.05e-02,5/151,58/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0097553,calcium ion transmembrane import into cytosol,2.68e-03,2.05e-02,5/151,58/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0098739,import across plasma membrane,2.68e-03,2.05e-02,5/151,58/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031589,cell-substrate adhesion,2.74e-03,2.09e-02,9/151,177/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010634,positive regulation of epithelial cell migration,2.84e-03,2.17e-02,6/151,85/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010810,regulation of cell-substrate adhesion,2.86e-03,2.17e-02,7/151,114/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032760,positive regulation of tumor necrosis factor production,2.86e-03,2.17e-02,4/151,36/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0048010,vascular endothelial growth factor receptor signaling pathway,2.89e-03,2.19e-02,5/151,59/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032271,regulation of protein polymerization,2.96e-03,2.23e-02,8/151,146/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0072657,protein localization to membrane,2.98e-03,2.24e-02,16/151,446/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045859,regulation of protein kinase activity,3.00e-03,2.24e-02,17/151,488/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032409,regulation of transporter activity,3.00e-03,2.24e-02,7/151,115/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043542,endothelial cell migration,3.00e-03,2.24e-02,7/151,115/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051046,regulation of secretion,3.01e-03,2.24e-02,13/151,326/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,3.02e-03,2.24e-02,6/151,86/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0098657,import into cell,3.02e-03,2.24e-02,6/151,86/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032689,negative regulation of interferon-gamma production,3.06e-03,2.27e-02,3/151,18/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0150077,regulation of neuroinflammatory response,3.06e-03,2.27e-02,3/151,18/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1902106,negative regulation of leukocyte differentiation,3.12e-03,2.30e-02,5/151,60/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2000106,regulation of leukocyte apoptotic process,3.12e-03,2.30e-02,5/151,60/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032233,positive regulation of actin filament bundle assembly,3.17e-03,2.32e-02,4/151,37/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045824,negative regulation of innate immune response,3.17e-03,2.32e-02,4/151,37/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070231,T cell apoptotic process,3.17e-03,2.32e-02,4/151,37/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903078,positive regulation of protein localization to plasma membrane,3.17e-03,2.32e-02,4/151,37/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0044057,regulation of system process,3.19e-03,2.33e-02,10/151,216/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050714,positive regulation of protein secretion,3.38e-03,2.46e-02,6/151,88/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903707,negative regulation of hemopoiesis,3.38e-03,2.46e-02,6/151,88/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002262,myeloid cell homeostasis,3.46e-03,2.50e-02,7/151,118/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032414,positive regulation of ion transmembrane transporter activity,3.50e-03,2.50e-02,4/151,38/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation",3.50e-03,2.50e-02,4/151,38/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045445,myoblast differentiation,3.50e-03,2.50e-02,4/151,38/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0090342,regulation of cell aging,3.50e-03,2.50e-02,4/151,38/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,3.50e-03,2.50e-02,4/151,38/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051347,positive regulation of transferase activity,3.50e-03,2.50e-02,15/151,412/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0007420,brain development,3.54e-03,2.53e-02,14/151,372/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032660,regulation of interleukin-17 production,3.59e-03,2.54e-02,3/151,19/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032753,positive regulation of interleukin-4 production,3.59e-03,2.54e-02,3/151,19/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051220,cytoplasmic sequestering of protein,3.59e-03,2.54e-02,3/151,19/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043367,"CD4-positive, alpha-beta T cell differentiation",3.60e-03,2.54e-02,5/151,62/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,3.60e-03,2.54e-02,5/151,62/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070997,neuron death,3.64e-03,2.56e-02,10/151,220/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043488,regulation of mRNA stability,3.64e-03,2.56e-02,8/151,151/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0052548,regulation of endopeptidase activity,3.76e-03,2.62e-02,10/151,221/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071222,cellular response to lipopolysaccharide,3.80e-03,2.62e-02,7/151,120/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,3.85e-03,2.62e-02,4/151,39/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002208,somatic diversification of immunoglobulins involved in immune response,3.85e-03,2.62e-02,4/151,39/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042267,natural killer cell mediated cytotoxicity,3.85e-03,2.62e-02,4/151,39/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045190,isotype switching,3.85e-03,2.62e-02,4/151,39/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045778,positive regulation of ossification,3.85e-03,2.62e-02,4/151,39/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001666,response to hypoxia,3.88e-03,2.62e-02,10/151,222/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032535,regulation of cellular component size,3.88e-03,2.62e-02,10/151,222/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032103,positive regulation of response to external stimulus,3.90e-03,2.62e-02,12/151,297/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001765,membrane raft assembly,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002501,peptide antigen assembly with MHC protein complex,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010612,regulation of cardiac muscle adaptation,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0019731,antibacterial humoral response,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031392,regulation of prostaglandin biosynthetic process,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042989,sequestering of actin monomers,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0048245,eosinophil chemotaxis,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051024,positive regulation of immunoglobulin secretion,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0061043,regulation of vascular wound healing,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0062149,detection of stimulus involved in sensory perception of pain,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070358,actin polymerization-dependent cell motility,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0086103,G protein-coupled receptor signaling pathway involved in heart process,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0097011,cellular response to granulocyte macrophage colony-stimulating factor stimulus,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0097012,response to granulocyte macrophage colony-stimulating factor,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903242,regulation of cardiac muscle hypertrophy in response to stress,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903800,positive regulation of production of miRNAs involved in gene silencing by miRNA,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903979,negative regulation of microglial cell activation,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2000169,regulation of peptidyl-cysteine S-nitrosylation,3.94e-03,2.62e-02,2/151,6/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,3.94e-03,2.62e-02,9/151,187/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050673,epithelial cell proliferation,3.94e-03,2.62e-02,9/151,187/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030041,actin filament polymerization,3.98e-03,2.64e-02,7/151,121/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051493,regulation of cytoskeleton organization,4.00e-03,2.64e-02,13/151,337/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0044409,entry into host,4.00e-03,2.64e-02,6/151,91/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010614,negative regulation of cardiac muscle hypertrophy,4.18e-03,2.74e-02,3/151,20/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010712,regulation of collagen metabolic process,4.18e-03,2.74e-02,3/151,20/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0014741,negative regulation of muscle hypertrophy,4.18e-03,2.74e-02,3/151,20/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0036037,"CD8-positive, alpha-beta T cell activation",4.18e-03,2.74e-02,3/151,20/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0033619,membrane protein proteolysis,4.22e-03,2.75e-02,4/151,40/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051204,protein insertion into mitochondrial membrane,4.22e-03,2.75e-02,4/151,40/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070527,platelet aggregation,4.22e-03,2.75e-02,4/151,40/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030168,platelet activation,4.22e-03,2.75e-02,6/151,92/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071219,cellular response to molecule of bacterial origin,4.36e-03,2.82e-02,7/151,123/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2001242,regulation of intrinsic apoptotic signaling pathway,4.36e-03,2.82e-02,7/151,123/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010811,positive regulation of cell-substrate adhesion,4.41e-03,2.85e-02,5/151,65/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903409,reactive oxygen species biosynthetic process,4.41e-03,2.85e-02,5/151,65/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0038093,Fc receptor signaling pathway,4.43e-03,2.86e-02,8/151,156/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030278,regulation of ossification,4.45e-03,2.86e-02,6/151,93/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0048545,response to steroid hormone,4.53e-03,2.91e-02,9/151,191/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071453,cellular response to oxygen levels,4.61e-03,2.94e-02,8/151,157/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002228,natural killer cell mediated immunity,4.62e-03,2.94e-02,4/151,41/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0006801,superoxide metabolic process,4.62e-03,2.94e-02,4/151,41/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0035306,positive regulation of dephosphorylation,4.62e-03,2.94e-02,4/151,41/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070228,regulation of lymphocyte apoptotic process,4.62e-03,2.94e-02,4/151,41/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002793,positive regulation of peptide secretion,4.69e-03,2.98e-02,6/151,94/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0060402,calcium ion transport into cytosol,4.71e-03,2.99e-02,5/151,66/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043537,negative regulation of blood vessel endothelial cell migration,4.81e-03,3.05e-02,3/151,21/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043405,regulation of MAP kinase activity,5.01e-03,3.16e-02,9/151,194/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045582,positive regulation of T cell differentiation,5.02e-03,3.16e-02,5/151,67/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071674,mononuclear cell migration,5.04e-03,3.16e-02,4/151,42/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903201,regulation of oxidative stress-induced cell death,5.04e-03,3.16e-02,4/151,42/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1904377,positive regulation of protein localization to cell periphery,5.04e-03,3.16e-02,4/151,42/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0052547,regulation of peptidase activity,5.13e-03,3.21e-02,10/151,231/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002396,MHC protein complex assembly,5.46e-03,3.33e-02,2/151,7/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002664,regulation of T cell tolerance induction,5.46e-03,3.33e-02,2/151,7/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010935,regulation of macrophage cytokine production,5.46e-03,3.33e-02,2/151,7/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0021535,cell migration in hindbrain,5.46e-03,3.33e-02,2/151,7/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031340,positive regulation of vesicle fusion,5.46e-03,3.33e-02,2/151,7/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0048549,positive regulation of pinocytosis,5.46e-03,3.33e-02,2/151,7/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050665,hydrogen peroxide biosynthetic process,5.46e-03,3.33e-02,2/151,7/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050974,detection of mechanical stimulus involved in sensory perception,5.46e-03,3.33e-02,2/151,7/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051683,establishment of Golgi localization,5.46e-03,3.33e-02,2/151,7/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1901660,calcium ion export,5.46e-03,3.33e-02,2/151,7/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903054,negative regulation of extracellular matrix organization,5.46e-03,3.33e-02,2/151,7/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2000343,positive regulation of chemokine (C-X-C motif) ligand 2 production,5.46e-03,3.33e-02,2/151,7/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2001198,regulation of dendritic cell differentiation,5.46e-03,3.33e-02,2/151,7/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2001279,regulation of unsaturated fatty acid biosynthetic process,5.46e-03,3.33e-02,2/151,7/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031032,actomyosin structure organization,5.47e-03,3.33e-02,6/151,97/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032411,positive regulation of transporter activity,5.48e-03,3.33e-02,4/151,43/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051928,positive regulation of calcium ion transport,5.48e-03,3.33e-02,4/151,43/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010922,positive regulation of phosphatase activity,5.51e-03,3.33e-02,3/151,22/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0046640,regulation of alpha-beta T cell proliferation,5.51e-03,3.33e-02,3/151,22/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2000108,positive regulation of leukocyte apoptotic process,5.51e-03,3.33e-02,3/151,22/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010632,regulation of epithelial cell migration,5.65e-03,3.40e-02,7/151,129/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043491,protein kinase B signaling,5.65e-03,3.40e-02,7/151,129/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0033209,tumor necrosis factor-mediated signaling pathway,5.89e-03,3.54e-02,7/151,130/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0016447,somatic recombination of immunoglobulin gene segments,5.95e-03,3.56e-02,4/151,44/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050709,negative regulation of protein secretion,5.95e-03,3.56e-02,4/151,44/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0090151,establishment of protein localization to mitochondrial membrane,5.95e-03,3.56e-02,4/151,44/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042493,response to drug,6.10e-03,3.64e-02,9/151,200/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071383,cellular response to steroid hormone stimulus,6.13e-03,3.66e-02,7/151,131/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030224,monocyte differentiation,6.26e-03,3.68e-02,3/151,23/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032620,interleukin-17 production,6.26e-03,3.68e-02,3/151,23/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045599,negative regulation of fat cell differentiation,6.26e-03,3.68e-02,3/151,23/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050869,negative regulation of B cell activation,6.26e-03,3.68e-02,3/151,23/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1900739,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,6.26e-03,3.68e-02,3/151,23/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,6.26e-03,3.68e-02,3/151,23/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,6.26e-03,3.68e-02,3/151,23/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903131,mononuclear cell differentiation,6.26e-03,3.68e-02,3/151,23/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0033993,response to lipid,6.29e-03,3.70e-02,16/151,482/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0090257,regulation of muscle system process,6.33e-03,3.71e-02,6/151,100/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071559,response to transforming growth factor beta,6.39e-03,3.74e-02,7/151,132/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0007266,Rho protein signal transduction,6.42e-03,3.74e-02,5/151,71/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0098754,detoxification,6.42e-03,3.74e-02,5/151,71/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,6.42e-03,3.74e-02,5/151,71/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0006826,iron ion transport,6.45e-03,3.74e-02,4/151,45/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032729,positive regulation of interferon-gamma production,6.45e-03,3.74e-02,4/151,45/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,6.45e-03,3.74e-02,4/151,45/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071902,positive regulation of protein serine/threonine kinase activity,6.71e-03,3.88e-02,9/151,203/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001501,skeletal system development,6.92e-03,4.00e-02,9/151,204/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030901,midbrain development,6.98e-03,4.02e-02,4/151,46/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002714,positive regulation of B cell mediated immunity,7.06e-03,4.02e-02,3/151,24/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002891,positive regulation of immunoglobulin mediated immune response,7.06e-03,4.02e-02,3/151,24/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0006027,glycosaminoglycan catabolic process,7.06e-03,4.02e-02,3/151,24/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031641,regulation of myelination,7.06e-03,4.02e-02,3/151,24/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045687,positive regulation of glial cell differentiation,7.06e-03,4.02e-02,3/151,24/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045744,negative regulation of G protein-coupled receptor signaling pathway,7.06e-03,4.02e-02,3/151,24/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070232,regulation of T cell apoptotic process,7.06e-03,4.02e-02,3/151,24/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0061013,regulation of mRNA catabolic process,7.13e-03,4.02e-02,8/151,169/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010934,macrophage cytokine production,7.20e-03,4.02e-02,2/151,8/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0014745,negative regulation of muscle adaptation,7.20e-03,4.02e-02,2/151,8/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030214,hyaluronan catabolic process,7.20e-03,4.02e-02,2/151,8/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0034112,positive regulation of homotypic cell-cell adhesion,7.20e-03,4.02e-02,2/151,8/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0034135,regulation of toll-like receptor 2 signaling pathway,7.20e-03,4.02e-02,2/151,8/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043031,negative regulation of macrophage activation,7.20e-03,4.02e-02,2/151,8/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045657,positive regulation of monocyte differentiation,7.20e-03,4.02e-02,2/151,8/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045723,positive regulation of fatty acid biosynthetic process,7.20e-03,4.02e-02,2/151,8/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0048548,regulation of pinocytosis,7.20e-03,4.02e-02,2/151,8/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051238,sequestering of metal ion,7.20e-03,4.02e-02,2/151,8/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070839,divalent metal ion export,7.20e-03,4.02e-02,2/151,8/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway,7.20e-03,4.02e-02,2/151,8/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0060337,type I interferon signaling pathway,7.22e-03,4.02e-02,5/151,73/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071357,cellular response to type I interferon,7.22e-03,4.02e-02,5/151,73/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0032412,regulation of ion transmembrane transporter activity,7.29e-03,4.05e-02,6/151,103/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2001235,positive regulation of apoptotic signaling pathway,7.49e-03,4.16e-02,7/151,136/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031295,T cell costimulation,7.53e-03,4.17e-02,4/151,47/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0050808,synapse organization,7.63e-03,4.21e-02,8/151,171/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010951,negative regulation of endopeptidase activity,7.64e-03,4.21e-02,6/151,104/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0035710,"CD4-positive, alpha-beta T cell activation",7.64e-03,4.21e-02,5/151,74/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0046456,icosanoid biosynthetic process,7.93e-03,4.35e-02,3/151,25/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0046596,regulation of viral entry into host cell,7.93e-03,4.35e-02,3/151,25/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0046633,alpha-beta T cell proliferation,7.93e-03,4.35e-02,3/151,25/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0008016,regulation of heart contraction,8.08e-03,4.42e-02,5/151,75/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031294,lymphocyte costimulation,8.11e-03,4.42e-02,4/151,48/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042093,T-helper cell differentiation,8.11e-03,4.42e-02,4/151,48/9080
CD4T,rs1131017_RPS26_negative,BP,GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",8.11e-03,4.42e-02,4/151,48/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010466,negative regulation of peptidase activity,8.36e-03,4.54e-02,6/151,106/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0009725,response to hormone,8.36e-03,4.54e-02,16/151,497/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0010608,posttranscriptional regulation of gene expression,8.36e-03,4.54e-02,16/151,497/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031334,positive regulation of protein-containing complex assembly,8.44e-03,4.57e-02,8/151,174/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0034340,response to type I interferon,8.53e-03,4.60e-02,5/151,76/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0097530,granulocyte migration,8.53e-03,4.60e-02,5/151,76/9080
CD4T,rs1131017_RPS26_negative,BP,GO:1903531,negative regulation of secretion by cell,8.53e-03,4.60e-02,5/151,76/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0048144,fibroblast proliferation,8.72e-03,4.67e-02,4/151,49/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0048145,regulation of fibroblast proliferation,8.72e-03,4.67e-02,4/151,49/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0072678,T cell migration,8.72e-03,4.67e-02,4/151,49/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0007163,establishment or maintenance of cell polarity,8.73e-03,4.67e-02,7/151,140/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071216,cellular response to biotic stimulus,8.73e-03,4.67e-02,7/151,140/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0001782,B cell homeostasis,8.86e-03,4.68e-02,3/151,26/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0006026,aminoglycan catabolic process,8.86e-03,4.68e-02,3/151,26/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0006509,membrane protein ectodomain proteolysis,8.86e-03,4.68e-02,3/151,26/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042269,regulation of natural killer cell mediated cytotoxicity,8.86e-03,4.68e-02,3/151,26/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,8.86e-03,4.68e-02,3/151,26/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042743,hydrogen peroxide metabolic process,8.86e-03,4.68e-02,3/151,26/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0048146,positive regulation of fibroblast proliferation,8.86e-03,4.68e-02,3/151,26/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0071675,regulation of mononuclear cell migration,8.86e-03,4.68e-02,3/151,26/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0031400,negative regulation of protein modification process,8.94e-03,4.72e-02,14/151,414/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045621,positive regulation of lymphocyte differentiation,9.00e-03,4.74e-02,5/151,77/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0048660,regulation of smooth muscle cell proliferation,9.00e-03,4.74e-02,5/151,77/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0042176,regulation of protein catabolic process,9.16e-03,4.75e-02,11/151,291/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002517,T cell tolerance induction,9.16e-03,4.75e-02,2/151,9/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0009310,amine catabolic process,9.16e-03,4.75e-02,2/151,9/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0030050,vesicle transport along actin filament,9.16e-03,4.75e-02,2/151,9/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0043517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",9.16e-03,4.75e-02,2/151,9/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0045060,negative thymic T cell selection,9.16e-03,4.75e-02,2/151,9/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0060074,synapse maturation,9.16e-03,4.75e-02,2/151,9/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070206,protein trimerization,9.16e-03,4.75e-02,2/151,9/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0070234,positive regulation of T cell apoptotic process,9.16e-03,4.75e-02,2/151,9/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0072677,eosinophil migration,9.16e-03,4.75e-02,2/151,9/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",9.36e-03,4.82e-02,4/151,50/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0016445,somatic diversification of immunoglobulins,9.36e-03,4.82e-02,4/151,50/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0046637,regulation of alpha-beta T cell differentiation,9.36e-03,4.82e-02,4/151,50/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0051205,protein insertion into membrane,9.36e-03,4.82e-02,4/151,50/9080
CD4T,rs1131017_RPS26_negative,BP,GO:0048659,smooth muscle cell proliferation,9.50e-03,4.89e-02,5/151,78/9080
CD4T,rs1131017_RPS26_negative,CC,GO:0009986,cell surface,1.86e-18,6.78e-16,34/151,334/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0098552,side of membrane,1.38e-15,2.53e-13,29/151,290/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0042611,MHC protein complex,7.05e-14,8.57e-12,10/151,19/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0005925,focal adhesion,1.04e-12,9.48e-11,26/151,296/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030055,cell-substrate junction,1.31e-12,9.58e-11,26/151,299/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0071556,integral component of lumenal side of endoplasmic reticulum membrane,2.37e-11,1.24e-09,9/151,22/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0098553,lumenal side of endoplasmic reticulum membrane,2.37e-11,1.24e-09,9/151,22/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0009897,external side of plasma membrane,5.34e-11,2.43e-09,18/151,157/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030666,endocytic vesicle membrane,1.83e-10,7.40e-09,14/151,92/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0098576,lumenal side of membrane,2.09e-10,7.62e-09,9/151,27/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0070161,anchoring junction,1.09e-09,3.62e-08,28/151,466/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030139,endocytic vesicle,1.38e-09,4.19e-08,18/151,191/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0012507,ER to Golgi transport vesicle membrane,5.11e-09,1.44e-07,10/151,50/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0042612,MHC class I protein complex,2.07e-08,5.39e-07,5/151,7/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0015629,actin cytoskeleton,8.82e-08,2.15e-06,19/151,277/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0005884,actin filament,1.72e-07,3.93e-06,10/151,71/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031252,cell leading edge,1.93e-07,4.15e-06,18/151,262/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030134,COPII-coated ER to Golgi transport vesicle,2.57e-07,5.21e-06,10/151,74/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0098797,plasma membrane protein complex,7.29e-07,1.33e-05,16/151,228/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0042613,MHC class II protein complex,7.31e-07,1.33e-05,5/151,12/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030660,Golgi-associated vesicle membrane,8.61e-07,1.50e-05,10/151,84/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030863,cortical cytoskeleton,2.08e-06,3.45e-05,8/151,54/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0062023,collagen-containing extracellular matrix,4.75e-06,7.53e-05,10/151,101/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031012,extracellular matrix,5.00e-06,7.61e-05,11/151,125/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0045335,phagocytic vesicle,7.35e-06,1.07e-04,10/151,106/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030659,cytoplasmic vesicle membrane,8.35e-06,1.17e-04,21/151,445/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0005887,integral component of plasma membrane,8.76e-06,1.18e-04,22/151,483/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0012506,vesicle membrane,1.43e-05,1.74e-04,21/151,461/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0099081,supramolecular polymer,1.43e-05,1.74e-04,21/151,461/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0099512,supramolecular fiber,1.43e-05,1.74e-04,21/151,461/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030141,secretory granule,1.51e-05,1.78e-04,22/151,500/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030176,integral component of endoplasmic reticulum membrane,1.64e-05,1.87e-04,10/151,116/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0072562,blood microparticle,2.06e-05,2.24e-04,6/151,36/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030669,clathrin-coated endocytic vesicle membrane,2.13e-05,2.24e-04,5/151,22/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030658,transport vesicle membrane,2.21e-05,2.24e-04,10/151,120/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031227,intrinsic component of endoplasmic reticulum membrane,2.21e-05,2.24e-04,10/151,120/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030662,coated vesicle membrane,2.55e-05,2.52e-04,10/151,122/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030670,phagocytic vesicle membrane,2.91e-05,2.80e-04,7/151,56/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0045121,membrane raft,3.35e-05,3.06e-04,12/151,181/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0098857,membrane microdomain,3.35e-05,3.06e-04,12/151,181/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0005798,Golgi-associated vesicle,4.42e-05,3.93e-04,10/151,130/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0098858,actin-based cell projection,4.60e-05,4.00e-04,9/151,105/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0098589,membrane region,5.13e-05,4.35e-04,12/151,189/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0005938,cell cortex,6.48e-05,5.37e-04,11/151,164/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0098978,glutamatergic synapse,8.97e-05,7.27e-04,11/151,170/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031256,leading edge membrane,1.11e-04,8.80e-04,8/151,92/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0045334,clathrin-coated endocytic vesicle,1.22e-04,9.51e-04,5/151,31/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0042383,sarcolemma,1.93e-04,1.47e-03,6/151,53/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0001726,ruffle,2.13e-04,1.59e-03,9/151,128/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0001725,stress fiber,2.22e-04,1.59e-03,5/151,35/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0097517,contractile actin filament bundle,2.22e-04,1.59e-03,5/151,35/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0032432,actin filament bundle,2.91e-04,2.02e-03,5/151,37/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0099513,polymeric cytoskeletal fiber,2.93e-04,2.02e-03,16/151,370/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0042470,melanosome,3.91e-04,2.59e-03,7/151,84/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0048770,pigment granule,3.91e-04,2.59e-03,7/151,84/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0005902,microvillus,5.32e-04,3.35e-03,5/151,42/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0042641,actomyosin,5.32e-04,3.35e-03,5/151,42/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0098685,Schaffer collateral - CA1 synapse,5.32e-04,3.35e-03,5/151,42/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0005885,Arp2/3 protein complex,6.13e-04,3.79e-03,3/151,11/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0034774,secretory granule lumen,6.35e-04,3.86e-03,11/151,213/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031983,vesicle lumen,6.86e-04,4.04e-03,11/151,215/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0060205,cytoplasmic vesicle lumen,6.86e-04,4.04e-03,11/151,215/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031258,lamellipodium membrane,8.08e-04,4.68e-03,3/151,12/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0005911,cell-cell junction,8.94e-04,5.10e-03,11/151,222/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030016,myofibril,9.90e-04,5.44e-03,7/151,98/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0005903,brush border,9.90e-04,5.44e-03,5/151,48/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031253,cell projection membrane,9.98e-04,5.44e-03,9/151,158/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030135,coated vesicle,1.33e-03,7.11e-03,10/151,198/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0043292,contractile fiber,1.57e-03,8.26e-03,7/151,106/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0010008,endosome membrane,1.58e-03,8.26e-03,14/151,352/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0000323,lytic vacuole,1.68e-03,8.50e-03,17/151,477/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0005764,lysosome,1.68e-03,8.50e-03,17/151,477/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030315,T-tubule,1.96e-03,9.68e-03,3/151,16/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0097386,glial cell projection,1.96e-03,9.68e-03,3/151,16/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031093,platelet alpha granule lumen,2.05e-03,9.99e-03,4/151,34/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030017,sarcomere,2.14e-03,1.02e-02,6/151,83/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0016323,basolateral plasma membrane,2.15e-03,1.02e-02,7/151,112/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030175,filopodium,2.33e-03,1.09e-02,5/151,58/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0036126,sperm flagellum,2.54e-03,1.16e-02,4/151,36/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0097729,9+2 motile cilium,2.54e-03,1.16e-02,4/151,36/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0048471,perinuclear region of cytoplasm,2.69e-03,1.21e-02,16/151,456/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0055038,recycling endosome membrane,2.91e-03,1.30e-02,5/151,61/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0019897,extrinsic component of plasma membrane,3.05e-03,1.34e-02,6/151,89/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0001772,immunological synapse,3.11e-03,1.35e-02,4/151,38/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030667,secretory granule membrane,3.18e-03,1.37e-02,9/151,187/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030864,cortical actin cytoskeleton,3.42e-03,1.45e-02,4/151,39/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0099059,integral component of presynaptic active zone membrane,3.70e-03,1.55e-02,2/151,6/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0032588,trans-Golgi network membrane,3.84e-03,1.59e-02,5/151,65/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030133,transport vesicle,4.08e-03,1.66e-02,10/151,231/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031514,motile cilium,4.10e-03,1.66e-02,5/151,66/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0098862,cluster of actin-based cell projections,4.38e-03,1.76e-02,5/151,67/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030027,lamellipodium,4.54e-03,1.80e-02,7/151,128/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031901,early endosome membrane,4.91e-03,1.92e-02,6/151,98/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030665,clathrin-coated vesicle membrane,4.96e-03,1.92e-02,5/151,69/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0032059,bleb,5.12e-03,1.92e-02,2/151,7/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0042824,MHC class I peptide loading complex,5.12e-03,1.92e-02,2/151,7/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0098945,intrinsic component of presynaptic active zone membrane,5.12e-03,1.92e-02,2/151,7/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0009898,cytoplasmic side of plasma membrane,5.16e-03,1.92e-02,6/151,99/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0016459,myosin complex,5.71e-03,2.11e-02,3/151,23/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031091,platelet alpha granule,6.72e-03,2.40e-02,4/151,47/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0016461,unconventional myosin complex,6.76e-03,2.40e-02,2/151,8/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0044754,autolysosome,6.76e-03,2.40e-02,2/151,8/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0097228,sperm principal piece,6.76e-03,2.40e-02,2/151,8/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0070820,tertiary granule,7.84e-03,2.75e-02,6/151,108/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0098686,hippocampal mossy fiber to CA3 synapse,8.60e-03,2.99e-02,2/151,9/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0030018,Z disc,8.96e-03,3.09e-02,4/151,51/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031301,integral component of organelle membrane,9.67e-03,3.28e-02,10/151,262/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0005912,adherens junction,9.71e-03,3.28e-02,5/151,81/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031968,organelle outer membrane,1.09e-02,3.63e-02,7/151,151/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031674,I band,1.09e-02,3.63e-02,4/151,54/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0098562,cytoplasmic side of membrane,1.14e-02,3.75e-02,6/151,117/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0019867,outer membrane,1.17e-02,3.81e-02,7/151,153/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0001931,uropod,1.29e-02,4.01e-02,2/151,11/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031254,cell trailing edge,1.29e-02,4.01e-02,2/151,11/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031528,microvillus membrane,1.29e-02,4.01e-02,2/151,11/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0071437,invadopodium,1.29e-02,4.01e-02,2/151,11/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0097225,sperm midpiece,1.29e-02,4.01e-02,2/151,11/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0098590,plasma membrane region,1.29e-02,4.01e-02,15/151,493/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0043209,myelin sheath,1.32e-02,4.01e-02,3/151,31/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0099699,integral component of synaptic membrane,1.32e-02,4.01e-02,3/151,31/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0055037,recycling endosome,1.33e-02,4.01e-02,6/151,121/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0005767,secondary lysosome,1.53e-02,4.56e-02,2/151,12/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0031300,intrinsic component of organelle membrane,1.56e-02,4.56e-02,10/151,282/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0044297,cell body,1.56e-02,4.56e-02,10/151,282/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0045177,apical part of cell,1.56e-02,4.56e-02,7/151,162/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0016324,apical plasma membrane,1.60e-02,4.62e-02,6/151,126/9383
CD4T,rs1131017_RPS26_negative,CC,GO:0099240,intrinsic component of synaptic membrane,1.70e-02,4.88e-02,3/151,34/9383
CD4T,rs1131017_RPS26_negative,MF,GO:0042605,peptide antigen binding,5.17e-13,2.51e-10,9/148,16/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0003823,antigen binding,2.47e-11,6.01e-09,10/148,31/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0019956,chemokine binding,2.16e-10,3.50e-08,8/148,19/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0003779,actin binding,6.30e-10,7.65e-08,20/148,233/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0051015,actin filament binding,1.51e-09,1.47e-07,14/148,109/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0019957,C-C chemokine binding,3.89e-08,3.15e-06,6/148,14/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0140375,immune receptor activity,9.83e-08,6.82e-06,10/148,68/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0019955,cytokine binding,1.31e-07,7.26e-06,10/148,70/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0048306,calcium-dependent protein binding,1.34e-07,7.26e-06,8/148,39/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0044548,S100 protein binding,4.01e-07,1.95e-05,5/148,11/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0004888,transmembrane signaling receptor activity,6.70e-07,2.96e-05,16/148,230/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0016493,C-C chemokine receptor activity,1.09e-06,4.41e-05,5/148,13/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0050839,cell adhesion molecule binding,1.59e-06,5.42e-05,18/148,307/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0001637,G protein-coupled chemoattractant receptor activity,1.67e-06,5.42e-05,5/148,14/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0004950,chemokine receptor activity,1.67e-06,5.42e-05,5/148,14/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0038023,signaling receptor activity,3.73e-06,1.07e-04,18/148,326/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0060089,molecular transducer activity,3.73e-06,1.07e-04,18/148,326/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0005031,tumor necrosis factor-activated receptor activity,4.05e-06,1.09e-04,4/148,8/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0045296,cadherin binding,4.69e-06,1.20e-04,15/148,236/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0005035,death receptor activity,7.20e-06,1.75e-04,4/148,9/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0042277,peptide binding,1.13e-05,2.61e-04,11/148,138/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0050840,extracellular matrix binding,1.20e-05,2.61e-04,5/148,20/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0004896,cytokine receptor activity,1.24e-05,2.61e-04,7/148,50/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0005509,calcium ion binding,1.33e-05,2.69e-04,14/148,226/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0097718,disordered domain specific binding,3.13e-05,6.08e-04,5/148,24/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0016494,C-X-C chemokine receptor activity,3.82e-05,6.87e-04,3/148,5/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0055102,lipase inhibitor activity,3.82e-05,6.87e-04,3/148,5/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0023026,MHC class II protein complex binding,5.37e-05,9.33e-04,4/148,14/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0050998,nitric-oxide synthase binding,7.55e-05,1.27e-03,3/148,6/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0001653,peptide receptor activity,9.70e-05,1.52e-03,5/148,30/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0008528,G protein-coupled peptide receptor activity,9.70e-05,1.52e-03,5/148,30/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0032395,MHC class II receptor activity,1.31e-04,1.82e-03,3/148,7/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0042609,CD4 receptor binding,1.31e-04,1.82e-03,3/148,7/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0046977,TAP binding,1.31e-04,1.82e-03,3/148,7/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0033218,amide binding,1.31e-04,1.82e-03,11/148,180/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0044325,ion channel binding,1.36e-04,1.84e-03,7/148,72/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0005200,structural constituent of cytoskeleton,1.44e-04,1.89e-03,6/148,51/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0042608,T cell receptor binding,2.06e-04,2.64e-03,3/148,8/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0023023,MHC protein complex binding,2.41e-04,3.01e-03,4/148,20/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0030898,actin-dependent ATPase activity,4.32e-04,5.12e-03,3/148,10/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0042056,chemoattractant activity,4.32e-04,5.12e-03,3/148,10/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0098631,cell adhesion mediator activity,5.04e-04,5.83e-03,4/148,24/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0019904,protein domain specific binding,5.70e-04,6.44e-03,18/148,480/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0072542,protein phosphatase activator activity,7.74e-04,8.36e-03,3/148,12/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0098641,cadherin binding involved in cell-cell adhesion,7.74e-04,8.36e-03,3/148,12/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0005516,calmodulin binding,8.55e-04,9.03e-03,7/148,97/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0019829,ATPase-coupled cation transmembrane transporter activity,1.21e-03,1.24e-02,4/148,30/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0019211,phosphatase activator activity,1.25e-03,1.24e-02,3/148,14/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0043236,laminin binding,1.25e-03,1.24e-02,3/148,14/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0042803,protein homodimerization activity,1.33e-03,1.29e-02,15/148,391/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0003785,actin monomer binding,1.55e-03,1.47e-02,3/148,15/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0042625,ATPase-coupled ion transmembrane transporter activity,1.74e-03,1.62e-02,4/148,33/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0048018,receptor ligand activity,1.98e-03,1.82e-02,7/148,112/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0004857,enzyme inhibitor activity,2.23e-03,1.96e-02,9/148,180/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0015662,"ion transmembrane transporter activity, phosphorylative mechanism",2.26e-03,1.96e-02,3/148,17/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0030546,signaling receptor activator activity,2.42e-03,1.96e-02,7/148,116/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0005388,"calcium transmembrane transporter activity, phosphorylative mechanism",2.42e-03,1.96e-02,2/148,5/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0008199,ferric iron binding,2.42e-03,1.96e-02,2/148,5/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0030235,nitric-oxide synthase regulator activity,2.42e-03,1.96e-02,2/148,5/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0030881,beta-2-microglobulin binding,2.42e-03,1.96e-02,2/148,5/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0005178,integrin binding,2.54e-03,2.02e-02,5/148,60/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0019901,protein kinase binding,2.64e-03,2.07e-02,16/148,462/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0005544,calcium-dependent phospholipid binding,2.68e-03,2.07e-02,3/148,18/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0030545,receptor regulator activity,2.93e-03,2.22e-02,7/148,120/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0098632,cell-cell adhesion mediator activity,3.66e-03,2.73e-02,3/148,20/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0005125,cytokine activity,3.85e-03,2.84e-02,5/148,66/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0016209,antioxidant activity,5.04e-03,3.66e-02,4/148,44/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0015026,coreceptor activity,5.49e-03,3.92e-02,3/148,23/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0004930,G protein-coupled receptor activity,6.28e-03,4.42e-02,5/148,74/9332
CD4T,rs1131017_RPS26_negative,MF,GO:0008330,protein tyrosine/threonine phosphatase activity,6.57e-03,4.56e-02,2/148,8/9332
CD8T,rs1131017_RPS26,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,1.17e-102,4.17e-99,77/268,92/7978
CD8T,rs1131017_RPS26,BP,GO:0006613,cotranslational protein targeting to membrane,9.11e-100,1.62e-96,77/268,96/7978
CD8T,rs1131017_RPS26,BP,GO:0045047,protein targeting to ER,3.19e-94,3.78e-91,77/268,105/7978
CD8T,rs1131017_RPS26,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,1.35e-92,1.15e-89,77/268,108/7978
CD8T,rs1131017_RPS26,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",1.62e-92,1.15e-89,78/268,112/7978
CD8T,rs1131017_RPS26,BP,GO:0006413,translational initiation,1.61e-87,9.53e-85,88/268,172/7978
CD8T,rs1131017_RPS26,BP,GO:0070972,protein localization to endoplasmic reticulum,1.28e-83,6.50e-81,77/268,128/7978
CD8T,rs1131017_RPS26,BP,GO:0006612,protein targeting to membrane,3.66e-81,1.63e-78,81/268,155/7978
CD8T,rs1131017_RPS26,BP,GO:0019083,viral transcription,1.63e-74,6.45e-72,79/268,167/7978
CD8T,rs1131017_RPS26,BP,GO:0019080,viral gene expression,1.63e-73,5.79e-71,81/268,183/7978
CD8T,rs1131017_RPS26,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,2.75e-70,8.89e-68,79/268,184/7978
CD8T,rs1131017_RPS26,BP,GO:0090150,establishment of protein localization to membrane,7.55e-65,2.24e-62,84/268,247/7978
CD8T,rs1131017_RPS26,BP,GO:0006402,mRNA catabolic process,2.06e-58,5.63e-56,86/268,307/7978
CD8T,rs1131017_RPS26,BP,GO:0006605,protein targeting,2.17e-55,5.51e-53,86/268,331/7978
CD8T,rs1131017_RPS26,BP,GO:0006401,RNA catabolic process,8.53e-55,2.02e-52,86/268,336/7978
CD8T,rs1131017_RPS26,BP,GO:0072657,protein localization to membrane,3.40e-53,7.57e-51,91/268,402/7978
CD8T,rs1131017_RPS26,BP,GO:0034655,nucleobase-containing compound catabolic process,9.25e-49,1.94e-46,89/268,426/7978
CD8T,rs1131017_RPS26,BP,GO:0046700,heterocycle catabolic process,5.99e-48,1.18e-45,89/268,435/7978
CD8T,rs1131017_RPS26,BP,GO:0044270,cellular nitrogen compound catabolic process,1.11e-47,2.07e-45,89/268,438/7978
CD8T,rs1131017_RPS26,BP,GO:0019439,aromatic compound catabolic process,3.03e-47,5.39e-45,89/268,443/7978
CD8T,rs1131017_RPS26,BP,GO:1901361,organic cyclic compound catabolic process,9.97e-47,1.69e-44,89/268,449/7978
CD8T,rs1131017_RPS26,BP,GO:0072594,establishment of protein localization to organelle,1.95e-46,3.15e-44,87/268,429/7978
CD8T,rs1131017_RPS26,BP,GO:0002181,cytoplasmic translation,8.31e-36,1.29e-33,40/268,90/7978
CD8T,rs1131017_RPS26,BP,GO:0042255,ribosome assembly,2.40e-18,3.55e-16,21/268,51/7978
CD8T,rs1131017_RPS26,BP,GO:0042254,ribosome biogenesis,2.77e-15,3.95e-13,39/268,266/7978
CD8T,rs1131017_RPS26,BP,GO:0022613,ribonucleoprotein complex biogenesis,2.15e-14,2.94e-12,46/268,386/7978
CD8T,rs1131017_RPS26,BP,GO:0042273,ribosomal large subunit biogenesis,8.60e-14,1.13e-11,19/268,63/7978
CD8T,rs1131017_RPS26,BP,GO:0071826,ribonucleoprotein complex subunit organization,9.35e-11,1.19e-08,26/268,173/7978
CD8T,rs1131017_RPS26,BP,GO:0022618,ribonucleoprotein complex assembly,2.39e-10,2.93e-08,25/268,167/7978
CD8T,rs1131017_RPS26,BP,GO:0042274,ribosomal small subunit biogenesis,3.19e-10,3.78e-08,16/268,66/7978
CD8T,rs1131017_RPS26,BP,GO:0000028,ribosomal small subunit assembly,4.44e-10,5.10e-08,9/268,16/7978
CD8T,rs1131017_RPS26,BP,GO:0000027,ribosomal large subunit assembly,2.00e-09,2.23e-07,10/268,24/7978
CD8T,rs1131017_RPS26,BP,GO:0006364,rRNA processing,7.32e-09,7.89e-07,25/268,196/7978
CD8T,rs1131017_RPS26,BP,GO:0050865,regulation of cell activation,1.39e-08,1.45e-06,32/268,313/7978
CD8T,rs1131017_RPS26,BP,GO:0016072,rRNA metabolic process,1.51e-08,1.53e-06,25/268,203/7978
CD8T,rs1131017_RPS26,BP,GO:0002694,regulation of leukocyte activation,2.17e-08,2.14e-06,31/268,302/7978
CD8T,rs1131017_RPS26,BP,GO:0098609,cell-cell adhesion,2.30e-08,2.21e-06,34/268,354/7978
CD8T,rs1131017_RPS26,BP,GO:0050867,positive regulation of cell activation,2.48e-08,2.32e-06,25/268,208/7978
CD8T,rs1131017_RPS26,BP,GO:0006959,humoral immune response,3.30e-08,3.01e-06,14/268,67/7978
CD8T,rs1131017_RPS26,BP,GO:0010608,posttranscriptional regulation of gene expression,4.86e-08,4.30e-06,39/268,456/7978
CD8T,rs1131017_RPS26,BP,GO:0001906,cell killing,4.95e-08,4.30e-06,15/268,80/7978
CD8T,rs1131017_RPS26,BP,GO:0002696,positive regulation of leukocyte activation,7.25e-08,6.14e-06,24/268,204/7978
CD8T,rs1131017_RPS26,BP,GO:0051249,regulation of lymphocyte activation,7.53e-08,6.23e-06,28/268,268/7978
CD8T,rs1131017_RPS26,BP,GO:0050863,regulation of T cell activation,7.97e-08,6.45e-06,24/268,205/7978
CD8T,rs1131017_RPS26,BP,GO:0019221,cytokine-mediated signaling pathway,9.75e-08,7.71e-06,38/268,449/7978
CD8T,rs1131017_RPS26,BP,GO:1903037,regulation of leukocyte cell-cell adhesion,1.31e-07,1.01e-05,23/268,195/7978
CD8T,rs1131017_RPS26,BP,GO:1903039,positive regulation of leukocyte cell-cell adhesion,1.84e-07,1.40e-05,20/268,154/7978
CD8T,rs1131017_RPS26,BP,GO:0045785,positive regulation of cell adhesion,2.16e-07,1.60e-05,25/268,232/7978
CD8T,rs1131017_RPS26,BP,GO:0051251,positive regulation of lymphocyte activation,2.37e-07,1.72e-05,22/268,186/7978
CD8T,rs1131017_RPS26,BP,GO:0007159,leukocyte cell-cell adhesion,2.57e-07,1.83e-05,24/268,218/7978
CD8T,rs1131017_RPS26,BP,GO:0050870,positive regulation of T cell activation,2.62e-07,1.83e-05,19/268,143/7978
CD8T,rs1131017_RPS26,BP,GO:0022407,regulation of cell-cell adhesion,3.83e-07,2.62e-05,25/268,239/7978
CD8T,rs1131017_RPS26,BP,GO:0006417,regulation of translation,4.31e-07,2.89e-05,27/268,274/7978
CD8T,rs1131017_RPS26,BP,GO:0002250,adaptive immune response,4.49e-07,2.96e-05,25/268,241/7978
CD8T,rs1131017_RPS26,BP,GO:0002449,lymphocyte mediated immunity,5.04e-07,3.22e-05,19/268,149/7978
CD8T,rs1131017_RPS26,BP,GO:0030155,regulation of cell adhesion,5.07e-07,3.22e-05,32/268,365/7978
CD8T,rs1131017_RPS26,BP,GO:0001913,T cell mediated cytotoxicity,6.73e-07,4.20e-05,8/268,24/7978
CD8T,rs1131017_RPS26,BP,GO:0022409,positive regulation of cell-cell adhesion,6.98e-07,4.29e-05,20/268,167/7978
CD8T,rs1131017_RPS26,BP,GO:0002480,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent",8.19e-07,4.94e-05,5/268,7/7978
CD8T,rs1131017_RPS26,BP,GO:0019730,antimicrobial humoral response,9.61e-07,5.70e-05,8/268,25/7978
CD8T,rs1131017_RPS26,BP,GO:0019835,cytolysis,1.06e-06,6.18e-05,6/268,12/7978
CD8T,rs1131017_RPS26,BP,GO:0042110,T cell activation,1.11e-06,6.36e-05,28/268,305/7978
CD8T,rs1131017_RPS26,BP,GO:0002407,dendritic cell chemotaxis,1.91e-06,1.06e-04,6/268,13/7978
CD8T,rs1131017_RPS26,BP,GO:0019883,antigen processing and presentation of endogenous antigen,1.91e-06,1.06e-04,6/268,13/7978
CD8T,rs1131017_RPS26,BP,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,2.25e-06,1.23e-04,18/268,149/7978
CD8T,rs1131017_RPS26,BP,GO:1901798,positive regulation of signal transduction by p53 class mediator,3.25e-06,1.75e-04,6/268,14/7978
CD8T,rs1131017_RPS26,BP,GO:0050921,positive regulation of chemotaxis,3.34e-06,1.78e-04,11/268,59/7978
CD8T,rs1131017_RPS26,BP,GO:0046649,lymphocyte activation,3.57e-06,1.87e-04,34/268,438/7978
CD8T,rs1131017_RPS26,BP,GO:1902105,regulation of leukocyte differentiation,4.94e-06,2.55e-04,19/268,173/7978
CD8T,rs1131017_RPS26,BP,GO:0032943,mononuclear cell proliferation,5.25e-06,2.60e-04,18/268,158/7978
CD8T,rs1131017_RPS26,BP,GO:0046651,lymphocyte proliferation,5.25e-06,2.60e-04,18/268,158/7978
CD8T,rs1131017_RPS26,BP,GO:0036336,dendritic cell migration,5.27e-06,2.60e-04,6/268,15/7978
CD8T,rs1131017_RPS26,BP,GO:0002456,T cell mediated immunity,5.55e-06,2.71e-04,11/268,62/7978
CD8T,rs1131017_RPS26,BP,GO:0002484,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,6.07e-06,2.84e-04,4/268,5/7978
CD8T,rs1131017_RPS26,BP,GO:0002486,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",6.07e-06,2.84e-04,4/268,5/7978
CD8T,rs1131017_RPS26,BP,GO:0019731,antibacterial humoral response,6.07e-06,2.84e-04,4/268,5/7978
CD8T,rs1131017_RPS26,BP,GO:0034248,regulation of cellular amide metabolic process,6.44e-06,2.97e-04,27/268,315/7978
CD8T,rs1131017_RPS26,BP,GO:0002183,cytoplasmic translational initiation,7.62e-06,3.48e-04,8/268,32/7978
CD8T,rs1131017_RPS26,BP,GO:0031341,regulation of cell killing,8.41e-06,3.79e-04,10/268,53/7978
CD8T,rs1131017_RPS26,BP,GO:0032944,regulation of mononuclear cell proliferation,1.06e-05,4.58e-04,15/268,120/7978
CD8T,rs1131017_RPS26,BP,GO:0050670,regulation of lymphocyte proliferation,1.06e-05,4.58e-04,15/268,120/7978
CD8T,rs1131017_RPS26,BP,GO:0070661,leukocyte proliferation,1.06e-05,4.58e-04,18/268,166/7978
CD8T,rs1131017_RPS26,BP,GO:0001914,regulation of T cell mediated cytotoxicity,1.23e-05,5.28e-04,6/268,17/7978
CD8T,rs1131017_RPS26,BP,GO:0002483,antigen processing and presentation of endogenous peptide antigen,1.61e-05,6.72e-04,5/268,11/7978
CD8T,rs1131017_RPS26,BP,GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,1.61e-05,6.72e-04,5/268,11/7978
CD8T,rs1131017_RPS26,BP,GO:0032946,positive regulation of mononuclear cell proliferation,1.64e-05,6.72e-04,12/268,82/7978
CD8T,rs1131017_RPS26,BP,GO:0050671,positive regulation of lymphocyte proliferation,1.64e-05,6.72e-04,12/268,82/7978
CD8T,rs1131017_RPS26,BP,GO:0070663,regulation of leukocyte proliferation,1.92e-05,7.75e-04,15/268,126/7978
CD8T,rs1131017_RPS26,BP,GO:0031343,positive regulation of cell killing,1.95e-05,7.80e-04,8/268,36/7978
CD8T,rs1131017_RPS26,BP,GO:0032101,regulation of response to external stimulus,2.26e-05,8.94e-04,35/268,498/7978
CD8T,rs1131017_RPS26,BP,GO:0050857,positive regulation of antigen receptor-mediated signaling pathway,2.55e-05,9.97e-04,6/268,19/7978
CD8T,rs1131017_RPS26,BP,GO:0070665,positive regulation of leukocyte proliferation,2.69e-05,1.02e-03,12/268,86/7978
CD8T,rs1131017_RPS26,BP,GO:0097529,myeloid leukocyte migration,2.69e-05,1.02e-03,12/268,86/7978
CD8T,rs1131017_RPS26,BP,GO:0045727,positive regulation of translation,2.70e-05,1.02e-03,13/268,100/7978
CD8T,rs1131017_RPS26,BP,GO:0032655,regulation of interleukin-12 production,2.88e-05,1.08e-03,7/268,28/7978
CD8T,rs1131017_RPS26,BP,GO:0042102,positive regulation of T cell proliferation,3.07e-05,1.14e-03,10/268,61/7978
CD8T,rs1131017_RPS26,BP,GO:0034341,response to interferon-gamma,3.12e-05,1.14e-03,14/268,116/7978
CD8T,rs1131017_RPS26,BP,GO:0001817,regulation of cytokine production,3.45e-05,1.25e-03,29/268,385/7978
CD8T,rs1131017_RPS26,BP,GO:0001909,leukocyte mediated cytotoxicity,3.55e-05,1.27e-03,10/268,62/7978
CD8T,rs1131017_RPS26,BP,GO:0034470,ncRNA processing,3.60e-05,1.27e-03,26/268,327/7978
CD8T,rs1131017_RPS26,BP,GO:0002709,regulation of T cell mediated immunity,3.63e-05,1.27e-03,8/268,39/7978
CD8T,rs1131017_RPS26,BP,GO:0032615,interleukin-12 production,3.69e-05,1.27e-03,7/268,29/7978
CD8T,rs1131017_RPS26,BP,GO:0071346,cellular response to interferon-gamma,3.72e-05,1.27e-03,13/268,103/7978
CD8T,rs1131017_RPS26,BP,GO:1902107,positive regulation of leukocyte differentiation,3.72e-05,1.27e-03,13/268,103/7978
CD8T,rs1131017_RPS26,BP,GO:0042129,regulation of T cell proliferation,3.82e-05,1.29e-03,12/268,89/7978
CD8T,rs1131017_RPS26,BP,GO:0016064,immunoglobulin mediated immune response,4.10e-05,1.38e-03,10/268,63/7978
CD8T,rs1131017_RPS26,BP,GO:0006954,inflammatory response,4.21e-05,1.39e-03,26/268,330/7978
CD8T,rs1131017_RPS26,BP,GO:0001916,positive regulation of T cell mediated cytotoxicity,4.25e-05,1.39e-03,5/268,13/7978
CD8T,rs1131017_RPS26,BP,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,4.25e-05,1.39e-03,5/268,13/7978
CD8T,rs1131017_RPS26,BP,GO:0050900,leukocyte migration,4.55e-05,1.47e-03,19/268,202/7978
CD8T,rs1131017_RPS26,BP,GO:0019724,B cell mediated immunity,5.41e-05,1.74e-03,10/268,65/7978
CD8T,rs1131017_RPS26,BP,GO:0002698,negative regulation of immune effector process,6.19e-05,1.97e-03,10/268,66/7978
CD8T,rs1131017_RPS26,BP,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,6.43e-05,2.01e-03,5/268,14/7978
CD8T,rs1131017_RPS26,BP,GO:0002455,humoral immune response mediated by circulating immunoglobulin,6.43e-05,2.01e-03,5/268,14/7978
CD8T,rs1131017_RPS26,BP,GO:0045087,innate immune response,6.65e-05,2.06e-03,32/268,461/7978
CD8T,rs1131017_RPS26,BP,GO:0001818,negative regulation of cytokine production,7.25e-05,2.23e-03,15/268,141/7978
CD8T,rs1131017_RPS26,BP,GO:0002690,positive regulation of leukocyte chemotaxis,7.62e-05,2.32e-03,8/268,43/7978
CD8T,rs1131017_RPS26,BP,GO:0032071,regulation of endodeoxyribonuclease activity,7.84e-05,2.36e-03,4/268,8/7978
CD8T,rs1131017_RPS26,BP,GO:0001774,microglial cell activation,8.47e-05,2.51e-03,6/268,23/7978
CD8T,rs1131017_RPS26,BP,GO:0002269,leukocyte activation involved in inflammatory response,8.47e-05,2.51e-03,6/268,23/7978
CD8T,rs1131017_RPS26,BP,GO:0009617,response to bacterium,8.53e-05,2.51e-03,21/268,248/7978
CD8T,rs1131017_RPS26,BP,GO:0002761,regulation of myeloid leukocyte differentiation,9.13e-05,2.66e-03,10/268,69/7978
CD8T,rs1131017_RPS26,BP,GO:0001732,formation of cytoplasmic translation initiation complex,9.38e-05,2.69e-03,5/268,15/7978
CD8T,rs1131017_RPS26,BP,GO:0031342,negative regulation of cell killing,9.38e-05,2.69e-03,5/268,15/7978
CD8T,rs1131017_RPS26,BP,GO:0001816,cytokine production,9.57e-05,2.72e-03,30/268,428/7978
CD8T,rs1131017_RPS26,BP,GO:0002576,platelet degranulation,1.04e-04,2.94e-03,9/268,57/7978
CD8T,rs1131017_RPS26,BP,GO:0042116,macrophage activation,1.07e-04,2.99e-03,8/268,45/7978
CD8T,rs1131017_RPS26,BP,GO:0042098,T cell proliferation,1.08e-04,3.01e-03,13/268,114/7978
CD8T,rs1131017_RPS26,BP,GO:0002707,negative regulation of lymphocyte mediated immunity,1.10e-04,3.03e-03,6/268,24/7978
CD8T,rs1131017_RPS26,BP,GO:0050778,positive regulation of immune response,1.20e-04,3.29e-03,28/268,392/7978
CD8T,rs1131017_RPS26,BP,GO:0045619,regulation of lymphocyte differentiation,1.29e-04,3.52e-03,13/268,116/7978
CD8T,rs1131017_RPS26,BP,GO:0031640,killing of cells of other organism,1.33e-04,3.55e-03,5/268,16/7978
CD8T,rs1131017_RPS26,BP,GO:0046641,positive regulation of alpha-beta T cell proliferation,1.33e-04,3.55e-03,5/268,16/7978
CD8T,rs1131017_RPS26,BP,GO:0034660,ncRNA metabolic process,1.34e-04,3.55e-03,27/268,374/7978
CD8T,rs1131017_RPS26,BP,GO:1904667,negative regulation of ubiquitin protein ligase activity,1.37e-04,3.62e-03,4/268,9/7978
CD8T,rs1131017_RPS26,BP,GO:0061900,glial cell activation,1.40e-04,3.67e-03,6/268,25/7978
CD8T,rs1131017_RPS26,BP,GO:0002573,myeloid leukocyte differentiation,1.41e-04,3.67e-03,13/268,117/7978
CD8T,rs1131017_RPS26,BP,GO:0008284,positive regulation of cell population proliferation,1.44e-04,3.73e-03,29/268,417/7978
CD8T,rs1131017_RPS26,BP,GO:0002443,leukocyte mediated immunity,1.60e-04,4.10e-03,32/268,483/7978
CD8T,rs1131017_RPS26,BP,GO:0051606,detection of stimulus,1.61e-04,4.10e-03,11/268,88/7978
CD8T,rs1131017_RPS26,BP,GO:0050727,regulation of inflammatory response,1.69e-04,4.26e-03,16/268,169/7978
CD8T,rs1131017_RPS26,BP,GO:0032103,positive regulation of response to external stimulus,1.76e-04,4.41e-03,21/268,261/7978
CD8T,rs1131017_RPS26,BP,GO:0002479,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",1.78e-04,4.44e-03,9/268,61/7978
CD8T,rs1131017_RPS26,BP,GO:0002521,leukocyte differentiation,1.80e-04,4.45e-03,24/268,320/7978
CD8T,rs1131017_RPS26,BP,GO:1903706,regulation of hemopoiesis,1.87e-04,4.59e-03,23/268,301/7978
CD8T,rs1131017_RPS26,BP,GO:0050920,regulation of chemotaxis,1.98e-04,4.82e-03,11/268,90/7978
CD8T,rs1131017_RPS26,BP,GO:0060326,cell chemotaxis,2.16e-04,5.23e-03,13/268,122/7978
CD8T,rs1131017_RPS26,BP,GO:0051272,positive regulation of cellular component movement,2.19e-04,5.25e-03,20/268,246/7978
CD8T,rs1131017_RPS26,BP,GO:0150076,neuroinflammatory response,2.22e-04,5.25e-03,6/268,27/7978
CD8T,rs1131017_RPS26,BP,GO:2000107,negative regulation of leukocyte apoptotic process,2.22e-04,5.25e-03,6/268,27/7978
CD8T,rs1131017_RPS26,BP,GO:0032070,regulation of deoxyribonuclease activity,2.23e-04,5.25e-03,4/268,10/7978
CD8T,rs1131017_RPS26,BP,GO:0034250,positive regulation of cellular amide metabolic process,2.34e-04,5.49e-03,13/268,123/7978
CD8T,rs1131017_RPS26,BP,GO:0002920,regulation of humoral immune response,2.46e-04,5.73e-03,5/268,18/7978
CD8T,rs1131017_RPS26,BP,GO:0002687,positive regulation of leukocyte migration,2.60e-04,5.96e-03,9/268,64/7978
CD8T,rs1131017_RPS26,BP,GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,2.60e-04,5.96e-03,9/268,64/7978
CD8T,rs1131017_RPS26,BP,GO:0002683,negative regulation of immune system process,2.86e-04,6.53e-03,19/268,232/7978
CD8T,rs1131017_RPS26,BP,GO:1990266,neutrophil migration,3.04e-04,6.90e-03,8/268,52/7978
CD8T,rs1131017_RPS26,BP,GO:0030595,leukocyte chemotaxis,3.20e-04,7.15e-03,11/268,95/7978
CD8T,rs1131017_RPS26,BP,GO:0034109,homotypic cell-cell adhesion,3.21e-04,7.15e-03,7/268,40/7978
CD8T,rs1131017_RPS26,BP,GO:0002548,monocyte chemotaxis,3.25e-04,7.15e-03,5/268,19/7978
CD8T,rs1131017_RPS26,BP,GO:0046640,regulation of alpha-beta T cell proliferation,3.25e-04,7.15e-03,5/268,19/7978
CD8T,rs1131017_RPS26,BP,GO:0070229,negative regulation of lymphocyte apoptotic process,3.25e-04,7.15e-03,5/268,19/7978
CD8T,rs1131017_RPS26,BP,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,3.36e-04,7.30e-03,6/268,29/7978
CD8T,rs1131017_RPS26,BP,GO:0002711,positive regulation of T cell mediated immunity,3.36e-04,7.30e-03,6/268,29/7978
CD8T,rs1131017_RPS26,BP,GO:0050777,negative regulation of immune response,3.54e-04,7.60e-03,10/268,81/7978
CD8T,rs1131017_RPS26,BP,GO:2000508,regulation of dendritic cell chemotaxis,3.57e-04,7.60e-03,3/268,5/7978
CD8T,rs1131017_RPS26,BP,GO:2000510,positive regulation of dendritic cell chemotaxis,3.57e-04,7.60e-03,3/268,5/7978
CD8T,rs1131017_RPS26,BP,GO:0030335,positive regulation of cell migration,3.75e-04,7.91e-03,19/268,237/7978
CD8T,rs1131017_RPS26,BP,GO:1903708,positive regulation of hemopoiesis,3.75e-04,7.91e-03,13/268,129/7978
CD8T,rs1131017_RPS26,BP,GO:0002819,regulation of adaptive immune response,3.84e-04,8.04e-03,11/268,97/7978
CD8T,rs1131017_RPS26,BP,GO:0002704,negative regulation of leukocyte mediated immunity,4.09e-04,8.51e-03,6/268,30/7978
CD8T,rs1131017_RPS26,BP,GO:0002697,regulation of immune effector process,4.18e-04,8.65e-03,18/268,220/7978
CD8T,rs1131017_RPS26,BP,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,4.32e-04,8.89e-03,10/268,83/7978
CD8T,rs1131017_RPS26,BP,GO:0001910,regulation of leukocyte mediated cytotoxicity,4.39e-04,8.98e-03,7/268,42/7978
CD8T,rs1131017_RPS26,BP,GO:0002688,regulation of leukocyte chemotaxis,4.51e-04,9.18e-03,8/268,55/7978
CD8T,rs1131017_RPS26,BP,GO:2000147,positive regulation of cell motility,4.63e-04,9.36e-03,19/268,241/7978
CD8T,rs1131017_RPS26,BP,GO:0032930,positive regulation of superoxide anion generation,4.98e-04,9.94e-03,4/268,12/7978
CD8T,rs1131017_RPS26,BP,GO:0045655,regulation of monocyte differentiation,4.98e-04,9.94e-03,4/268,12/7978
CD8T,rs1131017_RPS26,BP,GO:0002685,regulation of leukocyte migration,5.00e-04,9.94e-03,11/268,100/7978
CD8T,rs1131017_RPS26,BP,GO:0002367,cytokine production involved in immune response,5.12e-04,1.01e-02,8/268,56/7978
CD8T,rs1131017_RPS26,BP,GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,5.39e-04,1.05e-02,5/268,21/7978
CD8T,rs1131017_RPS26,BP,GO:1902622,regulation of neutrophil migration,5.39e-04,1.05e-02,5/268,21/7978
CD8T,rs1131017_RPS26,BP,GO:0040017,positive regulation of locomotion,5.39e-04,1.05e-02,19/268,244/7978
CD8T,rs1131017_RPS26,BP,GO:0019882,antigen processing and presentation,6.11e-04,1.18e-02,15/268,171/7978
CD8T,rs1131017_RPS26,BP,GO:0002706,regulation of lymphocyte mediated immunity,6.32e-04,1.22e-02,10/268,87/7978
CD8T,rs1131017_RPS26,BP,GO:0002718,regulation of cytokine production involved in immune response,6.78e-04,1.29e-02,7/268,45/7978
CD8T,rs1131017_RPS26,BP,GO:0046633,alpha-beta T cell proliferation,6.78e-04,1.29e-02,5/268,22/7978
CD8T,rs1131017_RPS26,BP,GO:0002501,peptide antigen assembly with MHC protein complex,6.95e-04,1.31e-02,3/268,6/7978
CD8T,rs1131017_RPS26,BP,GO:0010935,regulation of macrophage cytokine production,6.95e-04,1.31e-02,3/268,6/7978
CD8T,rs1131017_RPS26,BP,GO:0002861,regulation of inflammatory response to antigenic stimulus,7.00e-04,1.31e-02,4/268,13/7978
CD8T,rs1131017_RPS26,BP,GO:0050862,positive regulation of T cell receptor signaling pathway,7.00e-04,1.31e-02,4/268,13/7978
CD8T,rs1131017_RPS26,BP,GO:0043410,positive regulation of MAPK cascade,7.10e-04,1.32e-02,18/268,230/7978
CD8T,rs1131017_RPS26,BP,GO:0002478,antigen processing and presentation of exogenous peptide antigen,7.19e-04,1.33e-02,13/268,138/7978
CD8T,rs1131017_RPS26,BP,GO:0002703,regulation of leukocyte mediated immunity,7.25e-04,1.33e-02,12/268,121/7978
CD8T,rs1131017_RPS26,BP,GO:0031347,regulation of defense response,7.27e-04,1.33e-02,25/268,373/7978
CD8T,rs1131017_RPS26,BP,GO:0007249,I-kappaB kinase/NF-kappaB signaling,7.54e-04,1.37e-02,16/268,193/7978
CD8T,rs1131017_RPS26,BP,GO:0070374,positive regulation of ERK1 and ERK2 cascade,7.78e-04,1.40e-02,9/268,74/7978
CD8T,rs1131017_RPS26,BP,GO:0002702,positive regulation of production of molecular mediator of immune response,8.21e-04,1.47e-02,8/268,60/7978
CD8T,rs1131017_RPS26,BP,GO:0097530,granulocyte migration,8.21e-04,1.47e-02,8/268,60/7978
CD8T,rs1131017_RPS26,BP,GO:0031529,ruffle organization,8.27e-04,1.47e-02,6/268,34/7978
CD8T,rs1131017_RPS26,BP,GO:0043903,regulation of symbiotic process,8.36e-04,1.48e-02,14/268,158/7978
CD8T,rs1131017_RPS26,BP,GO:0000470,maturation of LSU-rRNA,8.43e-04,1.48e-02,5/268,23/7978
CD8T,rs1131017_RPS26,BP,GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,8.43e-04,1.48e-02,5/268,23/7978
CD8T,rs1131017_RPS26,BP,GO:0001819,positive regulation of cytokine production,8.81e-04,1.53e-02,19/268,254/7978
CD8T,rs1131017_RPS26,BP,GO:0019884,antigen processing and presentation of exogenous antigen,8.81e-04,1.53e-02,13/268,141/7978
CD8T,rs1131017_RPS26,BP,GO:0051050,positive regulation of transport,9.10e-04,1.57e-02,27/268,422/7978
CD8T,rs1131017_RPS26,BP,GO:0032675,regulation of interleukin-6 production,9.18e-04,1.58e-02,8/268,61/7978
CD8T,rs1131017_RPS26,BP,GO:0030099,myeloid cell differentiation,9.23e-04,1.58e-02,19/268,255/7978
CD8T,rs1131017_RPS26,BP,GO:0002274,myeloid leukocyte activation,9.33e-04,1.59e-02,26/268,401/7978
CD8T,rs1131017_RPS26,BP,GO:0042742,defense response to bacterium,9.45e-04,1.60e-02,9/268,76/7978
CD8T,rs1131017_RPS26,BP,GO:0032928,regulation of superoxide anion generation,9.55e-04,1.61e-02,4/268,14/7978
CD8T,rs1131017_RPS26,BP,GO:0002720,positive regulation of cytokine production involved in immune response,9.70e-04,1.63e-02,6/268,35/7978
CD8T,rs1131017_RPS26,BP,GO:0042330,taxis,1.01e-03,1.68e-02,18/268,237/7978
CD8T,rs1131017_RPS26,BP,GO:0002440,production of molecular mediator of immune response,1.04e-03,1.73e-02,12/268,126/7978
CD8T,rs1131017_RPS26,BP,GO:0031348,negative regulation of defense response,1.12e-03,1.85e-02,11/268,110/7978
CD8T,rs1131017_RPS26,BP,GO:0002396,MHC protein complex assembly,1.19e-03,1.92e-02,3/268,7/7978
CD8T,rs1131017_RPS26,BP,GO:0010934,macrophage cytokine production,1.19e-03,1.92e-02,3/268,7/7978
CD8T,rs1131017_RPS26,BP,GO:0016045,detection of bacterium,1.19e-03,1.92e-02,3/268,7/7978
CD8T,rs1131017_RPS26,BP,GO:0045586,regulation of gamma-delta T cell differentiation,1.19e-03,1.92e-02,3/268,7/7978
CD8T,rs1131017_RPS26,BP,GO:0090026,positive regulation of monocyte chemotaxis,1.19e-03,1.92e-02,3/268,7/7978
CD8T,rs1131017_RPS26,BP,GO:0051651,maintenance of location in cell,1.21e-03,1.94e-02,11/268,111/7978
CD8T,rs1131017_RPS26,BP,GO:0048002,antigen processing and presentation of peptide antigen,1.22e-03,1.95e-02,13/268,146/7978
CD8T,rs1131017_RPS26,BP,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,1.25e-03,1.99e-02,9/268,79/7978
CD8T,rs1131017_RPS26,BP,GO:0002700,regulation of production of molecular mediator of immune response,1.25e-03,1.99e-02,9/268,79/7978
CD8T,rs1131017_RPS26,BP,GO:0060333,interferon-gamma-mediated signaling pathway,1.26e-03,2.00e-02,8/268,64/7978
CD8T,rs1131017_RPS26,BP,GO:0070555,response to interleukin-1,1.28e-03,2.01e-02,12/268,129/7978
CD8T,rs1131017_RPS26,BP,GO:0006909,phagocytosis,1.30e-03,2.03e-02,13/268,147/7978
CD8T,rs1131017_RPS26,BP,GO:0035722,interleukin-12-mediated signaling pathway,1.31e-03,2.05e-02,6/268,37/7978
CD8T,rs1131017_RPS26,BP,GO:0006446,regulation of translational initiation,1.40e-03,2.18e-02,8/268,65/7978
CD8T,rs1131017_RPS26,BP,GO:0002699,positive regulation of immune effector process,1.46e-03,2.26e-02,12/268,131/7978
CD8T,rs1131017_RPS26,BP,GO:0002763,positive regulation of myeloid leukocyte differentiation,1.52e-03,2.33e-02,6/268,38/7978
CD8T,rs1131017_RPS26,BP,GO:0071349,cellular response to interleukin-12,1.52e-03,2.33e-02,6/268,38/7978
CD8T,rs1131017_RPS26,BP,GO:0045055,regulated exocytosis,1.53e-03,2.33e-02,27/268,437/7978
CD8T,rs1131017_RPS26,BP,GO:0051235,maintenance of location,1.61e-03,2.44e-02,14/268,169/7978
CD8T,rs1131017_RPS26,BP,GO:0002705,positive regulation of leukocyte mediated immunity,1.63e-03,2.47e-02,9/268,82/7978
CD8T,rs1131017_RPS26,BP,GO:0031579,membrane raft organization,1.65e-03,2.47e-02,4/268,16/7978
CD8T,rs1131017_RPS26,BP,GO:0051444,negative regulation of ubiquitin-protein transferase activity,1.65e-03,2.47e-02,4/268,16/7978
CD8T,rs1131017_RPS26,BP,GO:0019058,viral life cycle,1.69e-03,2.53e-02,17/268,228/7978
CD8T,rs1131017_RPS26,BP,GO:0045580,regulation of T cell differentiation,1.73e-03,2.58e-02,10/268,99/7978
CD8T,rs1131017_RPS26,BP,GO:0070671,response to interleukin-12,1.74e-03,2.59e-02,6/268,39/7978
CD8T,rs1131017_RPS26,BP,GO:0050792,regulation of viral process,1.76e-03,2.60e-02,13/268,152/7978
CD8T,rs1131017_RPS26,BP,GO:0071674,mononuclear cell migration,1.81e-03,2.66e-02,5/268,27/7978
CD8T,rs1131017_RPS26,BP,GO:0033077,T cell differentiation in thymus,1.83e-03,2.66e-02,7/268,53/7978
CD8T,rs1131017_RPS26,BP,GO:0042492,gamma-delta T cell differentiation,1.85e-03,2.66e-02,3/268,8/7978
CD8T,rs1131017_RPS26,BP,GO:0045060,negative thymic T cell selection,1.85e-03,2.66e-02,3/268,8/7978
CD8T,rs1131017_RPS26,BP,GO:0050832,defense response to fungus,1.85e-03,2.66e-02,3/268,8/7978
CD8T,rs1131017_RPS26,BP,GO:0098543,detection of other organism,1.85e-03,2.66e-02,3/268,8/7978
CD8T,rs1131017_RPS26,BP,GO:0090087,regulation of peptide transport,1.85e-03,2.66e-02,23/268,355/7978
CD8T,rs1131017_RPS26,BP,GO:0032635,interleukin-6 production,1.88e-03,2.69e-02,8/268,68/7978
CD8T,rs1131017_RPS26,BP,GO:0032755,positive regulation of interleukin-6 production,1.99e-03,2.84e-02,6/268,40/7978
CD8T,rs1131017_RPS26,BP,GO:1902624,positive regulation of neutrophil migration,2.10e-03,2.97e-02,4/268,17/7978
CD8T,rs1131017_RPS26,BP,GO:0051241,negative regulation of multicellular organismal process,2.10e-03,2.97e-02,29/268,492/7978
CD8T,rs1131017_RPS26,BP,GO:0045621,positive regulation of lymphocyte differentiation,2.27e-03,3.18e-02,8/268,70/7978
CD8T,rs1131017_RPS26,BP,GO:0097305,response to alcohol,2.27e-03,3.18e-02,11/268,120/7978
CD8T,rs1131017_RPS26,BP,GO:0006935,chemotaxis,2.33e-03,3.26e-02,17/268,235/7978
CD8T,rs1131017_RPS26,BP,GO:0030098,lymphocyte differentiation,2.44e-03,3.39e-02,17/268,236/7978
CD8T,rs1131017_RPS26,BP,GO:0002695,negative regulation of leukocyte activation,2.47e-03,3.42e-02,9/268,87/7978
CD8T,rs1131017_RPS26,BP,GO:0002437,inflammatory response to antigenic stimulus,2.52e-03,3.48e-02,5/268,29/7978
CD8T,rs1131017_RPS26,BP,GO:0042554,superoxide anion generation,2.63e-03,3.57e-02,4/268,18/7978
CD8T,rs1131017_RPS26,BP,GO:0097028,dendritic cell differentiation,2.63e-03,3.57e-02,4/268,18/7978
CD8T,rs1131017_RPS26,BP,GO:1904666,regulation of ubiquitin protein ligase activity,2.63e-03,3.57e-02,4/268,18/7978
CD8T,rs1131017_RPS26,BP,GO:0032102,negative regulation of response to external stimulus,2.63e-03,3.57e-02,13/268,159/7978
CD8T,rs1131017_RPS26,BP,GO:0002863,positive regulation of inflammatory response to antigenic stimulus,2.71e-03,3.58e-02,3/268,9/7978
CD8T,rs1131017_RPS26,BP,GO:0043383,negative T cell selection,2.71e-03,3.58e-02,3/268,9/7978
CD8T,rs1131017_RPS26,BP,GO:0046598,positive regulation of viral entry into host cell,2.71e-03,3.58e-02,3/268,9/7978
CD8T,rs1131017_RPS26,BP,GO:0046643,regulation of gamma-delta T cell activation,2.71e-03,3.58e-02,3/268,9/7978
CD8T,rs1131017_RPS26,BP,GO:0070233,negative regulation of T cell apoptotic process,2.71e-03,3.58e-02,3/268,9/7978
CD8T,rs1131017_RPS26,BP,GO:0075294,positive regulation by symbiont of entry into host,2.71e-03,3.58e-02,3/268,9/7978
CD8T,rs1131017_RPS26,BP,GO:0098581,detection of external biotic stimulus,2.71e-03,3.58e-02,3/268,9/7978
CD8T,rs1131017_RPS26,BP,GO:0046718,viral entry into host cell,2.72e-03,3.58e-02,8/268,72/7978
CD8T,rs1131017_RPS26,BP,GO:0042493,response to drug,2.75e-03,3.61e-02,14/268,179/7978
CD8T,rs1131017_RPS26,BP,GO:0006875,cellular metal ion homeostasis,2.78e-03,3.64e-02,17/268,239/7978
CD8T,rs1131017_RPS26,BP,GO:0030593,neutrophil chemotaxis,2.91e-03,3.80e-02,6/268,43/7978
CD8T,rs1131017_RPS26,BP,GO:1900024,regulation of substrate adhesion-dependent cell spreading,2.95e-03,3.83e-02,5/268,30/7978
CD8T,rs1131017_RPS26,BP,GO:0055065,metal ion homeostasis,3.08e-03,3.98e-02,18/268,262/7978
CD8T,rs1131017_RPS26,BP,GO:0051101,regulation of DNA binding,3.23e-03,4.15e-02,8/268,74/7978
CD8T,rs1131017_RPS26,BP,GO:0030224,monocyte differentiation,3.24e-03,4.15e-02,4/268,19/7978
CD8T,rs1131017_RPS26,BP,GO:1903131,mononuclear cell differentiation,3.24e-03,4.15e-02,4/268,19/7978
CD8T,rs1131017_RPS26,BP,GO:0050866,negative regulation of cell activation,3.36e-03,4.29e-02,9/268,91/7978
CD8T,rs1131017_RPS26,BP,GO:0070423,nucleotide-binding oligomerization domain containing signaling pathway,3.42e-03,4.35e-02,5/268,31/7978
CD8T,rs1131017_RPS26,BP,GO:0002253,activation of immune response,3.46e-03,4.38e-02,19/268,286/7978
CD8T,rs1131017_RPS26,BP,GO:0030490,maturation of SSU-rRNA,3.68e-03,4.63e-02,6/268,45/7978
CD8T,rs1131017_RPS26,BP,GO:0070371,ERK1 and ERK2 cascade,3.76e-03,4.63e-02,11/268,128/7978
CD8T,rs1131017_RPS26,BP,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,3.76e-03,4.63e-02,7/268,60/7978
CD8T,rs1131017_RPS26,BP,GO:0032695,negative regulation of interleukin-12 production,3.77e-03,4.63e-02,3/268,10/7978
CD8T,rs1131017_RPS26,BP,GO:0036035,osteoclast development,3.77e-03,4.63e-02,3/268,10/7978
CD8T,rs1131017_RPS26,BP,GO:0071677,positive regulation of mononuclear cell migration,3.77e-03,4.63e-02,3/268,10/7978
CD8T,rs1131017_RPS26,BP,GO:0072567,chemokine (C-X-C motif) ligand 2 production,3.77e-03,4.63e-02,3/268,10/7978
CD8T,rs1131017_RPS26,BP,GO:0090025,regulation of monocyte chemotaxis,3.77e-03,4.63e-02,3/268,10/7978
CD8T,rs1131017_RPS26,BP,GO:2000341,regulation of chemokine (C-X-C motif) ligand 2 production,3.77e-03,4.63e-02,3/268,10/7978
CD8T,rs1131017_RPS26,BP,GO:0050864,regulation of B cell activation,3.81e-03,4.66e-02,8/268,76/7978
CD8T,rs1131017_RPS26,BP,GO:0000717,"nucleotide-excision repair, DNA duplex unwinding",3.94e-03,4.74e-02,4/268,20/7978
CD8T,rs1131017_RPS26,BP,GO:0042276,error-prone translesion synthesis,3.94e-03,4.74e-02,4/268,20/7978
CD8T,rs1131017_RPS26,BP,GO:0045687,positive regulation of glial cell differentiation,3.94e-03,4.74e-02,4/268,20/7978
CD8T,rs1131017_RPS26,BP,GO:0032760,positive regulation of tumor necrosis factor production,3.94e-03,4.74e-02,5/268,32/7978
CD8T,rs1131017_RPS26,BP,GO:0035872,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",3.94e-03,4.74e-02,5/268,32/7978
CD8T,rs1131017_RPS26,BP,GO:0051347,positive regulation of transferase activity,3.99e-03,4.76e-02,22/268,355/7978
CD8T,rs1131017_RPS26,BP,GO:0043406,positive regulation of MAP kinase activity,3.99e-03,4.76e-02,11/268,129/7978
CD8T,rs1131017_RPS26,BP,GO:0000165,MAPK cascade,4.00e-03,4.76e-02,26/268,445/7978
CD8T,rs1131017_RPS26,BP,GO:0045637,regulation of myeloid cell differentiation,4.06e-03,4.81e-02,12/268,148/7978
CD8T,rs1131017_RPS26,BP,GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,4.11e-03,4.84e-02,6/268,46/7978
CD8T,rs1131017_RPS26,BP,GO:0016444,somatic cell DNA recombination,4.11e-03,4.84e-02,6/268,46/7978
CD8T,rs1131017_RPS26,BP,GO:0043066,negative regulation of apoptotic process,4.13e-03,4.84e-02,27/268,469/7978
CD8T,rs1131017_RPS26,BP,GO:0045582,positive regulation of T cell differentiation,4.13e-03,4.84e-02,7/268,61/7978
CD8T,rs1131017_RPS26,BP,GO:0006874,cellular calcium ion homeostasis,4.23e-03,4.93e-02,13/268,168/7978
CD8T,rs1131017_RPS26,CC,GO:0022626,cytosolic ribosome,5.15e-98,1.94e-95,77/274,99/8242
CD8T,rs1131017_RPS26,CC,GO:0044391,ribosomal subunit,3.83e-70,7.22e-68,77/274,173/8242
CD8T,rs1131017_RPS26,CC,GO:0005840,ribosome,3.42e-67,4.30e-65,80/274,206/8242
CD8T,rs1131017_RPS26,CC,GO:0022625,cytosolic large ribosomal subunit,1.30e-65,1.22e-63,47/274,52/8242
CD8T,rs1131017_RPS26,CC,GO:0015934,large ribosomal subunit,3.60e-42,2.71e-40,47/274,106/8242
CD8T,rs1131017_RPS26,CC,GO:0022627,cytosolic small ribosomal subunit,9.61e-37,6.04e-35,31/274,44/8242
CD8T,rs1131017_RPS26,CC,GO:0005925,focal adhesion,2.32e-33,1.25e-31,59/274,265/8242
CD8T,rs1131017_RPS26,CC,GO:0030055,cell-substrate junction,3.63e-33,1.71e-31,59/274,267/8242
CD8T,rs1131017_RPS26,CC,GO:0042788,polysomal ribosome,2.60e-30,1.09e-28,24/274,31/8242
CD8T,rs1131017_RPS26,CC,GO:0015935,small ribosomal subunit,6.20e-28,2.34e-26,31/274,70/8242
CD8T,rs1131017_RPS26,CC,GO:0070161,anchoring junction,1.38e-26,4.72e-25,64/274,413/8242
CD8T,rs1131017_RPS26,CC,GO:0005844,polysome,1.13e-24,3.54e-23,27/274,60/8242
CD8T,rs1131017_RPS26,CC,GO:0098552,side of membrane,3.68e-10,1.07e-08,31/274,258/8242
CD8T,rs1131017_RPS26,CC,GO:0098794,postsynapse,2.69e-09,7.24e-08,29/274,248/8242
CD8T,rs1131017_RPS26,CC,GO:0042611,MHC protein complex,3.00e-09,7.55e-08,9/274,19/8242
CD8T,rs1131017_RPS26,CC,GO:0030666,endocytic vesicle membrane,3.88e-09,9.14e-08,16/274,78/8242
CD8T,rs1131017_RPS26,CC,GO:0071556,integral component of lumenal side of endoplasmic reticulum membrane,9.01e-09,1.89e-07,9/274,21/8242
CD8T,rs1131017_RPS26,CC,GO:0098553,lumenal side of endoplasmic reticulum membrane,9.01e-09,1.89e-07,9/274,21/8242
CD8T,rs1131017_RPS26,CC,GO:0009986,cell surface,1.32e-08,2.63e-07,30/274,282/8242
CD8T,rs1131017_RPS26,CC,GO:0099572,postsynaptic specialization,2.86e-08,5.40e-07,21/274,153/8242
CD8T,rs1131017_RPS26,CC,GO:0098984,neuron to neuron synapse,3.22e-08,5.78e-07,21/274,154/8242
CD8T,rs1131017_RPS26,CC,GO:0014069,postsynaptic density,6.40e-08,1.10e-06,20/274,146/8242
CD8T,rs1131017_RPS26,CC,GO:0032279,asymmetric synapse,8.07e-08,1.30e-06,20/274,148/8242
CD8T,rs1131017_RPS26,CC,GO:0098576,lumenal side of membrane,8.28e-08,1.30e-06,9/274,26/8242
CD8T,rs1131017_RPS26,CC,GO:0042612,MHC class I protein complex,7.79e-07,1.17e-05,5/274,7/8242
CD8T,rs1131017_RPS26,CC,GO:0016282,eukaryotic 43S preinitiation complex,4.97e-06,7.20e-05,6/274,15/8242
CD8T,rs1131017_RPS26,CC,GO:0030139,endocytic vesicle,6.55e-06,9.14e-05,18/274,162/8242
CD8T,rs1131017_RPS26,CC,GO:0070993,translation preinitiation complex,7.73e-06,1.04e-04,6/274,16/8242
CD8T,rs1131017_RPS26,CC,GO:0009897,external side of plasma membrane,1.04e-05,1.35e-04,16/274,136/8242
CD8T,rs1131017_RPS26,CC,GO:0012507,ER to Golgi transport vesicle membrane,2.78e-05,3.49e-04,9/274,49/8242
CD8T,rs1131017_RPS26,CC,GO:0033290,eukaryotic 48S preinitiation complex,6.12e-05,7.45e-04,5/274,14/8242
CD8T,rs1131017_RPS26,CC,GO:0005852,eukaryotic translation initiation factor 3 complex,1.27e-04,1.49e-03,5/274,16/8242
CD8T,rs1131017_RPS26,CC,GO:0030670,phagocytic vesicle membrane,1.37e-04,1.57e-03,8/274,47/8242
CD8T,rs1131017_RPS26,CC,GO:0005791,rough endoplasmic reticulum,2.84e-04,3.15e-03,8/274,52/8242
CD8T,rs1131017_RPS26,CC,GO:0001726,ruffle,3.27e-04,3.52e-03,12/274,112/8242
CD8T,rs1131017_RPS26,CC,GO:0072562,blood microparticle,4.67e-04,4.75e-03,6/274,31/8242
CD8T,rs1131017_RPS26,CC,GO:0030134,COPII-coated ER to Golgi transport vesicle,4.78e-04,4.75e-03,9/274,70/8242
CD8T,rs1131017_RPS26,CC,GO:0042613,MHC class II protein complex,4.79e-04,4.75e-03,4/274,12/8242
CD8T,rs1131017_RPS26,CC,GO:0042824,MHC class I peptide loading complex,6.75e-04,6.52e-03,3/274,6/8242
CD8T,rs1131017_RPS26,CC,GO:0098562,cytoplasmic side of membrane,7.56e-04,7.13e-03,11/274,106/8242
CD8T,rs1131017_RPS26,CC,GO:0031252,cell leading edge,1.08e-03,9.93e-03,17/274,221/8242
CD8T,rs1131017_RPS26,CC,GO:0030660,Golgi-associated vesicle membrane,1.52e-03,1.37e-02,9/274,82/8242
CD8T,rs1131017_RPS26,CC,GO:0055038,recycling endosome membrane,1.93e-03,1.69e-02,7/274,54/8242
CD8T,rs1131017_RPS26,CC,GO:0030176,integral component of endoplasmic reticulum membrane,2.87e-03,2.40e-02,10/274,107/8242
CD8T,rs1131017_RPS26,CC,GO:0045335,phagocytic vesicle,2.91e-03,2.40e-02,9/274,90/8242
CD8T,rs1131017_RPS26,CC,GO:0032587,ruffle membrane,2.93e-03,2.40e-02,7/274,58/8242
CD8T,rs1131017_RPS26,CC,GO:0030669,clathrin-coated endocytic vesicle membrane,3.12e-03,2.50e-02,4/274,19/8242
CD8T,rs1131017_RPS26,CC,GO:0001725,stress fiber,3.27e-03,2.52e-02,5/274,31/8242
CD8T,rs1131017_RPS26,CC,GO:0097517,contractile actin filament bundle,3.27e-03,2.52e-02,5/274,31/8242
CD8T,rs1131017_RPS26,CC,GO:0098797,plasma membrane protein complex,3.40e-03,2.56e-02,15/274,205/8242
CD8T,rs1131017_RPS26,CC,GO:0031227,intrinsic component of endoplasmic reticulum membrane,3.75e-03,2.74e-02,10/274,111/8242
CD8T,rs1131017_RPS26,CC,GO:0032432,actin filament bundle,3.77e-03,2.74e-02,5/274,32/8242
CD8T,rs1131017_RPS26,CC,GO:0030662,coated vesicle membrane,4.54e-03,3.23e-02,10/274,114/8242
CD8T,rs1131017_RPS26,CC,GO:0098554,cytoplasmic side of endoplasmic reticulum membrane,4.92e-03,3.43e-02,3/274,11/8242
CD8T,rs1131017_RPS26,CC,GO:0030659,cytoplasmic vesicle membrane,5.31e-03,3.64e-02,23/274,390/8242
CD8T,rs1131017_RPS26,CC,GO:0042641,actomyosin,6.34e-03,4.27e-02,5/274,36/8242
CD8T,rs1131017_RPS26,CC,GO:0005798,Golgi-associated vesicle,6.89e-03,4.56e-02,10/274,121/8242
CD8T,rs1131017_RPS26,CC,GO:0098978,glutamatergic synapse,7.21e-03,4.68e-02,11/274,141/8242
CD8T,rs1131017_RPS26,MF,GO:0003735,structural constituent of ribosome,4.97e-75,2.63e-72,76/273,149/8204
CD8T,rs1131017_RPS26,MF,GO:0005198,structural molecule activity,2.81e-57,7.46e-55,83/273,290/8204
CD8T,rs1131017_RPS26,MF,GO:0019843,rRNA binding,1.93e-15,3.40e-13,19/273,53/8204
CD8T,rs1131017_RPS26,MF,GO:0003823,antigen binding,1.81e-10,2.40e-08,12/273,32/8204
CD8T,rs1131017_RPS26,MF,GO:0045182,translation regulator activity,5.23e-10,5.55e-08,19/273,100/8204
CD8T,rs1131017_RPS26,MF,GO:0050839,cell adhesion molecule binding,3.73e-09,3.30e-07,31/273,283/8204
CD8T,rs1131017_RPS26,MF,GO:0090079,"translation regulator activity, nucleic acid binding",1.02e-08,7.69e-07,16/273,83/8204
CD8T,rs1131017_RPS26,MF,GO:0003729,mRNA binding,2.09e-08,1.38e-06,25/273,208/8204
CD8T,rs1131017_RPS26,MF,GO:0008135,"translation factor activity, RNA binding",4.38e-08,2.58e-06,14/273,69/8204
CD8T,rs1131017_RPS26,MF,GO:0048027,mRNA 5'-UTR binding,1.90e-07,1.00e-05,8/273,21/8204
CD8T,rs1131017_RPS26,MF,GO:0042605,peptide antigen binding,3.70e-07,1.78e-05,7/273,16/8204
CD8T,rs1131017_RPS26,MF,GO:0045296,cadherin binding,1.26e-06,5.57e-05,23/273,223/8204
CD8T,rs1131017_RPS26,MF,GO:1990948,ubiquitin ligase inhibitor activity,5.84e-06,2.38e-04,4/273,5/8204
CD8T,rs1131017_RPS26,MF,GO:0003743,translation initiation factor activity,1.36e-05,5.14e-04,9/273,45/8204
CD8T,rs1131017_RPS26,MF,GO:0055105,ubiquitin-protein transferase inhibitor activity,1.71e-05,6.03e-04,4/273,6/8204
CD8T,rs1131017_RPS26,MF,GO:0042277,peptide binding,7.78e-05,2.47e-03,14/273,127/8204
CD8T,rs1131017_RPS26,MF,GO:0005509,calcium ion binding,7.93e-05,2.47e-03,17/273,177/8204
CD8T,rs1131017_RPS26,MF,GO:0003746,translation elongation factor activity,8.98e-05,2.64e-03,5/273,15/8204
CD8T,rs1131017_RPS26,MF,GO:0008097,5S rRNA binding,1.32e-04,3.69e-03,4/273,9/8204
CD8T,rs1131017_RPS26,MF,GO:0031386,protein tag,3.29e-04,8.31e-03,4/273,11/8204
CD8T,rs1131017_RPS26,MF,GO:0043021,ribonucleoprotein complex binding,3.29e-04,8.31e-03,12/273,112/8204
CD8T,rs1131017_RPS26,MF,GO:0048306,calcium-dependent protein binding,3.89e-04,9.34e-03,6/273,30/8204
CD8T,rs1131017_RPS26,MF,GO:0033218,amide binding,4.06e-04,9.34e-03,15/273,166/8204
CD8T,rs1131017_RPS26,MF,GO:0023023,MHC protein complex binding,5.16e-04,1.14e-02,5/273,21/8204
CD8T,rs1131017_RPS26,MF,GO:0042287,MHC protein binding,6.50e-04,1.20e-02,5/273,22/8204
CD8T,rs1131017_RPS26,MF,GO:0050840,extracellular matrix binding,6.76e-04,1.20e-02,4/273,13/8204
CD8T,rs1131017_RPS26,MF,GO:0055106,ubiquitin-protein transferase regulator activity,6.76e-04,1.20e-02,4/273,13/8204
CD8T,rs1131017_RPS26,MF,GO:0001846,opsonin binding,6.77e-04,1.20e-02,3/273,6/8204
CD8T,rs1131017_RPS26,MF,GO:0001848,complement binding,6.77e-04,1.20e-02,3/273,6/8204
CD8T,rs1131017_RPS26,MF,GO:0046977,TAP binding,6.77e-04,1.20e-02,3/273,6/8204
CD8T,rs1131017_RPS26,MF,GO:0003730,mRNA 3'-UTR binding,7.73e-04,1.32e-02,8/273,60/8204
CD8T,rs1131017_RPS26,MF,GO:0023026,MHC class II protein complex binding,9.22e-04,1.53e-02,4/273,14/8204
CD8T,rs1131017_RPS26,MF,GO:0051015,actin filament binding,1.08e-03,1.74e-02,10/273,94/8204
CD8T,rs1131017_RPS26,MF,GO:0042609,CD4 receptor binding,1.15e-03,1.80e-02,3/273,7/8204
CD8T,rs1131017_RPS26,MF,GO:0140375,immune receptor activity,1.74e-03,2.63e-02,7/273,53/8204
CD8T,rs1131017_RPS26,MF,GO:0042608,T cell receptor binding,1.80e-03,2.65e-02,3/273,8/8204
CD8T,rs1131017_RPS26,MF,GO:0008201,heparin binding,2.06e-03,2.95e-02,5/273,28/8204
CD8T,rs1131017_RPS26,MF,GO:0003779,actin binding,2.34e-03,3.26e-02,15/273,197/8204
CD8T,rs1131017_RPS26,MF,GO:0044548,S100 protein binding,2.64e-03,3.58e-02,3/273,9/8204
CD8T,rs1131017_RPS26,MF,GO:0043236,laminin binding,3.68e-03,4.74e-02,3/273,10/8204
CD8T,rs1131017_RPS26,MF,GO:0070181,small ribosomal subunit rRNA binding,3.68e-03,4.74e-02,3/273,10/8204
CD8T,rs1131017_RPS26,MF,GO:0038023,signaling receptor activity,3.85e-03,4.74e-02,18/273,270/8204
CD8T,rs1131017_RPS26,MF,GO:0060089,molecular transducer activity,3.85e-03,4.74e-02,18/273,270/8204
CD8T,rs1131017_RPS26,MF,GO:0004888,transmembrane signaling receptor activity,3.96e-03,4.77e-02,14/273,188/8204
CD8T,rs4147638_SMDT1,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,1.37e-61,8.14e-59,34/42,92/7978
CD8T,rs4147638_SMDT1,BP,GO:0006613,cotranslational protein targeting to membrane,8.13e-61,2.42e-58,34/42,96/7978
CD8T,rs4147638_SMDT1,BP,GO:0045047,protein targeting to ER,3.25e-59,6.44e-57,34/42,105/7978
CD8T,rs4147638_SMDT1,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,1.02e-58,1.52e-56,34/42,108/7978
CD8T,rs4147638_SMDT1,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",4.43e-58,5.26e-56,34/42,112/7978
CD8T,rs4147638_SMDT1,BP,GO:0070972,protein localization to endoplasmic reticulum,8.87e-56,8.78e-54,34/42,128/7978
CD8T,rs4147638_SMDT1,BP,GO:0006612,protein targeting to membrane,1.44e-52,1.22e-50,34/42,155/7978
CD8T,rs4147638_SMDT1,BP,GO:0019083,viral transcription,2.43e-51,1.81e-49,34/42,167/7978
CD8T,rs4147638_SMDT1,BP,GO:0006413,translational initiation,7.39e-51,4.87e-49,34/42,172/7978
CD8T,rs4147638_SMDT1,BP,GO:0019080,viral gene expression,7.53e-50,4.47e-48,34/42,183/7978
CD8T,rs4147638_SMDT1,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,9.22e-50,4.98e-48,34/42,184/7978
CD8T,rs4147638_SMDT1,BP,GO:0090150,establishment of protein localization to membrane,2.90e-47,1.44e-45,35/42,247/7978
CD8T,rs4147638_SMDT1,BP,GO:0006402,mRNA catabolic process,1.14e-41,5.23e-40,34/42,307/7978
CD8T,rs4147638_SMDT1,BP,GO:0006605,protein targeting,1.67e-40,7.07e-39,34/42,331/7978
CD8T,rs4147638_SMDT1,BP,GO:0006401,RNA catabolic process,2.83e-40,1.12e-38,34/42,336/7978
CD8T,rs4147638_SMDT1,BP,GO:0072657,protein localization to membrane,1.75e-39,6.50e-38,35/42,402/7978
CD8T,rs4147638_SMDT1,BP,GO:0034655,nucleobase-containing compound catabolic process,1.20e-36,4.20e-35,34/42,426/7978
CD8T,rs4147638_SMDT1,BP,GO:0072594,establishment of protein localization to organelle,1.54e-36,5.07e-35,34/42,429/7978
CD8T,rs4147638_SMDT1,BP,GO:0046700,heterocycle catabolic process,2.49e-36,7.80e-35,34/42,435/7978
CD8T,rs4147638_SMDT1,BP,GO:0044270,cellular nitrogen compound catabolic process,3.17e-36,9.42e-35,34/42,438/7978
CD8T,rs4147638_SMDT1,BP,GO:0019439,aromatic compound catabolic process,4.71e-36,1.33e-34,34/42,443/7978
CD8T,rs4147638_SMDT1,BP,GO:1901361,organic cyclic compound catabolic process,7.53e-36,2.03e-34,34/42,449/7978
CD8T,rs4147638_SMDT1,BP,GO:0002181,cytoplasmic translation,2.24e-21,5.79e-20,16/42,90/7978
CD8T,rs4147638_SMDT1,BP,GO:0042273,ribosomal large subunit biogenesis,2.40e-11,5.94e-10,9/42,63/7978
CD8T,rs4147638_SMDT1,BP,GO:0042254,ribosome biogenesis,5.06e-10,1.20e-08,13/42,266/7978
CD8T,rs4147638_SMDT1,BP,GO:0022613,ribonucleoprotein complex biogenesis,4.67e-09,1.07e-07,14/42,386/7978
CD8T,rs4147638_SMDT1,BP,GO:0042255,ribosome assembly,6.48e-09,1.42e-07,7/42,51/7978
CD8T,rs4147638_SMDT1,BP,GO:0006364,rRNA processing,4.73e-08,1.00e-06,10/42,196/7978
CD8T,rs4147638_SMDT1,BP,GO:0016072,rRNA metabolic process,6.60e-08,1.35e-06,10/42,203/7978
CD8T,rs4147638_SMDT1,BP,GO:0000027,ribosomal large subunit assembly,1.25e-07,2.47e-06,5/42,24/7978
CD8T,rs4147638_SMDT1,BP,GO:0022618,ribonucleoprotein complex assembly,2.01e-06,3.85e-05,8/42,167/7978
CD8T,rs4147638_SMDT1,BP,GO:0071826,ribonucleoprotein complex subunit organization,2.62e-06,4.86e-05,8/42,173/7978
CD8T,rs4147638_SMDT1,BP,GO:0034470,ncRNA processing,5.32e-06,9.58e-05,10/42,327/7978
CD8T,rs4147638_SMDT1,BP,GO:0034660,ncRNA metabolic process,1.74e-05,3.04e-04,10/42,374/7978
CD8T,rs4147638_SMDT1,BP,GO:0042274,ribosomal small subunit biogenesis,2.23e-05,3.79e-04,5/42,66/7978
CD8T,rs4147638_SMDT1,BP,GO:0000028,ribosomal small subunit assembly,7.24e-05,1.20e-03,3/42,16/7978
CD8T,rs4147638_SMDT1,BP,GO:1904667,negative regulation of ubiquitin protein ligase activity,9.52e-04,1.53e-02,2/42,9/7978
CD8T,rs4147638_SMDT1,BP,GO:0030490,maturation of SSU-rRNA,1.65e-03,2.58e-02,3/42,45/7978
CD8T,rs4147638_SMDT1,BP,GO:0019835,cytolysis,1.73e-03,2.63e-02,2/42,12/7978
CD8T,rs4147638_SMDT1,BP,GO:0045116,protein neddylation,2.03e-03,2.95e-02,2/42,13/7978
CD8T,rs4147638_SMDT1,BP,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,2.03e-03,2.95e-02,2/42,13/7978
CD8T,rs4147638_SMDT1,BP,GO:0006417,regulation of translation,2.88e-03,4.07e-02,6/42,274/7978
CD8T,rs4147638_SMDT1,BP,GO:0031640,killing of cells of other organism,3.10e-03,4.18e-02,2/42,16/7978
CD8T,rs4147638_SMDT1,BP,GO:0051444,negative regulation of ubiquitin-protein transferase activity,3.10e-03,4.18e-02,2/42,16/7978
CD8T,rs4147638_SMDT1,BP,GO:0070925,organelle assembly,3.49e-03,4.61e-02,8/42,489/7978
CD8T,rs4147638_SMDT1,CC,GO:0022626,cytosolic ribosome,4.56e-60,4.65e-58,34/43,99/8242
CD8T,rs4147638_SMDT1,CC,GO:0044391,ribosomal subunit,1.43e-50,7.29e-49,34/43,173/8242
CD8T,rs4147638_SMDT1,CC,GO:0005840,ribosome,9.42e-48,3.20e-46,34/43,206/8242
CD8T,rs4147638_SMDT1,CC,GO:0022625,cytosolic large ribosomal subunit,5.67e-37,1.45e-35,21/43,52/8242
CD8T,rs4147638_SMDT1,CC,GO:0015934,large ribosomal subunit,2.05e-29,4.18e-28,21/43,106/8242
CD8T,rs4147638_SMDT1,CC,GO:0022627,cytosolic small ribosomal subunit,1.33e-20,2.26e-19,13/43,44/8242
CD8T,rs4147638_SMDT1,CC,GO:0005925,focal adhesion,3.39e-19,4.93e-18,20/43,265/8242
CD8T,rs4147638_SMDT1,CC,GO:0030055,cell-substrate junction,3.94e-19,5.02e-18,20/43,267/8242
CD8T,rs4147638_SMDT1,CC,GO:0042788,polysomal ribosome,1.53e-18,1.73e-17,11/43,31/8242
CD8T,rs4147638_SMDT1,CC,GO:0015935,small ribosomal subunit,1.11e-17,1.13e-16,13/43,70/8242
CD8T,rs4147638_SMDT1,CC,GO:0005844,polysome,8.92e-17,8.27e-16,12/43,60/8242
CD8T,rs4147638_SMDT1,CC,GO:0070161,anchoring junction,2.10e-15,1.79e-14,20/43,413/8242
CD8T,rs4147638_SMDT1,CC,GO:0014069,postsynaptic density,2.60e-09,2.04e-08,10/43,146/8242
CD8T,rs4147638_SMDT1,CC,GO:0032279,asymmetric synapse,2.97e-09,2.16e-08,10/43,148/8242
CD8T,rs4147638_SMDT1,CC,GO:0099572,postsynaptic specialization,4.10e-09,2.79e-08,10/43,153/8242
CD8T,rs4147638_SMDT1,CC,GO:0098984,neuron to neuron synapse,4.37e-09,2.79e-08,10/43,154/8242
CD8T,rs4147638_SMDT1,CC,GO:0098794,postsynapse,4.06e-07,2.44e-06,10/43,248/8242
CD8T,rs4147638_SMDT1,CC,GO:0005791,rough endoplasmic reticulum,1.45e-04,8.22e-04,4/43,52/8242
CD8T,rs4147638_SMDT1,CC,GO:0098554,cytoplasmic side of endoplasmic reticulum membrane,1.42e-03,7.62e-03,2/43,11/8242
CD8T,rs4147638_SMDT1,CC,GO:0031904,endosome lumen,2.67e-03,1.36e-02,2/43,15/8242
CD8T,rs4147638_SMDT1,CC,GO:0030867,rough endoplasmic reticulum membrane,5.75e-03,2.79e-02,2/43,22/8242
CD8T,rs4147638_SMDT1,MF,GO:0003735,structural constituent of ribosome,5.82e-53,4.89e-51,34/43,149/8204
CD8T,rs4147638_SMDT1,MF,GO:0005198,structural molecule activity,2.24e-44,9.41e-43,35/43,290/8204
CD8T,rs4147638_SMDT1,MF,GO:0019843,rRNA binding,4.59e-12,1.28e-10,9/43,53/8204
CD8T,rs4147638_SMDT1,MF,GO:0048027,mRNA 5'-UTR binding,3.67e-06,7.71e-05,4/43,21/8204
CD8T,rs4147638_SMDT1,MF,GO:0008097,5S rRNA binding,1.10e-05,1.85e-04,3/43,9/8204
CD8T,rs4147638_SMDT1,MF,GO:0003729,mRNA binding,9.03e-05,1.26e-03,7/43,208/8204
CD8T,rs4147638_SMDT1,MF,GO:1990948,ubiquitin ligase inhibitor activity,2.66e-04,3.19e-03,2/43,5/8204
CD8T,rs4147638_SMDT1,MF,GO:0055105,ubiquitin-protein transferase inhibitor activity,3.97e-04,4.17e-03,2/43,6/8204
CD8T,rs4147638_SMDT1,MF,GO:0070181,small ribosomal subunit rRNA binding,1.18e-03,1.10e-02,2/43,10/8204
CD8T,rs4147638_SMDT1,MF,GO:0055106,ubiquitin-protein transferase regulator activity,2.02e-03,1.70e-02,2/43,13/8204
CD8T,rs4147638_SMDT1,MF,GO:0003785,actin monomer binding,2.35e-03,1.79e-02,2/43,14/8204
CD8T,rs6708265_PASK,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,1.31e-16,1.98e-14,9/11,92/7978
CD8T,rs6708265_PASK,BP,GO:0006613,cotranslational protein targeting to membrane,1.95e-16,1.98e-14,9/11,96/7978
CD8T,rs6708265_PASK,BP,GO:0045047,protein targeting to ER,4.50e-16,2.97e-14,9/11,105/7978
CD8T,rs6708265_PASK,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,5.86e-16,2.97e-14,9/11,108/7978
CD8T,rs6708265_PASK,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",8.22e-16,3.34e-14,9/11,112/7978
CD8T,rs6708265_PASK,BP,GO:0070972,protein localization to endoplasmic reticulum,2.84e-15,9.61e-14,9/11,128/7978
CD8T,rs6708265_PASK,BP,GO:0006612,protein targeting to membrane,1.66e-14,4.82e-13,9/11,155/7978
CD8T,rs6708265_PASK,BP,GO:0019083,viral transcription,3.30e-14,8.38e-13,9/11,167/7978
CD8T,rs6708265_PASK,BP,GO:0006413,translational initiation,4.33e-14,9.77e-13,9/11,172/7978
CD8T,rs6708265_PASK,BP,GO:0019080,viral gene expression,7.64e-14,1.48e-12,9/11,183/7978
CD8T,rs6708265_PASK,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,8.04e-14,1.48e-12,9/11,184/7978
CD8T,rs6708265_PASK,BP,GO:0090150,establishment of protein localization to membrane,1.18e-12,2.00e-11,9/11,247/7978
CD8T,rs6708265_PASK,BP,GO:0006402,mRNA catabolic process,8.48e-12,1.32e-10,9/11,307/7978
CD8T,rs6708265_PASK,BP,GO:0006605,protein targeting,1.67e-11,2.43e-10,9/11,331/7978
CD8T,rs6708265_PASK,BP,GO:0006401,RNA catabolic process,1.92e-11,2.59e-10,9/11,336/7978
CD8T,rs6708265_PASK,BP,GO:0072657,protein localization to membrane,9.65e-11,1.22e-09,9/11,402/7978
CD8T,rs6708265_PASK,BP,GO:0034655,nucleobase-containing compound catabolic process,1.63e-10,1.94e-09,9/11,426/7978
CD8T,rs6708265_PASK,BP,GO:0072594,establishment of protein localization to organelle,1.73e-10,1.95e-09,9/11,429/7978
CD8T,rs6708265_PASK,BP,GO:0046700,heterocycle catabolic process,1.96e-10,2.10e-09,9/11,435/7978
CD8T,rs6708265_PASK,BP,GO:0044270,cellular nitrogen compound catabolic process,2.09e-10,2.12e-09,9/11,438/7978
CD8T,rs6708265_PASK,BP,GO:0019439,aromatic compound catabolic process,2.31e-10,2.23e-09,9/11,443/7978
CD8T,rs6708265_PASK,BP,GO:1901361,organic cyclic compound catabolic process,2.61e-10,2.41e-09,9/11,449/7978
CD8T,rs6708265_PASK,BP,GO:0002181,cytoplasmic translation,7.69e-10,6.79e-09,6/11,90/7978
CD8T,rs6708265_PASK,BP,GO:0042273,ribosomal large subunit biogenesis,7.40e-05,6.26e-04,3/11,63/7978
CD8T,rs6708265_PASK,BP,GO:0006364,rRNA processing,1.02e-04,8.27e-04,4/11,196/7978
CD8T,rs6708265_PASK,BP,GO:0016072,rRNA metabolic process,1.17e-04,9.11e-04,4/11,203/7978
CD8T,rs6708265_PASK,BP,GO:0042254,ribosome biogenesis,3.31e-04,2.49e-03,4/11,266/7978
CD8T,rs6708265_PASK,BP,GO:0034470,ncRNA processing,7.27e-04,5.27e-03,4/11,327/7978
CD8T,rs6708265_PASK,BP,GO:0034660,ncRNA metabolic process,1.21e-03,8.44e-03,4/11,374/7978
CD8T,rs6708265_PASK,BP,GO:0022613,ribonucleoprotein complex biogenesis,1.36e-03,9.18e-03,4/11,386/7978
CD8T,rs6708265_PASK,BP,GO:0002484,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,6.88e-03,4.11e-02,1/11,5/7978
CD8T,rs6708265_PASK,BP,GO:0002486,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",6.88e-03,4.11e-02,1/11,5/7978
CD8T,rs6708265_PASK,BP,GO:0002517,T cell tolerance induction,6.88e-03,4.11e-02,1/11,5/7978
CD8T,rs6708265_PASK,BP,GO:2001198,regulation of dendritic cell differentiation,6.88e-03,4.11e-02,1/11,5/7978
CD8T,rs6708265_PASK,CC,GO:0022626,cytosolic ribosome,7.68e-16,4.84e-14,9/12,99/8242
CD8T,rs6708265_PASK,CC,GO:0044391,ribosomal subunit,1.34e-13,4.22e-12,9/12,173/8242
CD8T,rs6708265_PASK,CC,GO:0022625,cytosolic large ribosomal subunit,2.02e-13,4.25e-12,7/12,52/8242
CD8T,rs6708265_PASK,CC,GO:0005840,ribosome,6.60e-13,1.04e-11,9/12,206/8242
CD8T,rs6708265_PASK,CC,GO:0015934,large ribosomal subunit,3.58e-11,4.51e-10,7/12,106/8242
CD8T,rs6708265_PASK,CC,GO:0042788,polysomal ribosome,7.94e-08,8.33e-07,4/12,31/8242
CD8T,rs6708265_PASK,CC,GO:0005844,polysome,1.20e-06,1.08e-05,4/12,60/8242
CD8T,rs6708265_PASK,CC,GO:0022627,cytosolic small ribosomal subunit,1.78e-03,1.40e-02,2/12,44/8242
CD8T,rs6708265_PASK,CC,GO:0015935,small ribosomal subunit,4.44e-03,3.11e-02,2/12,70/8242
CD8T,rs6708265_PASK,MF,GO:0003735,structural constituent of ribosome,3.54e-14,8.86e-13,9/12,149/8204
CD8T,rs6708265_PASK,MF,GO:0005198,structural molecule activity,1.53e-11,1.91e-10,9/12,290/8204
CD8T,rs6708265_PASK,MF,GO:1990948,ubiquitin ligase inhibitor activity,7.29e-03,4.37e-02,1/12,5/8204
CD8T,rs6708265_PASK,MF,GO:0046977,TAP binding,8.75e-03,4.37e-02,1/12,6/8204
CD8T,rs6708265_PASK,MF,GO:0055105,ubiquitin-protein transferase inhibitor activity,8.75e-03,4.37e-02,1/12,6/8204
CD8T,rs7605824_SH3YL1,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,4.62e-27,5.30e-24,17/28,92/7978
CD8T,rs7605824_SH3YL1,BP,GO:0006613,cotranslational protein targeting to membrane,1.02e-26,5.83e-24,17/28,96/7978
CD8T,rs7605824_SH3YL1,BP,GO:0045047,protein targeting to ER,5.28e-26,2.02e-23,17/28,105/7978
CD8T,rs7605824_SH3YL1,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,8.84e-26,2.54e-23,17/28,108/7978
CD8T,rs7605824_SH3YL1,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",1.72e-25,3.94e-23,17/28,112/7978
CD8T,rs7605824_SH3YL1,BP,GO:0070972,protein localization to endoplasmic reticulum,1.92e-24,3.68e-22,17/28,128/7978
CD8T,rs7605824_SH3YL1,BP,GO:0019083,viral transcription,2.58e-24,4.22e-22,18/28,167/7978
CD8T,rs7605824_SH3YL1,BP,GO:0006413,translational initiation,4.48e-24,6.43e-22,18/28,172/7978
CD8T,rs7605824_SH3YL1,BP,GO:0019080,viral gene expression,1.43e-23,1.82e-21,18/28,183/7978
CD8T,rs7605824_SH3YL1,BP,GO:0006612,protein targeting to membrane,5.87e-23,6.74e-21,17/28,155/7978
CD8T,rs7605824_SH3YL1,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,1.21e-21,1.26e-19,17/28,184/7978
CD8T,rs7605824_SH3YL1,BP,GO:0090150,establishment of protein localization to membrane,2.02e-19,1.94e-17,17/28,247/7978
CD8T,rs7605824_SH3YL1,BP,GO:0006402,mRNA catabolic process,8.42e-18,7.44e-16,17/28,307/7978
CD8T,rs7605824_SH3YL1,BP,GO:0072657,protein localization to membrane,2.50e-17,2.05e-15,18/28,402/7978
CD8T,rs7605824_SH3YL1,BP,GO:0006605,protein targeting,3.03e-17,2.32e-15,17/28,331/7978
CD8T,rs7605824_SH3YL1,BP,GO:0006401,RNA catabolic process,3.91e-17,2.80e-15,17/28,336/7978
CD8T,rs7605824_SH3YL1,BP,GO:0034655,nucleobase-containing compound catabolic process,7.04e-17,4.75e-15,18/28,426/7978
CD8T,rs7605824_SH3YL1,BP,GO:0072594,establishment of protein localization to organelle,7.97e-17,5.09e-15,18/28,429/7978
CD8T,rs7605824_SH3YL1,BP,GO:0046700,heterocycle catabolic process,1.02e-16,6.17e-15,18/28,435/7978
CD8T,rs7605824_SH3YL1,BP,GO:0044270,cellular nitrogen compound catabolic process,1.15e-16,6.63e-15,18/28,438/7978
CD8T,rs7605824_SH3YL1,BP,GO:0019439,aromatic compound catabolic process,1.41e-16,7.72e-15,18/28,443/7978
CD8T,rs7605824_SH3YL1,BP,GO:1901361,organic cyclic compound catabolic process,1.80e-16,9.37e-15,18/28,449/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002484,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,3.85e-07,1.84e-05,3/28,5/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002486,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",3.85e-07,1.84e-05,3/28,5/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002480,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent",1.34e-06,6.17e-05,3/28,7/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002483,antigen processing and presentation of endogenous peptide antigen,6.27e-06,2.67e-04,3/28,11/7978
CD8T,rs7605824_SH3YL1,BP,GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,6.27e-06,2.67e-04,3/28,11/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002709,regulation of T cell mediated immunity,9.18e-06,3.76e-04,4/28,39/7978
CD8T,rs7605824_SH3YL1,BP,GO:0001916,positive regulation of T cell mediated cytotoxicity,1.08e-05,4.14e-04,3/28,13/7978
CD8T,rs7605824_SH3YL1,BP,GO:0019883,antigen processing and presentation of endogenous antigen,1.08e-05,4.14e-04,3/28,13/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002181,cytoplasmic translation,1.31e-05,4.84e-04,5/28,90/7978
CD8T,rs7605824_SH3YL1,BP,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,1.37e-05,4.93e-04,3/28,14/7978
CD8T,rs7605824_SH3YL1,BP,GO:0031342,negative regulation of cell killing,1.71e-05,5.96e-04,3/28,15/7978
CD8T,rs7605824_SH3YL1,BP,GO:0001914,regulation of T cell mediated cytotoxicity,2.55e-05,8.60e-04,3/28,17/7978
CD8T,rs7605824_SH3YL1,BP,GO:0042102,positive regulation of T cell proliferation,5.52e-05,1.81e-03,4/28,61/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002456,T cell mediated immunity,5.89e-05,1.88e-03,4/28,62/7978
CD8T,rs7605824_SH3YL1,BP,GO:0001913,T cell mediated cytotoxicity,7.46e-05,2.25e-03,3/28,24/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002707,negative regulation of lymphocyte mediated immunity,7.46e-05,2.25e-03,3/28,24/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002424,T cell mediated immune response to tumor cell,1.18e-04,3.35e-03,2/28,5/7978
CD8T,rs7605824_SH3YL1,BP,GO:2001198,regulation of dendritic cell differentiation,1.18e-04,3.35e-03,2/28,5/7978
CD8T,rs7605824_SH3YL1,BP,GO:0032655,regulation of interleukin-12 production,1.20e-04,3.35e-03,3/28,28/7978
CD8T,rs7605824_SH3YL1,BP,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,1.33e-04,3.47e-03,3/28,29/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002711,positive regulation of T cell mediated immunity,1.33e-04,3.47e-03,3/28,29/7978
CD8T,rs7605824_SH3YL1,BP,GO:0032615,interleukin-12 production,1.33e-04,3.47e-03,3/28,29/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002704,negative regulation of leukocyte mediated immunity,1.48e-04,3.76e-03,3/28,30/7978
CD8T,rs7605824_SH3YL1,BP,GO:0032946,positive regulation of mononuclear cell proliferation,1.76e-04,4.22e-03,4/28,82/7978
CD8T,rs7605824_SH3YL1,BP,GO:0050671,positive regulation of lymphocyte proliferation,1.76e-04,4.22e-03,4/28,82/7978
CD8T,rs7605824_SH3YL1,BP,GO:1903979,negative regulation of microglial cell activation,1.77e-04,4.22e-03,2/28,6/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1.84e-04,4.32e-03,4/28,83/7978
CD8T,rs7605824_SH3YL1,BP,GO:0070665,positive regulation of leukocyte proliferation,2.12e-04,4.86e-03,4/28,86/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002706,regulation of lymphocyte mediated immunity,2.21e-04,4.98e-03,4/28,87/7978
CD8T,rs7605824_SH3YL1,BP,GO:0042129,regulation of T cell proliferation,2.41e-04,5.06e-03,4/28,89/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002643,regulation of tolerance induction,2.47e-04,5.06e-03,2/28,7/7978
CD8T,rs7605824_SH3YL1,BP,GO:0016045,detection of bacterium,2.47e-04,5.06e-03,2/28,7/7978
CD8T,rs7605824_SH3YL1,BP,GO:0043031,negative regulation of macrophage activation,2.47e-04,5.06e-03,2/28,7/7978
CD8T,rs7605824_SH3YL1,BP,GO:0090026,positive regulation of monocyte chemotaxis,2.47e-04,5.06e-03,2/28,7/7978
CD8T,rs7605824_SH3YL1,BP,GO:0031343,positive regulation of cell killing,2.56e-04,5.15e-03,3/28,36/7978
CD8T,rs7605824_SH3YL1,BP,GO:0098543,detection of other organism,3.28e-04,6.39e-03,2/28,8/7978
CD8T,rs7605824_SH3YL1,BP,GO:0150079,negative regulation of neuroinflammatory response,3.28e-04,6.39e-03,2/28,8/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002819,regulation of adaptive immune response,3.36e-04,6.43e-03,4/28,97/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002274,myeloid leukocyte activation,3.63e-04,6.83e-03,7/28,401/7978
CD8T,rs7605824_SH3YL1,BP,GO:0001910,regulation of leukocyte mediated cytotoxicity,4.06e-04,7.47e-03,3/28,42/7978
CD8T,rs7605824_SH3YL1,BP,GO:0098581,detection of external biotic stimulus,4.21e-04,7.47e-03,2/28,9/7978
CD8T,rs7605824_SH3YL1,BP,GO:1904667,negative regulation of ubiquitin protein ligase activity,4.21e-04,7.47e-03,2/28,9/7978
CD8T,rs7605824_SH3YL1,BP,GO:0071346,cellular response to interferon-gamma,4.23e-04,7.47e-03,4/28,103/7978
CD8T,rs7605824_SH3YL1,BP,GO:0008284,positive regulation of cell population proliferation,4.60e-04,8.01e-03,7/28,417/7978
CD8T,rs7605824_SH3YL1,BP,GO:0071677,positive regulation of mononuclear cell migration,5.25e-04,8.87e-03,2/28,10/7978
CD8T,rs7605824_SH3YL1,BP,GO:0090025,regulation of monocyte chemotaxis,5.25e-04,8.87e-03,2/28,10/7978
CD8T,rs7605824_SH3YL1,BP,GO:0031348,negative regulation of defense response,5.43e-04,9.03e-03,4/28,110/7978
CD8T,rs7605824_SH3YL1,BP,GO:0042098,T cell proliferation,6.21e-04,1.02e-02,4/28,114/7978
CD8T,rs7605824_SH3YL1,BP,GO:0045953,negative regulation of natural killer cell mediated cytotoxicity,6.41e-04,1.02e-02,2/28,11/7978
CD8T,rs7605824_SH3YL1,BP,GO:1903978,regulation of microglial cell activation,6.41e-04,1.02e-02,2/28,11/7978
CD8T,rs7605824_SH3YL1,BP,GO:0034341,response to interferon-gamma,6.64e-04,1.04e-02,4/28,116/7978
CD8T,rs7605824_SH3YL1,BP,GO:0042255,ribosome assembly,7.20e-04,1.11e-02,3/28,51/7978
CD8T,rs7605824_SH3YL1,BP,GO:0042119,neutrophil activation,7.44e-04,1.11e-02,6/28,323/7978
CD8T,rs7605824_SH3YL1,BP,GO:0032944,regulation of mononuclear cell proliferation,7.54e-04,1.11e-02,4/28,120/7978
CD8T,rs7605824_SH3YL1,BP,GO:0050670,regulation of lymphocyte proliferation,7.54e-04,1.11e-02,4/28,120/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002418,immune response to tumor cell,7.67e-04,1.11e-02,2/28,12/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002716,negative regulation of natural killer cell mediated immunity,7.67e-04,1.11e-02,2/28,12/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002703,regulation of leukocyte mediated immunity,7.78e-04,1.12e-02,4/28,121/7978
CD8T,rs7605824_SH3YL1,BP,GO:0036230,granulocyte activation,7.94e-04,1.12e-02,6/28,327/7978
CD8T,rs7605824_SH3YL1,BP,GO:0031341,regulation of cell killing,8.07e-04,1.13e-02,3/28,53/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002347,response to tumor cell,9.05e-04,1.21e-02,2/28,13/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002407,dendritic cell chemotaxis,9.05e-04,1.21e-02,2/28,13/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002507,tolerance induction,9.05e-04,1.21e-02,2/28,13/7978
CD8T,rs7605824_SH3YL1,BP,GO:0070663,regulation of leukocyte proliferation,9.05e-04,1.21e-02,4/28,126/7978
CD8T,rs7605824_SH3YL1,BP,GO:1901798,positive regulation of signal transduction by p53 class mediator,1.05e-03,1.39e-02,2/28,14/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002683,negative regulation of immune system process,1.13e-03,1.46e-02,5/28,232/7978
CD8T,rs7605824_SH3YL1,BP,GO:0045785,positive regulation of cell adhesion,1.13e-03,1.46e-02,5/28,232/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1.16e-03,1.48e-02,3/28,60/7978
CD8T,rs7605824_SH3YL1,BP,GO:0009595,detection of biotic stimulus,1.21e-03,1.49e-02,2/28,15/7978
CD8T,rs7605824_SH3YL1,BP,GO:0036336,dendritic cell migration,1.21e-03,1.49e-02,2/28,15/7978
CD8T,rs7605824_SH3YL1,BP,GO:0150077,regulation of neuroinflammatory response,1.21e-03,1.49e-02,2/28,15/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002479,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",1.22e-03,1.49e-02,3/28,61/7978
CD8T,rs7605824_SH3YL1,BP,GO:0001909,leukocyte mediated cytotoxicity,1.27e-03,1.54e-02,3/28,62/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002708,positive regulation of lymphocyte mediated immunity,1.34e-03,1.56e-02,3/28,63/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002250,adaptive immune response,1.34e-03,1.56e-02,5/28,241/7978
CD8T,rs7605824_SH3YL1,BP,GO:0032735,positive regulation of interleukin-12 production,1.38e-03,1.56e-02,2/28,16/7978
CD8T,rs7605824_SH3YL1,BP,GO:0046641,positive regulation of alpha-beta T cell proliferation,1.38e-03,1.56e-02,2/28,16/7978
CD8T,rs7605824_SH3YL1,BP,GO:0050918,positive chemotaxis,1.38e-03,1.56e-02,2/28,16/7978
CD8T,rs7605824_SH3YL1,BP,GO:0051444,negative regulation of ubiquitin-protein transferase activity,1.38e-03,1.56e-02,2/28,16/7978
CD8T,rs7605824_SH3YL1,BP,GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,1.40e-03,1.56e-02,3/28,64/7978
CD8T,rs7605824_SH3YL1,BP,GO:0060333,interferon-gamma-mediated signaling pathway,1.40e-03,1.56e-02,3/28,64/7978
CD8T,rs7605824_SH3YL1,BP,GO:0050870,positive regulation of T cell activation,1.45e-03,1.60e-02,4/28,143/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002821,positive regulation of adaptive immune response,1.46e-03,1.60e-02,3/28,65/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002698,negative regulation of immune effector process,1.53e-03,1.61e-02,3/28,66/7978
CD8T,rs7605824_SH3YL1,BP,GO:0046634,regulation of alpha-beta T cell activation,1.53e-03,1.61e-02,3/28,66/7978
CD8T,rs7605824_SH3YL1,BP,GO:0060337,type I interferon signaling pathway,1.53e-03,1.61e-02,3/28,66/7978
CD8T,rs7605824_SH3YL1,BP,GO:0071357,cellular response to type I interferon,1.53e-03,1.61e-02,3/28,66/7978
CD8T,rs7605824_SH3YL1,BP,GO:0031347,regulation of defense response,1.57e-03,1.64e-02,6/28,373/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002449,lymphocyte mediated immunity,1.69e-03,1.73e-02,4/28,149/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1.69e-03,1.73e-02,4/28,149/7978
CD8T,rs7605824_SH3YL1,BP,GO:0034340,response to type I interferon,1.74e-03,1.74e-02,3/28,69/7978
CD8T,rs7605824_SH3YL1,BP,GO:0071675,regulation of mononuclear cell migration,1.76e-03,1.74e-02,2/28,18/7978
CD8T,rs7605824_SH3YL1,BP,GO:0097028,dendritic cell differentiation,1.76e-03,1.74e-02,2/28,18/7978
CD8T,rs7605824_SH3YL1,BP,GO:1904666,regulation of ubiquitin protein ligase activity,1.76e-03,1.74e-02,2/28,18/7978
CD8T,rs7605824_SH3YL1,BP,GO:1903039,positive regulation of leukocyte cell-cell adhesion,1.91e-03,1.87e-02,4/28,154/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002548,monocyte chemotaxis,1.96e-03,1.89e-02,2/28,19/7978
CD8T,rs7605824_SH3YL1,BP,GO:0046640,regulation of alpha-beta T cell proliferation,1.96e-03,1.89e-02,2/28,19/7978
CD8T,rs7605824_SH3YL1,BP,GO:0032943,mononuclear cell proliferation,2.09e-03,1.99e-02,4/28,158/7978
CD8T,rs7605824_SH3YL1,BP,GO:0046651,lymphocyte proliferation,2.09e-03,1.99e-02,4/28,158/7978
CD8T,rs7605824_SH3YL1,BP,GO:0070374,positive regulation of ERK1 and ERK2 cascade,2.12e-03,2.00e-02,3/28,74/7978
CD8T,rs7605824_SH3YL1,BP,GO:0032102,negative regulation of response to external stimulus,2.14e-03,2.00e-02,4/28,159/7978
CD8T,rs7605824_SH3YL1,BP,GO:0070661,leukocyte proliferation,2.51e-03,2.32e-02,4/28,166/7978
CD8T,rs7605824_SH3YL1,BP,GO:0022409,positive regulation of cell-cell adhesion,2.56e-03,2.33e-02,4/28,167/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,2.56e-03,2.33e-02,3/28,79/7978
CD8T,rs7605824_SH3YL1,BP,GO:0046633,alpha-beta T cell proliferation,2.63e-03,2.38e-02,2/28,22/7978
CD8T,rs7605824_SH3YL1,BP,GO:0001906,cell killing,2.66e-03,2.38e-02,3/28,80/7978
CD8T,rs7605824_SH3YL1,BP,GO:0050777,negative regulation of immune response,2.75e-03,2.45e-02,3/28,81/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002705,positive regulation of leukocyte mediated immunity,2.85e-03,2.48e-02,3/28,82/7978
CD8T,rs7605824_SH3YL1,BP,GO:0001774,microglial cell activation,2.87e-03,2.48e-02,2/28,23/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002269,leukocyte activation involved in inflammatory response,2.87e-03,2.48e-02,2/28,23/7978
CD8T,rs7605824_SH3YL1,BP,GO:0043030,regulation of macrophage activation,2.87e-03,2.48e-02,2/28,23/7978
CD8T,rs7605824_SH3YL1,BP,GO:0000027,ribosomal large subunit assembly,3.13e-03,2.68e-02,2/28,24/7978
CD8T,rs7605824_SH3YL1,BP,GO:0042177,negative regulation of protein catabolic process,3.26e-03,2.77e-02,3/28,86/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002695,negative regulation of leukocyte activation,3.37e-03,2.84e-02,3/28,87/7978
CD8T,rs7605824_SH3YL1,BP,GO:0061900,glial cell activation,3.39e-03,2.84e-02,2/28,25/7978
CD8T,rs7605824_SH3YL1,BP,GO:0045055,regulated exocytosis,3.51e-03,2.92e-02,6/28,437/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002694,regulation of leukocyte activation,3.61e-03,2.98e-02,5/28,302/7978
CD8T,rs7605824_SH3YL1,BP,GO:0042269,regulation of natural killer cell mediated cytotoxicity,3.66e-03,3.01e-02,2/28,26/7978
CD8T,rs7605824_SH3YL1,BP,GO:0051251,positive regulation of lymphocyte activation,3.78e-03,3.08e-02,4/28,186/7978
CD8T,rs7605824_SH3YL1,BP,GO:0050866,negative regulation of cell activation,3.83e-03,3.09e-02,3/28,91/7978
CD8T,rs7605824_SH3YL1,BP,GO:0071674,mononuclear cell migration,3.95e-03,3.15e-02,2/28,27/7978
CD8T,rs7605824_SH3YL1,BP,GO:0150076,neuroinflammatory response,3.95e-03,3.15e-02,2/28,27/7978
CD8T,rs7605824_SH3YL1,BP,GO:0019221,cytokine-mediated signaling pathway,4.01e-03,3.17e-02,6/28,449/7978
CD8T,rs7605824_SH3YL1,BP,GO:0050865,regulation of cell activation,4.20e-03,3.29e-02,5/28,313/7978
CD8T,rs7605824_SH3YL1,BP,GO:0001960,negative regulation of cytokine-mediated signaling pathway,4.24e-03,3.29e-02,2/28,28/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002715,regulation of natural killer cell mediated immunity,4.24e-03,3.29e-02,2/28,28/7978
CD8T,rs7605824_SH3YL1,BP,GO:0043312,neutrophil degranulation,4.44e-03,3.42e-02,5/28,317/7978
CD8T,rs7605824_SH3YL1,BP,GO:1903037,regulation of leukocyte cell-cell adhesion,4.47e-03,3.42e-02,4/28,195/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002283,neutrophil activation involved in immune response,4.50e-03,3.42e-02,5/28,318/7978
CD8T,rs7605824_SH3YL1,BP,GO:0045088,regulation of innate immune response,4.72e-03,3.57e-02,4/28,198/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002446,neutrophil mediated immunity,4.87e-03,3.65e-02,5/28,324/7978
CD8T,rs7605824_SH3YL1,BP,GO:0060761,negative regulation of response to cytokine stimulus,5.19e-03,3.87e-02,2/28,31/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002696,positive regulation of leukocyte activation,5.25e-03,3.88e-02,4/28,204/7978
CD8T,rs7605824_SH3YL1,BP,GO:0046631,alpha-beta T cell activation,5.27e-03,3.88e-02,3/28,102/7978
CD8T,rs7605824_SH3YL1,BP,GO:0050863,regulation of T cell activation,5.34e-03,3.91e-02,4/28,205/7978
CD8T,rs7605824_SH3YL1,BP,GO:0032760,positive regulation of tumor necrosis factor production,5.52e-03,4.01e-02,2/28,32/7978
CD8T,rs7605824_SH3YL1,BP,GO:0050867,positive regulation of cell activation,5.62e-03,4.06e-02,4/28,208/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002443,leukocyte mediated immunity,5.74e-03,4.12e-02,6/28,483/7978
CD8T,rs7605824_SH3YL1,BP,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,6.22e-03,4.43e-02,2/28,34/7978
CD8T,rs7605824_SH3YL1,BP,GO:0043299,leukocyte degranulation,6.27e-03,4.44e-02,5/28,344/7978
CD8T,rs7605824_SH3YL1,BP,GO:0045824,negative regulation of innate immune response,6.58e-03,4.60e-02,2/28,35/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002275,myeloid cell activation involved in immune response,6.58e-03,4.60e-02,5/28,348/7978
CD8T,rs7605824_SH3YL1,BP,GO:0007159,leukocyte cell-cell adhesion,6.63e-03,4.60e-02,4/28,218/7978
CD8T,rs7605824_SH3YL1,BP,GO:0032101,regulation of response to external stimulus,6.65e-03,4.60e-02,6/28,498/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002697,regulation of immune effector process,6.85e-03,4.71e-02,4/28,220/7978
CD8T,rs7605824_SH3YL1,BP,GO:0098609,cell-cell adhesion,7.07e-03,4.83e-02,5/28,354/7978
CD8T,rs7605824_SH3YL1,BP,GO:0002444,myeloid leukocyte mediated immunity,7.24e-03,4.92e-02,5/28,356/7978
CD8T,rs7605824_SH3YL1,CC,GO:0022626,cytosolic ribosome,2.47e-26,3.02e-24,17/29,99/8242
CD8T,rs7605824_SH3YL1,CC,GO:0044391,ribosomal subunit,5.62e-22,3.43e-20,17/29,173/8242
CD8T,rs7605824_SH3YL1,CC,GO:0005840,ribosome,1.19e-20,4.85e-19,17/29,206/8242
CD8T,rs7605824_SH3YL1,CC,GO:0022625,cytosolic large ribosomal subunit,7.32e-16,2.23e-14,10/29,52/8242
CD8T,rs7605824_SH3YL1,CC,GO:0015934,large ribosomal subunit,1.31e-12,3.21e-11,10/29,106/8242
CD8T,rs7605824_SH3YL1,CC,GO:0022627,cytosolic small ribosomal subunit,1.07e-10,2.18e-09,7/29,44/8242
CD8T,rs7605824_SH3YL1,CC,GO:0015935,small ribosomal subunit,3.16e-09,5.50e-08,7/29,70/8242
CD8T,rs7605824_SH3YL1,CC,GO:0005925,focal adhesion,1.16e-08,1.70e-07,10/29,265/8242
CD8T,rs7605824_SH3YL1,CC,GO:0030055,cell-substrate junction,1.25e-08,1.70e-07,10/29,267/8242
CD8T,rs7605824_SH3YL1,CC,GO:0070161,anchoring junction,7.60e-07,9.27e-06,10/29,413/8242
CD8T,rs7605824_SH3YL1,CC,GO:0042612,MHC class I protein complex,1.36e-06,1.51e-05,3/29,7/8242
CD8T,rs7605824_SH3YL1,CC,GO:0005844,polysome,1.79e-06,1.82e-05,5/29,60/8242
CD8T,rs7605824_SH3YL1,CC,GO:0042788,polysomal ribosome,3.64e-06,3.42e-05,4/29,31/8242
CD8T,rs7605824_SH3YL1,CC,GO:0042611,MHC protein complex,3.65e-05,3.18e-04,3/29,19/8242
CD8T,rs7605824_SH3YL1,CC,GO:0071556,integral component of lumenal side of endoplasmic reticulum membrane,4.99e-05,3.81e-04,3/29,21/8242
CD8T,rs7605824_SH3YL1,CC,GO:0098553,lumenal side of endoplasmic reticulum membrane,4.99e-05,3.81e-04,3/29,21/8242
CD8T,rs7605824_SH3YL1,CC,GO:0098576,lumenal side of membrane,9.64e-05,6.92e-04,3/29,26/8242
CD8T,rs7605824_SH3YL1,CC,GO:0030670,phagocytic vesicle membrane,5.72e-04,3.88e-03,3/29,47/8242
CD8T,rs7605824_SH3YL1,CC,GO:0012507,ER to Golgi transport vesicle membrane,6.47e-04,4.16e-03,3/29,49/8242
CD8T,rs7605824_SH3YL1,CC,GO:0055038,recycling endosome membrane,8.61e-04,5.25e-03,3/29,54/8242
CD8T,rs7605824_SH3YL1,CC,GO:0030134,COPII-coated ER to Golgi transport vesicle,1.83e-03,1.03e-02,3/29,70/8242
CD8T,rs7605824_SH3YL1,CC,GO:0098552,side of membrane,1.85e-03,1.03e-02,5/29,258/8242
CD8T,rs7605824_SH3YL1,CC,GO:0030666,endocytic vesicle membrane,2.50e-03,1.32e-02,3/29,78/8242
CD8T,rs7605824_SH3YL1,CC,GO:0009986,cell surface,2.74e-03,1.39e-02,5/29,282/8242
CD8T,rs7605824_SH3YL1,CC,GO:0030660,Golgi-associated vesicle membrane,2.88e-03,1.40e-02,3/29,82/8242
CD8T,rs7605824_SH3YL1,CC,GO:0045335,phagocytic vesicle,3.75e-03,1.75e-02,3/29,90/8242
CD8T,rs7605824_SH3YL1,CC,GO:0031901,early endosome membrane,3.87e-03,1.75e-02,3/29,91/8242
CD8T,rs7605824_SH3YL1,CC,GO:0098797,plasma membrane protein complex,5.42e-03,2.36e-02,4/29,205/8242
CD8T,rs7605824_SH3YL1,CC,GO:0030658,transport vesicle membrane,5.93e-03,2.47e-02,3/29,106/8242
CD8T,rs7605824_SH3YL1,CC,GO:0030176,integral component of endoplasmic reticulum membrane,6.08e-03,2.47e-02,3/29,107/8242
CD8T,rs7605824_SH3YL1,CC,GO:0055037,recycling endosome,6.40e-03,2.52e-02,3/29,109/8242
CD8T,rs7605824_SH3YL1,CC,GO:0031227,intrinsic component of endoplasmic reticulum membrane,6.73e-03,2.57e-02,3/29,111/8242
CD8T,rs7605824_SH3YL1,CC,GO:0030662,coated vesicle membrane,7.25e-03,2.68e-02,3/29,114/8242
CD8T,rs7605824_SH3YL1,CC,GO:0005798,Golgi-associated vesicle,8.54e-03,3.06e-02,3/29,121/8242
CD8T,rs7605824_SH3YL1,CC,GO:0098794,postsynapse,1.05e-02,3.66e-02,4/29,248/8242
CD8T,rs7605824_SH3YL1,CC,GO:0005887,integral component of plasma membrane,1.19e-02,4.03e-02,5/29,400/8242
CD8T,rs7605824_SH3YL1,CC,GO:0030863,cortical cytoskeleton,1.32e-02,4.35e-02,2/29,50/8242
CD8T,rs7605824_SH3YL1,CC,GO:0014069,postsynaptic density,1.42e-02,4.56e-02,3/29,146/8242
CD8T,rs7605824_SH3YL1,CC,GO:0032279,asymmetric synapse,1.47e-02,4.61e-02,3/29,148/8242
CD8T,rs7605824_SH3YL1,CC,GO:0031226,intrinsic component of plasma membrane,1.53e-02,4.64e-02,5/29,426/8242
CD8T,rs7605824_SH3YL1,CC,GO:0030141,secretory granule,1.56e-02,4.64e-02,5/29,428/8242
CD8T,rs7605824_SH3YL1,CC,GO:0099572,postsynaptic specialization,1.61e-02,4.65e-02,3/29,153/8242
CD8T,rs7605824_SH3YL1,CC,GO:0098984,neuron to neuron synapse,1.64e-02,4.65e-02,3/29,154/8242
CD8T,rs7605824_SH3YL1,MF,GO:0003735,structural constituent of ribosome,4.33e-23,6.10e-21,17/29,149/8204
CD8T,rs7605824_SH3YL1,MF,GO:0005198,structural molecule activity,4.68e-18,3.30e-16,17/29,290/8204
CD8T,rs7605824_SH3YL1,MF,GO:0046977,TAP binding,7.89e-07,3.45e-05,3/29,6/8204
CD8T,rs7605824_SH3YL1,MF,GO:0019843,rRNA binding,9.80e-07,3.45e-05,5/29,53/8204
CD8T,rs7605824_SH3YL1,MF,GO:0042605,peptide antigen binding,2.16e-05,6.08e-04,3/29,16/8204
CD8T,rs7605824_SH3YL1,MF,GO:1990948,ubiquitin ligase inhibitor activity,1.20e-04,2.82e-03,2/29,5/8204
CD8T,rs7605824_SH3YL1,MF,GO:0055105,ubiquitin-protein transferase inhibitor activity,1.79e-04,3.24e-03,2/29,6/8204
CD8T,rs7605824_SH3YL1,MF,GO:0003823,antigen binding,1.84e-04,3.24e-03,3/29,32/8204
CD8T,rs7605824_SH3YL1,MF,GO:0042056,chemoattractant activity,3.33e-04,5.22e-03,2/29,8/8204
CD8T,rs7605824_SH3YL1,MF,GO:0005125,cytokine activity,7.38e-04,1.04e-02,3/29,51/8204
CD8T,rs7605824_SH3YL1,MF,GO:0055106,ubiquitin-protein transferase regulator activity,9.19e-04,1.18e-02,2/29,13/8204
CD8T,rs7605824_SH3YL1,MF,GO:0048018,receptor ligand activity,3.45e-03,4.05e-02,3/29,87/8204
CD8T,rs7605824_SH3YL1,MF,GO:0030546,signaling receptor activator activity,3.92e-03,4.25e-02,3/29,91/8204
CD8T,rs7605824_SH3YL1,MF,GO:0030545,receptor regulator activity,4.42e-03,4.45e-02,3/29,95/8204
CD8T,rs9271520_HLA-DQA2,BP,GO:0070229,negative regulation of lymphocyte apoptotic process,5.35e-05,1.05e-02,2/5,19/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0071622,regulation of granulocyte chemotaxis,6.57e-05,1.05e-02,2/5,21/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0019083,viral transcription,8.74e-05,1.05e-02,3/5,167/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0006413,translational initiation,9.54e-05,1.05e-02,3/5,172/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:2000107,negative regulation of leukocyte apoptotic process,1.10e-04,1.05e-02,2/5,27/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0019080,viral gene expression,1.15e-04,1.05e-02,3/5,183/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0070228,regulation of lymphocyte apoptotic process,1.85e-04,1.45e-02,2/5,35/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002690,positive regulation of leukocyte chemotaxis,2.81e-04,1.61e-02,2/5,43/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0030593,neutrophil chemotaxis,2.81e-04,1.61e-02,2/5,43/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0070227,lymphocyte apoptotic process,3.50e-04,1.61e-02,2/5,48/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1903902,positive regulation of viral life cycle,3.50e-04,1.61e-02,2/5,48/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0071621,granulocyte chemotaxis,3.65e-04,1.61e-02,2/5,49/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:2000106,regulation of leukocyte apoptotic process,3.96e-04,1.61e-02,2/5,51/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1990266,neutrophil migration,4.12e-04,1.61e-02,2/5,52/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002688,regulation of leukocyte chemotaxis,4.61e-04,1.68e-02,2/5,55/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0050921,positive regulation of chemotaxis,5.30e-04,1.77e-02,2/5,59/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0097530,granulocyte migration,5.48e-04,1.77e-02,2/5,60/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002687,positive regulation of leukocyte migration,6.24e-04,1.90e-02,2/5,64/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0071887,leukocyte apoptotic process,7.04e-04,2.01e-02,2/5,68/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0070374,positive regulation of ERK1 and ERK2 cascade,8.34e-04,2.01e-02,2/5,74/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,8.56e-04,2.01e-02,2/5,75/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,8.79e-04,2.01e-02,2/5,76/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,8.79e-04,2.01e-02,2/5,76/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,8.79e-04,2.01e-02,2/5,76/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0032946,positive regulation of mononuclear cell proliferation,1.02e-03,2.13e-02,2/5,82/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0050671,positive regulation of lymphocyte proliferation,1.02e-03,2.13e-02,2/5,82/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0050778,positive regulation of immune response,1.09e-03,2.13e-02,3/5,392/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0070665,positive regulation of leukocyte proliferation,1.12e-03,2.13e-02,2/5,86/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0097529,myeloid leukocyte migration,1.12e-03,2.13e-02,2/5,86/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0048524,positive regulation of viral process,1.20e-03,2.18e-02,2/5,89/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0050920,regulation of chemotaxis,1.23e-03,2.18e-02,2/5,90/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,1.29e-03,2.20e-02,2/5,92/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0030595,leukocyte chemotaxis,1.37e-03,2.26e-02,2/5,95/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0006613,cotranslational protein targeting to membrane,1.40e-03,2.26e-02,2/5,96/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002685,regulation of leukocyte migration,1.52e-03,2.28e-02,2/5,100/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1903900,regulation of viral life cycle,1.55e-03,2.28e-02,2/5,101/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0001959,regulation of cytokine-mediated signaling pathway,1.58e-03,2.28e-02,2/5,102/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0071346,cellular response to interferon-gamma,1.61e-03,2.28e-02,2/5,103/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0019221,cytokine-mediated signaling pathway,1.63e-03,2.28e-02,3/5,449/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0045047,protein targeting to ER,1.67e-03,2.29e-02,2/5,105/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,1.77e-03,2.35e-02,2/5,108/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0060759,regulation of response to cytokine stimulus,1.80e-03,2.35e-02,2/5,109/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",1.90e-03,2.42e-02,2/5,112/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0034341,response to interferon-gamma,2.04e-03,2.48e-02,2/5,116/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,2.04e-03,2.48e-02,2/5,116/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0070372,regulation of ERK1 and ERK2 cascade,2.11e-03,2.49e-02,2/5,118/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0032944,regulation of mononuclear cell proliferation,2.18e-03,2.49e-02,2/5,120/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0050670,regulation of lymphocyte proliferation,2.18e-03,2.49e-02,2/5,120/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0060326,cell chemotaxis,2.25e-03,2.52e-02,2/5,122/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0070663,regulation of leukocyte proliferation,2.40e-03,2.61e-02,2/5,126/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0070371,ERK1 and ERK2 cascade,2.47e-03,2.61e-02,2/5,128/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0070972,protein localization to endoplasmic reticulum,2.47e-03,2.61e-02,2/5,128/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002478,antigen processing and presentation of exogenous peptide antigen,2.87e-03,2.73e-02,2/5,138/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0019884,antigen processing and presentation of exogenous antigen,3.00e-03,2.73e-02,2/5,141/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0050870,positive regulation of T cell activation,3.08e-03,2.73e-02,2/5,143/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002606,positive regulation of dendritic cell antigen processing and presentation,3.13e-03,2.73e-02,1/5,5/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0031584,activation of phospholipase D activity,3.13e-03,2.73e-02,1/5,5/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0048245,eosinophil chemotaxis,3.13e-03,2.73e-02,1/5,5/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:2000501,regulation of natural killer cell chemotaxis,3.13e-03,2.73e-02,1/5,5/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:2001280,positive regulation of unsaturated fatty acid biosynthetic process,3.13e-03,2.73e-02,1/5,5/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0048002,antigen processing and presentation of peptide antigen,3.21e-03,2.73e-02,2/5,146/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0050792,regulation of viral process,3.47e-03,2.73e-02,2/5,152/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1903039,positive regulation of leukocyte cell-cell adhesion,3.56e-03,2.73e-02,2/5,154/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0006612,protein targeting to membrane,3.61e-03,2.73e-02,2/5,155/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0032943,mononuclear cell proliferation,3.75e-03,2.73e-02,2/5,158/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0043903,regulation of symbiotic process,3.75e-03,2.73e-02,2/5,158/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0046651,lymphocyte proliferation,3.75e-03,2.73e-02,2/5,158/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002579,positive regulation of antigen processing and presentation,3.76e-03,2.73e-02,1/5,6/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0010533,regulation of activation of Janus kinase activity,3.76e-03,2.73e-02,1/5,6/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0010759,positive regulation of macrophage chemotaxis,3.76e-03,2.73e-02,1/5,6/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0010935,regulation of macrophage cytokine production,3.76e-03,2.73e-02,1/5,6/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0031392,regulation of prostaglandin biosynthetic process,3.76e-03,2.73e-02,1/5,6/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0034112,positive regulation of homotypic cell-cell adhesion,3.76e-03,2.73e-02,1/5,6/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0045657,positive regulation of monocyte differentiation,3.76e-03,2.73e-02,1/5,6/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:2000343,positive regulation of chemokine (C-X-C motif) ligand 2 production,3.76e-03,2.73e-02,1/5,6/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002791,regulation of peptide secretion,4.03e-03,2.73e-02,2/5,164/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0018108,peptidyl-tyrosine phosphorylation,4.13e-03,2.73e-02,2/5,166/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0070661,leukocyte proliferation,4.13e-03,2.73e-02,2/5,166/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0022409,positive regulation of cell-cell adhesion,4.18e-03,2.73e-02,2/5,167/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0018212,peptidyl-tyrosine modification,4.23e-03,2.73e-02,2/5,168/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0019882,antigen processing and presentation,4.38e-03,2.73e-02,2/5,171/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002468,dendritic cell antigen processing and presentation,4.38e-03,2.73e-02,1/5,7/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002544,chronic inflammatory response,4.38e-03,2.73e-02,1/5,7/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002604,regulation of dendritic cell antigen processing and presentation,4.38e-03,2.73e-02,1/5,7/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0010934,macrophage cytokine production,4.38e-03,2.73e-02,1/5,7/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0035747,natural killer cell chemotaxis,4.38e-03,2.73e-02,1/5,7/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0090026,positive regulation of monocyte chemotaxis,4.38e-03,2.73e-02,1/5,7/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:2000109,regulation of macrophage apoptotic process,4.38e-03,2.73e-02,1/5,7/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0032147,activation of protein kinase activity,4.79e-03,2.87e-02,2/5,179/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0045060,negative thymic T cell selection,5.00e-03,2.87e-02,1/5,8/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0070206,protein trimerization,5.00e-03,2.87e-02,1/5,8/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0070234,positive regulation of T cell apoptotic process,5.00e-03,2.87e-02,1/5,8/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0072677,eosinophil migration,5.00e-03,2.87e-02,1/5,8/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:2001279,regulation of unsaturated fatty acid biosynthetic process,5.00e-03,2.87e-02,1/5,8/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,5.05e-03,2.87e-02,2/5,184/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0051251,positive regulation of lymphocyte activation,5.16e-03,2.87e-02,2/5,186/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0033033,negative regulation of myeloid cell apoptotic process,5.63e-03,2.87e-02,1/5,9/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0033632,regulation of cell-cell adhesion mediated by integrin,5.63e-03,2.87e-02,1/5,9/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0042976,activation of Janus kinase activity,5.63e-03,2.87e-02,1/5,9/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0043383,negative T cell selection,5.63e-03,2.87e-02,1/5,9/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0043518,"negative regulation of DNA damage response, signal transduction by p53 class mediator",5.63e-03,2.87e-02,1/5,9/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0045723,positive regulation of fatty acid biosynthetic process,5.63e-03,2.87e-02,1/5,9/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0046598,positive regulation of viral entry into host cell,5.63e-03,2.87e-02,1/5,9/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0070233,negative regulation of T cell apoptotic process,5.63e-03,2.87e-02,1/5,9/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0071888,macrophage apoptotic process,5.63e-03,2.87e-02,1/5,9/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0075294,positive regulation by symbiont of entry into host,5.63e-03,2.87e-02,1/5,9/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1905523,positive regulation of macrophage migration,5.63e-03,2.87e-02,1/5,9/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1903037,regulation of leukocyte cell-cell adhesion,5.66e-03,2.87e-02,2/5,195/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0050900,leukocyte migration,6.07e-03,2.88e-02,2/5,202/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002696,positive regulation of leukocyte activation,6.18e-03,2.88e-02,2/5,204/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0050863,regulation of T cell activation,6.24e-03,2.88e-02,2/5,205/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0010819,regulation of T cell chemotaxis,6.25e-03,2.88e-02,1/5,10/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0010820,positive regulation of T cell chemotaxis,6.25e-03,2.88e-02,1/5,10/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0033630,positive regulation of cell adhesion mediated by integrin,6.25e-03,2.88e-02,1/5,10/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0070230,positive regulation of lymphocyte apoptotic process,6.25e-03,2.88e-02,1/5,10/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0071677,positive regulation of mononuclear cell migration,6.25e-03,2.88e-02,1/5,10/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0072567,chemokine (C-X-C motif) ligand 2 production,6.25e-03,2.88e-02,1/5,10/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0090025,regulation of monocyte chemotaxis,6.25e-03,2.88e-02,1/5,10/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:2000341,regulation of chemokine (C-X-C motif) ligand 2 production,6.25e-03,2.88e-02,1/5,10/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0050867,positive regulation of cell activation,6.42e-03,2.93e-02,2/5,208/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002830,positive regulation of type 2 immune response,6.88e-03,3.04e-02,1/5,11/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002903,negative regulation of B cell apoptotic process,6.88e-03,3.04e-02,1/5,11/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0010758,regulation of macrophage chemotaxis,6.88e-03,3.04e-02,1/5,11/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0043922,negative regulation by host of viral transcription,6.88e-03,3.04e-02,1/5,11/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002790,peptide secretion,7.04e-03,3.06e-02,2/5,218/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0007159,leukocyte cell-cell adhesion,7.04e-03,3.06e-02,2/5,218/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002577,regulation of antigen processing and presentation,7.50e-03,3.16e-02,1/5,12/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0045059,positive thymic T cell selection,7.50e-03,3.16e-02,1/5,12/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0045655,regulation of monocyte differentiation,7.50e-03,3.16e-02,1/5,12/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,7.50e-03,3.16e-02,1/5,12/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0019058,viral life cycle,7.68e-03,3.21e-02,2/5,228/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0043410,positive regulation of MAPK cascade,7.81e-03,3.21e-02,2/5,230/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0045785,positive regulation of cell adhesion,7.95e-03,3.21e-02,2/5,232/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002407,dendritic cell chemotaxis,8.12e-03,3.21e-02,1/5,13/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0019883,antigen processing and presentation of endogenous antigen,8.12e-03,3.21e-02,1/5,13/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0033631,cell-cell adhesion mediated by integrin,8.12e-03,3.21e-02,1/5,13/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response,8.12e-03,3.21e-02,1/5,13/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0140131,positive regulation of lymphocyte chemotaxis,8.12e-03,3.21e-02,1/5,13/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0006935,chemotaxis,8.15e-03,3.21e-02,2/5,235/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0030335,positive regulation of cell migration,8.28e-03,3.22e-02,2/5,237/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0042330,taxis,8.28e-03,3.22e-02,2/5,237/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0022407,regulation of cell-cell adhesion,8.42e-03,3.22e-02,2/5,239/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002250,adaptive immune response,8.56e-03,3.22e-02,2/5,241/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:2000147,positive regulation of cell motility,8.56e-03,3.22e-02,2/5,241/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0014911,positive regulation of smooth muscle cell migration,8.75e-03,3.22e-02,1/5,14/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0071624,positive regulation of granulocyte chemotaxis,8.75e-03,3.22e-02,1/5,14/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0090023,positive regulation of neutrophil chemotaxis,8.75e-03,3.22e-02,1/5,14/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1902165,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,8.75e-03,3.22e-02,1/5,14/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0040017,positive regulation of locomotion,8.76e-03,3.22e-02,2/5,244/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0051272,positive regulation of cellular component movement,8.90e-03,3.23e-02,2/5,246/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0090150,establishment of protein localization to membrane,8.97e-03,3.23e-02,2/5,247/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0001516,prostaglandin biosynthetic process,9.37e-03,3.23e-02,1/5,15/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0006925,inflammatory cell apoptotic process,9.37e-03,3.23e-02,1/5,15/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0034110,regulation of homotypic cell-cell adhesion,9.37e-03,3.23e-02,1/5,15/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0036336,dendritic cell migration,9.37e-03,3.23e-02,1/5,15/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0046457,prostanoid biosynthetic process,9.37e-03,3.23e-02,1/5,15/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0048246,macrophage chemotaxis,9.37e-03,3.23e-02,1/5,15/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1901623,regulation of lymphocyte chemotaxis,9.37e-03,3.23e-02,1/5,15/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,9.37e-03,3.23e-02,1/5,15/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0032103,positive regulation of response to external stimulus,9.99e-03,3.34e-02,2/5,261/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002902,regulation of B cell apoptotic process,9.99e-03,3.34e-02,1/5,16/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0045923,positive regulation of fatty acid metabolic process,9.99e-03,3.34e-02,1/5,16/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0050918,positive chemotaxis,9.99e-03,3.34e-02,1/5,16/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0090022,regulation of neutrophil chemotaxis,9.99e-03,3.34e-02,1/5,16/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0051249,regulation of lymphocyte activation,1.05e-02,3.42e-02,2/5,268/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0010818,T cell chemotaxis,1.06e-02,3.42e-02,1/5,17/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0045061,thymic T cell selection,1.06e-02,3.42e-02,1/5,17/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0061082,myeloid leukocyte cytokine production,1.06e-02,3.42e-02,1/5,17/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1902624,positive regulation of neutrophil migration,1.06e-02,3.42e-02,1/5,17/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1905521,regulation of macrophage migration,1.06e-02,3.42e-02,1/5,17/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0045860,positive regulation of protein kinase activity,1.09e-02,3.49e-02,2/5,273/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002828,regulation of type 2 immune response,1.12e-02,3.49e-02,1/5,18/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0032722,positive regulation of chemokine production,1.12e-02,3.49e-02,1/5,18/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0033032,regulation of myeloid cell apoptotic process,1.12e-02,3.49e-02,1/5,18/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0071675,regulation of mononuclear cell migration,1.12e-02,3.49e-02,1/5,18/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:2000108,positive regulation of leukocyte apoptotic process,1.12e-02,3.49e-02,1/5,18/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0051046,regulation of secretion,1.13e-02,3.49e-02,2/5,278/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002548,monocyte chemotaxis,1.19e-02,3.57e-02,1/5,19/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0030224,monocyte differentiation,1.19e-02,3.57e-02,1/5,19/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0070232,regulation of T cell apoptotic process,1.19e-02,3.57e-02,1/5,19/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1901797,negative regulation of signal transduction by p53 class mediator,1.19e-02,3.57e-02,1/5,19/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1903131,mononuclear cell differentiation,1.19e-02,3.57e-02,1/5,19/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0001782,B cell homeostasis,1.25e-02,3.66e-02,1/5,20/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0043516,"regulation of DNA damage response, signal transduction by p53 class mediator",1.25e-02,3.66e-02,1/5,20/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0061098,positive regulation of protein tyrosine kinase activity,1.25e-02,3.66e-02,1/5,20/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,1.25e-02,3.66e-02,1/5,20/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0033674,positive regulation of kinase activity,1.29e-02,3.66e-02,2/5,298/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0001783,B cell apoptotic process,1.31e-02,3.66e-02,1/5,21/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0010518,positive regulation of phospholipase activity,1.31e-02,3.66e-02,1/5,21/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0032897,negative regulation of viral transcription,1.31e-02,3.66e-02,1/5,21/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0033028,myeloid cell apoptotic process,1.31e-02,3.66e-02,1/5,21/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0042092,type 2 immune response,1.31e-02,3.66e-02,1/5,21/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0046596,regulation of viral entry into host cell,1.31e-02,3.66e-02,1/5,21/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,1.31e-02,3.66e-02,1/5,21/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1902622,regulation of neutrophil migration,1.31e-02,3.66e-02,1/5,21/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1905517,macrophage migration,1.31e-02,3.66e-02,1/5,21/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002694,regulation of leukocyte activation,1.32e-02,3.68e-02,2/5,302/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0042110,T cell activation,1.35e-02,3.73e-02,2/5,305/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0006402,mRNA catabolic process,1.37e-02,3.76e-02,2/5,307/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:2000406,positive regulation of T cell migration,1.37e-02,3.76e-02,1/5,22/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0050865,regulation of cell activation,1.42e-02,3.87e-02,2/5,313/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0043030,regulation of macrophage activation,1.43e-02,3.87e-02,1/5,23/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0046456,icosanoid biosynthetic process,1.43e-02,3.87e-02,1/5,23/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0006692,prostanoid metabolic process,1.50e-02,3.88e-02,1/5,24/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0006693,prostaglandin metabolic process,1.50e-02,3.88e-02,1/5,24/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0042304,regulation of fatty acid biosynthetic process,1.50e-02,3.88e-02,1/5,24/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0045581,negative regulation of T cell differentiation,1.50e-02,3.88e-02,1/5,24/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0045744,negative regulation of G protein-coupled receptor signaling pathway,1.50e-02,3.88e-02,1/5,24/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0048247,lymphocyte chemotaxis,1.50e-02,3.88e-02,1/5,24/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0051085,chaperone cofactor-dependent protein refolding,1.50e-02,3.88e-02,1/5,24/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0052372,modulation by symbiont of entry into host,1.50e-02,3.88e-02,1/5,24/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0014910,regulation of smooth muscle cell migration,1.56e-02,3.91e-02,1/5,25/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0032642,regulation of chemokine production,1.56e-02,3.91e-02,1/5,25/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0033628,regulation of cell adhesion mediated by integrin,1.56e-02,3.91e-02,1/5,25/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,1.56e-02,3.91e-02,1/5,25/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0045948,positive regulation of translational initiation,1.56e-02,3.91e-02,1/5,25/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0060193,positive regulation of lipase activity,1.56e-02,3.91e-02,1/5,25/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:2000403,positive regulation of lymphocyte migration,1.56e-02,3.91e-02,1/5,25/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0006605,protein targeting,1.58e-02,3.95e-02,2/5,331/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0010517,regulation of phospholipase activity,1.62e-02,3.98e-02,1/5,26/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0030890,positive regulation of B cell proliferation,1.62e-02,3.98e-02,1/5,26/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0048146,positive regulation of fibroblast proliferation,1.62e-02,3.98e-02,1/5,26/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0006401,RNA catabolic process,1.63e-02,3.98e-02,2/5,336/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0043408,regulation of MAPK cascade,1.63e-02,3.98e-02,2/5,336/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0006636,unsaturated fatty acid biosynthetic process,1.68e-02,3.99e-02,1/5,27/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0014909,smooth muscle cell migration,1.68e-02,3.99e-02,1/5,27/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0032602,chemokine production,1.68e-02,3.99e-02,1/5,27/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0045620,negative regulation of lymphocyte differentiation,1.68e-02,3.99e-02,1/5,27/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0051084,de novo' posttranslational protein folding,1.68e-02,3.99e-02,1/5,27/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0071674,mononuclear cell migration,1.68e-02,3.99e-02,1/5,27/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,1.68e-02,3.99e-02,1/5,27/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0001960,negative regulation of cytokine-mediated signaling pathway,1.74e-02,4.12e-02,1/5,28/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0098609,cell-cell adhesion,1.80e-02,4.18e-02,2/5,354/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0043368,positive T cell selection,1.80e-02,4.18e-02,1/5,29/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:2000404,regulation of T cell migration,1.80e-02,4.18e-02,1/5,29/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0051347,positive regulation of transferase activity,1.81e-02,4.18e-02,2/5,355/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0090087,regulation of peptide transport,1.81e-02,4.18e-02,2/5,355/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0001961,positive regulation of cytokine-mediated signaling pathway,1.87e-02,4.28e-02,1/5,30/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0070098,chemokine-mediated signaling pathway,1.87e-02,4.28e-02,1/5,30/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0030155,regulation of cell adhesion,1.90e-02,4.33e-02,2/5,365/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0006458,de novo' protein folding,1.93e-02,4.33e-02,1/5,31/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0032757,positive regulation of interleukin-8 production,1.93e-02,4.33e-02,1/5,31/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0060761,negative regulation of response to cytokine stimulus,1.93e-02,4.33e-02,1/5,31/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0070231,T cell apoptotic process,1.93e-02,4.33e-02,1/5,31/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0045070,positive regulation of viral genome replication,1.99e-02,4.45e-02,1/5,32/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0000462,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",2.05e-02,4.52e-02,1/5,33/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0014812,muscle cell migration,2.05e-02,4.52e-02,1/5,33/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0033627,cell adhesion mediated by integrin,2.05e-02,4.52e-02,1/5,33/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0060191,regulation of lipase activity,2.05e-02,4.52e-02,1/5,33/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0042509,regulation of tyrosine phosphorylation of STAT protein,2.11e-02,4.61e-02,1/5,34/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0060760,positive regulation of response to cytokine stimulus,2.11e-02,4.61e-02,1/5,34/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002720,positive regulation of cytokine production involved in immune response,2.17e-02,4.71e-02,1/5,35/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0007260,tyrosine phosphorylation of STAT protein,2.17e-02,4.71e-02,1/5,35/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0030334,regulation of cell migration,2.18e-02,4.71e-02,2/5,392/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0031663,lipopolysaccharide-mediated signaling pathway,2.24e-02,4.77e-02,1/5,36/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1990868,response to chemokine,2.24e-02,4.77e-02,1/5,36/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1990869,cellular response to chemokine,2.24e-02,4.77e-02,1/5,36/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002274,myeloid leukocyte activation,2.28e-02,4.81e-02,2/5,401/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0072657,protein localization to membrane,2.29e-02,4.81e-02,2/5,402/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,2.30e-02,4.81e-02,1/5,37/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,2.30e-02,4.81e-02,1/5,37/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT,2.30e-02,4.81e-02,1/5,37/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002763,positive regulation of myeloid leukocyte differentiation,2.36e-02,4.84e-02,1/5,38/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0002792,negative regulation of peptide secretion,2.36e-02,4.84e-02,1/5,38/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0045058,T cell selection,2.36e-02,4.84e-02,1/5,38/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0046889,positive regulation of lipid biosynthetic process,2.36e-02,4.84e-02,1/5,38/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0051928,positive regulation of calcium ion transport,2.36e-02,4.84e-02,1/5,38/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0030888,regulation of B cell proliferation,2.42e-02,4.93e-02,1/5,39/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:1904894,positive regulation of receptor signaling pathway via STAT,2.42e-02,4.93e-02,1/5,39/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:2000145,regulation of cell motility,2.44e-02,4.95e-02,2/5,416/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0008284,positive regulation of cell population proliferation,2.45e-02,4.95e-02,2/5,417/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0006690,icosanoid metabolic process,2.48e-02,4.95e-02,1/5,40/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0032755,positive regulation of interleukin-6 production,2.48e-02,4.95e-02,1/5,40/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0034109,homotypic cell-cell adhesion,2.48e-02,4.95e-02,1/5,40/7978
CD8T,rs9271520_HLA-DQA2,BP,GO:0051851,modulation by host of symbiont process,2.48e-02,4.95e-02,1/5,40/7978
CD8T,rs9271520_HLA-DQA2,CC,GO:0042613,MHC class II protein complex,4.06e-05,1.49e-03,2/7,12/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0030669,clathrin-coated endocytic vesicle membrane,1.05e-04,1.49e-03,2/7,19/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0042611,MHC protein complex,1.05e-04,1.49e-03,2/7,19/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0071556,integral component of lumenal side of endoplasmic reticulum membrane,1.29e-04,1.49e-03,2/7,21/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0098553,lumenal side of endoplasmic reticulum membrane,1.29e-04,1.49e-03,2/7,21/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0098576,lumenal side of membrane,1.99e-04,1.92e-03,2/7,26/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0045334,clathrin-coated endocytic vesicle,2.31e-04,1.92e-03,2/7,28/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0012507,ER to Golgi transport vesicle membrane,7.13e-04,5.17e-03,2/7,49/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0030665,clathrin-coated vesicle membrane,1.18e-03,7.05e-03,2/7,63/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0032588,trans-Golgi network membrane,1.22e-03,7.05e-03,2/7,64/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0030134,COPII-coated ER to Golgi transport vesicle,1.45e-03,7.66e-03,2/7,70/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0030666,endocytic vesicle membrane,1.80e-03,8.70e-03,2/7,78/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0030660,Golgi-associated vesicle membrane,1.99e-03,8.87e-03,2/7,82/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0022626,cytosolic ribosome,2.88e-03,1.15e-02,2/7,99/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0030136,clathrin-coated vesicle,3.30e-03,1.15e-02,2/7,106/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0030658,transport vesicle membrane,3.30e-03,1.15e-02,2/7,106/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0030176,integral component of endoplasmic reticulum membrane,3.36e-03,1.15e-02,2/7,107/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0031227,intrinsic component of endoplasmic reticulum membrane,3.61e-03,1.16e-02,2/7,111/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0030662,coated vesicle membrane,3.81e-03,1.16e-02,2/7,114/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0005798,Golgi-associated vesicle,4.28e-03,1.24e-02,2/7,121/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0005802,trans-Golgi network,6.68e-03,1.84e-02,2/7,152/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0030139,endocytic vesicle,7.56e-03,1.99e-02,2/7,162/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0044391,ribosomal subunit,8.58e-03,2.16e-02,2/7,173/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0030135,coated vesicle,9.37e-03,2.26e-02,2/7,181/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0098797,plasma membrane protein complex,1.19e-02,2.58e-02,2/7,205/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0005840,ribosome,1.20e-02,2.58e-02,2/7,206/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0030133,transport vesicle,1.20e-02,2.58e-02,2/7,206/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0098791,Golgi apparatus subcompartment,1.38e-02,2.85e-02,2/7,221/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0031984,organelle subcompartment,1.58e-02,3.13e-02,2/7,238/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0031301,integral component of organelle membrane,1.64e-02,3.13e-02,2/7,242/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0005765,lysosomal membrane,1.73e-02,3.13e-02,2/7,249/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0098852,lytic vacuole membrane,1.73e-02,3.13e-02,2/7,249/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0031300,intrinsic component of organelle membrane,1.85e-02,3.15e-02,2/7,258/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0098552,side of membrane,1.85e-02,3.15e-02,2/7,258/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0005774,vacuolar membrane,2.22e-02,3.67e-02,2/7,284/8242
CD8T,rs9271520_HLA-DQA2,CC,GO:0005771,multivesicular body,2.60e-02,4.20e-02,1/7,31/8242
CD8T,rs9271520_HLA-DQA2,MF,GO:0140375,immune receptor activity,8.42e-04,2.77e-02,2/7,53/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0042289,MHC class II protein binding,4.26e-03,2.77e-02,1/7,5/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0048019,receptor antagonist activity,4.26e-03,2.77e-02,1/7,5/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0050998,nitric-oxide synthase binding,4.26e-03,2.77e-02,1/7,5/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0042277,peptide binding,4.75e-03,2.77e-02,2/7,127/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0030296,protein tyrosine kinase activator activity,5.11e-03,2.77e-02,1/7,6/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0030547,receptor inhibitor activity,5.11e-03,2.77e-02,1/7,6/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0031730,CCR5 chemokine receptor binding,5.11e-03,2.77e-02,1/7,6/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0032395,MHC class II receptor activity,5.96e-03,2.77e-02,1/7,7/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0042609,CD4 receptor binding,5.96e-03,2.77e-02,1/7,7/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0003735,structural constituent of ribosome,6.48e-03,2.77e-02,2/7,149/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0016004,phospholipase activator activity,6.81e-03,2.77e-02,1/7,8/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0042056,chemoattractant activity,6.81e-03,2.77e-02,1/7,8/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0060229,lipase activator activity,6.81e-03,2.77e-02,1/7,8/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0033218,amide binding,7.99e-03,3.03e-02,2/7,166/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0048020,CCR chemokine receptor binding,8.50e-03,3.03e-02,1/7,10/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0004435,phosphatidylinositol phospholipase C activity,9.35e-03,3.06e-02,1/7,11/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0004888,transmembrane signaling receptor activity,1.02e-02,3.06e-02,2/7,188/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0004629,phospholipase C activity,1.02e-02,3.06e-02,1/7,12/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0008009,chemokine activity,1.10e-02,3.15e-02,1/7,13/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0023026,MHC class II protein complex binding,1.19e-02,3.23e-02,1/7,14/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0042605,peptide antigen binding,1.36e-02,3.52e-02,1/7,16/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0042379,chemokine receptor binding,1.53e-02,3.78e-02,1/7,18/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0044183,protein folding chaperone,1.69e-02,4.02e-02,1/7,20/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0023023,MHC protein complex binding,1.78e-02,4.06e-02,1/7,21/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0042287,MHC protein binding,1.86e-02,4.08e-02,1/7,22/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0038023,signaling receptor activity,2.03e-02,4.14e-02,2/7,270/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0060089,molecular transducer activity,2.03e-02,4.14e-02,2/7,270/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0001540,amyloid-beta binding,2.28e-02,4.42e-02,1/7,27/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0005198,structural molecule activity,2.32e-02,4.42e-02,2/7,290/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0003823,antigen binding,2.70e-02,4.81e-02,1/7,32/8204
CD8T,rs9271520_HLA-DQA2,MF,GO:0004620,phospholipase activity,2.70e-02,4.81e-02,1/7,32/8204
CD8T,rs9306156_PRMT2,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,2.44e-07,9.84e-06,4/6,92/7978
CD8T,rs9306156_PRMT2,BP,GO:0006613,cotranslational protein targeting to membrane,2.90e-07,9.84e-06,4/6,96/7978
CD8T,rs9306156_PRMT2,BP,GO:0045047,protein targeting to ER,4.17e-07,9.84e-06,4/6,105/7978
CD8T,rs9306156_PRMT2,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,4.67e-07,9.84e-06,4/6,108/7978
CD8T,rs9306156_PRMT2,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",5.40e-07,9.84e-06,4/6,112/7978
CD8T,rs9306156_PRMT2,BP,GO:0070972,protein localization to endoplasmic reticulum,9.25e-07,1.40e-05,4/6,128/7978
CD8T,rs9306156_PRMT2,BP,GO:0006612,protein targeting to membrane,2.00e-06,2.59e-05,4/6,155/7978
CD8T,rs9306156_PRMT2,BP,GO:0019083,viral transcription,2.69e-06,3.06e-05,4/6,167/7978
CD8T,rs9306156_PRMT2,BP,GO:0006413,translational initiation,3.03e-06,3.06e-05,4/6,172/7978
CD8T,rs9306156_PRMT2,BP,GO:0019080,viral gene expression,3.88e-06,3.28e-05,4/6,183/7978
CD8T,rs9306156_PRMT2,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,3.96e-06,3.28e-05,4/6,184/7978
CD8T,rs9306156_PRMT2,BP,GO:0090150,establishment of protein localization to membrane,1.28e-05,9.72e-05,4/6,247/7978
CD8T,rs9306156_PRMT2,BP,GO:0006402,mRNA catabolic process,3.03e-05,2.12e-04,4/6,307/7978
CD8T,rs9306156_PRMT2,BP,GO:0006605,protein targeting,4.09e-05,2.63e-04,4/6,331/7978
CD8T,rs9306156_PRMT2,BP,GO:0006401,RNA catabolic process,4.34e-05,2.63e-04,4/6,336/7978
CD8T,rs9306156_PRMT2,BP,GO:0072657,protein localization to membrane,8.79e-05,5.00e-04,4/6,402/7978
CD8T,rs9306156_PRMT2,BP,GO:0034655,nucleobase-containing compound catabolic process,1.10e-04,5.58e-04,4/6,426/7978
CD8T,rs9306156_PRMT2,BP,GO:0072594,establishment of protein localization to organelle,1.13e-04,5.58e-04,4/6,429/7978
CD8T,rs9306156_PRMT2,BP,GO:0046700,heterocycle catabolic process,1.20e-04,5.58e-04,4/6,435/7978
CD8T,rs9306156_PRMT2,BP,GO:0044270,cellular nitrogen compound catabolic process,1.23e-04,5.58e-04,4/6,438/7978
CD8T,rs9306156_PRMT2,BP,GO:0019439,aromatic compound catabolic process,1.29e-04,5.58e-04,4/6,443/7978
CD8T,rs9306156_PRMT2,BP,GO:1901361,organic cyclic compound catabolic process,1.36e-04,5.61e-04,4/6,449/7978
CD8T,rs9306156_PRMT2,BP,GO:0042274,ribosomal small subunit biogenesis,9.90e-04,3.92e-03,2/6,66/7978
CD8T,rs9306156_PRMT2,BP,GO:0006414,translational elongation,3.08e-03,1.17e-02,2/6,117/7978
CD8T,rs9306156_PRMT2,BP,GO:1904714,regulation of chaperone-mediated autophagy,3.76e-03,1.37e-02,1/6,5/7978
CD8T,rs9306156_PRMT2,BP,GO:0006364,rRNA processing,8.44e-03,2.83e-02,2/6,196/7978
CD8T,rs9306156_PRMT2,BP,GO:0048535,lymph node development,8.99e-03,2.83e-02,1/6,12/7978
CD8T,rs9306156_PRMT2,BP,GO:0061684,chaperone-mediated autophagy,8.99e-03,2.83e-02,1/6,12/7978
CD8T,rs9306156_PRMT2,BP,GO:0016072,rRNA metabolic process,9.03e-03,2.83e-02,2/6,203/7978
CD8T,rs9306156_PRMT2,BP,GO:0000028,ribosomal small subunit assembly,1.20e-02,3.52e-02,1/6,16/7978
CD8T,rs9306156_PRMT2,BP,GO:0032735,positive regulation of interleukin-12 production,1.20e-02,3.52e-02,1/6,16/7978
CD8T,rs9306156_PRMT2,BP,GO:0042254,ribosome biogenesis,1.52e-02,4.32e-02,2/6,266/7978
CD8T,rs9306156_PRMT2,CC,GO:0022626,cytosolic ribosome,2.88e-07,1.33e-05,4/6,99/8242
CD8T,rs9306156_PRMT2,CC,GO:0044391,ribosomal subunit,2.72e-06,6.26e-05,4/6,173/8242
CD8T,rs9306156_PRMT2,CC,GO:0005840,ribosome,5.47e-06,8.38e-05,4/6,206/8242
CD8T,rs9306156_PRMT2,CC,GO:0022627,cytosolic small ribosomal subunit,4.12e-04,4.74e-03,2/6,44/8242
CD8T,rs9306156_PRMT2,CC,GO:0022625,cytosolic large ribosomal subunit,5.76e-04,5.30e-03,2/6,52/8242
CD8T,rs9306156_PRMT2,CC,GO:0015935,small ribosomal subunit,1.04e-03,8.00e-03,2/6,70/8242
CD8T,rs9306156_PRMT2,CC,GO:0015934,large ribosomal subunit,2.38e-03,1.56e-02,2/6,106/8242
CD8T,rs9306156_PRMT2,MF,GO:0003735,structural constituent of ribosome,1.52e-06,5.33e-05,4/6,149/8204
CD8T,rs9306156_PRMT2,MF,GO:0005198,structural molecule activity,2.17e-05,3.80e-04,4/6,290/8204
monocyte,rs111454690_HLA-DRB5,BP,GO:0002250,adaptive immune response,1.69e-06,8.86e-04,7/20,255/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0050832,defense response to fungus,2.19e-06,8.86e-04,3/20,11/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0006959,humoral immune response,2.74e-06,8.86e-04,5/20,94/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0032103,positive regulation of response to external stimulus,6.09e-06,1.43e-03,7/20,309/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0097529,myeloid leukocyte migration,7.40e-06,1.43e-03,5/20,115/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0030593,neutrophil chemotaxis,9.67e-06,1.43e-03,4/20,56/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0030595,leukocyte chemotaxis,1.03e-05,1.43e-03,5/20,123/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0042116,macrophage activation,1.87e-05,1.48e-03,4/20,66/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:1990266,neutrophil migration,1.87e-05,1.48e-03,4/20,66/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0071621,granulocyte chemotaxis,1.98e-05,1.48e-03,4/20,67/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002478,antigen processing and presentation of exogenous peptide antigen,2.00e-05,1.48e-03,5/20,141/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0009620,response to fungus,2.30e-05,1.48e-03,3/20,23/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0014002,astrocyte development,2.30e-05,1.48e-03,3/20,23/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0019884,antigen processing and presentation of exogenous antigen,2.37e-05,1.48e-03,5/20,146/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0048002,antigen processing and presentation of peptide antigen,2.61e-05,1.48e-03,5/20,149/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,2.64e-05,1.48e-03,4/20,72/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,2.79e-05,1.48e-03,4/20,73/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,2.94e-05,1.48e-03,4/20,74/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0060326,cell chemotaxis,2.97e-05,1.48e-03,5/20,153/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0043312,neutrophil degranulation,3.09e-05,1.48e-03,7/20,396/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002283,neutrophil activation involved in immune response,3.19e-05,1.48e-03,7/20,398/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002446,neutrophil mediated immunity,3.51e-05,1.48e-03,7/20,404/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0042119,neutrophil activation,3.51e-05,1.48e-03,7/20,404/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0036230,granulocyte activation,3.81e-05,1.48e-03,7/20,409/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0097530,granulocyte migration,3.81e-05,1.48e-03,4/20,79/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:2000772,regulation of cellular senescence,5.22e-05,1.89e-03,3/20,30/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0043299,leukocyte degranulation,5.25e-05,1.89e-03,7/20,430/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002275,myeloid cell activation involved in immune response,5.57e-05,1.93e-03,7/20,434/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0019882,antigen processing and presentation,6.14e-05,1.93e-03,5/20,178/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002444,myeloid leukocyte mediated immunity,6.35e-05,1.93e-03,7/20,443/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0001774,microglial cell activation,6.36e-05,1.93e-03,3/20,32/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002269,leukocyte activation involved in inflammatory response,6.36e-05,1.93e-03,3/20,32/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0090342,regulation of cell aging,7.65e-05,2.25e-03,3/20,34/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0061900,glial cell activation,8.35e-05,2.39e-03,3/20,35/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002523,leukocyte migration involved in inflammatory response,8.89e-05,2.40e-03,2/20,6/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0035425,autocrine signaling,8.89e-05,2.40e-03,2/20,6/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0019730,antimicrobial humoral response,1.07e-04,2.81e-03,3/20,38/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0150076,neuroinflammatory response,1.25e-04,3.20e-03,3/20,40/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0048708,astrocyte differentiation,1.35e-04,3.36e-03,3/20,41/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0032602,chemokine production,1.56e-04,3.73e-03,3/20,43/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0017014,protein nitrosylation,1.65e-04,3.73e-03,2/20,8/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0018119,peptidyl-cysteine S-nitrosylation,1.65e-04,3.73e-03,2/20,8/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0051238,sequestering of metal ion,1.65e-04,3.73e-03,2/20,8/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0071346,cellular response to interferon-gamma,2.01e-04,4.44e-03,4/20,121/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0070206,protein trimerization,2.12e-04,4.56e-03,2/20,9/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0090398,cellular senescence,2.16e-04,4.56e-03,3/20,48/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0050900,leukocyte migration,2.57e-04,5.30e-03,5/20,241/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0034341,response to interferon-gamma,3.07e-04,6.20e-03,4/20,135/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0070486,leukocyte aggregation,3.23e-04,6.41e-03,2/20,11/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0006954,inflammatory response,3.32e-04,6.45e-03,6/20,402/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0021782,glial cell development,3.80e-04,7.23e-03,3/20,58/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002544,chronic inflammatory response,3.87e-04,7.23e-03,2/20,12/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0050778,positive regulation of immune response,4.43e-04,8.12e-03,6/20,424/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:2000773,negative regulation of cellular senescence,4.57e-04,8.21e-03,2/20,13/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0006935,chemotaxis,4.65e-04,8.21e-03,5/20,274/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0042330,taxis,4.81e-04,8.34e-03,5/20,276/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002449,lymphocyte mediated immunity,4.94e-04,8.42e-03,4/20,153/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0007417,central nervous system development,5.74e-04,9.61e-03,6/20,445/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0019883,antigen processing and presentation of endogenous antigen,6.14e-04,1.01e-02,2/20,15/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0016064,immunoglobulin mediated immune response,6.33e-04,1.02e-02,3/20,69/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,6.42e-04,1.02e-02,4/20,164/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0019724,B cell mediated immunity,6.61e-04,1.02e-02,3/20,70/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0060333,interferon-gamma-mediated signaling pathway,6.61e-04,1.02e-02,3/20,70/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0090344,negative regulation of cell aging,7.00e-04,1.06e-02,2/20,16/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0010035,response to inorganic substance,7.26e-04,1.08e-02,5/20,302/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0009617,response to bacterium,8.06e-04,1.17e-02,5/20,309/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0007569,cell aging,8.09e-04,1.17e-02,3/20,75/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0001816,cytokine production,8.49e-04,1.21e-02,6/20,479/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0007568,aging,9.70e-04,1.36e-02,4/20,183/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0006882,cellular zinc ion homeostasis,9.93e-04,1.36e-02,2/20,19/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0010039,response to iron ion,9.93e-04,1.36e-02,2/20,19/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0010038,response to metal ion,1.03e-03,1.39e-02,4/20,186/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0055069,zinc ion homeostasis,1.10e-03,1.44e-02,2/20,20/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,1.10e-03,1.44e-02,2/20,20/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0050729,positive regulation of inflammatory response,1.12e-03,1.44e-02,3/20,84/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0055076,transition metal ion homeostasis,1.12e-03,1.44e-02,3/20,84/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002455,humoral immune response mediated by circulating immunoglobulin,1.34e-03,1.68e-02,2/20,22/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002237,response to molecule of bacterial origin,1.35e-03,1.68e-02,4/20,200/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0046456,icosanoid biosynthetic process,1.73e-03,2.12e-02,2/20,25/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0042742,defense response to bacterium,1.76e-03,2.13e-02,3/20,98/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0007159,leukocyte cell-cell adhesion,1.79e-03,2.15e-02,4/20,216/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0018198,peptidyl-cysteine modification,1.87e-03,2.21e-02,2/20,26/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0006636,unsaturated fatty acid biosynthetic process,2.01e-03,2.34e-02,2/20,27/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0010001,glial cell differentiation,2.03e-03,2.34e-02,3/20,103/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0051092,positive regulation of NF-kappaB transcription factor activity,2.32e-03,2.65e-02,3/20,108/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0031349,positive regulation of defense response,2.48e-03,2.80e-02,4/20,236/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0009636,response to toxic substance,2.57e-03,2.87e-02,3/20,112/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002548,monocyte chemotaxis,2.83e-03,3.12e-02,2/20,32/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0051651,maintenance of location in cell,3.06e-03,3.30e-02,3/20,119/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:2001242,regulation of intrinsic apoptotic signaling pathway,3.06e-03,3.30e-02,3/20,119/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0051093,negative regulation of developmental process,3.12e-03,3.30e-02,5/20,419/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0051259,protein complex oligomerization,3.13e-03,3.30e-02,3/20,120/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0048678,response to axon injury,3.19e-03,3.33e-02,2/20,34/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002720,positive regulation of cytokine production involved in immune response,3.77e-03,3.89e-02,2/20,37/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0002440,production of molecular mediator of immune response,4.10e-03,4.19e-02,3/20,132/7986
monocyte,rs111454690_HLA-DRB5,BP,GO:0033993,response to lipid,4.72e-03,4.77e-02,5/20,461/7986
monocyte,rs111454690_HLA-DRB5,CC,GO:0042611,MHC protein complex,5.63e-10,6.59e-08,5/20,19/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0042613,MHC class II protein complex,1.24e-08,7.27e-07,4/20,12/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0012507,ER to Golgi transport vesicle membrane,4.24e-06,1.65e-04,4/20,47/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0034774,secretory granule lumen,1.16e-05,2.32e-04,6/20,227/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0031983,vesicle lumen,1.19e-05,2.32e-04,6/20,228/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0060205,cytoplasmic vesicle lumen,1.19e-05,2.32e-04,6/20,228/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0071556,integral component of lumenal side of endoplasmic reticulum membrane,1.59e-05,2.33e-04,3/20,21/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0098553,lumenal side of endoplasmic reticulum membrane,1.59e-05,2.33e-04,3/20,21/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0030134,COPII-coated ER to Golgi transport vesicle,1.99e-05,2.47e-04,4/20,69/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0030669,clathrin-coated endocytic vesicle membrane,2.11e-05,2.47e-04,3/20,23/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0098576,lumenal side of membrane,2.73e-05,2.91e-04,3/20,25/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0030660,Golgi-associated vesicle membrane,3.40e-05,3.31e-04,4/20,79/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0062023,collagen-containing extracellular matrix,5.68e-05,4.87e-04,4/20,90/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0045334,clathrin-coated endocytic vesicle,5.83e-05,4.87e-04,3/20,32/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0000323,lytic vacuole,8.78e-05,5.80e-04,7/20,480/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0005764,lysosome,8.78e-05,5.80e-04,7/20,480/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0030139,endocytic vesicle,8.87e-05,5.80e-04,5/20,198/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0030666,endocytic vesicle membrane,8.92e-05,5.80e-04,4/20,101/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0030176,integral component of endoplasmic reticulum membrane,1.16e-04,6.53e-04,4/20,108/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0030658,transport vesicle membrane,1.16e-04,6.53e-04,4/20,108/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0098797,plasma membrane protein complex,1.17e-04,6.53e-04,5/20,210/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0031012,extracellular matrix,1.29e-04,6.78e-04,4/20,111/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0031227,intrinsic component of endoplasmic reticulum membrane,1.33e-04,6.78e-04,4/20,112/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0030662,coated vesicle membrane,1.48e-04,7.20e-04,4/20,115/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0005798,Golgi-associated vesicle,2.04e-04,9.54e-04,4/20,125/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0098552,side of membrane,3.67e-04,1.61e-03,5/20,268/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0032588,trans-Golgi network membrane,3.85e-04,1.61e-03,3/20,60/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0005765,lysosomal membrane,3.99e-04,1.61e-03,5/20,273/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0098852,lytic vacuole membrane,3.99e-04,1.61e-03,5/20,273/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0030665,clathrin-coated vesicle membrane,4.66e-04,1.82e-03,3/20,64/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0005774,vacuolar membrane,7.26e-04,2.74e-03,5/20,311/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0030135,coated vesicle,1.04e-03,3.80e-03,4/20,192/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0030133,transport vesicle,1.69e-03,6.00e-03,4/20,219/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0031301,integral component of organelle membrane,2.44e-03,8.32e-03,4/20,242/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0030136,clathrin-coated vesicle,2.49e-03,8.32e-03,3/20,114/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0005788,endoplasmic reticulum lumen,2.68e-03,8.71e-03,3/20,117/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0005771,multivesicular body,3.01e-03,9.29e-03,2/20,34/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0001726,ruffle,3.02e-03,9.29e-03,3/20,122/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0031300,intrinsic component of organelle membrane,3.17e-03,9.50e-03,4/20,260/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:1904724,tertiary granule lumen,4.56e-03,1.33e-02,2/20,42/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0005802,trans-Golgi network,5.50e-03,1.57e-02,3/20,151/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0043202,lysosomal lumen,7.19e-03,2.00e-02,2/20,53/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0010008,endosome membrane,8.21e-03,2.23e-02,4/20,340/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0032587,ruffle membrane,9.14e-03,2.43e-02,2/20,60/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0005770,late endosome,1.10e-02,2.85e-02,3/20,194/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0070937,CRD-mediated mRNA stability complex,1.21e-02,3.01e-02,1/20,5/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0071204,histone pre-mRNA 3'end processing complex,1.21e-02,3.01e-02,1/20,5/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0031965,nuclear membrane,1.27e-02,3.10e-02,3/20,205/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0042824,MHC class I peptide loading complex,1.45e-02,3.46e-02,1/20,6/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0098791,Golgi apparatus subcompartment,1.54e-02,3.60e-02,3/20,220/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0031256,leading edge membrane,1.58e-02,3.63e-02,2/20,80/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0042612,MHC class I protein complex,1.69e-02,3.73e-02,1/20,7/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:1990124,messenger ribonucleoprotein complex,1.69e-02,3.73e-02,1/20,7/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0031984,organelle subcompartment,1.92e-02,4.15e-02,3/20,239/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0031252,cell leading edge,1.98e-02,4.21e-02,3/20,242/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0015629,actin cytoskeleton,2.25e-02,4.70e-02,3/20,254/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0030659,cytoplasmic vesicle membrane,2.32e-02,4.72e-02,4/20,462/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0000139,Golgi membrane,2.34e-02,4.72e-02,4/20,463/8226
monocyte,rs111454690_HLA-DRB5,CC,GO:0005581,collagen trimer,2.41e-02,4.77e-02,1/20,10/8226
monocyte,rs111454690_HLA-DRB5,MF,GO:0036041,long-chain fatty acid binding,4.32e-07,4.49e-05,3/20,7/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0050786,RAGE receptor binding,1.47e-06,7.67e-05,3/20,10/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0005504,fatty acid binding,5.55e-06,1.92e-04,3/20,15/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:1901567,fatty acid derivative binding,9.90e-06,2.57e-04,3/20,18/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0042277,peptide binding,1.77e-05,3.67e-04,5/20,141/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0033293,monocarboxylic acid binding,2.13e-05,3.70e-04,3/20,23/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0033218,amide binding,5.58e-05,8.28e-04,5/20,179/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0001540,amyloid-beta binding,7.73e-05,1.01e-03,3/20,35/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0048306,calcium-dependent protein binding,1.16e-04,1.23e-03,3/20,40/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0032395,MHC class II receptor activity,1.18e-04,1.23e-03,2/20,7/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0003785,actin monomer binding,3.07e-04,2.66e-03,2/20,11/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0035325,Toll-like receptor binding,3.07e-04,2.66e-03,2/20,11/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0140375,immune receptor activity,4.28e-04,3.43e-03,3/20,62/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0023026,MHC class II protein complex binding,5.06e-04,3.76e-03,2/20,14/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0042605,peptide antigen binding,6.65e-04,4.61e-03,2/20,16/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0031406,carboxylic acid binding,7.79e-04,5.07e-03,3/20,76/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0043177,organic acid binding,9.05e-04,5.45e-03,3/20,80/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0023023,MHC protein complex binding,9.43e-04,5.45e-03,2/20,19/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0005509,calcium ion binding,1.60e-03,8.77e-03,4/20,215/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0003823,antigen binding,3.58e-03,1.86e-02,2/20,37/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0016209,antioxidant activity,4.81e-03,2.38e-02,2/20,43/8198
monocyte,rs111454690_HLA-DRB5,MF,GO:0008092,cytoskeletal protein binding,5.57e-03,2.63e-02,5/20,492/8198
monocyte,rs1131017_RPS26,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,2.35e-130,4.15e-127,75/125,92/7986
monocyte,rs1131017_RPS26,BP,GO:0006613,cotranslational protein targeting to membrane,1.27e-127,1.12e-124,75/125,96/7986
monocyte,rs1131017_RPS26,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",2.23e-122,1.12e-119,77/125,115/7986
monocyte,rs1131017_RPS26,BP,GO:0045047,protein targeting to ER,2.53e-122,1.12e-119,75/125,105/7986
monocyte,rs1131017_RPS26,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,9.28e-121,3.28e-118,75/125,108/7986
monocyte,rs1131017_RPS26,BP,GO:0070972,protein localization to endoplasmic reticulum,1.15e-111,3.38e-109,75/125,129/7986
monocyte,rs1131017_RPS26,BP,GO:0006413,translational initiation,1.69e-110,4.27e-108,81/125,176/7986
monocyte,rs1131017_RPS26,BP,GO:0006612,protein targeting to membrane,2.78e-104,6.15e-102,76/125,159/7986
monocyte,rs1131017_RPS26,BP,GO:0019083,viral transcription,9.10e-100,1.78e-97,75/125,168/7986
monocyte,rs1131017_RPS26,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,6.56e-99,1.16e-96,77/125,189/7986
monocyte,rs1131017_RPS26,BP,GO:0019080,viral gene expression,5.37e-98,8.62e-96,76/125,184/7986
monocyte,rs1131017_RPS26,BP,GO:0090150,establishment of protein localization to membrane,1.06e-85,1.57e-83,76/125,250/7986
monocyte,rs1131017_RPS26,BP,GO:0006402,mRNA catabolic process,2.06e-80,2.80e-78,78/125,315/7986
monocyte,rs1131017_RPS26,BP,GO:0006401,RNA catabolic process,9.03e-79,1.14e-76,79/125,344/7986
monocyte,rs1131017_RPS26,BP,GO:0006605,protein targeting,2.10e-76,2.48e-74,77/125,335/7986
monocyte,rs1131017_RPS26,BP,GO:0034655,nucleobase-containing compound catabolic process,6.42e-72,7.09e-70,80/125,431/7986
monocyte,rs1131017_RPS26,BP,GO:0046700,heterocycle catabolic process,1.46e-70,1.51e-68,80/125,447/7986
monocyte,rs1131017_RPS26,BP,GO:0044270,cellular nitrogen compound catabolic process,2.58e-70,2.53e-68,80/125,450/7986
monocyte,rs1131017_RPS26,BP,GO:0019439,aromatic compound catabolic process,3.76e-70,3.49e-68,80/125,452/7986
monocyte,rs1131017_RPS26,BP,GO:1901361,organic cyclic compound catabolic process,2.42e-69,2.14e-67,80/125,462/7986
monocyte,rs1131017_RPS26,BP,GO:0072657,protein localization to membrane,3.95e-69,3.32e-67,77/125,409/7986
monocyte,rs1131017_RPS26,BP,GO:0072594,establishment of protein localization to organelle,5.20e-67,4.17e-65,77/125,434/7986
monocyte,rs1131017_RPS26,BP,GO:0002181,cytoplasmic translation,6.34e-43,4.87e-41,36/125,91/7986
monocyte,rs1131017_RPS26,BP,GO:0022613,ribonucleoprotein complex biogenesis,2.62e-23,1.93e-21,40/125,377/7986
monocyte,rs1131017_RPS26,BP,GO:0042254,ribosome biogenesis,1.10e-22,7.79e-21,34/125,260/7986
monocyte,rs1131017_RPS26,BP,GO:0042255,ribosome assembly,5.48e-20,3.72e-18,18/125,54/7986
monocyte,rs1131017_RPS26,BP,GO:0022618,ribonucleoprotein complex assembly,4.92e-17,3.14e-15,24/125,167/7986
monocyte,rs1131017_RPS26,BP,GO:0042273,ribosomal large subunit biogenesis,4.97e-17,3.14e-15,17/125,64/7986
monocyte,rs1131017_RPS26,BP,GO:0071826,ribonucleoprotein complex subunit organization,1.13e-16,6.91e-15,24/125,173/7986
monocyte,rs1131017_RPS26,BP,GO:0006364,rRNA processing,1.40e-14,8.23e-13,23/125,192/7986
monocyte,rs1131017_RPS26,BP,GO:0016072,rRNA metabolic process,2.75e-14,1.56e-12,23/125,198/7986
monocyte,rs1131017_RPS26,BP,GO:0042274,ribosomal small subunit biogenesis,4.84e-14,2.67e-12,15/125,66/7986
monocyte,rs1131017_RPS26,BP,GO:0000027,ribosomal large subunit assembly,1.00e-12,5.35e-11,10/125,24/7986
monocyte,rs1131017_RPS26,BP,GO:0000028,ribosomal small subunit assembly,1.82e-12,9.46e-11,9/125,18/7986
monocyte,rs1131017_RPS26,BP,GO:0034470,ncRNA processing,3.73e-10,1.88e-08,23/125,312/7986
monocyte,rs1131017_RPS26,BP,GO:0034660,ncRNA metabolic process,4.66e-09,2.29e-07,23/125,355/7986
monocyte,rs1131017_RPS26,BP,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,4.22e-07,2.02e-05,6/125,20/7986
monocyte,rs1131017_RPS26,BP,GO:0006417,regulation of translation,5.63e-07,2.62e-05,18/125,292/7986
monocyte,rs1131017_RPS26,BP,GO:1904667,negative regulation of ubiquitin protein ligase activity,8.38e-07,3.79e-05,4/125,6/7986
monocyte,rs1131017_RPS26,BP,GO:0001732,formation of cytoplasmic translation initiation complex,2.30e-06,1.01e-04,5/125,15/7986
monocyte,rs1131017_RPS26,BP,GO:0034248,regulation of cellular amide metabolic process,3.30e-06,1.42e-04,18/125,330/7986
monocyte,rs1131017_RPS26,BP,GO:0002183,cytoplasmic translational initiation,1.02e-05,4.30e-04,6/125,33/7986
monocyte,rs1131017_RPS26,BP,GO:0019730,antimicrobial humoral response,2.39e-05,9.81e-04,6/125,38/7986
monocyte,rs1131017_RPS26,BP,GO:0051444,negative regulation of ubiquitin-protein transferase activity,3.67e-05,1.47e-03,4/125,13/7986
monocyte,rs1131017_RPS26,BP,GO:0070925,organelle assembly,4.67e-05,1.83e-03,20/125,478/7986
monocyte,rs1131017_RPS26,BP,GO:0010608,posttranscriptional regulation of gene expression,5.11e-05,1.95e-03,20/125,481/7986
monocyte,rs1131017_RPS26,BP,GO:0045727,positive regulation of translation,5.19e-05,1.95e-03,9/125,110/7986
monocyte,rs1131017_RPS26,BP,GO:0030490,maturation of SSU-rRNA,5.66e-05,2.08e-03,6/125,44/7986
monocyte,rs1131017_RPS26,BP,GO:1904666,regulation of ubiquitin protein ligase activity,9.00e-05,3.24e-03,4/125,16/7986
monocyte,rs1131017_RPS26,BP,GO:1901798,positive regulation of signal transduction by p53 class mediator,1.16e-04,4.11e-03,4/125,17/7986
monocyte,rs1131017_RPS26,BP,GO:0000462,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",1.24e-04,4.31e-03,5/125,32/7986
monocyte,rs1131017_RPS26,BP,GO:0031640,killing of cells of other organism,1.48e-04,5.02e-03,4/125,18/7986
monocyte,rs1131017_RPS26,BP,GO:0034250,positive regulation of cellular amide metabolic process,1.68e-04,5.61e-03,9/125,128/7986
monocyte,rs1131017_RPS26,BP,GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,3.36e-04,1.10e-02,4/125,22/7986
monocyte,rs1131017_RPS26,BP,GO:0051438,regulation of ubiquitin-protein transferase activity,4.64e-04,1.49e-02,5/125,42/7986
monocyte,rs1131017_RPS26,BP,GO:0000470,maturation of LSU-rRNA,4.77e-04,1.50e-02,4/125,24/7986
monocyte,rs1131017_RPS26,BP,GO:2001242,regulation of intrinsic apoptotic signaling pathway,5.29e-04,1.64e-02,8/125,119/7986
monocyte,rs1131017_RPS26,BP,GO:0006959,humoral immune response,6.45e-04,1.96e-02,7/125,94/7986
monocyte,rs1131017_RPS26,BP,GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,7.60e-04,2.27e-02,4/125,27/7986
monocyte,rs1131017_RPS26,CC,GO:0022626,cytosolic ribosome,1.02e-125,2.19e-123,75/126,100/8226
monocyte,rs1131017_RPS26,CC,GO:0044391,ribosomal subunit,7.37e-99,7.89e-97,75/126,174/8226
monocyte,rs1131017_RPS26,CC,GO:0005840,ribosome,1.10e-97,7.81e-96,78/126,207/8226
monocyte,rs1131017_RPS26,CC,GO:0022625,cytosolic large ribosomal subunit,4.32e-80,2.31e-78,46/126,53/8226
monocyte,rs1131017_RPS26,CC,GO:0015934,large ribosomal subunit,7.30e-58,3.12e-56,46/126,107/8226
monocyte,rs1131017_RPS26,CC,GO:0022627,cytosolic small ribosomal subunit,8.66e-46,3.09e-44,30/126,44/8226
monocyte,rs1131017_RPS26,CC,GO:0042788,polysomal ribosome,6.69e-39,2.05e-37,24/126,31/8226
monocyte,rs1131017_RPS26,CC,GO:0015935,small ribosomal subunit,3.10e-37,8.28e-36,30/126,70/8226
monocyte,rs1131017_RPS26,CC,GO:0005844,polysome,5.48e-34,1.30e-32,27/126,61/8226
monocyte,rs1131017_RPS26,CC,GO:0005925,focal adhesion,5.48e-32,1.17e-30,43/126,285/8226
monocyte,rs1131017_RPS26,CC,GO:0030055,cell-substrate junction,6.39e-32,1.24e-30,43/126,286/8226
monocyte,rs1131017_RPS26,CC,GO:0070161,anchoring junction,1.32e-26,2.36e-25,45/126,428/8226
monocyte,rs1131017_RPS26,CC,GO:0014069,postsynaptic density,5.10e-14,8.40e-13,20/126,147/8226
monocyte,rs1131017_RPS26,CC,GO:0032279,asymmetric synapse,6.65e-14,1.02e-12,20/126,149/8226
monocyte,rs1131017_RPS26,CC,GO:0098984,neuron to neuron synapse,1.11e-13,1.49e-12,20/126,153/8226
monocyte,rs1131017_RPS26,CC,GO:0099572,postsynaptic specialization,1.11e-13,1.49e-12,20/126,153/8226
monocyte,rs1131017_RPS26,CC,GO:0098794,postsynapse,3.01e-09,3.79e-08,20/126,266/8226
monocyte,rs1131017_RPS26,CC,GO:0033290,eukaryotic 48S preinitiation complex,1.40e-06,1.66e-05,5/126,14/8226
monocyte,rs1131017_RPS26,CC,GO:0005791,rough endoplasmic reticulum,1.61e-06,1.82e-05,8/126,55/8226
monocyte,rs1131017_RPS26,CC,GO:0005852,eukaryotic translation initiation factor 3 complex,2.97e-06,3.03e-05,5/126,16/8226
monocyte,rs1131017_RPS26,CC,GO:0016282,eukaryotic 43S preinitiation complex,2.97e-06,3.03e-05,5/126,16/8226
monocyte,rs1131017_RPS26,CC,GO:0070993,translation preinitiation complex,4.16e-06,4.04e-05,5/126,17/8226
monocyte,rs1131017_RPS26,CC,GO:0042613,MHC class II protein complex,2.36e-05,2.20e-04,4/126,12/8226
monocyte,rs1131017_RPS26,CC,GO:0042611,MHC protein complex,1.70e-04,1.52e-03,4/126,19/8226
monocyte,rs1131017_RPS26,CC,GO:0071556,integral component of lumenal side of endoplasmic reticulum membrane,2.57e-04,2.11e-03,4/126,21/8226
monocyte,rs1131017_RPS26,CC,GO:0098553,lumenal side of endoplasmic reticulum membrane,2.57e-04,2.11e-03,4/126,21/8226
monocyte,rs1131017_RPS26,CC,GO:0030669,clathrin-coated endocytic vesicle membrane,3.71e-04,2.94e-03,4/126,23/8226
monocyte,rs1131017_RPS26,CC,GO:0098576,lumenal side of membrane,5.17e-04,3.91e-03,4/126,25/8226
monocyte,rs1131017_RPS26,CC,GO:0098554,cytoplasmic side of endoplasmic reticulum membrane,5.29e-04,3.91e-03,3/126,11/8226
monocyte,rs1131017_RPS26,CC,GO:0030666,endocytic vesicle membrane,8.74e-04,6.23e-03,7/126,101/8226
monocyte,rs1131017_RPS26,CC,GO:0045334,clathrin-coated endocytic vesicle,1.35e-03,9.35e-03,4/126,32/8226
monocyte,rs1131017_RPS26,CC,GO:0032588,trans-Golgi network membrane,2.17e-03,1.45e-02,5/126,60/8226
monocyte,rs1131017_RPS26,CC,GO:0030665,clathrin-coated vesicle membrane,2.88e-03,1.87e-02,5/126,64/8226
monocyte,rs1131017_RPS26,CC,GO:0030139,endocytic vesicle,3.29e-03,2.07e-02,9/126,198/8226
monocyte,rs1131017_RPS26,CC,GO:0030867,rough endoplasmic reticulum membrane,3.81e-03,2.33e-02,3/126,21/8226
monocyte,rs1131017_RPS26,CC,GO:0071541,"eukaryotic translation initiation factor 3 complex, eIF3m",4.65e-03,2.76e-02,2/126,7/8226
monocyte,rs1131017_RPS26,CC,GO:0012507,ER to Golgi transport vesicle membrane,5.63e-03,3.26e-02,4/126,47/8226
monocyte,rs1131017_RPS26,CC,GO:0030660,Golgi-associated vesicle membrane,7.11e-03,4.00e-02,5/126,79/8226
monocyte,rs1131017_RPS26,MF,GO:0003735,structural constituent of ribosome,3.07e-106,7.83e-104,75/124,149/8198
monocyte,rs1131017_RPS26,MF,GO:0005198,structural molecule activity,4.42e-84,5.64e-82,78/124,296/8198
monocyte,rs1131017_RPS26,MF,GO:0019843,rRNA binding,1.67e-21,1.42e-19,19/124,56/8198
monocyte,rs1131017_RPS26,MF,GO:0048027,mRNA 5'-UTR binding,1.49e-08,9.50e-07,7/124,21/8198
monocyte,rs1131017_RPS26,MF,GO:0045182,translation regulator activity,6.86e-08,3.50e-06,12/124,108/8198
monocyte,rs1131017_RPS26,MF,GO:1990948,ubiquitin ligase inhibitor activity,2.46e-07,1.05e-05,4/124,5/8198
monocyte,rs1131017_RPS26,MF,GO:0055105,ubiquitin-protein transferase inhibitor activity,7.31e-07,2.53e-05,4/124,6/8198
monocyte,rs1131017_RPS26,MF,GO:0003729,mRNA binding,7.93e-07,2.53e-05,15/124,216/8198
monocyte,rs1131017_RPS26,MF,GO:0090079,"translation regulator activity, nucleic acid binding",5.35e-06,1.51e-04,9/124,86/8198
monocyte,rs1131017_RPS26,MF,GO:0008097,5S rRNA binding,9.76e-06,2.49e-04,4/124,10/8198
monocyte,rs1131017_RPS26,MF,GO:0008135,"translation factor activity, RNA binding",1.43e-05,3.31e-04,8/124,74/8198
monocyte,rs1131017_RPS26,MF,GO:0055106,ubiquitin-protein transferase regulator activity,4.44e-05,9.43e-04,4/124,14/8198
monocyte,rs1131017_RPS26,MF,GO:0045296,cadherin binding,1.07e-04,2.09e-03,12/124,218/8198
monocyte,rs1131017_RPS26,MF,GO:0050839,cell adhesion molecule binding,3.68e-04,6.38e-03,13/124,286/8198
monocyte,rs1131017_RPS26,MF,GO:0070181,small ribosomal subunit rRNA binding,3.75e-04,6.38e-03,3/124,10/8198
monocyte,rs1131017_RPS26,MF,GO:0003743,translation initiation factor activity,7.43e-04,1.18e-02,5/124,48/8198
monocyte,rs1131017_RPS26,MF,GO:0003746,translation elongation factor activity,1.64e-03,2.32e-02,3/124,16/8198
monocyte,rs1131017_RPS26,MF,GO:0042605,peptide antigen binding,1.64e-03,2.32e-02,3/124,16/8198
monocyte,rs1131017_RPS26,MF,GO:0003823,antigen binding,2.24e-03,3.00e-02,4/124,37/8198
monocyte,rs11577318_CD52,MF,GO:0019864,IgG binding,5.84e-03,3.19e-02,1/6,8/8198
monocyte,rs11577318_CD52,MF,GO:0033691,sialic acid binding,5.84e-03,3.19e-02,1/6,8/8198
monocyte,rs11577318_CD52,MF,GO:0050786,RAGE receptor binding,7.30e-03,3.19e-02,1/6,10/8198
monocyte,rs11577318_CD52,MF,GO:0003779,actin binding,9.32e-03,3.19e-02,2/6,212/8198
monocyte,rs11577318_CD52,MF,GO:0019865,immunoglobulin binding,9.48e-03,3.19e-02,1/6,13/8198
monocyte,rs11577318_CD52,MF,GO:0005509,calcium ion binding,9.58e-03,3.19e-02,2/6,215/8198
monocyte,rs3758833_CTSC,BP,GO:0019730,antimicrobial humoral response,7.81e-09,6.78e-06,5/16,38/7986
monocyte,rs3758833_CTSC,BP,GO:0006959,humoral immune response,8.00e-07,2.34e-04,5/16,94/7986
monocyte,rs3758833_CTSC,BP,GO:0042742,defense response to bacterium,9.86e-07,2.34e-04,5/16,98/7986
monocyte,rs3758833_CTSC,BP,GO:0050832,defense response to fungus,1.08e-06,2.34e-04,3/16,11/7986
monocyte,rs3758833_CTSC,BP,GO:0097529,myeloid leukocyte migration,2.18e-06,3.79e-04,5/16,115/7986
monocyte,rs3758833_CTSC,BP,GO:0030595,leukocyte chemotaxis,3.05e-06,4.41e-04,5/16,123/7986
monocyte,rs3758833_CTSC,BP,GO:0031640,killing of cells of other organism,5.29e-06,6.56e-04,3/16,18/7986
monocyte,rs3758833_CTSC,BP,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,7.37e-06,7.62e-04,3/16,20/7986
monocyte,rs3758833_CTSC,BP,GO:0060326,cell chemotaxis,8.91e-06,7.62e-04,5/16,153/7986
monocyte,rs3758833_CTSC,BP,GO:0006935,chemotaxis,9.26e-06,7.62e-04,6/16,274/7986
monocyte,rs3758833_CTSC,BP,GO:0042330,taxis,9.65e-06,7.62e-04,6/16,276/7986
monocyte,rs3758833_CTSC,BP,GO:0009620,response to fungus,1.14e-05,8.25e-04,3/16,23/7986
monocyte,rs3758833_CTSC,BP,GO:0050729,positive regulation of inflammatory response,1.88e-05,1.26e-03,4/16,84/7986
monocyte,rs3758833_CTSC,BP,GO:0002523,leukocyte migration involved in inflammatory response,5.62e-05,3.25e-03,2/16,6/7986
monocyte,rs3758833_CTSC,BP,GO:0035425,autocrine signaling,5.62e-05,3.25e-03,2/16,6/7986
monocyte,rs3758833_CTSC,BP,GO:0050900,leukocyte migration,7.99e-05,4.33e-03,5/16,241/7986
monocyte,rs3758833_CTSC,BP,GO:0017014,protein nitrosylation,1.05e-04,4.69e-03,2/16,8/7986
monocyte,rs3758833_CTSC,BP,GO:0018119,peptidyl-cysteine S-nitrosylation,1.05e-04,4.69e-03,2/16,8/7986
monocyte,rs3758833_CTSC,BP,GO:0051238,sequestering of metal ion,1.05e-04,4.69e-03,2/16,8/7986
monocyte,rs3758833_CTSC,BP,GO:2001235,positive regulation of apoptotic signaling pathway,1.08e-04,4.69e-03,4/16,131/7986
monocyte,rs3758833_CTSC,BP,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,1.48e-04,6.10e-03,4/16,142/7986
monocyte,rs3758833_CTSC,BP,GO:0030593,neutrophil chemotaxis,1.71e-04,6.76e-03,3/16,56/7986
monocyte,rs3758833_CTSC,BP,GO:0070486,leukocyte aggregation,2.05e-04,7.37e-03,2/16,11/7986
monocyte,rs3758833_CTSC,BP,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,2.11e-04,7.37e-03,3/16,60/7986
monocyte,rs3758833_CTSC,BP,GO:2000116,regulation of cysteine-type endopeptidase activity,2.12e-04,7.37e-03,4/16,156/7986
monocyte,rs3758833_CTSC,BP,GO:0051091,positive regulation of DNA-binding transcription factor activity,2.45e-04,7.72e-03,4/16,162/7986
monocyte,rs3758833_CTSC,BP,GO:0002544,chronic inflammatory response,2.46e-04,7.72e-03,2/16,12/7986
monocyte,rs3758833_CTSC,BP,GO:0009617,response to bacterium,2.58e-04,7.72e-03,5/16,309/7986
monocyte,rs3758833_CTSC,BP,GO:0032103,positive regulation of response to external stimulus,2.58e-04,7.72e-03,5/16,309/7986
monocyte,rs3758833_CTSC,BP,GO:1990266,neutrophil migration,2.80e-04,8.09e-03,3/16,66/7986
monocyte,rs3758833_CTSC,BP,GO:0071621,granulocyte chemotaxis,2.92e-04,8.19e-03,3/16,67/7986
monocyte,rs3758833_CTSC,BP,GO:2000179,positive regulation of neural precursor cell proliferation,3.38e-04,9.16e-03,2/16,14/7986
monocyte,rs3758833_CTSC,BP,GO:0001906,cell killing,4.24e-04,1.12e-02,3/16,76/7986
monocyte,rs3758833_CTSC,BP,GO:0097530,granulocyte migration,4.76e-04,1.21e-02,3/16,79/7986
monocyte,rs3758833_CTSC,BP,GO:0050727,regulation of inflammatory response,5.80e-04,1.44e-02,4/16,203/7986
monocyte,rs3758833_CTSC,BP,GO:0006882,cellular zinc ion homeostasis,6.31e-04,1.48e-02,2/16,19/7986
monocyte,rs3758833_CTSC,BP,GO:0030307,positive regulation of cell growth,6.31e-04,1.48e-02,3/16,87/7986
monocyte,rs3758833_CTSC,BP,GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,6.97e-04,1.54e-02,3/16,90/7986
monocyte,rs3758833_CTSC,BP,GO:0055069,zinc ion homeostasis,7.00e-04,1.54e-02,2/16,20/7986
monocyte,rs3758833_CTSC,BP,GO:0052548,regulation of endopeptidase activity,7.08e-04,1.54e-02,4/16,214/7986
monocyte,rs3758833_CTSC,BP,GO:0043312,neutrophil degranulation,8.10e-04,1.61e-02,5/16,396/7986
monocyte,rs3758833_CTSC,BP,GO:0002283,neutrophil activation involved in immune response,8.29e-04,1.61e-02,5/16,398/7986
monocyte,rs3758833_CTSC,BP,GO:0052547,regulation of peptidase activity,8.41e-04,1.61e-02,4/16,224/7986
monocyte,rs3758833_CTSC,BP,GO:0006954,inflammatory response,8.68e-04,1.61e-02,5/16,402/7986
monocyte,rs3758833_CTSC,BP,GO:0002446,neutrophil mediated immunity,8.88e-04,1.61e-02,5/16,404/7986
monocyte,rs3758833_CTSC,BP,GO:0042119,neutrophil activation,8.88e-04,1.61e-02,5/16,404/7986
monocyte,rs3758833_CTSC,BP,GO:0014002,astrocyte development,9.29e-04,1.61e-02,2/16,23/7986
monocyte,rs3758833_CTSC,BP,GO:0050829,defense response to Gram-negative bacterium,9.29e-04,1.61e-02,2/16,23/7986
monocyte,rs3758833_CTSC,BP,GO:0090200,positive regulation of release of cytochrome c from mitochondria,9.29e-04,1.61e-02,2/16,23/7986
monocyte,rs3758833_CTSC,BP,GO:0036230,granulocyte activation,9.39e-04,1.61e-02,5/16,409/7986
monocyte,rs3758833_CTSC,BP,GO:2001056,positive regulation of cysteine-type endopeptidase activity,9.48e-04,1.61e-02,3/16,100/7986
monocyte,rs3758833_CTSC,BP,GO:0031349,positive regulation of defense response,1.02e-03,1.71e-02,4/16,236/7986
monocyte,rs3758833_CTSC,BP,GO:0010638,positive regulation of organelle organization,1.06e-03,1.73e-02,5/16,420/7986
monocyte,rs3758833_CTSC,BP,GO:0043299,leukocyte degranulation,1.18e-03,1.84e-02,5/16,430/7986
monocyte,rs3758833_CTSC,BP,GO:0051092,positive regulation of NF-kappaB transcription factor activity,1.18e-03,1.84e-02,3/16,108/7986
monocyte,rs3758833_CTSC,BP,GO:0018198,peptidyl-cysteine modification,1.19e-03,1.84e-02,2/16,26/7986
monocyte,rs3758833_CTSC,BP,GO:0002275,myeloid cell activation involved in immune response,1.23e-03,1.87e-02,5/16,434/7986
monocyte,rs3758833_CTSC,BP,GO:0002444,myeloid leukocyte mediated immunity,1.35e-03,2.02e-02,5/16,443/7986
monocyte,rs3758833_CTSC,BP,GO:0010950,positive regulation of endopeptidase activity,1.39e-03,2.04e-02,3/16,114/7986
monocyte,rs3758833_CTSC,BP,GO:0051090,regulation of DNA-binding transcription factor activity,1.47e-03,2.12e-02,4/16,260/7986
monocyte,rs3758833_CTSC,BP,GO:2001242,regulation of intrinsic apoptotic signaling pathway,1.57e-03,2.21e-02,3/16,119/7986
monocyte,rs3758833_CTSC,BP,GO:0051781,positive regulation of cell division,1.58e-03,2.21e-02,2/16,30/7986
monocyte,rs3758833_CTSC,BP,GO:0045927,positive regulation of growth,1.61e-03,2.21e-02,3/16,120/7986
monocyte,rs3758833_CTSC,BP,GO:2000177,regulation of neural precursor cell proliferation,1.69e-03,2.29e-02,2/16,31/7986
monocyte,rs3758833_CTSC,BP,GO:0010952,positive regulation of peptidase activity,1.72e-03,2.30e-02,3/16,123/7986
monocyte,rs3758833_CTSC,BP,GO:0002548,monocyte chemotaxis,1.80e-03,2.37e-02,2/16,32/7986
monocyte,rs3758833_CTSC,BP,GO:2001233,regulation of apoptotic signaling pathway,1.88e-03,2.43e-02,4/16,278/7986
monocyte,rs3758833_CTSC,BP,GO:0051493,regulation of cytoskeleton organization,2.51e-03,3.19e-02,4/16,301/7986
monocyte,rs3758833_CTSC,BP,GO:0090199,regulation of release of cytochrome c from mitochondria,2.54e-03,3.19e-02,2/16,38/7986
monocyte,rs3758833_CTSC,BP,GO:0048708,astrocyte differentiation,2.95e-03,3.66e-02,2/16,41/7986
monocyte,rs3758833_CTSC,BP,GO:0032602,chemokine production,3.24e-03,3.96e-02,2/16,43/7986
monocyte,rs3758833_CTSC,BP,GO:0001836,release of cytochrome c from mitochondria,3.54e-03,4.21e-02,2/16,45/7986
monocyte,rs3758833_CTSC,BP,GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,3.54e-03,4.21e-02,2/16,45/7986
monocyte,rs3758833_CTSC,BP,GO:0071674,mononuclear cell migration,3.70e-03,4.34e-02,2/16,46/7986
monocyte,rs3758833_CTSC,CC,GO:0034774,secretory granule lumen,5.22e-05,1.60e-03,5/16,227/8226
monocyte,rs3758833_CTSC,CC,GO:0031983,vesicle lumen,5.33e-05,1.60e-03,5/16,228/8226
monocyte,rs3758833_CTSC,CC,GO:0060205,cytoplasmic vesicle lumen,5.33e-05,1.60e-03,5/16,228/8226
monocyte,rs3758833_CTSC,CC,GO:0031012,extracellular matrix,1.18e-03,2.65e-02,3/16,111/8226
monocyte,rs3758833_CTSC,MF,GO:0050786,RAGE receptor binding,5.90e-07,5.43e-05,3/15,10/8198
monocyte,rs3758833_CTSC,MF,GO:0048306,calcium-dependent protein binding,4.70e-05,2.00e-03,3/15,40/8198
monocyte,rs3758833_CTSC,MF,GO:0036041,long-chain fatty acid binding,6.53e-05,2.00e-03,2/15,7/8198
monocyte,rs3758833_CTSC,MF,GO:0035325,Toll-like receptor binding,1.70e-04,3.92e-03,2/15,11/8198
monocyte,rs3758833_CTSC,MF,GO:0005504,fatty acid binding,3.24e-04,5.96e-03,2/15,15/8198
monocyte,rs3758833_CTSC,MF,GO:1901567,fatty acid derivative binding,4.70e-04,7.21e-03,2/15,18/8198
monocyte,rs3758833_CTSC,MF,GO:0033293,monocarboxylic acid binding,7.73e-04,1.02e-02,2/15,23/8198
monocyte,rs5756736_LGALS2,BP,GO:0019730,antimicrobial humoral response,1.35e-08,1.33e-05,6/36,38/7986
monocyte,rs5756736_LGALS2,BP,GO:0006954,inflammatory response,9.36e-08,4.62e-05,12/36,402/7986
monocyte,rs5756736_LGALS2,BP,GO:0050727,regulation of inflammatory response,2.49e-06,8.20e-04,8/36,203/7986
monocyte,rs5756736_LGALS2,BP,GO:0006959,humoral immune response,3.32e-06,8.20e-04,6/36,94/7986
monocyte,rs5756736_LGALS2,BP,GO:0042742,defense response to bacterium,4.23e-06,8.37e-04,6/36,98/7986
monocyte,rs5756736_LGALS2,BP,GO:0009617,response to bacterium,6.47e-06,1.07e-03,9/36,309/7986
monocyte,rs5756736_LGALS2,BP,GO:0097529,myeloid leukocyte migration,1.07e-05,1.51e-03,6/36,115/7986
monocyte,rs5756736_LGALS2,BP,GO:0050832,defense response to fungus,1.35e-05,1.67e-03,3/36,11/7986
monocyte,rs5756736_LGALS2,BP,GO:0030595,leukocyte chemotaxis,1.58e-05,1.73e-03,6/36,123/7986
monocyte,rs5756736_LGALS2,BP,GO:0002544,chronic inflammatory response,1.80e-05,1.78e-03,3/36,12/7986
monocyte,rs5756736_LGALS2,BP,GO:0060326,cell chemotaxis,5.43e-05,4.88e-03,6/36,153/7986
monocyte,rs5756736_LGALS2,BP,GO:0031640,killing of cells of other organism,6.55e-05,5.40e-03,3/36,18/7986
monocyte,rs5756736_LGALS2,BP,GO:0050900,leukocyte migration,8.25e-05,6.27e-03,7/36,241/7986
monocyte,rs5756736_LGALS2,BP,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,9.10e-05,6.42e-03,3/36,20/7986
monocyte,rs5756736_LGALS2,BP,GO:0009620,response to fungus,1.40e-04,9.22e-03,3/36,23/7986
monocyte,rs5756736_LGALS2,BP,GO:0002523,leukocyte migration involved in inflammatory response,2.93e-04,1.70e-02,2/36,6/7986
monocyte,rs5756736_LGALS2,BP,GO:0035425,autocrine signaling,2.93e-04,1.70e-02,2/36,6/7986
monocyte,rs5756736_LGALS2,BP,GO:0002548,monocyte chemotaxis,3.81e-04,2.09e-02,3/36,32/7986
monocyte,rs5756736_LGALS2,BP,GO:0051450,myoblast proliferation,4.09e-04,2.13e-02,2/36,7/7986
monocyte,rs5756736_LGALS2,BP,GO:0031347,regulation of defense response,4.50e-04,2.22e-02,8/36,420/7986
monocyte,rs5756736_LGALS2,BP,GO:0050729,positive regulation of inflammatory response,5.19e-04,2.24e-02,4/36,84/7986
monocyte,rs5756736_LGALS2,BP,GO:0017014,protein nitrosylation,5.44e-04,2.24e-02,2/36,8/7986
monocyte,rs5756736_LGALS2,BP,GO:0018119,peptidyl-cysteine S-nitrosylation,5.44e-04,2.24e-02,2/36,8/7986
monocyte,rs5756736_LGALS2,BP,GO:0051238,sequestering of metal ion,5.44e-04,2.24e-02,2/36,8/7986
monocyte,rs5756736_LGALS2,BP,GO:0070486,leukocyte aggregation,1.06e-03,4.19e-02,2/36,11/7986
monocyte,rs5756736_LGALS2,BP,GO:0071674,mononuclear cell migration,1.12e-03,4.25e-02,3/36,46/7986
monocyte,rs5756736_LGALS2,BP,GO:0006935,chemotaxis,1.26e-03,4.44e-02,6/36,274/7986
monocyte,rs5756736_LGALS2,BP,GO:0046597,negative regulation of viral entry into host cell,1.27e-03,4.44e-02,2/36,12/7986
monocyte,rs5756736_LGALS2,BP,GO:0042330,taxis,1.31e-03,4.44e-02,6/36,276/7986
monocyte,rs5756736_LGALS2,BP,GO:0001934,positive regulation of protein phosphorylation,1.35e-03,4.44e-02,8/36,496/7986
monocyte,rs5756736_LGALS2,MF,GO:0050786,RAGE receptor binding,8.38e-06,1.23e-03,3/35,10/8198
monocyte,rs5756736_LGALS2,MF,GO:0036041,long-chain fatty acid binding,3.67e-04,2.70e-02,2/35,7/8198
monocyte,rs5756736_LGALS2,MF,GO:0048306,calcium-dependent protein binding,6.32e-04,3.10e-02,3/35,40/8198
monocyte,rs5756736_LGALS2,MF,GO:0035325,Toll-like receptor binding,9.51e-04,3.49e-02,2/35,11/8198
monocyte,rs7806458_TMEM176A,BP,GO:0019730,antimicrobial humoral response,1.60e-05,7.29e-03,3/11,38/7986
monocyte,rs7806458_TMEM176A,BP,GO:0009617,response to bacterium,3.20e-05,7.29e-03,5/11,309/7986
monocyte,rs7806458_TMEM176A,BP,GO:0043312,neutrophil degranulation,1.05e-04,7.29e-03,5/11,396/7986
monocyte,rs7806458_TMEM176A,BP,GO:0032680,regulation of tumor necrosis factor production,1.06e-04,7.29e-03,3/11,71/7986
monocyte,rs7806458_TMEM176A,BP,GO:0002283,neutrophil activation involved in immune response,1.08e-04,7.29e-03,5/11,398/7986
monocyte,rs7806458_TMEM176A,BP,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,1.15e-04,7.29e-03,3/11,73/7986
monocyte,rs7806458_TMEM176A,BP,GO:0002446,neutrophil mediated immunity,1.16e-04,7.29e-03,5/11,404/7986
monocyte,rs7806458_TMEM176A,BP,GO:0042119,neutrophil activation,1.16e-04,7.29e-03,5/11,404/7986
monocyte,rs7806458_TMEM176A,BP,GO:0036230,granulocyte activation,1.23e-04,7.29e-03,5/11,409/7986
monocyte,rs7806458_TMEM176A,BP,GO:0032640,tumor necrosis factor production,1.29e-04,7.29e-03,3/11,76/7986
monocyte,rs7806458_TMEM176A,BP,GO:0071706,tumor necrosis factor superfamily cytokine production,1.40e-04,7.29e-03,3/11,78/7986
monocyte,rs7806458_TMEM176A,BP,GO:0043299,leukocyte degranulation,1.56e-04,7.29e-03,5/11,430/7986
monocyte,rs7806458_TMEM176A,BP,GO:0002275,myeloid cell activation involved in immune response,1.63e-04,7.29e-03,5/11,434/7986
monocyte,rs7806458_TMEM176A,BP,GO:0002444,myeloid leukocyte mediated immunity,1.80e-04,7.46e-03,5/11,443/7986
monocyte,rs7806458_TMEM176A,BP,GO:0006959,humoral immune response,2.43e-04,9.43e-03,3/11,94/7986
monocyte,rs7806458_TMEM176A,BP,GO:0001816,cytokine production,2.60e-04,9.43e-03,5/11,479/7986
monocyte,rs7806458_TMEM176A,BP,GO:0042742,defense response to bacterium,2.75e-04,9.43e-03,3/11,98/7986
monocyte,rs7806458_TMEM176A,BP,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,3.23e-04,1.05e-02,2/11,20/7986
monocyte,rs7806458_TMEM176A,BP,GO:0050829,defense response to Gram-negative bacterium,4.30e-04,1.32e-02,2/11,23/7986
monocyte,rs7806458_TMEM176A,BP,GO:0042168,heme metabolic process,4.68e-04,1.36e-02,2/11,24/7986
monocyte,rs7806458_TMEM176A,BP,GO:0006778,porphyrin-containing compound metabolic process,5.94e-04,1.65e-02,2/11,27/7986
monocyte,rs7806458_TMEM176A,BP,GO:0032720,negative regulation of tumor necrosis factor production,6.86e-04,1.78e-02,2/11,29/7986
monocyte,rs7806458_TMEM176A,BP,GO:0006821,chloride transport,7.35e-04,1.78e-02,2/11,30/7986
monocyte,rs7806458_TMEM176A,BP,GO:1903556,negative regulation of tumor necrosis factor superfamily cytokine production,7.35e-04,1.78e-02,2/11,30/7986
monocyte,rs7806458_TMEM176A,BP,GO:0050830,defense response to Gram-positive bacterium,1.00e-03,2.33e-02,2/11,35/7986
monocyte,rs7806458_TMEM176A,BP,GO:0033013,tetrapyrrole metabolic process,1.06e-03,2.37e-02,2/11,36/7986
monocyte,rs7806458_TMEM176A,BP,GO:0042440,pigment metabolic process,1.37e-03,2.96e-02,2/11,41/7986
monocyte,rs7806458_TMEM176A,BP,GO:0032496,response to lipopolysaccharide,1.99e-03,4.12e-02,3/11,193/7986
monocyte,rs7806458_TMEM176A,BP,GO:0001817,regulation of cytokine production,2.06e-03,4.12e-02,4/11,432/7986
monocyte,rs7806458_TMEM176A,BP,GO:0002237,response to molecule of bacterial origin,2.20e-03,4.27e-02,3/11,200/7986
monocyte,rs7806458_TMEM176A,CC,GO:0034774,secretory granule lumen,1.60e-04,2.50e-03,4/11,227/8226
monocyte,rs7806458_TMEM176A,CC,GO:0031983,vesicle lumen,1.63e-04,2.50e-03,4/11,228/8226
monocyte,rs7806458_TMEM176A,CC,GO:0060205,cytoplasmic vesicle lumen,1.63e-04,2.50e-03,4/11,228/8226
monocyte,rs7806458_TMEM176A,CC,GO:0070820,tertiary granule,5.67e-04,6.52e-03,3/11,129/8226
monocyte,rs7806458_TMEM176A,CC,GO:0035580,specific granule lumen,1.30e-03,1.04e-02,2/11,41/8226
monocyte,rs7806458_TMEM176A,CC,GO:1904724,tertiary granule lumen,1.36e-03,1.04e-02,2/11,42/8226
monocyte,rs7806458_TMEM176A,CC,GO:0035578,azurophil granule lumen,3.63e-03,2.39e-02,2/11,69/8226
monocyte,rs7806458_TMEM176A,CC,GO:0005775,vacuolar lumen,8.69e-03,3.67e-02,2/11,108/8226
monocyte,rs7806458_TMEM176A,CC,GO:0008290,F-actin capping protein complex,9.33e-03,3.67e-02,1/11,7/8226
monocyte,rs7806458_TMEM176A,CC,GO:0101002,ficolin-1-rich granule,1.05e-02,3.67e-02,2/11,119/8226
monocyte,rs7806458_TMEM176A,CC,GO:1904813,ficolin-1-rich granule lumen,1.05e-02,3.67e-02,2/11,119/8226
monocyte,rs7806458_TMEM176A,CC,GO:0005766,primary lysosome,1.10e-02,3.67e-02,2/11,122/8226
monocyte,rs7806458_TMEM176A,CC,GO:0042582,azurophil granule,1.10e-02,3.67e-02,2/11,122/8226
monocyte,rs7806458_TMEM176A,CC,GO:0042581,specific granule,1.12e-02,3.67e-02,2/11,123/8226
monocyte,rs7806458_TMEM176B,BP,GO:0043312,neutrophil degranulation,1.68e-06,9.79e-05,5/6,396/7986
monocyte,rs7806458_TMEM176B,BP,GO:0002283,neutrophil activation involved in immune response,1.73e-06,9.79e-05,5/6,398/7986
monocyte,rs7806458_TMEM176B,BP,GO:0002446,neutrophil mediated immunity,1.86e-06,9.79e-05,5/6,404/7986
monocyte,rs7806458_TMEM176B,BP,GO:0042119,neutrophil activation,1.86e-06,9.79e-05,5/6,404/7986
monocyte,rs7806458_TMEM176B,BP,GO:0036230,granulocyte activation,1.98e-06,9.79e-05,5/6,409/7986
monocyte,rs7806458_TMEM176B,BP,GO:0043299,leukocyte degranulation,2.54e-06,9.79e-05,5/6,430/7986
monocyte,rs7806458_TMEM176B,BP,GO:0002275,myeloid cell activation involved in immune response,2.66e-06,9.79e-05,5/6,434/7986
monocyte,rs7806458_TMEM176B,BP,GO:0002444,myeloid leukocyte mediated immunity,2.94e-06,9.79e-05,5/6,443/7986
monocyte,rs7806458_TMEM176B,BP,GO:0002221,pattern recognition receptor signaling pathway,1.08e-04,3.19e-03,3/6,143/7986
monocyte,rs7806458_TMEM176B,CC,GO:0070820,tertiary granule,7.28e-05,4.08e-03,3/6,129/8226
monocyte,rs7806458_TMEM176B,CC,GO:0070821,tertiary granule membrane,7.70e-04,1.99e-02,2/6,60/8226
monocyte,rs7806458_TMEM176B,CC,GO:0035579,specific granule membrane,1.23e-03,1.99e-02,2/6,76/8226
monocyte,rs7806458_TMEM176B,CC,GO:0062023,collagen-containing extracellular matrix,1.73e-03,1.99e-02,2/6,90/8226
monocyte,rs7806458_TMEM176B,CC,GO:0005775,vacuolar lumen,2.48e-03,1.99e-02,2/6,108/8226
monocyte,rs7806458_TMEM176B,CC,GO:0031012,extracellular matrix,2.61e-03,1.99e-02,2/6,111/8226
monocyte,rs7806458_TMEM176B,CC,GO:0101002,ficolin-1-rich granule,3.00e-03,1.99e-02,2/6,119/8226
monocyte,rs7806458_TMEM176B,CC,GO:1904813,ficolin-1-rich granule lumen,3.00e-03,1.99e-02,2/6,119/8226
monocyte,rs7806458_TMEM176B,CC,GO:0042581,specific granule,3.20e-03,1.99e-02,2/6,123/8226
monocyte,rs7806458_TMEM176B,CC,GO:0009897,external side of plasma membrane,4.07e-03,2.28e-02,2/6,139/8226
monocyte,rs7806458_TMEM176B,CC,GO:0071541,"eukaryotic translation initiation factor 3 complex, eIF3m",5.10e-03,2.59e-02,1/6,7/8226
monocyte,rs7806458_TMEM176B,CC,GO:0005581,collagen trimer,7.27e-03,2.88e-02,1/6,10/8226
monocyte,rs7806458_TMEM176B,CC,GO:0030667,secretory granule membrane,9.09e-03,2.88e-02,2/6,210/8226
monocyte,rs7806458_TMEM176B,CC,GO:0008305,integrin complex,1.02e-02,2.88e-02,1/6,14/8226
monocyte,rs7806458_TMEM176B,CC,GO:0033290,eukaryotic 48S preinitiation complex,1.02e-02,2.88e-02,1/6,14/8226
monocyte,rs7806458_TMEM176B,CC,GO:0034774,secretory granule lumen,1.06e-02,2.88e-02,2/6,227/8226
monocyte,rs7806458_TMEM176B,CC,GO:0031983,vesicle lumen,1.07e-02,2.88e-02,2/6,228/8226
monocyte,rs7806458_TMEM176B,CC,GO:0060205,cytoplasmic vesicle lumen,1.07e-02,2.88e-02,2/6,228/8226
monocyte,rs7806458_TMEM176B,CC,GO:0036019,endolysosome,1.09e-02,2.88e-02,1/6,15/8226
monocyte,rs7806458_TMEM176B,CC,GO:0098636,protein complex involved in cell adhesion,1.09e-02,2.88e-02,1/6,15/8226
monocyte,rs7806458_TMEM176B,CC,GO:0005852,eukaryotic translation initiation factor 3 complex,1.16e-02,2.88e-02,1/6,16/8226
monocyte,rs7806458_TMEM176B,CC,GO:0016282,eukaryotic 43S preinitiation complex,1.16e-02,2.88e-02,1/6,16/8226
monocyte,rs7806458_TMEM176B,CC,GO:0031904,endosome lumen,1.23e-02,2.88e-02,1/6,17/8226
monocyte,rs7806458_TMEM176B,CC,GO:0070993,translation preinitiation complex,1.23e-02,2.88e-02,1/6,17/8226
monocyte,rs7806458_TMEM176B,CC,GO:0098552,side of membrane,1.45e-02,3.26e-02,2/6,268/8226
monocyte,rs7806458_TMEM176B,CC,GO:0009986,cell surface,1.91e-02,4.11e-02,2/6,309/8226
monocyte,rs7806458_TMEM176B,MF,GO:0030246,carbohydrate binding,3.07e-03,4.27e-02,2/6,120/8198
monocyte,rs7806458_TMEM176B,MF,GO:0001851,complement component C3b binding,3.65e-03,4.27e-02,1/6,5/8198
monocyte,rs7806458_TMEM176B,MF,GO:0033691,sialic acid binding,5.84e-03,4.27e-02,1/6,8/8198
monocyte,rs7806458_TMEM176B,MF,GO:0001846,opsonin binding,7.30e-03,4.27e-02,1/6,10/8198
monocyte,rs7806458_TMEM176B,MF,GO:0001848,complement binding,8.03e-03,4.27e-02,1/6,11/8198
monocyte,rs7806458_TMEM176B,MF,GO:0001968,fibronectin binding,8.03e-03,4.27e-02,1/6,11/8198
monocyte,rs7806458_TMEM176B,MF,GO:0043236,laminin binding,8.03e-03,4.27e-02,1/6,11/8198
monocyte,rs7806458_TMEM176B,MF,GO:0043394,proteoglycan binding,8.75e-03,4.27e-02,1/6,12/8198
monocyte,rs7806458_TMEM176B,MF,GO:0038187,pattern recognition receptor activity,1.09e-02,4.74e-02,1/6,15/8198
monocyte,rs9271520_HLA-DQA2,BP,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,5.39e-15,1.53e-12,9/17,72/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,6.14e-15,1.53e-12,9/17,73/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,6.99e-15,1.53e-12,9/17,74/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002478,antigen processing and presentation of exogenous peptide antigen,2.78e-12,4.56e-10,9/17,141/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0019884,antigen processing and presentation of exogenous antigen,3.82e-12,5.01e-10,9/17,146/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0048002,antigen processing and presentation of peptide antigen,4.60e-12,5.03e-10,9/17,149/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0019882,antigen processing and presentation,2.31e-11,2.17e-09,9/17,178/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002501,peptide antigen assembly with MHC protein complex,2.10e-10,1.72e-08,4/17,6/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002396,MHC protein complex assembly,4.90e-10,3.57e-08,4/17,7/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002250,adaptive immune response,5.83e-10,3.82e-08,9/17,255/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0060333,interferon-gamma-mediated signaling pathway,4.18e-09,2.49e-07,6/17,70/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,2.22e-08,1.21e-06,6/17,92/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0006613,cotranslational protein targeting to membrane,2.87e-08,1.44e-06,6/17,96/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0045047,protein targeting to ER,4.92e-08,2.30e-06,6/17,105/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,5.83e-08,2.55e-06,6/17,108/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",8.51e-08,3.48e-06,6/17,115/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0071346,cellular response to interferon-gamma,1.15e-07,4.45e-06,6/17,121/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0070972,protein localization to endoplasmic reticulum,1.69e-07,6.15e-06,6/17,129/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0034341,response to interferon-gamma,2.22e-07,7.65e-06,6/17,135/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0050852,T cell receptor signaling pathway,5.03e-07,1.65e-05,6/17,155/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0006612,protein targeting to membrane,5.85e-07,1.83e-05,6/17,159/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0019083,viral transcription,8.10e-07,2.41e-05,6/17,168/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0050778,positive regulation of immune response,9.41e-07,2.68e-05,8/17,424/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0006413,translational initiation,1.06e-06,2.91e-05,6/17,176/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0019080,viral gene expression,1.38e-06,3.62e-05,6/17,184/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0050851,antigen receptor-mediated signaling pathway,1.47e-06,3.71e-05,6/17,186/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,1.62e-06,3.92e-05,6/17,189/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0032944,regulation of mononuclear cell proliferation,5.19e-06,1.17e-04,5/17,128/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0050670,regulation of lymphocyte proliferation,5.19e-06,1.17e-04,5/17,128/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0070663,regulation of leukocyte proliferation,6.99e-06,1.53e-04,5/17,136/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0090150,establishment of protein localization to membrane,8.21e-06,1.73e-04,6/17,250/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002429,immune response-activating cell surface receptor signaling pathway,1.28e-05,2.53e-04,6/17,270/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002757,immune response-activating signal transduction,1.28e-05,2.53e-04,6/17,270/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0032943,mononuclear cell proliferation,1.79e-05,3.36e-04,5/17,165/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0046651,lymphocyte proliferation,1.79e-05,3.36e-04,5/17,165/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002768,immune response-regulating cell surface receptor signaling pathway,2.00e-05,3.64e-04,6/17,292/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002764,immune response-regulating signaling pathway,2.08e-05,3.68e-04,6/17,294/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0070661,leukocyte proliferation,2.38e-05,4.00e-04,5/17,175/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0032946,positive regulation of mononuclear cell proliferation,2.44e-05,4.00e-04,4/17,84/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0050671,positive regulation of lymphocyte proliferation,2.44e-05,4.00e-04,4/17,84/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002253,activation of immune response,2.91e-05,4.65e-04,6/17,312/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0006402,mRNA catabolic process,3.07e-05,4.79e-04,6/17,315/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0070665,positive regulation of leukocyte proliferation,3.21e-05,4.89e-04,4/17,90/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0019221,cytokine-mediated signaling pathway,3.42e-05,5.09e-04,7/17,487/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0042129,regulation of T cell proliferation,3.81e-05,5.55e-04,4/17,94/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:1903037,regulation of leukocyte cell-cell adhesion,3.92e-05,5.58e-04,5/17,194/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0006605,protein targeting,4.35e-05,6.07e-04,6/17,335/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0050863,regulation of T cell activation,4.76e-05,6.49e-04,5/17,202/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0006401,RNA catabolic process,5.05e-05,6.76e-04,6/17,344/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0007159,leukocyte cell-cell adhesion,6.56e-05,8.59e-04,5/17,216/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0042098,T cell proliferation,9.60e-05,1.23e-03,4/17,119/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0022407,regulation of cell-cell adhesion,1.15e-04,1.45e-03,5/17,243/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0045657,positive regulation of monocyte differentiation,1.19e-04,1.46e-03,2/17,8/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0072657,protein localization to membrane,1.33e-04,1.61e-03,6/17,409/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0046598,positive regulation of viral entry into host cell,1.52e-04,1.78e-03,2/17,9/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0075294,positive regulation by symbiont of entry into host,1.52e-04,1.78e-03,2/17,9/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0042254,ribosome biogenesis,1.58e-04,1.81e-03,5/17,260/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0050870,positive regulation of T cell activation,1.71e-04,1.93e-03,4/17,138/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0034655,nucleobase-containing compound catabolic process,1.77e-04,1.97e-03,6/17,431/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0072594,establishment of protein localization to organelle,1.84e-04,2.01e-03,6/17,434/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0051249,regulation of lymphocyte activation,2.06e-04,2.21e-03,5/17,275/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0046700,heterocycle catabolic process,2.17e-04,2.29e-03,6/17,447/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0044270,cellular nitrogen compound catabolic process,2.25e-04,2.34e-03,6/17,450/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0019439,aromatic compound catabolic process,2.30e-04,2.36e-03,6/17,452/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:1903039,positive regulation of leukocyte cell-cell adhesion,2.48e-04,2.49e-03,4/17,152/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0032649,regulation of interferon-gamma production,2.54e-04,2.49e-03,3/17,60/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0042102,positive regulation of T cell proliferation,2.54e-04,2.49e-03,3/17,60/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:1901361,organic cyclic compound catabolic process,2.60e-04,2.50e-03,6/17,462/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0042273,ribosomal large subunit biogenesis,3.08e-04,2.92e-03,3/17,64/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0042110,T cell activation,3.13e-04,2.93e-03,5/17,301/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0032609,interferon-gamma production,3.38e-04,3.11e-03,3/17,66/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0022409,positive regulation of cell-cell adhesion,3.55e-04,3.23e-03,4/17,167/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0045655,regulation of monocyte differentiation,3.82e-04,3.36e-03,2/17,14/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:1902165,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,3.82e-04,3.36e-03,2/17,14/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0016064,immunoglobulin mediated immune response,3.85e-04,3.36e-03,3/17,69/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0019724,B cell mediated immunity,4.02e-04,3.46e-03,3/17,70/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002694,regulation of leukocyte activation,4.22e-04,3.59e-03,5/17,321/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0050865,regulation of cell activation,5.35e-04,4.50e-03,5/17,338/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0051251,positive regulation of lymphocyte activation,5.57e-04,4.62e-03,4/17,188/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0006364,rRNA processing,6.03e-04,4.94e-03,4/17,192/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0016072,rRNA metabolic process,6.77e-04,5.48e-03,4/17,198/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0098609,cell-cell adhesion,7.52e-04,6.00e-03,5/17,364/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002696,positive regulation of leukocyte activation,8.75e-04,6.88e-03,4/17,212/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0022613,ribonucleoprotein complex biogenesis,8.82e-04,6.88e-03,5/17,377/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0030155,regulation of cell adhesion,9.47e-04,7.07e-03,5/17,383/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002455,humoral immune response mediated by circulating immunoglobulin,9.61e-04,7.07e-03,2/17,22/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0030224,monocyte differentiation,9.61e-04,7.07e-03,2/17,22/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,9.61e-04,7.07e-03,2/17,22/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:1903131,mononuclear cell differentiation,9.61e-04,7.07e-03,2/17,22/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0050867,positive regulation of cell activation,9.89e-04,7.19e-03,4/17,219/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0000027,ribosomal large subunit assembly,1.15e-03,8.07e-03,2/17,24/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0043516,"regulation of DNA damage response, signal transduction by p53 class mediator",1.15e-03,8.07e-03,2/17,24/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0046596,regulation of viral entry into host cell,1.15e-03,8.07e-03,2/17,24/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0045785,positive regulation of cell adhesion,1.43e-03,9.99e-03,4/17,242/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,1.45e-03,1.00e-02,2/17,27/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0052372,modulation by symbiont of entry into host,1.56e-03,1.06e-02,2/17,28/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0008284,positive regulation of cell population proliferation,1.63e-03,1.10e-02,5/17,432/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0046649,lymphocyte activation,1.73e-03,1.16e-02,5/17,438/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:1901796,regulation of signal transduction by p53 class mediator,2.48e-03,1.64e-02,3/17,131/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002440,production of molecular mediator of immune response,2.53e-03,1.66e-02,3/17,132/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,2.72e-03,1.76e-02,2/17,37/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0032729,positive regulation of interferon-gamma production,3.02e-03,1.94e-02,2/17,39/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002381,immunoglobulin production involved in immunoglobulin mediated immune response,3.17e-03,2.02e-02,2/17,40/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002763,positive regulation of myeloid leukocyte differentiation,3.33e-03,2.10e-02,2/17,41/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0051438,regulation of ubiquitin-protein transferase activity,3.49e-03,2.18e-02,2/17,42/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0034470,ncRNA processing,3.63e-03,2.24e-02,4/17,312/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002449,lymphocyte mediated immunity,3.85e-03,2.36e-02,3/17,153/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,4.68e-03,2.84e-02,3/17,164/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:1903902,positive regulation of viral life cycle,5.11e-03,3.07e-02,2/17,51/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0042255,ribosome assembly,5.72e-03,3.40e-02,2/17,54/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0034660,ncRNA metabolic process,5.76e-03,3.40e-02,4/17,355/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,5.93e-03,3.47e-02,2/17,55/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0072331,signal transduction by p53 class mediator,6.95e-03,4.03e-02,3/17,189/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0050868,negative regulation of T cell activation,7.48e-03,4.30e-02,2/17,62/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:0002286,T cell activation involved in immune response,7.96e-03,4.53e-02,2/17,64/7986
monocyte,rs9271520_HLA-DQA2,BP,GO:1903038,negative regulation of leukocyte cell-cell adhesion,8.69e-03,4.91e-02,2/17,67/7986
monocyte,rs9271520_HLA-DQA2,CC,GO:0042613,MHC class II protein complex,1.13e-23,1.14e-21,9/17,12/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0042611,MHC protein complex,4.70e-21,2.38e-19,9/17,19/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0071556,integral component of lumenal side of endoplasmic reticulum membrane,4.42e-15,1.12e-13,7/17,21/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0098553,lumenal side of endoplasmic reticulum membrane,4.42e-15,1.12e-13,7/17,21/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0030669,clathrin-coated endocytic vesicle membrane,9.29e-15,1.88e-13,7/17,23/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0098576,lumenal side of membrane,1.82e-14,3.06e-13,7/17,25/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0045334,clathrin-coated endocytic vesicle,1.26e-13,1.82e-12,7/17,32/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0012507,ER to Golgi transport vesicle membrane,2.32e-12,2.93e-11,7/17,47/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0032588,trans-Golgi network membrane,1.41e-11,1.58e-10,7/17,60/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0005765,lysosomal membrane,2.18e-11,1.90e-10,10/17,273/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0098852,lytic vacuole membrane,2.18e-11,1.90e-10,10/17,273/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0030665,clathrin-coated vesicle membrane,2.25e-11,1.90e-10,7/17,64/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0030134,COPII-coated ER to Golgi transport vesicle,3.89e-11,3.02e-10,7/17,69/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0098797,plasma membrane protein complex,7.91e-11,5.36e-10,9/17,210/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0005774,vacuolar membrane,7.95e-11,5.36e-10,10/17,311/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0030660,Golgi-associated vesicle membrane,1.03e-10,6.53e-10,7/17,79/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0000323,lytic vacuole,2.15e-10,1.21e-09,11/17,480/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0005764,lysosome,2.15e-10,1.21e-09,11/17,480/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0030666,endocytic vesicle membrane,6.00e-10,3.19e-09,7/17,101/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0030176,integral component of endoplasmic reticulum membrane,9.65e-10,4.64e-09,7/17,108/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0030658,transport vesicle membrane,9.65e-10,4.64e-09,7/17,108/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0031227,intrinsic component of endoplasmic reticulum membrane,1.25e-09,5.73e-09,7/17,112/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0030136,clathrin-coated vesicle,1.41e-09,6.21e-09,7/17,114/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0030662,coated vesicle membrane,1.50e-09,6.33e-09,7/17,115/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0005798,Golgi-associated vesicle,2.71e-09,1.09e-08,7/17,125/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0005802,trans-Golgi network,1.02e-08,3.96e-08,7/17,151/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0098552,side of membrane,2.16e-08,8.07e-08,8/17,268/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0022626,cytosolic ribosome,3.08e-08,1.11e-07,6/17,100/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0030135,coated vesicle,5.40e-08,1.88e-07,7/17,192/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0030139,endocytic vesicle,6.68e-08,2.25e-07,7/17,198/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0030133,transport vesicle,1.34e-07,4.22e-07,7/17,219/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0010008,endosome membrane,1.38e-07,4.22e-07,8/17,340/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0098791,Golgi apparatus subcompartment,1.38e-07,4.22e-07,7/17,220/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0031984,organelle subcompartment,2.43e-07,7.22e-07,7/17,239/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0031301,integral component of organelle membrane,2.65e-07,7.63e-07,7/17,242/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0031300,intrinsic component of organelle membrane,4.31e-07,1.21e-06,7/17,260/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0044391,ribosomal subunit,8.38e-07,2.29e-06,6/17,174/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0005770,late endosome,1.59e-06,4.22e-06,6/17,194/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0005840,ribosome,2.32e-06,6.01e-06,6/17,207/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0030659,cytoplasmic vesicle membrane,2.00e-05,5.00e-05,7/17,462/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0000139,Golgi membrane,2.03e-05,5.00e-05,7/17,463/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0009986,cell surface,2.33e-05,5.61e-05,6/17,309/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0012506,vesicle membrane,2.47e-05,5.79e-05,7/17,477/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0031902,late endosome membrane,4.68e-05,1.08e-04,4/17,102/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0022627,cytosolic small ribosomal subunit,9.22e-05,2.07e-04,3/17,44/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0022625,cytosolic large ribosomal subunit,1.61e-04,3.54e-04,3/17,53/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0015935,small ribosomal subunit,3.68e-04,7.92e-04,3/17,70/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0015934,large ribosomal subunit,1.27e-03,2.68e-03,3/17,107/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0005771,multivesicular body,2.17e-03,4.47e-03,2/17,34/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0005887,integral component of plasma membrane,1.26e-02,2.55e-02,4/17,458/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0031226,intrinsic component of plasma membrane,1.51e-02,3.00e-02,4/17,483/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:0101002,ficolin-1-rich granule,2.45e-02,4.67e-02,2/17,119/8226
monocyte,rs9271520_HLA-DQA2,CC,GO:1904813,ficolin-1-rich granule lumen,2.45e-02,4.67e-02,2/17,119/8226
monocyte,rs9271520_HLA-DQA2,MF,GO:0042605,peptide antigen binding,2.33e-13,1.32e-11,6/17,16/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0032395,MHC class II receptor activity,4.21e-13,1.32e-11,5/17,7/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0023026,MHC class II protein complex binding,3.98e-11,8.35e-10,5/17,14/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0003823,antigen binding,6.60e-11,1.04e-09,6/17,37/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0042277,peptide binding,1.34e-10,1.69e-09,8/17,141/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0023023,MHC protein complex binding,2.30e-10,2.41e-09,5/17,19/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0033218,amide binding,9.09e-10,8.18e-09,8/17,179/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0140375,immune receptor activity,1.69e-09,1.33e-08,6/17,62/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0003735,structural constituent of ribosome,3.42e-07,2.39e-06,6/17,149/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0005198,structural molecule activity,1.06e-06,6.69e-06,7/17,296/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0004888,transmembrane signaling receptor activity,3.74e-06,2.14e-05,6/17,224/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0038023,signaling receptor activity,2.65e-05,1.29e-04,6/17,315/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0060089,molecular transducer activity,2.65e-05,1.29e-04,6/17,315/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0042609,CD4 receptor binding,8.45e-05,3.80e-04,2/17,7/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0030247,polysaccharide binding,1.44e-04,6.07e-04,2/17,9/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0048027,mRNA 5'-UTR binding,8.31e-04,3.27e-03,2/17,21/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0001540,amyloid-beta binding,2.31e-03,8.57e-03,2/17,35/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0003729,mRNA binding,9.34e-03,3.25e-02,3/17,216/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0050998,nitric-oxide synthase binding,1.03e-02,3.25e-02,1/17,5/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:1990948,ubiquitin ligase inhibitor activity,1.03e-02,3.25e-02,1/17,5/8198
monocyte,rs9271520_HLA-DQA2,MF,GO:0055105,ubiquitin-protein transferase inhibitor activity,1.24e-02,3.71e-02,1/17,6/8198
NK,rs1131017_RPS26,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,3.25e-139,3.75e-136,75/94,90/6171
NK,rs1131017_RPS26,BP,GO:0006613,cotranslational protein targeting to membrane,5.12e-137,2.96e-134,75/94,93/6171
NK,rs1131017_RPS26,BP,GO:0045047,protein targeting to ER,1.67e-132,6.42e-130,75/94,100/6171
NK,rs1131017_RPS26,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,8.92e-131,2.58e-128,75/94,103/6171
NK,rs1131017_RPS26,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",1.32e-127,3.05e-125,75/94,109/6171
NK,rs1131017_RPS26,BP,GO:0070972,protein localization to endoplasmic reticulum,9.48e-125,1.83e-122,75/94,115/6171
NK,rs1131017_RPS26,BP,GO:0006612,protein targeting to membrane,1.07e-116,1.76e-114,76/94,143/6171
NK,rs1131017_RPS26,BP,GO:0019083,viral transcription,1.08e-111,1.56e-109,75/94,151/6171
NK,rs1131017_RPS26,BP,GO:0006413,translational initiation,3.85e-109,4.94e-107,75/94,160/6171
NK,rs1131017_RPS26,BP,GO:0019080,viral gene expression,8.26e-108,9.55e-106,75/94,165/6171
NK,rs1131017_RPS26,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,8.65e-106,9.09e-104,75/94,173/6171
NK,rs1131017_RPS26,BP,GO:0090150,establishment of protein localization to membrane,5.68e-102,5.48e-100,77/94,212/6171
NK,rs1131017_RPS26,BP,GO:0006605,protein targeting,3.63e-91,3.23e-89,77/94,278/6171
NK,rs1131017_RPS26,BP,GO:0006402,mRNA catabolic process,5.23e-87,4.32e-85,75/94,278/6171
NK,rs1131017_RPS26,BP,GO:0072657,protein localization to membrane,7.53e-86,5.80e-84,78/94,337/6171
NK,rs1131017_RPS26,BP,GO:0006401,RNA catabolic process,1.11e-83,8.01e-82,75/94,304/6171
NK,rs1131017_RPS26,BP,GO:0072594,establishment of protein localization to organelle,1.16e-80,7.89e-79,77/94,367/6171
NK,rs1131017_RPS26,BP,GO:0006412,translation,7.29e-78,4.68e-76,79/94,439/6171
NK,rs1131017_RPS26,BP,GO:0043043,peptide biosynthetic process,1.07e-76,6.53e-75,79/94,453/6171
NK,rs1131017_RPS26,BP,GO:0034655,nucleobase-containing compound catabolic process,4.64e-76,2.68e-74,75/94,375/6171
NK,rs1131017_RPS26,BP,GO:0046700,heterocycle catabolic process,2.12e-75,1.17e-73,75/94,382/6171
NK,rs1131017_RPS26,BP,GO:0019439,aromatic compound catabolic process,3.26e-75,1.64e-73,75/94,384/6171
NK,rs1131017_RPS26,BP,GO:0044270,cellular nitrogen compound catabolic process,3.26e-75,1.64e-73,75/94,384/6171
NK,rs1131017_RPS26,BP,GO:1901361,organic cyclic compound catabolic process,9.42e-75,4.54e-73,75/94,389/6171
NK,rs1131017_RPS26,BP,GO:0002181,cytoplasmic translation,3.78e-36,1.75e-34,30/94,78/6171
NK,rs1131017_RPS26,BP,GO:0042254,ribosome biogenesis,5.12e-26,2.28e-24,34/94,223/6171
NK,rs1131017_RPS26,BP,GO:0022613,ribonucleoprotein complex biogenesis,1.12e-21,4.81e-20,35/94,323/6171
NK,rs1131017_RPS26,BP,GO:0042255,ribosome assembly,2.81e-21,1.16e-19,18/94,49/6171
NK,rs1131017_RPS26,BP,GO:0042273,ribosomal large subunit biogenesis,1.73e-18,6.89e-17,17/94,56/6171
NK,rs1131017_RPS26,BP,GO:0006364,rRNA processing,5.98e-17,2.30e-15,23/94,159/6171
NK,rs1131017_RPS26,BP,GO:0016072,rRNA metabolic process,1.21e-16,4.53e-15,23/94,164/6171
NK,rs1131017_RPS26,BP,GO:0042274,ribosomal small subunit biogenesis,4.04e-15,1.46e-13,15/94,59/6171
NK,rs1131017_RPS26,BP,GO:0022618,ribonucleoprotein complex assembly,3.13e-13,1.07e-11,19/94,146/6171
NK,rs1131017_RPS26,BP,GO:0000028,ribosomal small subunit assembly,3.14e-13,1.07e-11,9/94,16/6171
NK,rs1131017_RPS26,BP,GO:0071826,ribonucleoprotein complex subunit organization,5.83e-13,1.93e-11,19/94,151/6171
NK,rs1131017_RPS26,BP,GO:0000027,ribosomal large subunit assembly,6.80e-13,2.18e-11,10/94,24/6171
NK,rs1131017_RPS26,BP,GO:0034470,ncRNA processing,2.78e-12,8.67e-11,23/94,259/6171
NK,rs1131017_RPS26,BP,GO:0034660,ncRNA metabolic process,4.45e-11,1.35e-09,23/94,296/6171
NK,rs1131017_RPS26,BP,GO:1904667,negative regulation of ubiquitin protein ligase activity,1.71e-06,5.06e-05,4/94,7/6171
NK,rs1131017_RPS26,BP,GO:0070925,organelle assembly,2.54e-06,7.33e-05,20/94,411/6171
NK,rs1131017_RPS26,BP,GO:0051444,negative regulation of ubiquitin-protein transferase activity,2.28e-05,6.37e-04,4/94,12/6171
NK,rs1131017_RPS26,BP,GO:0030490,maturation of SSU-rRNA,2.31e-05,6.37e-04,6/94,39/6171
NK,rs1131017_RPS26,BP,GO:1901798,positive regulation of signal transduction by p53 class mediator,4.50e-05,1.18e-03,4/94,14/6171
NK,rs1131017_RPS26,BP,GO:1904666,regulation of ubiquitin protein ligase activity,4.50e-05,1.18e-03,4/94,14/6171
NK,rs1131017_RPS26,BP,GO:0051438,regulation of ubiquitin-protein transferase activity,5.49e-05,1.41e-03,5/94,28/6171
NK,rs1131017_RPS26,BP,GO:0000462,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",6.55e-05,1.65e-03,5/94,29/6171
NK,rs1131017_RPS26,BP,GO:0000470,maturation of LSU-rRNA,2.03e-04,4.89e-03,4/94,20/6171
NK,rs1131017_RPS26,BP,GO:0019730,antimicrobial humoral response,2.03e-04,4.89e-03,4/94,20/6171
NK,rs1131017_RPS26,BP,GO:0006417,regulation of translation,2.10e-04,4.95e-03,12/94,235/6171
NK,rs1131017_RPS26,BP,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,3.80e-04,8.79e-03,3/94,10/6171
NK,rs1131017_RPS26,BP,GO:0034248,regulation of cellular amide metabolic process,6.73e-04,1.53e-02,12/94,267/6171
NK,rs1131017_RPS26,BP,GO:0031397,negative regulation of protein ubiquitination,8.28e-04,1.84e-02,5/94,49/6171
NK,rs1131017_RPS26,BP,GO:0001906,cell killing,8.57e-04,1.87e-02,6/94,74/6171
NK,rs1131017_RPS26,BP,GO:0006959,humoral immune response,1.09e-03,2.33e-02,5/94,52/6171
NK,rs1131017_RPS26,BP,GO:1903321,negative regulation of protein modification by small protein conjugation or removal,1.29e-03,2.72e-02,5/94,54/6171
NK,rs1131017_RPS26,BP,GO:0031640,killing of cells of other organism,1.36e-03,2.82e-02,3/94,15/6171
NK,rs1131017_RPS26,BP,GO:0010608,posttranscriptional regulation of gene expression,2.09e-03,4.24e-02,14/94,389/6171
NK,rs1131017_RPS26,BP,GO:0019731,antibacterial humoral response,2.23e-03,4.37e-02,2/94,5/6171
NK,rs1131017_RPS26,BP,GO:1902231,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,2.23e-03,4.37e-02,2/94,5/6171
NK,rs1131017_RPS26,BP,GO:2000059,negative regulation of ubiquitin-dependent protein catabolic process,2.27e-03,4.37e-02,4/94,37/6171
NK,rs1131017_RPS26,CC,GO:0022626,cytosolic ribosome,1.05e-134,1.62e-132,75/94,98/6360
NK,rs1131017_RPS26,CC,GO:0044391,ribosomal subunit,2.82e-108,2.18e-106,75/94,167/6360
NK,rs1131017_RPS26,CC,GO:0005840,ribosome,1.93e-102,9.98e-101,75/94,192/6360
NK,rs1131017_RPS26,CC,GO:0022625,cytosolic large ribosomal subunit,1.66e-82,6.42e-81,46/94,53/6360
NK,rs1131017_RPS26,CC,GO:0015934,large ribosomal subunit,3.28e-61,1.02e-59,46/94,103/6360
NK,rs1131017_RPS26,CC,GO:0022627,cytosolic small ribosomal subunit,2.33e-47,6.01e-46,30/94,43/6360
NK,rs1131017_RPS26,CC,GO:0015935,small ribosomal subunit,5.01e-39,1.11e-37,30/94,67/6360
NK,rs1131017_RPS26,CC,GO:0005925,focal adhesion,8.28e-37,1.60e-35,42/94,228/6360
NK,rs1131017_RPS26,CC,GO:0030055,cell-substrate junction,1.01e-36,1.73e-35,42/94,229/6360
NK,rs1131017_RPS26,CC,GO:0042788,polysomal ribosome,4.37e-33,6.77e-32,21/94,30/6360
NK,rs1131017_RPS26,CC,GO:0070161,anchoring junction,1.05e-29,1.48e-28,42/94,333/6360
NK,rs1131017_RPS26,CC,GO:0005844,polysome,1.99e-29,2.57e-28,23/94,53/6360
NK,rs1131017_RPS26,CC,GO:0014069,postsynaptic density,7.17e-15,8.54e-14,18/94,106/6360
NK,rs1131017_RPS26,CC,GO:0032279,asymmetric synapse,8.52e-15,9.43e-14,18/94,107/6360
NK,rs1131017_RPS26,CC,GO:0045202,synapse,1.52e-14,1.57e-13,30/94,393/6360
NK,rs1131017_RPS26,CC,GO:0098984,neuron to neuron synapse,1.67e-14,1.62e-13,18/94,111/6360
NK,rs1131017_RPS26,CC,GO:0099572,postsynaptic specialization,1.96e-14,1.79e-13,18/94,112/6360
NK,rs1131017_RPS26,CC,GO:0098794,postsynapse,1.84e-11,1.59e-10,19/94,188/6360
NK,rs1131017_RPS26,CC,GO:0005791,rough endoplasmic reticulum,1.60e-07,1.30e-06,8/94,43/6360
NK,rs1131017_RPS26,CC,GO:0098554,cytoplasmic side of endoplasmic reticulum membrane,4.73e-04,3.67e-03,3/94,11/6360
NK,rs1131017_RPS26,CC,GO:0030867,rough endoplasmic reticulum membrane,2.97e-03,2.19e-02,3/94,20/6360
NK,rs1131017_RPS26,CC,GO:0042612,MHC class I protein complex,4.32e-03,3.05e-02,2/94,7/6360
NK,rs1131017_RPS26,MF,GO:0003735,structural constituent of ribosome,8.08e-115,1.22e-112,75/93,146/6348
NK,rs1131017_RPS26,MF,GO:0005198,structural molecule activity,1.33e-95,1.00e-93,77/93,259/6348
NK,rs1131017_RPS26,MF,GO:0019843,rRNA binding,1.39e-21,6.98e-20,18/93,49/6348
NK,rs1131017_RPS26,MF,GO:0048027,mRNA 5'-UTR binding,5.04e-09,1.90e-07,7/93,19/6348
NK,rs1131017_RPS26,MF,GO:1990948,ubiquitin ligase inhibitor activity,2.14e-07,6.45e-06,4/93,5/6348
NK,rs1131017_RPS26,MF,GO:0003729,mRNA binding,2.94e-07,7.40e-06,14/93,181/6348
NK,rs1131017_RPS26,MF,GO:0055105,ubiquitin-protein transferase inhibitor activity,6.33e-07,1.37e-05,4/93,6/6348
NK,rs1131017_RPS26,MF,GO:0055106,ubiquitin-protein transferase regulator activity,1.95e-05,3.69e-04,4/93,12/6348
NK,rs1131017_RPS26,MF,GO:0045296,cadherin binding,2.29e-04,3.29e-03,10/93,176/6348
NK,rs1131017_RPS26,MF,GO:0008097,5S rRNA binding,2.40e-04,3.29e-03,3/93,9/6348
NK,rs1131017_RPS26,MF,GO:0070181,small ribosomal subunit rRNA binding,2.40e-04,3.29e-03,3/93,9/6348
NK,rs1131017_RPS26,MF,GO:0050839,cell adhesion molecule binding,4.41e-04,5.54e-03,11/93,227/6348
NK,rs1131017_RPS26,MF,GO:0003746,translation elongation factor activity,1.22e-03,1.42e-02,3/93,15/6348
NK,rs1131017_RPS26,MF,GO:0045182,translation regulator activity,1.74e-03,1.87e-02,6/93,88/6348
NK,rs12151742_GNLY,BP,GO:0042989,sequestering of actin monomers,3.53e-05,2.31e-02,2/10,6/6171
NK,rs12151742_GNLY,BP,GO:0030833,regulation of actin filament polymerization,1.58e-04,2.41e-02,3/10,70/6171
NK,rs12151742_GNLY,BP,GO:0008064,regulation of actin polymerization or depolymerization,2.02e-04,2.41e-02,3/10,76/6171
NK,rs12151742_GNLY,BP,GO:0030832,regulation of actin filament length,2.02e-04,2.41e-02,3/10,76/6171
NK,rs12151742_GNLY,BP,GO:0030041,actin filament polymerization,2.27e-04,2.41e-02,3/10,79/6171
NK,rs12151742_GNLY,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,3.34e-04,2.41e-02,3/10,90/6171
NK,rs12151742_GNLY,BP,GO:0051651,maintenance of location in cell,3.34e-04,2.41e-02,3/10,90/6171
NK,rs12151742_GNLY,BP,GO:0006613,cotranslational protein targeting to membrane,3.68e-04,2.41e-02,3/10,93/6171
NK,rs12151742_GNLY,BP,GO:0008154,actin polymerization or depolymerization,3.68e-04,2.41e-02,3/10,93/6171
NK,rs12151742_GNLY,BP,GO:0032271,regulation of protein polymerization,3.68e-04,2.41e-02,3/10,93/6171
NK,rs12151742_GNLY,BP,GO:0045047,protein targeting to ER,4.56e-04,2.56e-02,3/10,100/6171
NK,rs12151742_GNLY,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,4.98e-04,2.56e-02,3/10,103/6171
NK,rs12151742_GNLY,BP,GO:0110053,regulation of actin filament organization,5.72e-04,2.56e-02,3/10,108/6171
NK,rs12151742_GNLY,BP,GO:0097435,supramolecular fiber organization,5.85e-04,2.56e-02,4/10,267/6171
NK,rs12151742_GNLY,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",5.88e-04,2.56e-02,3/10,109/6171
NK,rs12151742_GNLY,BP,GO:0070972,protein localization to endoplasmic reticulum,6.88e-04,2.67e-02,3/10,115/6171
NK,rs12151742_GNLY,BP,GO:0030837,negative regulation of actin filament polymerization,6.95e-04,2.67e-02,2/10,25/6171
NK,rs12151742_GNLY,BP,GO:0051258,protein polymerization,9.40e-04,3.39e-02,3/10,128/6171
NK,rs12151742_GNLY,BP,GO:0051235,maintenance of location,1.03e-03,3.39e-02,3/10,132/6171
NK,rs12151742_GNLY,BP,GO:0032272,negative regulation of protein polymerization,1.14e-03,3.39e-02,2/10,32/6171
NK,rs12151742_GNLY,BP,GO:0032956,regulation of actin cytoskeleton organization,1.25e-03,3.39e-02,3/10,141/6171
NK,rs12151742_GNLY,BP,GO:0002274,myeloid leukocyte activation,1.26e-03,3.39e-02,4/10,327/6171
NK,rs12151742_GNLY,BP,GO:0042493,response to drug,1.27e-03,3.39e-02,3/10,142/6171
NK,rs12151742_GNLY,BP,GO:0006612,protein targeting to membrane,1.30e-03,3.39e-02,3/10,143/6171
NK,rs12151742_GNLY,BP,GO:0032535,regulation of cellular component size,1.35e-03,3.39e-02,3/10,145/6171
NK,rs12151742_GNLY,BP,GO:1902903,regulation of supramolecular fiber organization,1.35e-03,3.39e-02,3/10,145/6171
NK,rs12151742_GNLY,BP,GO:0032970,regulation of actin filament-based process,1.46e-03,3.53e-02,3/10,149/6171
NK,rs12151742_GNLY,BP,GO:0019083,viral transcription,1.52e-03,3.54e-02,3/10,151/6171
NK,rs12151742_GNLY,BP,GO:0032507,maintenance of protein location in cell,1.78e-03,3.88e-02,2/10,40/6171
NK,rs12151742_GNLY,BP,GO:0006413,translational initiation,1.80e-03,3.88e-02,3/10,160/6171
NK,rs12151742_GNLY,BP,GO:0045055,regulated exocytosis,1.88e-03,3.88e-02,4/10,364/6171
NK,rs12151742_GNLY,BP,GO:0019080,viral gene expression,1.96e-03,3.88e-02,3/10,165/6171
NK,rs12151742_GNLY,BP,GO:0043269,regulation of ion transport,1.96e-03,3.88e-02,3/10,165/6171
NK,rs12151742_GNLY,BP,GO:0007015,actin filament organization,2.17e-03,4.06e-02,3/10,171/6171
NK,rs12151742_GNLY,BP,GO:0090066,regulation of anatomical structure size,2.17e-03,4.06e-02,3/10,171/6171
NK,rs12151742_GNLY,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,2.25e-03,4.08e-02,3/10,173/6171
NK,rs12151742_GNLY,BP,GO:0002479,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",2.56e-03,4.52e-02,2/10,48/6171
NK,rs12151742_GNLY,BP,GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,2.78e-03,4.77e-02,2/10,50/6171
NK,rs12151742_GNLY,CC,GO:0005925,focal adhesion,4.35e-04,1.84e-02,4/11,228/6360
NK,rs12151742_GNLY,CC,GO:0030055,cell-substrate junction,4.43e-04,1.84e-02,4/11,229/6360
NK,rs12151742_GNLY,CC,GO:0022626,cytosolic ribosome,5.35e-04,1.84e-02,3/11,98/6360
NK,rs12151742_GNLY,CC,GO:0070161,anchoring junction,1.82e-03,3.23e-02,4/11,333/6360
NK,rs12151742_GNLY,CC,GO:0030670,phagocytic vesicle membrane,2.26e-03,3.23e-02,2/11,42/6360
NK,rs12151742_GNLY,CC,GO:0030141,secretory granule,2.33e-03,3.23e-02,4/11,356/6360
NK,rs12151742_GNLY,CC,GO:0022627,cytosolic small ribosomal subunit,2.36e-03,3.23e-02,2/11,43/6360
NK,rs12151742_GNLY,CC,GO:0044391,ribosomal subunit,2.51e-03,3.23e-02,3/11,167/6360
NK,rs12151742_GNLY,CC,GO:0005844,polysome,3.57e-03,3.50e-02,2/11,53/6360
NK,rs12151742_GNLY,CC,GO:0099503,secretory vesicle,3.70e-03,3.50e-02,4/11,404/6360
NK,rs12151742_GNLY,CC,GO:0005840,ribosome,3.74e-03,3.50e-02,3/11,192/6360
NK,rs12151742_GNLY,CC,GO:0005768,endosome,5.25e-03,4.16e-02,4/11,445/6360
NK,rs12151742_GNLY,CC,GO:0015935,small ribosomal subunit,5.66e-03,4.16e-02,2/11,67/6360
NK,rs12151742_GNLY,CC,GO:0030666,endocytic vesicle membrane,5.66e-03,4.16e-02,2/11,67/6360
NK,rs12151742_GNLY,CC,GO:0045335,phagocytic vesicle,6.68e-03,4.59e-02,2/11,73/6360
NK,rs12151742_GNLY,CC,GO:0042581,specific granule,7.41e-03,4.61e-02,2/11,77/6360
NK,rs12151742_GNLY,CC,GO:0070820,tertiary granule,7.60e-03,4.61e-02,2/11,78/6360
NK,rs12151742_GNLY,MF,GO:0003785,actin monomer binding,1.22e-04,4.39e-03,2/11,10/6348
NK,rs12151742_GNLY,MF,GO:0005198,structural molecule activity,7.12e-04,1.28e-02,4/11,259/6348
NK,rs12151742_GNLY,MF,GO:0003735,structural constituent of ribosome,1.72e-03,1.77e-02,3/11,146/6348
NK,rs12151742_GNLY,MF,GO:0003779,actin binding,1.97e-03,1.77e-02,3/11,153/6348
NK,rs62480001_MYOM2,CC,GO:0022627,cytosolic small ribosomal subunit,6.58e-04,2.44e-02,2/6,43/6360
NK,rs62480001_MYOM2,CC,GO:0015935,small ribosomal subunit,1.60e-03,2.95e-02,2/6,67/6360
NK,rs62480001_MYOM2,CC,GO:0022626,cytosolic ribosome,3.39e-03,4.18e-02,2/6,98/6360
B,rs1131017_RPS26,BP,GO:0006613,cotranslational protein targeting to membrane,1.07e-42,3.46e-40,33/35,83/1518
B,rs1131017_RPS26,BP,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,1.07e-42,3.46e-40,33/35,83/1518
B,rs1131017_RPS26,BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",4.65e-42,1.00e-39,33/35,86/1518
B,rs1131017_RPS26,BP,GO:0045047,protein targeting to ER,2.99e-41,4.85e-39,33/35,90/1518
B,rs1131017_RPS26,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,4.69e-41,6.07e-39,33/35,91/1518
B,rs1131017_RPS26,BP,GO:0070972,protein localization to endoplasmic reticulum,1.13e-40,1.22e-38,33/35,93/1518
B,rs1131017_RPS26,BP,GO:0019083,viral transcription,2.66e-40,2.46e-38,33/35,95/1518
B,rs1131017_RPS26,BP,GO:0019080,viral gene expression,2.06e-39,1.67e-37,33/35,100/1518
B,rs1131017_RPS26,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,3.06e-39,1.98e-37,33/35,101/1518
B,rs1131017_RPS26,BP,GO:0006612,protein targeting to membrane,3.06e-39,1.98e-37,33/35,101/1518
B,rs1131017_RPS26,BP,GO:0006413,translational initiation,2.96e-38,1.74e-36,33/35,107/1518
B,rs1131017_RPS26,BP,GO:0090150,establishment of protein localization to membrane,6.93e-35,3.74e-33,33/35,131/1518
B,rs1131017_RPS26,BP,GO:0006402,mRNA catabolic process,1.23e-34,6.11e-33,33/35,133/1518
B,rs1131017_RPS26,BP,GO:0006605,protein targeting,6.40e-34,2.96e-32,33/35,139/1518
B,rs1131017_RPS26,BP,GO:0006401,RNA catabolic process,1.84e-33,7.95e-32,33/35,143/1518
B,rs1131017_RPS26,BP,GO:0034655,nucleobase-containing compound catabolic process,5.79e-32,2.34e-30,33/35,157/1518
B,rs1131017_RPS26,BP,GO:0019439,aromatic compound catabolic process,7.31e-32,2.63e-30,33/35,158/1518
B,rs1131017_RPS26,BP,GO:0046700,heterocycle catabolic process,7.31e-32,2.63e-30,33/35,158/1518
B,rs1131017_RPS26,BP,GO:0044270,cellular nitrogen compound catabolic process,9.21e-32,2.98e-30,33/35,159/1518
B,rs1131017_RPS26,BP,GO:1901361,organic cyclic compound catabolic process,9.21e-32,2.98e-30,33/35,159/1518
B,rs1131017_RPS26,BP,GO:0072657,protein localization to membrane,1.16e-31,3.57e-30,33/35,160/1518
B,rs1131017_RPS26,BP,GO:0006412,translation,2.74e-31,8.06e-30,34/35,188/1518
B,rs1131017_RPS26,BP,GO:0043043,peptide biosynthetic process,3.33e-31,9.39e-30,34/35,189/1518
B,rs1131017_RPS26,BP,GO:0072594,establishment of protein localization to organelle,1.31e-30,3.53e-29,33/35,171/1518
B,rs1131017_RPS26,BP,GO:0043604,amide biosynthetic process,3.93e-30,1.02e-28,34/35,202/1518
B,rs1131017_RPS26,BP,GO:0006518,peptide metabolic process,1.38e-29,3.45e-28,34/35,209/1518
B,rs1131017_RPS26,BP,GO:0009057,macromolecule catabolic process,4.17e-28,1.00e-26,35/35,265/1518
B,rs1131017_RPS26,BP,GO:0043603,cellular amide metabolic process,8.71e-28,2.02e-26,34/35,234/1518
B,rs1131017_RPS26,BP,GO:1901566,organonitrogen compound biosynthetic process,2.50e-27,5.59e-26,35/35,278/1518
B,rs1131017_RPS26,BP,GO:0044265,cellular macromolecule catabolic process,3.44e-27,7.44e-26,34/35,243/1518
B,rs1131017_RPS26,BP,GO:0033365,protein localization to organelle,4.06e-27,8.49e-26,33/35,214/1518
B,rs1131017_RPS26,BP,GO:0016071,mRNA metabolic process,2.79e-26,5.66e-25,33/35,226/1518
B,rs1131017_RPS26,BP,GO:0006886,intracellular protein transport,3.02e-26,5.94e-25,34/35,258/1518
B,rs1131017_RPS26,BP,GO:0016032,viral process,9.50e-26,1.81e-24,33/35,234/1518
B,rs1131017_RPS26,BP,GO:1901575,organic substance catabolic process,2.32e-25,4.29e-24,35/35,314/1518
B,rs1131017_RPS26,BP,GO:0044403,symbiotic process,3.09e-25,5.56e-24,33/35,242/1518
B,rs1131017_RPS26,BP,GO:0044248,cellular catabolic process,4.88e-24,8.55e-23,35/35,341/1518
B,rs1131017_RPS26,BP,GO:0009056,catabolic process,4.88e-23,8.32e-22,35/35,363/1518
B,rs1131017_RPS26,BP,GO:0046907,intracellular transport,4.82e-22,8.02e-21,34/35,338/1518
B,rs1131017_RPS26,BP,GO:0015031,protein transport,6.60e-22,1.07e-20,34/35,341/1518
B,rs1131017_RPS26,BP,GO:0015833,peptide transport,7.32e-22,1.13e-20,34/35,342/1518
B,rs1131017_RPS26,BP,GO:0034613,cellular protein localization,7.32e-22,1.13e-20,34/35,342/1518
B,rs1131017_RPS26,BP,GO:0070727,cellular macromolecule localization,9.01e-22,1.36e-20,34/35,344/1518
B,rs1131017_RPS26,BP,GO:0042886,amide transport,9.98e-22,1.47e-20,34/35,345/1518
B,rs1131017_RPS26,BP,GO:0045184,establishment of protein localization,3.03e-21,4.37e-20,34/35,356/1518
B,rs1131017_RPS26,BP,GO:0010629,negative regulation of gene expression,9.29e-21,1.31e-19,33/35,326/1518
B,rs1131017_RPS26,BP,GO:0071705,nitrogen compound transport,9.80e-21,1.35e-19,34/35,368/1518
B,rs1131017_RPS26,BP,GO:0071702,organic substance transport,6.33e-20,8.55e-19,34/35,388/1518
B,rs1131017_RPS26,BP,GO:0010605,negative regulation of macromolecule metabolic process,1.85e-19,2.44e-18,34/35,400/1518
B,rs1131017_RPS26,BP,GO:0044419,interspecies interaction between organisms,2.73e-19,3.54e-18,33/35,360/1518
B,rs1131017_RPS26,BP,GO:0008104,protein localization,4.40e-19,5.59e-18,34/35,410/1518
B,rs1131017_RPS26,BP,GO:0051649,establishment of localization in cell,4.85e-19,6.04e-18,35/35,467/1518
B,rs1131017_RPS26,BP,GO:0009892,negative regulation of metabolic process,1.83e-18,2.23e-17,34/35,427/1518
B,rs1131017_RPS26,BP,GO:0033036,macromolecule localization,3.50e-18,4.20e-17,34/35,435/1518
B,rs1131017_RPS26,BP,GO:0002181,cytoplasmic translation,2.68e-11,3.16e-10,13/35,54/1518
B,rs1131017_RPS26,BP,GO:0042254,ribosome biogenesis,7.74e-10,8.96e-09,14/35,84/1518
B,rs1131017_RPS26,BP,GO:0042255,ribosome assembly,5.61e-08,6.38e-07,8/35,27/1518
B,rs1131017_RPS26,BP,GO:0022613,ribonucleoprotein complex biogenesis,7.97e-08,8.90e-07,14/35,118/1518
B,rs1131017_RPS26,BP,GO:0006364,rRNA processing,5.11e-07,5.61e-06,10/35,62/1518
B,rs1131017_RPS26,BP,GO:0016072,rRNA metabolic process,5.98e-07,6.45e-06,10/35,63/1518
B,rs1131017_RPS26,BP,GO:0042274,ribosomal small subunit biogenesis,1.18e-06,1.26e-05,7/35,27/1518
B,rs1131017_RPS26,BP,GO:0034470,ncRNA processing,2.49e-06,2.60e-05,10/35,73/1518
B,rs1131017_RPS26,BP,GO:0000028,ribosomal small subunit assembly,5.48e-06,5.64e-05,5/35,13/1518
B,rs1131017_RPS26,BP,GO:0034660,ncRNA metabolic process,5.90e-06,5.98e-05,10/35,80/1518
B,rs1131017_RPS26,BP,GO:0022618,ribonucleoprotein complex assembly,4.28e-05,4.27e-04,8/35,61/1518
B,rs1131017_RPS26,BP,GO:0071826,ribonucleoprotein complex subunit organization,4.84e-05,4.75e-04,8/35,62/1518
B,rs1131017_RPS26,BP,GO:0070925,organelle assembly,2.16e-04,2.09e-03,9/35,97/1518
B,rs1131017_RPS26,BP,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,3.69e-04,3.52e-03,3/35,7/1518
B,rs1131017_RPS26,BP,GO:0042273,ribosomal large subunit biogenesis,3.87e-04,3.64e-03,5/35,29/1518
B,rs1131017_RPS26,BP,GO:1901798,positive regulation of signal transduction by p53 class mediator,5.82e-04,5.38e-03,3/35,8/1518
B,rs1131017_RPS26,BP,GO:0019730,antimicrobial humoral response,8.59e-04,7.84e-03,3/35,9/1518
B,rs1131017_RPS26,BP,GO:0000027,ribosomal large subunit assembly,2.14e-03,1.93e-02,3/35,12/1518
B,rs1131017_RPS26,BP,GO:0006396,RNA processing,2.42e-03,2.15e-02,11/35,190/1518
B,rs1131017_RPS26,BP,GO:0051438,regulation of ubiquitin-protein transferase activity,2.74e-03,2.37e-02,3/35,13/1518
B,rs1131017_RPS26,BP,GO:1903051,negative regulation of proteolysis involved in cellular protein catabolic process,2.74e-03,2.37e-02,3/35,13/1518
B,rs1131017_RPS26,BP,GO:0030490,maturation of SSU-rRNA,3.44e-03,2.93e-02,3/35,14/1518
B,rs1131017_RPS26,BP,GO:1903363,negative regulation of cellular protein catabolic process,4.23e-03,3.56e-02,3/35,15/1518
B,rs1131017_RPS26,BP,GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,4.95e-03,4.11e-02,2/35,5/1518
B,rs1131017_RPS26,BP,GO:0042742,defense response to bacterium,5.12e-03,4.20e-02,3/35,16/1518
B,rs1131017_RPS26,CC,GO:0022626,cytosolic ribosome,1.93e-43,1.81e-41,33/35,81/1550
B,rs1131017_RPS26,CC,GO:0044391,ribosomal subunit,1.02e-38,4.81e-37,33/35,106/1550
B,rs1131017_RPS26,CC,GO:0005840,ribosome,3.39e-37,1.06e-35,33/35,116/1550
B,rs1131017_RPS26,CC,GO:1990904,ribonucleoprotein complex,7.46e-27,1.75e-25,33/35,222/1550
B,rs1131017_RPS26,CC,GO:0022627,cytosolic small ribosomal subunit,4.90e-22,9.21e-21,17/35,32/1550
B,rs1131017_RPS26,CC,GO:0015935,small ribosomal subunit,5.19e-19,8.13e-18,17/35,44/1550
B,rs1131017_RPS26,CC,GO:0022625,cytosolic large ribosomal subunit,2.72e-16,3.66e-15,16/35,50/1550
B,rs1131017_RPS26,CC,GO:0015934,large ribosomal subunit,1.73e-14,2.04e-13,16/35,63/1550
B,rs1131017_RPS26,CC,GO:0042788,polysomal ribosome,2.24e-11,2.34e-10,10/35,25/1550
B,rs1131017_RPS26,CC,GO:0005844,polysome,5.62e-10,5.29e-09,10/35,33/1550
B,rs1131017_RPS26,CC,GO:0005925,focal adhesion,2.71e-08,2.13e-07,14/35,111/1550
B,rs1131017_RPS26,CC,GO:0030055,cell-substrate junction,2.71e-08,2.13e-07,14/35,111/1550
B,rs1131017_RPS26,CC,GO:0070161,anchoring junction,3.90e-07,2.82e-06,14/35,136/1550
B,rs1131017_RPS26,CC,GO:0005730,nucleolus,1.00e-06,6.74e-06,15/35,170/1550
B,rs1131017_RPS26,CC,GO:0070062,extracellular exosome,2.44e-06,1.42e-05,20/35,326/1550
B,rs1131017_RPS26,CC,GO:0043230,extracellular organelle,2.57e-06,1.42e-05,20/35,327/1550
B,rs1131017_RPS26,CC,GO:1903561,extracellular vesicle,2.57e-06,1.42e-05,20/35,327/1550
B,rs1131017_RPS26,CC,GO:0005615,extracellular space,2.81e-06,1.47e-05,21/35,362/1550
B,rs1131017_RPS26,CC,GO:0030054,cell junction,4.16e-06,2.06e-05,17/35,244/1550
B,rs1131017_RPS26,CC,GO:0005576,extracellular region,2.21e-05,1.04e-04,21/35,408/1550
B,rs1131017_RPS26,CC,GO:0014069,postsynaptic density,5.28e-05,2.26e-04,7/35,47/1550
B,rs1131017_RPS26,CC,GO:0032279,asymmetric synapse,5.28e-05,2.26e-04,7/35,47/1550
B,rs1131017_RPS26,CC,GO:0098984,neuron to neuron synapse,6.98e-05,2.73e-04,7/35,49/1550
B,rs1131017_RPS26,CC,GO:0099572,postsynaptic specialization,6.98e-05,2.73e-04,7/35,49/1550
B,rs1131017_RPS26,CC,GO:0005791,rough endoplasmic reticulum,2.05e-04,7.69e-04,5/35,26/1550
B,rs1131017_RPS26,CC,GO:0005783,endoplasmic reticulum,6.10e-04,2.21e-03,12/35,193/1550
B,rs1131017_RPS26,CC,GO:0098794,postsynapse,9.74e-04,3.34e-03,7/35,74/1550
B,rs1131017_RPS26,CC,GO:0045202,synapse,9.94e-04,3.34e-03,10/35,147/1550
B,rs1131017_RPS26,CC,GO:0031982,vesicle,1.18e-03,3.82e-03,20/35,484/1550
B,rs1131017_RPS26,CC,GO:0098554,cytoplasmic side of endoplasmic reticulum membrane,4.75e-03,1.49e-02,2/35,5/1550
B,rs1131017_RPS26,MF,GO:0003735,structural constituent of ribosome,3.11e-39,2.06e-37,33/35,102/1535
B,rs1131017_RPS26,MF,GO:0005198,structural molecule activity,3.59e-35,1.18e-33,33/35,130/1535
B,rs1131017_RPS26,MF,GO:0003723,RNA binding,1.01e-16,2.23e-15,32/35,390/1535
B,rs1131017_RPS26,MF,GO:0019843,rRNA binding,8.03e-09,1.32e-07,8/35,22/1535
B,rs1131017_RPS26,MF,GO:0048027,mRNA 5'-UTR binding,9.87e-05,1.30e-03,4/35,12/1535
B,rs1131017_RPS26,MF,GO:0003729,mRNA binding,5.09e-04,5.60e-03,7/35,66/1535
B,rs1131017_RPS26,MF,GO:0000049,tRNA binding,4.84e-03,3.55e-02,2/35,5/1535
B,rs1131017_RPS26,MF,GO:0019838,growth factor binding,4.84e-03,3.55e-02,2/35,5/1535
B,rs1131017_RPS26,MF,GO:0055106,ubiquitin-protein transferase regulator activity,4.84e-03,3.55e-02,2/35,5/1535
DC,rs7935082_MS4A7,BP,GO:0032527,protein exit from endoplasmic reticulum,1.51e-05,1.60e-02,4/25,33/5234
DC,rs7935082_MS4A7,BP,GO:0030970,"retrograde protein transport, ER to cytosol",1.40e-04,4.92e-02,3/25,22/5234
DC,rs7935082_MS4A7,BP,GO:1903513,endoplasmic reticulum to cytosol transport,1.40e-04,4.92e-02,3/25,22/5234
DC,rs7935082_MS4A7,CC,GO:0005791,rough endoplasmic reticulum,7.14e-05,1.15e-02,4/26,48/5395
DC,rs7935082_MS4A7,CC,GO:0030867,rough endoplasmic reticulum membrane,1.25e-04,1.15e-02,3/26,21/5395
DC,rs7935082_MS4A7,CC,GO:0071256,translocon complex,3.31e-04,2.03e-02,2/26,6/5395
DC,rs7935082_MS4A7,CC,GO:0034663,endoplasmic reticulum chaperone complex,7.88e-04,3.62e-02,2/26,9/5395
DC,rs7935082_MS4A7,CC,GO:0043198,dendritic shaft,1.20e-03,4.40e-02,2/26,11/5395
DC,rs9271520_HLA-DQA2,BP,GO:0060333,interferon-gamma-mediated signaling pathway,4.69e-08,1.08e-05,5/11,55/5234
DC,rs9271520_HLA-DQA2,BP,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,7.97e-08,1.08e-05,5/11,61/5234
DC,rs9271520_HLA-DQA2,BP,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,8.66e-08,1.08e-05,5/11,62/5234
DC,rs9271520_HLA-DQA2,BP,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,9.40e-08,1.08e-05,5/11,63/5234
DC,rs9271520_HLA-DQA2,BP,GO:0071346,cellular response to interferon-gamma,5.73e-07,5.27e-05,5/11,90/5234
DC,rs9271520_HLA-DQA2,BP,GO:0034341,response to interferon-gamma,1.07e-06,8.22e-05,5/11,102/5234
DC,rs9271520_HLA-DQA2,BP,GO:0050852,T cell receptor signaling pathway,1.49e-06,9.82e-05,5/11,109/5234
DC,rs9271520_HLA-DQA2,BP,GO:0002478,antigen processing and presentation of exogenous peptide antigen,2.22e-06,1.28e-04,5/11,118/5234
DC,rs9271520_HLA-DQA2,BP,GO:0048002,antigen processing and presentation of peptide antigen,2.73e-06,1.31e-04,5/11,123/5234
DC,rs9271520_HLA-DQA2,BP,GO:0019884,antigen processing and presentation of exogenous antigen,2.84e-06,1.31e-04,5/11,124/5234
DC,rs9271520_HLA-DQA2,BP,GO:0050851,antigen receptor-mediated signaling pathway,3.87e-06,1.62e-04,5/11,132/5234
DC,rs9271520_HLA-DQA2,BP,GO:0019882,antigen processing and presentation,7.27e-06,2.79e-04,5/11,150/5234
DC,rs9271520_HLA-DQA2,BP,GO:0002250,adaptive immune response,1.31e-05,4.62e-04,5/11,169/5234
DC,rs9271520_HLA-DQA2,BP,GO:0002429,immune response-activating cell surface receptor signaling pathway,2.50e-05,7.66e-04,5/11,193/5234
DC,rs9271520_HLA-DQA2,BP,GO:0002757,immune response-activating signal transduction,2.50e-05,7.66e-04,5/11,193/5234
DC,rs9271520_HLA-DQA2,BP,GO:0002768,immune response-regulating cell surface receptor signaling pathway,3.59e-05,1.02e-03,5/11,208/5234
DC,rs9271520_HLA-DQA2,BP,GO:0002764,immune response-regulating signaling pathway,3.76e-05,1.02e-03,5/11,210/5234
DC,rs9271520_HLA-DQA2,BP,GO:0002253,activation of immune response,4.81e-05,1.23e-03,5/11,221/5234
DC,rs9271520_HLA-DQA2,BP,GO:0071345,cellular response to cytokine stimulus,1.94e-04,4.69e-03,6/11,487/5234
DC,rs9271520_HLA-DQA2,BP,GO:0050778,positive regulation of immune response,2.04e-04,4.70e-03,5/11,299/5234
DC,rs9271520_HLA-DQA2,BP,GO:0019221,cytokine-mediated signaling pathway,4.77e-04,1.04e-02,5/11,358/5234
DC,rs9271520_HLA-DQA2,BP,GO:0045087,innate immune response,5.77e-04,1.21e-02,5/11,373/5234
DC,rs9271520_HLA-DQA2,BP,GO:0050776,regulation of immune response,7.89e-04,1.58e-02,5/11,399/5234
DC,rs9271520_HLA-DQA2,BP,GO:0002684,positive regulation of immune system process,1.13e-03,2.16e-02,5/11,431/5234
DC,rs9271520_HLA-DQA2,BP,GO:0098542,defense response to other organism,1.33e-03,2.45e-02,5/11,447/5234
DC,rs9271520_HLA-DQA2,BP,GO:0032729,positive regulation of interferon-gamma production,1.47e-03,2.61e-02,2/11,28/5234
DC,rs9271520_HLA-DQA2,BP,GO:0031330,negative regulation of cellular catabolic process,1.54e-03,2.62e-02,3/11,116/5234
DC,rs9271520_HLA-DQA2,BP,GO:0045861,negative regulation of proteolysis,2.09e-03,3.43e-02,3/11,129/5234
DC,rs9271520_HLA-DQA2,BP,GO:0009895,negative regulation of catabolic process,2.69e-03,4.27e-02,3/11,141/5234
DC,rs9271520_HLA-DQA2,CC,GO:0042613,MHC class II protein complex,1.55e-11,1.58e-09,5/11,13/5395
DC,rs9271520_HLA-DQA2,CC,GO:0030669,clathrin-coated endocytic vesicle membrane,1.86e-10,3.79e-09,5/11,20/5395
DC,rs9271520_HLA-DQA2,CC,GO:0042611,MHC protein complex,1.86e-10,3.79e-09,5/11,20/5395
DC,rs9271520_HLA-DQA2,CC,GO:0071556,integral component of lumenal side of endoplasmic reticulum membrane,1.86e-10,3.79e-09,5/11,20/5395
DC,rs9271520_HLA-DQA2,CC,GO:0098553,lumenal side of endoplasmic reticulum membrane,1.86e-10,3.79e-09,5/11,20/5395
DC,rs9271520_HLA-DQA2,CC,GO:0098576,lumenal side of membrane,5.07e-10,8.63e-09,5/11,24/5395
DC,rs9271520_HLA-DQA2,CC,GO:0045334,clathrin-coated endocytic vesicle,7.84e-10,1.14e-08,5/11,26/5395
DC,rs9271520_HLA-DQA2,CC,GO:0012507,ER to Golgi transport vesicle membrane,8.81e-09,1.12e-07,5/11,41/5395
DC,rs9271520_HLA-DQA2,CC,GO:0032588,trans-Golgi network membrane,9.99e-09,1.13e-07,5/11,42/5395
DC,rs9271520_HLA-DQA2,CC,GO:0030665,clathrin-coated vesicle membrane,3.02e-08,3.08e-07,5/11,52/5395
DC,rs9271520_HLA-DQA2,CC,GO:0030134,COPII-coated ER to Golgi transport vesicle,5.79e-08,5.36e-07,5/11,59/5395
DC,rs9271520_HLA-DQA2,CC,GO:0030660,Golgi-associated vesicle membrane,1.03e-07,8.72e-07,5/11,66/5395
DC,rs9271520_HLA-DQA2,CC,GO:0030176,integral component of endoplasmic reticulum membrane,1.96e-07,1.43e-06,5/11,75/5395
DC,rs9271520_HLA-DQA2,CC,GO:0030666,endocytic vesicle membrane,1.96e-07,1.43e-06,5/11,75/5395
DC,rs9271520_HLA-DQA2,CC,GO:0031227,intrinsic component of endoplasmic reticulum membrane,2.25e-07,1.53e-06,5/11,77/5395
DC,rs9271520_HLA-DQA2,CC,GO:0030136,clathrin-coated vesicle,3.70e-07,2.22e-06,5/11,85/5395
DC,rs9271520_HLA-DQA2,CC,GO:0030658,transport vesicle membrane,3.70e-07,2.22e-06,5/11,85/5395
DC,rs9271520_HLA-DQA2,CC,GO:0030662,coated vesicle membrane,6.14e-07,3.48e-06,5/11,94/5395
DC,rs9271520_HLA-DQA2,CC,GO:0005798,Golgi-associated vesicle,9.25e-07,4.96e-06,5/11,102/5395
DC,rs9271520_HLA-DQA2,CC,GO:0005802,trans-Golgi network,1.07e-06,5.45e-06,5/11,105/5395
DC,rs9271520_HLA-DQA2,CC,GO:0030139,endocytic vesicle,5.31e-06,2.58e-05,5/11,145/5395
DC,rs9271520_HLA-DQA2,CC,GO:0030135,coated vesicle,6.07e-06,2.82e-05,5/11,149/5395
DC,rs9271520_HLA-DQA2,CC,GO:0098797,plasma membrane protein complex,6.70e-06,2.97e-05,5/11,152/5395
DC,rs9271520_HLA-DQA2,CC,GO:0031301,integral component of organelle membrane,8.10e-06,3.31e-05,5/11,158/5395
DC,rs9271520_HLA-DQA2,CC,GO:0098791,Golgi apparatus subcompartment,8.10e-06,3.31e-05,5/11,158/5395
DC,rs9271520_HLA-DQA2,CC,GO:0030133,transport vesicle,8.89e-06,3.49e-05,5/11,161/5395
DC,rs9271520_HLA-DQA2,CC,GO:0031300,intrinsic component of organelle membrane,1.10e-05,4.14e-05,5/11,168/5395
DC,rs9271520_HLA-DQA2,CC,GO:0031984,organelle subcompartment,1.23e-05,4.48e-05,5/11,172/5395
DC,rs9271520_HLA-DQA2,CC,GO:0098552,side of membrane,2.00e-05,7.03e-05,5/11,190/5395
DC,rs9271520_HLA-DQA2,CC,GO:0005765,lysosomal membrane,2.38e-05,7.84e-05,5/11,197/5395
DC,rs9271520_HLA-DQA2,CC,GO:0098852,lytic vacuole membrane,2.38e-05,7.84e-05,5/11,197/5395
DC,rs9271520_HLA-DQA2,CC,GO:0000323,lytic vacuole,2.71e-05,8.38e-05,6/11,355/5395
DC,rs9271520_HLA-DQA2,CC,GO:0005764,lysosome,2.71e-05,8.38e-05,6/11,355/5395
DC,rs9271520_HLA-DQA2,CC,GO:0005774,vacuolar membrane,4.44e-05,1.33e-04,5/11,224/5395
DC,rs9271520_HLA-DQA2,CC,GO:0005773,vacuole,5.29e-05,1.54e-04,6/11,399/5395
DC,rs9271520_HLA-DQA2,CC,GO:0010008,endosome membrane,6.32e-05,1.79e-04,5/11,241/5395
DC,rs9271520_HLA-DQA2,CC,GO:0005768,endosome,7.48e-05,2.06e-04,6/11,424/5395
DC,rs9271520_HLA-DQA2,CC,GO:0098796,membrane protein complex,1.06e-04,2.85e-04,6/11,451/5395
DC,rs9271520_HLA-DQA2,CC,GO:0000139,Golgi membrane,3.21e-04,8.38e-04,5/11,339/5395
DC,rs9271520_HLA-DQA2,CC,GO:0030659,cytoplasmic vesicle membrane,3.67e-04,9.37e-04,5/11,349/5395
DC,rs9271520_HLA-DQA2,CC,GO:0012506,vesicle membrane,4.09e-04,1.02e-03,5/11,357/5395
DC,rs9271520_HLA-DQA2,CC,GO:0005789,endoplasmic reticulum membrane,1.33e-03,3.24e-03,5/11,461/5395
DC,rs9271520_HLA-DQA2,CC,GO:0042175,nuclear outer membrane-endoplasmic reticulum membrane network,1.49e-03,3.52e-03,5/11,472/5395
DC,rs9271520_HLA-DQA2,CC,GO:0009986,cell surface,9.79e-03,2.25e-02,3/11,230/5395
DC,rs9271520_HLA-DQA2,CC,GO:0070937,CRD-mediated mRNA stability complex,1.02e-02,2.25e-02,1/11,5/5395
DC,rs9271520_HLA-DQA2,CC,GO:1990124,messenger ribonucleoprotein complex,1.02e-02,2.25e-02,1/11,5/5395
DC,rs9271520_HLA-DQA2,CC,GO:0034707,chloride channel complex,1.42e-02,3.08e-02,1/11,7/5395
DC,rs9271520_HLA-DQA2,CC,GO:0043198,dendritic shaft,2.22e-02,4.72e-02,1/11,11/5395
DC,rs9271520_HLA-DQA2,CC,GO:0005887,integral component of plasma membrane,2.35e-02,4.89e-02,3/11,318/5395
DC,rs9271520_HLA-DQA2,CC,GO:0005604,basement membrane,2.42e-02,4.94e-02,1/11,12/5395
DC,rs9271520_HLA-DQA2,MF,GO:0042605,peptide antigen binding,3.74e-11,2.77e-09,5/11,15/5358
DC,rs9271520_HLA-DQA2,MF,GO:0032395,MHC class II receptor activity,6.71e-10,2.48e-08,4/11,8/5358
DC,rs9271520_HLA-DQA2,MF,GO:0003823,antigen binding,2.47e-09,6.09e-08,5/11,32/5358
DC,rs9271520_HLA-DQA2,MF,GO:0042277,peptide binding,2.78e-08,5.14e-07,6/11,110/5358
DC,rs9271520_HLA-DQA2,MF,GO:0033218,amide binding,8.34e-08,1.23e-06,6/11,132/5358
DC,rs9271520_HLA-DQA2,MF,GO:0140375,immune receptor activity,2.29e-06,2.82e-05,4/11,51/5358
DC,rs9271520_HLA-DQA2,MF,GO:0004888,transmembrane signaling receptor activity,1.90e-04,2.01e-03,4/11,155/5358
DC,rs9271520_HLA-DQA2,MF,GO:0038023,signaling receptor activity,6.43e-04,5.29e-03,4/11,213/5358
DC,rs9271520_HLA-DQA2,MF,GO:0060089,molecular transducer activity,6.43e-04,5.29e-03,4/11,213/5358